Query 040917
Match_columns 494
No_of_seqs 274 out of 3338
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 13:05:27 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/040917.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/040917hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0615 Serine/threonine prote 100.0 2.2E-58 4.7E-63 425.3 18.1 268 31-299 170-446 (475)
2 KOG0575 Polo-like serine/threo 100.0 8.6E-54 1.9E-58 414.4 26.2 262 33-302 18-281 (592)
3 KOG0032 Ca2+/calmodulin-depend 100.0 1.8E-51 4E-56 399.6 33.0 323 27-353 29-353 (382)
4 KOG0581 Mitogen-activated prot 100.0 1.7E-52 3.6E-57 383.8 23.3 256 33-297 79-342 (364)
5 KOG0033 Ca2+/calmodulin-depend 100.0 1.1E-53 2.4E-58 368.2 11.7 298 31-330 9-307 (355)
6 KOG0598 Ribosomal protein S6 k 100.0 2.2E-51 4.8E-56 376.4 23.0 257 32-295 24-286 (357)
7 KOG0595 Serine/threonine-prote 100.0 1E-50 2.3E-55 375.0 24.6 265 30-297 7-275 (429)
8 KOG0592 3-phosphoinositide-dep 100.0 9.9E-51 2.2E-55 386.7 21.6 256 33-295 73-343 (604)
9 KOG0593 Predicted protein kina 100.0 9.7E-51 2.1E-55 360.4 15.9 257 33-295 2-289 (396)
10 KOG0660 Mitogen-activated prot 100.0 8.3E-50 1.8E-54 364.5 19.2 301 26-332 15-352 (359)
11 KOG0616 cAMP-dependent protein 100.0 2.8E-49 6.1E-54 350.3 20.8 253 33-295 44-302 (355)
12 KOG0583 Serine/threonine prote 100.0 1.7E-48 3.7E-53 379.3 28.4 259 30-295 14-280 (370)
13 KOG0588 Serine/threonine prote 100.0 3.1E-49 6.7E-54 384.1 22.1 257 33-297 12-270 (786)
14 KOG0661 MAPK related serine/th 100.0 5.3E-50 1.1E-54 376.1 15.8 261 31-297 8-298 (538)
15 KOG0659 Cdk activating kinase 100.0 2.4E-48 5.1E-53 339.5 21.3 261 33-299 2-290 (318)
16 KOG0605 NDR and related serine 100.0 2.6E-48 5.5E-53 370.6 22.9 260 31-295 139-450 (550)
17 KOG0599 Phosphorylase kinase g 100.0 7.7E-49 1.7E-53 343.3 12.4 262 31-295 15-288 (411)
18 KOG0600 Cdc2-related protein k 100.0 2.4E-47 5.1E-52 360.8 21.8 261 31-297 115-407 (560)
19 KOG0582 Ste20-like serine/thre 100.0 1E-46 2.2E-51 351.4 24.2 264 28-297 21-300 (516)
20 KOG0591 NIMA (never in mitosis 100.0 1.5E-48 3.2E-53 343.1 10.5 246 32-284 18-275 (375)
21 KOG0198 MEKK and related serin 100.0 2.7E-47 5.8E-52 356.0 19.2 257 32-297 16-283 (313)
22 KOG0663 Protein kinase PITSLRE 100.0 5.4E-47 1.2E-51 340.9 20.3 264 33-302 76-373 (419)
23 KOG0597 Serine-threonine prote 100.0 1.8E-47 4E-52 364.9 16.3 255 33-297 2-258 (808)
24 KOG0694 Serine/threonine prote 100.0 3.5E-46 7.5E-51 365.7 22.4 255 33-295 368-629 (694)
25 cd05612 STKc_PRKX_like Catalyt 100.0 7.3E-46 1.6E-50 356.0 24.3 253 33-295 1-259 (291)
26 PTZ00263 protein kinase A cata 100.0 1.8E-45 3.9E-50 359.3 25.8 253 33-295 18-276 (329)
27 KOG0578 p21-activated serine/t 100.0 2.1E-46 4.5E-51 360.2 18.7 258 28-295 268-528 (550)
28 KOG0604 MAP kinase-activated p 100.0 1.4E-46 3.1E-51 333.2 15.6 278 22-307 50-339 (400)
29 KOG0585 Ca2+/calmodulin-depend 100.0 5.6E-46 1.2E-50 348.6 19.9 260 31-296 95-378 (576)
30 KOG0580 Serine/threonine prote 100.0 1E-46 2.2E-51 324.6 13.6 254 33-295 22-278 (281)
31 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 3.4E-45 7.4E-50 358.3 26.0 257 33-295 1-262 (333)
32 KOG0611 Predicted serine/threo 100.0 2.3E-46 5E-51 344.2 16.3 258 28-294 48-307 (668)
33 cd05571 STKc_PKB Catalytic dom 100.0 2.8E-45 6.1E-50 357.1 25.0 249 39-295 1-256 (323)
34 cd05631 STKc_GRK4 Catalytic do 100.0 3.6E-45 7.7E-50 350.2 25.3 258 35-296 2-267 (285)
35 cd05628 STKc_NDR1 Catalytic do 100.0 9.3E-45 2E-49 359.1 27.9 259 33-296 1-299 (363)
36 PTZ00426 cAMP-dependent protei 100.0 7E-45 1.5E-49 355.9 25.4 254 32-295 29-289 (340)
37 cd05599 STKc_NDR_like Catalyti 100.0 9.8E-45 2.1E-49 359.6 25.9 259 33-296 1-302 (364)
38 KOG0192 Tyrosine kinase specif 100.0 1.2E-44 2.7E-49 348.8 25.5 248 33-289 41-298 (362)
39 cd05573 STKc_ROCK_NDR_like Cat 100.0 7.2E-45 1.6E-49 358.8 23.9 259 33-296 1-291 (350)
40 KOG0594 Protein kinase PCTAIRE 100.0 1.1E-44 2.4E-49 332.2 22.7 263 32-300 10-312 (323)
41 cd05626 STKc_LATS2 Catalytic d 100.0 3.1E-44 6.6E-49 357.7 27.6 259 34-296 2-311 (381)
42 cd05585 STKc_YPK1_like Catalyt 100.0 2E-44 4.3E-49 349.5 25.5 248 41-296 1-253 (312)
43 cd05596 STKc_ROCK Catalytic do 100.0 2.7E-44 5.8E-49 356.1 26.6 259 32-295 42-309 (370)
44 cd05590 STKc_nPKC_eta Catalyti 100.0 2.5E-44 5.5E-49 349.8 25.5 250 39-295 1-258 (320)
45 cd05598 STKc_LATS Catalytic do 100.0 1.7E-44 3.7E-49 359.3 24.6 258 33-295 1-306 (376)
46 cd05625 STKc_LATS1 Catalytic d 100.0 3.3E-44 7.3E-49 357.8 26.6 257 34-295 2-310 (382)
47 cd05629 STKc_NDR_like_fungal C 100.0 2.4E-44 5.3E-49 358.1 25.6 258 33-295 1-310 (377)
48 cd05587 STKc_cPKC Catalytic do 100.0 4.9E-44 1.1E-48 348.6 27.1 255 34-295 1-262 (324)
49 KOG0610 Putative serine/threon 100.0 1.2E-44 2.5E-49 335.0 21.1 258 33-296 77-398 (459)
50 KOG4717 Serine/threonine prote 100.0 5.8E-45 1.3E-49 344.0 19.5 318 28-364 13-335 (864)
51 cd05593 STKc_PKB_gamma Catalyt 100.0 3.7E-44 8E-49 349.7 25.8 249 39-295 1-256 (328)
52 cd07871 STKc_PCTAIRE3 Catalyti 100.0 5.2E-44 1.1E-48 342.7 26.0 254 33-293 5-288 (288)
53 cd05595 STKc_PKB_beta Catalyti 100.0 3.7E-44 8E-49 349.1 24.7 249 39-295 1-256 (323)
54 cd05621 STKc_ROCK2 Catalytic d 100.0 6.2E-44 1.3E-48 353.1 26.2 261 31-296 41-310 (370)
55 cd05591 STKc_nPKC_epsilon Cata 100.0 5.9E-44 1.3E-48 347.6 25.5 250 39-295 1-259 (321)
56 cd05601 STKc_CRIK Catalytic do 100.0 3.2E-44 6.9E-49 351.1 23.2 258 33-295 1-268 (330)
57 KOG0201 Serine/threonine prote 100.0 5.9E-46 1.3E-50 346.1 10.1 255 32-295 12-268 (467)
58 cd05616 STKc_cPKC_beta Catalyt 100.0 1.1E-43 2.4E-48 346.0 26.7 255 34-295 1-262 (323)
59 cd07848 STKc_CDKL5 Catalytic d 100.0 1E-43 2.2E-48 340.7 25.9 256 33-293 1-287 (287)
60 cd05588 STKc_aPKC Catalytic do 100.0 1.5E-43 3.3E-48 345.7 25.9 250 39-295 1-267 (329)
61 cd05570 STKc_PKC Catalytic dom 100.0 1.3E-43 2.9E-48 344.5 25.4 250 39-295 1-257 (318)
62 cd05627 STKc_NDR2 Catalytic do 100.0 9E-44 2E-48 351.8 24.4 259 33-296 1-299 (360)
63 cd07859 STKc_TDY_MAPK_plant Ca 100.0 2.2E-43 4.7E-48 346.5 26.7 259 34-298 1-298 (338)
64 cd07869 STKc_PFTAIRE1 Catalyti 100.0 2.9E-43 6.2E-48 340.2 26.7 258 33-297 5-295 (303)
65 cd05592 STKc_nPKC_theta_delta 100.0 2.1E-43 4.6E-48 342.7 25.9 250 39-295 1-253 (316)
66 KOG0658 Glycogen synthase kina 100.0 3E-44 6.4E-49 328.8 18.6 259 30-299 21-315 (364)
67 cd05589 STKc_PKN Catalytic dom 100.0 2.4E-43 5.1E-48 343.8 26.2 252 35-295 1-262 (324)
68 cd05605 STKc_GRK4_like Catalyt 100.0 2.4E-43 5.2E-48 337.6 25.7 258 34-295 1-266 (285)
69 cd05622 STKc_ROCK1 Catalytic d 100.0 2.7E-43 5.9E-48 348.9 26.8 259 32-295 42-309 (371)
70 cd05620 STKc_nPKC_delta Cataly 100.0 2.3E-43 4.9E-48 342.5 25.7 250 39-295 1-253 (316)
71 cd05594 STKc_PKB_alpha Catalyt 100.0 1E-43 2.2E-48 346.5 23.3 249 39-295 1-257 (325)
72 cd05614 STKc_MSK2_N N-terminal 100.0 1.4E-43 3E-48 346.8 23.9 255 34-295 1-272 (332)
73 cd06649 PKc_MEK2 Catalytic dom 100.0 1E-42 2.2E-47 340.3 29.0 259 32-297 4-308 (331)
74 KOG0667 Dual-specificity tyros 100.0 1.7E-43 3.7E-48 346.7 23.3 263 26-296 179-508 (586)
75 cd05619 STKc_nPKC_theta Cataly 100.0 4.2E-43 9.2E-48 340.4 26.0 251 39-296 1-254 (316)
76 cd05615 STKc_cPKC_alpha Cataly 100.0 5.6E-43 1.2E-47 340.8 26.7 256 34-296 1-263 (323)
77 cd05618 STKc_aPKC_iota Catalyt 100.0 4.9E-43 1.1E-47 342.0 26.2 250 39-295 1-267 (329)
78 cd07862 STKc_CDK6 Catalytic do 100.0 6.9E-43 1.5E-47 335.4 26.8 256 33-293 1-290 (290)
79 cd05575 STKc_SGK Catalytic dom 100.0 4.3E-43 9.4E-48 341.8 24.4 249 39-295 1-256 (323)
80 PHA03212 serine/threonine kina 100.0 9.7E-43 2.1E-47 346.4 27.2 258 32-303 91-389 (391)
81 cd05597 STKc_DMPK_like Catalyt 100.0 1.5E-42 3.3E-47 339.0 27.3 259 33-295 1-271 (331)
82 cd05584 STKc_p70S6K Catalytic 100.0 9E-43 1.9E-47 339.5 25.4 250 38-295 1-261 (323)
83 KOG0589 Serine/threonine prote 100.0 8.7E-44 1.9E-48 340.5 17.8 256 32-295 3-263 (426)
84 cd05586 STKc_Sck1_like Catalyt 100.0 3.8E-43 8.2E-48 343.4 21.5 250 41-296 1-259 (330)
85 cd05617 STKc_aPKC_zeta Catalyt 100.0 1.6E-42 3.6E-47 338.1 25.8 250 39-295 1-265 (327)
86 cd05608 STKc_GRK1 Catalytic do 100.0 1.5E-42 3.3E-47 331.1 24.6 252 41-296 1-263 (280)
87 PTZ00036 glycogen synthase kin 100.0 1.2E-42 2.6E-47 351.2 25.0 255 31-296 64-357 (440)
88 cd07875 STKc_JNK1 Catalytic do 100.0 4.6E-42 1E-46 340.3 28.5 262 26-295 17-323 (364)
89 cd07863 STKc_CDK4 Catalytic do 100.0 3.2E-42 6.9E-47 330.4 26.2 255 34-293 1-288 (288)
90 PF00069 Pkinase: Protein kina 100.0 1E-42 2.2E-47 328.6 22.3 254 35-293 1-260 (260)
91 cd07876 STKc_JNK2 Catalytic do 100.0 2E-42 4.3E-47 342.2 25.0 266 23-296 11-321 (359)
92 cd05630 STKc_GRK6 Catalytic do 100.0 3.3E-42 7.1E-47 329.6 25.6 255 34-295 1-266 (285)
93 cd05632 STKc_GRK5 Catalytic do 100.0 6.3E-42 1.4E-46 327.7 27.4 259 34-296 1-267 (285)
94 cd05604 STKc_SGK3 Catalytic do 100.0 1.6E-42 3.4E-47 338.1 23.5 249 39-295 1-256 (325)
95 KOG0607 MAP kinase-interacting 100.0 2.1E-43 4.6E-48 315.6 15.6 266 31-299 75-370 (463)
96 cd07874 STKc_JNK3 Catalytic do 100.0 4.8E-42 1E-46 339.1 26.9 268 22-297 6-318 (355)
97 cd05582 STKc_RSK_N N-terminal 100.0 1.2E-42 2.5E-47 338.1 21.8 248 39-295 2-259 (318)
98 cd05623 STKc_MRCK_alpha Cataly 100.0 6.1E-42 1.3E-46 334.9 26.3 259 33-295 1-271 (332)
99 cd05602 STKc_SGK1 Catalytic do 100.0 3.4E-42 7.3E-47 335.8 24.4 249 39-295 1-256 (325)
100 cd05624 STKc_MRCK_beta Catalyt 100.0 5.6E-42 1.2E-46 334.9 25.9 259 33-295 1-271 (331)
101 PLN00034 mitogen-activated pro 100.0 4.6E-42 1E-46 338.7 25.0 256 32-297 73-335 (353)
102 cd06650 PKc_MEK1 Catalytic dom 100.0 1.2E-41 2.6E-46 332.8 27.4 258 32-296 4-305 (333)
103 KOG0197 Tyrosine kinases [Sign 100.0 2E-42 4.3E-47 332.1 21.3 246 32-289 205-456 (468)
104 cd07872 STKc_PCTAIRE2 Catalyti 100.0 6.9E-42 1.5E-46 331.4 25.3 258 33-297 6-293 (309)
105 cd05607 STKc_GRK7 Catalytic do 100.0 7.9E-42 1.7E-46 325.6 25.2 248 41-295 1-259 (277)
106 cd05603 STKc_SGK2 Catalytic do 100.0 6.2E-42 1.3E-46 333.5 24.3 249 39-295 1-256 (321)
107 cd07878 STKc_p38beta_MAPK11 Ca 100.0 4.4E-42 9.6E-47 337.7 23.2 269 23-300 5-308 (343)
108 cd05580 STKc_PKA Catalytic dom 100.0 2.8E-41 6.2E-46 324.1 27.7 254 33-296 1-260 (290)
109 PTZ00267 NIMA-related protein 100.0 2.9E-41 6.3E-46 344.9 28.9 255 31-295 65-328 (478)
110 cd06625 STKc_MEKK3_like Cataly 100.0 3.7E-41 7.9E-46 318.6 27.0 255 33-293 2-263 (263)
111 cd07853 STKc_NLK Catalytic dom 100.0 1.3E-41 2.9E-46 337.9 25.0 257 34-296 1-294 (372)
112 PTZ00266 NIMA-related protein 100.0 3.3E-41 7.1E-46 355.1 28.5 265 28-297 8-302 (1021)
113 PTZ00283 serine/threonine prot 100.0 3.7E-41 8E-46 344.3 27.3 257 31-295 30-302 (496)
114 PTZ00284 protein kinase; Provi 100.0 2.3E-41 5.1E-46 345.6 25.5 260 30-296 126-444 (467)
115 KOG4236 Serine/threonine prote 100.0 8.3E-43 1.8E-47 330.2 13.5 253 38-295 569-824 (888)
116 cd07873 STKc_PCTAIRE1 Catalyti 100.0 6.3E-41 1.4E-45 323.5 26.6 258 33-297 6-293 (301)
117 cd07847 STKc_CDKL1_4 Catalytic 100.0 9.2E-41 2E-45 319.9 27.0 256 33-293 1-286 (286)
118 KOG0579 Ste20-like serine/thre 100.0 6.1E-43 1.3E-47 337.4 11.2 260 30-297 29-296 (1187)
119 cd05578 STKc_Yank1 Catalytic d 100.0 3.3E-41 7.1E-46 318.1 22.8 252 34-293 1-258 (258)
120 cd05574 STKc_phototropin_like 100.0 1.5E-40 3.3E-45 323.2 27.9 259 33-297 1-296 (316)
121 KOG0577 Serine/threonine prote 100.0 5.1E-42 1.1E-46 328.9 17.0 256 30-295 23-283 (948)
122 cd06615 PKc_MEK Catalytic doma 100.0 2.1E-40 4.5E-45 320.8 28.5 257 33-296 1-293 (308)
123 cd06609 STKc_MST3_like Catalyt 100.0 1.4E-40 3.1E-45 316.6 26.9 257 33-298 1-259 (274)
124 KOG0596 Dual specificity; seri 100.0 1.3E-41 2.7E-46 324.7 19.3 254 32-295 360-632 (677)
125 cd08529 STKc_FA2-like Catalyti 100.0 2.6E-40 5.6E-45 311.5 28.0 252 34-293 1-256 (256)
126 cd06645 STKc_MAP4K3 Catalytic 100.0 9.4E-41 2E-45 316.6 24.6 254 32-292 8-267 (267)
127 cd05609 STKc_MAST Catalytic do 100.0 2.2E-40 4.8E-45 320.3 27.6 257 34-295 2-278 (305)
128 KOG1989 ARK protein kinase fam 100.0 2.5E-41 5.4E-46 341.8 21.5 260 19-290 23-307 (738)
129 cd06637 STKc_TNIK Catalytic do 100.0 2.1E-40 4.6E-45 315.1 26.4 254 31-293 4-272 (272)
130 cd06610 STKc_OSR1_SPAK Catalyt 100.0 2.9E-40 6.3E-45 313.1 27.2 255 33-293 1-267 (267)
131 cd05102 PTKc_VEGFR3 Catalytic 100.0 1E-40 2.3E-45 327.4 24.9 250 32-289 6-329 (338)
132 cd06654 STKc_PAK1 Catalytic do 100.0 3.5E-40 7.6E-45 317.4 28.1 260 28-296 15-276 (296)
133 cd07861 STKc_CDK1_euk Catalyti 100.0 2.4E-40 5.3E-45 316.9 26.8 254 34-293 1-285 (285)
134 cd08220 STKc_Nek8 Catalytic do 100.0 4.1E-40 9E-45 310.1 27.7 253 34-293 1-256 (256)
135 cd06628 STKc_MAPKKK_Byr2_like 100.0 3.7E-40 8E-45 312.5 27.4 253 34-293 1-267 (267)
136 cd05572 STKc_cGK_PKG Catalytic 100.0 2.4E-40 5.2E-45 312.9 26.0 249 41-295 1-257 (262)
137 cd07841 STKc_CDK7 Catalytic do 100.0 1.8E-40 3.9E-45 319.9 25.6 263 34-301 1-293 (298)
138 cd08223 STKc_Nek4 Catalytic do 100.0 5E-40 1.1E-44 309.8 27.9 252 34-293 1-257 (257)
139 cd05611 STKc_Rim15_like Cataly 100.0 2.3E-40 5E-45 312.7 25.6 251 39-295 2-256 (260)
140 cd06646 STKc_MAP4K5 Catalytic 100.0 1.9E-40 4.1E-45 314.6 25.0 255 31-292 7-267 (267)
141 cd06656 STKc_PAK3 Catalytic do 100.0 2.2E-40 4.8E-45 318.9 25.8 263 28-299 14-278 (297)
142 PHA02988 hypothetical protein; 100.0 2.8E-40 6E-45 315.7 26.2 241 39-289 26-274 (283)
143 cd06611 STKc_SLK_like Catalyti 100.0 2.3E-40 5.1E-45 316.2 25.4 257 32-296 4-268 (280)
144 KOG2345 Serine/threonine prote 100.0 5.5E-42 1.2E-46 296.7 12.5 250 32-290 20-296 (302)
145 KOG0574 STE20-like serine/thre 100.0 2.1E-43 4.5E-48 313.2 3.7 257 32-298 32-291 (502)
146 cd06644 STKc_STK10_LOK Catalyt 100.0 5.2E-40 1.1E-44 315.7 27.6 259 31-297 10-276 (292)
147 cd06655 STKc_PAK2 Catalytic do 100.0 7E-40 1.5E-44 315.2 28.3 260 30-298 16-277 (296)
148 cd07839 STKc_CDK5 Catalytic do 100.0 1.2E-40 2.6E-45 318.9 22.6 254 34-293 1-284 (284)
149 cd06619 PKc_MKK5 Catalytic dom 100.0 5.8E-40 1.3E-44 313.3 27.1 251 33-296 1-259 (279)
150 cd06643 STKc_SLK Catalytic dom 100.0 7E-40 1.5E-44 313.2 27.4 257 33-297 5-269 (282)
151 cd05577 STKc_GRK Catalytic dom 100.0 2.8E-40 6E-45 315.1 24.5 251 41-295 1-259 (277)
152 cd06639 STKc_myosinIIIB Cataly 100.0 1.2E-39 2.7E-44 313.0 29.1 258 29-294 18-291 (291)
153 cd07868 STKc_CDK8 Catalytic do 100.0 2.6E-40 5.7E-45 321.6 24.5 249 38-293 6-317 (317)
154 cd08221 STKc_Nek9 Catalytic do 100.0 1.2E-39 2.6E-44 307.0 28.2 252 34-293 1-256 (256)
155 cd07832 STKc_CCRK Catalytic do 100.0 5E-40 1.1E-44 314.8 25.9 255 34-294 1-286 (286)
156 cd06613 STKc_MAP4K3_like Catal 100.0 9.4E-40 2E-44 308.8 27.3 254 32-292 2-262 (262)
157 KOG0584 Serine/threonine prote 100.0 1.6E-41 3.5E-46 329.8 15.4 257 33-296 39-302 (632)
158 cd06631 STKc_YSK4 Catalytic do 100.0 7.5E-40 1.6E-44 310.1 26.5 254 34-293 1-265 (265)
159 cd06612 STKc_MST1_2 Catalytic 100.0 4.9E-40 1.1E-44 309.6 24.9 251 33-293 3-256 (256)
160 cd06638 STKc_myosinIIIA Cataly 100.0 8E-40 1.7E-44 313.5 26.8 260 26-293 11-286 (286)
161 PHA03209 serine/threonine kina 100.0 2.8E-40 6.1E-45 326.1 24.1 249 33-295 66-356 (357)
162 cd07880 STKc_p38gamma_MAPK12 C 100.0 8.1E-40 1.7E-44 321.3 27.2 300 24-332 6-341 (343)
163 cd08227 PK_STRAD_alpha Pseudok 100.0 4.8E-40 1.1E-44 321.0 25.3 255 37-296 2-313 (327)
164 cd08218 STKc_Nek1 Catalytic do 100.0 1.1E-39 2.5E-44 307.2 26.9 252 34-293 1-256 (256)
165 PHA03207 serine/threonine kina 100.0 1.8E-40 3.9E-45 331.6 22.6 255 30-297 89-382 (392)
166 cd06640 STKc_MST4 Catalytic do 100.0 6.9E-40 1.5E-44 312.4 25.6 256 32-297 3-260 (277)
167 cd07851 STKc_p38 Catalytic dom 100.0 3.3E-40 7.1E-45 324.2 24.0 302 22-332 4-341 (343)
168 cd06651 STKc_MEKK3 Catalytic d 100.0 1.4E-39 3.1E-44 308.3 27.4 255 33-294 2-265 (266)
169 cd06608 STKc_myosinIII_like Ca 100.0 9.6E-40 2.1E-44 310.9 26.2 255 31-293 4-275 (275)
170 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 5E-40 1.1E-44 314.9 24.4 258 33-297 1-269 (286)
171 cd07858 STKc_TEY_MAPK_plant Ca 100.0 7E-40 1.5E-44 321.2 25.9 267 30-302 2-303 (337)
172 cd07837 STKc_CdkB_plant Cataly 100.0 1.3E-39 2.7E-44 313.6 27.1 258 33-294 1-295 (295)
173 cd06626 STKc_MEKK4 Catalytic d 100.0 2E-39 4.2E-44 306.9 28.0 254 34-293 1-264 (264)
174 cd06630 STKc_MEKK1 Catalytic d 100.0 7.5E-40 1.6E-44 310.6 25.1 258 34-294 1-268 (268)
175 cd07850 STKc_JNK Catalytic dom 100.0 6.9E-40 1.5E-44 323.3 25.8 268 21-296 4-317 (353)
176 cd06636 STKc_MAP4K4_6 Catalyti 100.0 7.9E-40 1.7E-44 312.9 25.4 254 31-293 14-282 (282)
177 KOG0586 Serine/threonine prote 100.0 8E-41 1.7E-45 324.6 18.6 260 29-297 52-313 (596)
178 cd07846 STKc_CDKL2_3 Catalytic 100.0 4.4E-40 9.6E-45 315.2 23.4 256 33-293 1-286 (286)
179 PHA03390 pk1 serine/threonine- 100.0 9.2E-40 2E-44 309.6 25.2 248 33-295 14-267 (267)
180 cd07831 STKc_MOK Catalytic dom 100.0 9.7E-40 2.1E-44 312.2 25.5 252 35-293 1-282 (282)
181 KOG4721 Serine/threonine prote 100.0 1.9E-41 4.2E-46 323.7 13.3 235 38-290 129-364 (904)
182 cd06629 STKc_MAPKKK_Bck1_like 100.0 1.9E-39 4.2E-44 308.5 27.1 256 34-293 2-272 (272)
183 PHA03211 serine/threonine kina 100.0 1.1E-39 2.5E-44 328.2 26.8 250 32-295 168-460 (461)
184 cd05633 STKc_GRK3 Catalytic do 100.0 1.1E-39 2.3E-44 311.3 25.3 251 40-295 1-260 (279)
185 cd07845 STKc_CDK10 Catalytic d 100.0 1.4E-39 3.1E-44 315.3 26.5 262 32-299 6-299 (309)
186 cd06607 STKc_TAO Catalytic dom 100.0 1.9E-39 4.2E-44 314.0 27.2 259 29-297 11-274 (307)
187 cd06632 STKc_MEKK1_plant Catal 100.0 2.2E-39 4.8E-44 305.4 26.9 254 34-293 1-258 (258)
188 cd06652 STKc_MEKK2 Catalytic d 100.0 4E-39 8.7E-44 305.1 28.0 255 33-294 2-265 (265)
189 cd05064 PTKc_EphR_A10 Catalyti 100.0 2.4E-39 5.1E-44 306.8 26.4 248 33-289 5-260 (266)
190 cd08217 STKc_Nek2 Catalytic do 100.0 3.2E-39 6.9E-44 305.5 27.0 252 34-293 1-265 (265)
191 cd07849 STKc_ERK1_2_like Catal 100.0 1.4E-39 3E-44 319.1 25.4 266 30-303 2-305 (336)
192 cd06658 STKc_PAK5 Catalytic do 100.0 9E-40 2E-44 313.8 23.3 265 28-301 17-283 (292)
193 cd06605 PKc_MAPKK Catalytic do 100.0 9.3E-40 2E-44 309.4 23.1 255 33-296 1-263 (265)
194 cd06617 PKc_MKK3_6 Catalytic d 100.0 3E-39 6.5E-44 309.0 26.5 257 33-297 1-268 (283)
195 cd05104 PTKc_Kit Catalytic dom 100.0 1.5E-39 3.2E-44 322.8 25.0 250 33-289 35-369 (375)
196 PLN00009 cyclin-dependent kina 100.0 4.3E-39 9.3E-44 309.7 27.5 260 33-297 2-291 (294)
197 cd07833 STKc_CDKL Catalytic do 100.0 1.7E-39 3.7E-44 311.5 24.6 256 33-293 1-288 (288)
198 KOG0690 Serine/threonine prote 100.0 4.9E-41 1.1E-45 301.1 12.6 255 33-295 168-429 (516)
199 cd06623 PKc_MAPKK_plant_like C 100.0 2.9E-39 6.4E-44 305.7 25.4 254 34-296 2-262 (264)
200 cd07843 STKc_CDC2L1 Catalytic 100.0 1.4E-39 3.1E-44 312.9 23.5 255 33-293 5-293 (293)
201 cd06648 STKc_PAK_II Catalytic 100.0 8E-39 1.7E-43 306.3 28.3 258 33-299 19-278 (285)
202 cd05581 STKc_PDK1 Catalytic do 100.0 1.7E-39 3.7E-44 310.1 23.6 253 34-293 2-280 (280)
203 KOG0986 G protein-coupled rece 100.0 6.1E-41 1.3E-45 312.8 13.0 255 33-295 185-451 (591)
204 cd08228 STKc_Nek6 Catalytic do 100.0 4.3E-39 9.3E-44 305.2 26.1 251 33-289 2-260 (267)
205 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3.5E-39 7.5E-44 308.7 25.6 259 33-300 5-276 (284)
206 cd05048 PTKc_Ror Catalytic Dom 100.0 3E-39 6.5E-44 309.0 25.1 249 33-290 5-279 (283)
207 cd07860 STKc_CDK2_3 Catalytic 100.0 2.2E-39 4.8E-44 310.1 24.1 254 34-293 1-284 (284)
208 cd05096 PTKc_DDR1 Catalytic do 100.0 5.9E-39 1.3E-43 310.2 27.3 252 32-289 4-300 (304)
209 cd07854 STKc_MAPK4_6 Catalytic 100.0 3.2E-39 7E-44 317.0 25.7 266 31-304 3-314 (342)
210 cd07855 STKc_ERK5 Catalytic do 100.0 1.5E-39 3.1E-44 318.6 23.0 267 31-303 3-307 (334)
211 cd05106 PTKc_CSF-1R Catalytic 100.0 2.2E-39 4.8E-44 321.2 24.6 250 33-289 38-367 (374)
212 KOG0983 Mitogen-activated prot 100.0 2.9E-40 6.4E-45 289.6 15.8 257 34-297 93-356 (391)
213 cd06917 STKc_NAK1_like Catalyt 100.0 5.4E-39 1.2E-43 306.3 26.1 256 34-297 2-262 (277)
214 cd07844 STKc_PCTAIRE_like Cata 100.0 6E-39 1.3E-43 308.2 26.5 254 33-293 5-291 (291)
215 PRK13184 pknD serine/threonine 100.0 5.6E-39 1.2E-43 337.1 28.4 252 33-289 2-284 (932)
216 cd07865 STKc_CDK9 Catalytic do 100.0 6.2E-39 1.3E-43 310.9 26.6 258 30-293 9-310 (310)
217 cd05579 STKc_MAST_like Catalyt 100.0 3.5E-39 7.6E-44 305.2 24.2 249 41-295 1-262 (265)
218 cd08219 STKc_Nek3 Catalytic do 100.0 1E-38 2.2E-43 300.6 27.0 248 34-290 1-252 (255)
219 cd06642 STKc_STK25-YSK1 Cataly 100.0 1.4E-39 3E-44 310.3 21.0 255 32-296 3-259 (277)
220 cd05088 PTKc_Tie2 Catalytic do 100.0 5.4E-39 1.2E-43 310.2 25.4 250 33-290 7-276 (303)
221 cd08215 STKc_Nek Catalytic dom 100.0 1.5E-38 3.2E-43 299.6 27.6 252 34-293 1-258 (258)
222 cd05036 PTKc_ALK_LTK Catalytic 100.0 9.4E-39 2E-43 304.6 26.5 252 33-290 6-274 (277)
223 cd07867 STKc_CDC2L6 Catalytic 100.0 4.9E-39 1.1E-43 312.8 25.0 249 38-293 6-317 (317)
224 KOG4279 Serine/threonine prote 100.0 2.5E-40 5.5E-45 322.4 15.7 253 40-299 582-841 (1226)
225 cd06616 PKc_MKK4 Catalytic dom 100.0 3.8E-39 8.3E-44 309.1 23.7 257 33-295 4-272 (288)
226 cd05606 STKc_beta_ARK Catalyti 100.0 1.1E-38 2.3E-43 304.2 26.2 249 40-296 1-261 (278)
227 cd07836 STKc_Pho85 Catalytic d 100.0 8.7E-39 1.9E-43 305.9 25.6 253 34-293 1-284 (284)
228 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 2.8E-38 6E-43 302.9 28.8 258 33-297 1-273 (287)
229 KOG0671 LAMMER dual specificit 100.0 1.4E-40 3E-45 305.2 12.1 267 23-296 79-412 (415)
230 PTZ00024 cyclin-dependent prot 100.0 8E-39 1.7E-43 313.6 25.5 265 31-300 6-323 (335)
231 cd06641 STKc_MST3 Catalytic do 100.0 1.7E-38 3.7E-43 302.8 27.0 254 33-296 4-259 (277)
232 cd06606 STKc_MAPKKK Catalytic 100.0 2.4E-38 5.3E-43 298.2 27.8 253 34-293 1-260 (260)
233 cd06659 STKc_PAK6 Catalytic do 100.0 6.5E-39 1.4E-43 308.6 24.4 262 31-301 19-282 (297)
234 cd07835 STKc_CDK1_like Catalyt 100.0 6.8E-39 1.5E-43 306.5 24.1 253 35-293 1-283 (283)
235 KOG0612 Rho-associated, coiled 100.0 1.3E-40 2.7E-45 341.0 12.7 258 33-295 75-343 (1317)
236 cd08225 STKc_Nek5 Catalytic do 100.0 1.4E-38 2.9E-43 299.9 25.7 253 34-293 1-257 (257)
237 cd06633 STKc_TAO3 Catalytic do 100.0 3.9E-38 8.4E-43 305.5 29.4 256 31-296 19-279 (313)
238 cd07840 STKc_CDK9_like Catalyt 100.0 1E-38 2.2E-43 305.8 25.0 253 35-293 1-287 (287)
239 cd05122 PKc_STE Catalytic doma 100.0 3.9E-38 8.4E-43 295.6 28.3 251 34-292 1-253 (253)
240 cd07834 STKc_MAPK Catalytic do 100.0 4.1E-39 8.8E-44 315.1 22.4 263 34-302 1-301 (330)
241 cd06647 STKc_PAK_I Catalytic d 100.0 1E-38 2.2E-43 306.7 24.8 260 30-298 16-277 (293)
242 cd05049 PTKc_Trk Catalytic dom 100.0 1.1E-38 2.4E-43 304.6 24.8 248 33-289 5-276 (280)
243 cd06627 STKc_Cdc7_like Catalyt 100.0 4.2E-38 9.1E-43 295.9 28.2 252 34-293 1-254 (254)
244 cd05613 STKc_MSK1_N N-terminal 100.0 1.3E-38 2.9E-43 305.7 25.2 257 34-297 1-275 (290)
245 cd06653 STKc_MEKK3_like_1 Cata 100.0 4.6E-38 1E-42 297.6 28.6 254 33-293 2-264 (264)
246 cd08229 STKc_Nek7 Catalytic do 100.0 1E-38 2.2E-43 302.7 23.9 251 33-289 2-260 (267)
247 cd05052 PTKc_Abl Catalytic dom 100.0 3.5E-38 7.5E-43 298.3 27.0 247 32-289 5-257 (263)
248 cd07842 STKc_CDK8_like Catalyt 100.0 1.3E-38 2.9E-43 309.6 24.7 258 34-293 1-316 (316)
249 KOG0193 Serine/threonine prote 100.0 5.2E-40 1.1E-44 317.3 14.6 250 31-289 390-648 (678)
250 cd07870 STKc_PFTAIRE2 Catalyti 100.0 2.6E-38 5.7E-43 303.7 26.3 254 33-293 5-291 (291)
251 cd05114 PTKc_Tec_Rlk Catalytic 100.0 4.2E-38 9.1E-43 296.5 26.9 245 33-289 4-253 (256)
252 cd07857 STKc_MPK1 Catalytic do 100.0 3E-38 6.5E-43 309.0 26.8 263 34-301 1-303 (332)
253 KOG0666 Cyclin C-dependent kin 100.0 7.3E-40 1.6E-44 292.0 13.9 265 32-299 23-346 (438)
254 cd06624 STKc_ASK Catalytic dom 100.0 4.3E-38 9.3E-43 298.5 27.1 249 38-293 13-268 (268)
255 cd06614 STKc_PAK Catalytic dom 100.0 3.1E-38 6.7E-43 302.5 26.3 257 30-295 16-275 (286)
256 cd06635 STKc_TAO1 Catalytic do 100.0 1.2E-37 2.6E-42 302.8 30.7 256 31-296 23-283 (317)
257 cd05089 PTKc_Tie1 Catalytic do 100.0 3E-38 6.5E-43 304.2 26.3 249 33-289 2-270 (297)
258 cd05123 STKc_AGC Catalytic dom 100.0 2.3E-38 5E-43 297.1 24.9 245 41-293 1-250 (250)
259 cd05062 PTKc_IGF-1R Catalytic 100.0 3.3E-38 7.2E-43 300.8 26.0 251 31-290 4-274 (277)
260 cd07838 STKc_CDK4_6_like Catal 100.0 4.3E-38 9.2E-43 301.6 26.8 254 35-293 1-287 (287)
261 cd05093 PTKc_TrkB Catalytic do 100.0 4.5E-38 9.8E-43 301.6 27.0 247 33-289 5-274 (288)
262 cd06634 STKc_TAO2 Catalytic do 100.0 4.5E-38 9.8E-43 304.5 27.1 257 31-297 13-274 (308)
263 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 5.7E-38 1.2E-42 297.4 27.2 251 33-289 2-260 (267)
264 cd05105 PTKc_PDGFR_alpha Catal 100.0 3.2E-38 6.9E-43 314.2 26.4 255 27-289 31-392 (400)
265 cd05113 PTKc_Btk_Bmx Catalytic 100.0 4.6E-38 1E-42 296.2 26.1 246 33-290 4-254 (256)
266 cd06657 STKc_PAK4 Catalytic do 100.0 3.6E-38 7.8E-43 302.6 25.6 259 33-300 20-280 (292)
267 cd08530 STKc_CNK2-like Catalyt 100.0 4.4E-38 9.5E-43 296.2 25.5 251 34-293 1-256 (256)
268 PF07714 Pkinase_Tyr: Protein 100.0 1.7E-38 3.7E-43 299.5 22.8 245 36-289 2-257 (259)
269 cd07877 STKc_p38alpha_MAPK14 C 100.0 3E-38 6.6E-43 310.4 25.4 272 23-303 7-313 (345)
270 cd07852 STKc_MAPK15 Catalytic 100.0 1.9E-38 4.1E-43 311.2 23.6 265 30-300 4-305 (337)
271 cd05054 PTKc_VEGFR Catalytic d 100.0 2.2E-38 4.7E-43 310.0 23.8 251 32-290 6-329 (337)
272 cd05033 PTKc_EphR Catalytic do 100.0 7.4E-38 1.6E-42 296.6 26.7 249 33-290 4-261 (266)
273 cd06618 PKc_MKK7 Catalytic dom 100.0 5.7E-38 1.2E-42 302.1 26.1 259 32-297 14-280 (296)
274 cd05061 PTKc_InsR Catalytic do 100.0 1E-37 2.2E-42 299.2 27.4 255 32-295 5-285 (288)
275 PHA03210 serine/threonine kina 100.0 2.4E-38 5.2E-43 324.6 24.4 264 28-296 143-460 (501)
276 cd05084 PTKc_Fes Catalytic dom 100.0 6.5E-38 1.4E-42 294.5 25.3 242 39-289 1-248 (252)
277 cd05072 PTKc_Lyn Catalytic dom 100.0 8.2E-38 1.8E-42 295.4 26.0 245 33-289 6-256 (261)
278 cd05108 PTKc_EGFR Catalytic do 100.0 5.6E-38 1.2E-42 305.0 25.5 248 33-290 7-264 (316)
279 cd07879 STKc_p38delta_MAPK13 C 100.0 4.4E-38 9.6E-43 309.0 24.9 266 23-298 5-305 (342)
280 cd07864 STKc_CDK12 Catalytic d 100.0 4.5E-38 9.7E-43 303.8 24.5 257 31-293 5-302 (302)
281 cd00192 PTKc Catalytic domain 100.0 8.6E-38 1.9E-42 295.0 25.9 243 39-290 1-260 (262)
282 cd05051 PTKc_DDR Catalytic dom 100.0 8.4E-38 1.8E-42 301.0 26.1 252 32-289 4-292 (296)
283 cd07830 STKc_MAK_like Catalyti 100.0 4.3E-38 9.4E-43 301.0 23.7 253 35-293 1-283 (283)
284 cd05053 PTKc_FGFR Catalytic do 100.0 7.4E-38 1.6E-42 301.0 25.3 251 32-290 11-287 (293)
285 cd05098 PTKc_FGFR1 Catalytic d 100.0 1E-37 2.2E-42 301.9 26.3 253 29-289 14-294 (307)
286 KOG0603 Ribosomal protein S6 k 100.0 1.1E-38 2.4E-43 311.4 19.4 247 30-294 319-567 (612)
287 cd05090 PTKc_Ror1 Catalytic do 100.0 1.1E-37 2.5E-42 298.1 26.3 249 33-290 5-279 (283)
288 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 1.3E-37 2.8E-42 303.6 27.0 266 30-304 7-302 (328)
289 cd05055 PTKc_PDGFR Catalytic d 100.0 1.5E-37 3.3E-42 299.8 26.8 252 31-289 33-296 (302)
290 cd05118 STKc_CMGC Catalytic do 100.0 4.4E-38 9.5E-43 300.8 22.8 253 35-293 1-283 (283)
291 cd05032 PTKc_InsR_like Catalyt 100.0 1.4E-37 3E-42 296.5 26.2 249 32-289 5-273 (277)
292 cd05116 PTKc_Syk Catalytic dom 100.0 1.5E-37 3.3E-42 292.9 26.1 241 40-289 2-250 (257)
293 cd05583 STKc_MSK_N N-terminal 100.0 6.2E-38 1.3E-42 300.7 23.7 256 34-296 1-272 (288)
294 cd07866 STKc_BUR1 Catalytic do 100.0 6.1E-38 1.3E-42 304.1 23.9 256 32-293 7-311 (311)
295 cd05109 PTKc_HER2 Catalytic do 100.0 1.9E-37 4.2E-42 295.9 26.9 247 33-289 7-263 (279)
296 KOG0669 Cyclin T-dependent kin 100.0 5.4E-40 1.2E-44 284.8 8.3 263 31-299 15-324 (376)
297 KOG0662 Cyclin-dependent kinas 100.0 1.3E-38 2.9E-43 262.6 16.1 259 33-297 2-290 (292)
298 cd05068 PTKc_Frk_like Catalyti 100.0 2.1E-37 4.5E-42 292.7 26.6 246 32-289 5-256 (261)
299 cd07829 STKc_CDK_like Catalyti 100.0 6.5E-38 1.4E-42 299.5 23.0 253 35-293 1-282 (282)
300 cd05094 PTKc_TrkC Catalytic do 100.0 2E-37 4.3E-42 297.6 26.4 247 33-289 5-277 (291)
301 cd05059 PTKc_Tec_like Catalyti 100.0 1.7E-37 3.6E-42 292.4 25.1 245 33-289 4-253 (256)
302 cd05071 PTKc_Src Catalytic dom 100.0 2.4E-37 5.1E-42 292.4 26.2 245 32-289 5-255 (262)
303 cd05066 PTKc_EphR_A Catalytic 100.0 2.9E-37 6.2E-42 292.7 26.6 248 33-289 4-261 (267)
304 cd05099 PTKc_FGFR4 Catalytic d 100.0 3.7E-37 8E-42 299.0 27.8 251 31-289 10-288 (314)
305 cd05610 STKc_MASTL Catalytic d 100.0 2.7E-37 5.8E-42 326.4 28.9 149 33-185 4-152 (669)
306 cd05091 PTKc_Ror2 Catalytic do 100.0 1.3E-37 2.9E-42 297.6 24.2 248 33-289 5-278 (283)
307 cd05148 PTKc_Srm_Brk Catalytic 100.0 1.1E-37 2.5E-42 294.4 23.4 247 32-289 5-256 (261)
308 cd05101 PTKc_FGFR2 Catalytic d 100.0 2.9E-37 6.2E-42 298.4 26.5 251 31-289 13-291 (304)
309 cd05092 PTKc_TrkA Catalytic do 100.0 2.6E-37 5.6E-42 295.1 25.8 247 33-289 5-276 (280)
310 cd05047 PTKc_Tie Catalytic dom 100.0 3.2E-37 6.9E-42 292.9 26.2 243 39-289 1-263 (270)
311 cd08226 PK_STRAD_beta Pseudoki 100.0 8.8E-38 1.9E-42 305.2 22.9 255 39-298 4-316 (328)
312 cd05097 PTKc_DDR_like Catalyti 100.0 2.4E-37 5.1E-42 297.7 25.3 251 33-289 5-291 (295)
313 KOG1035 eIF-2alpha kinase GCN2 100.0 6E-38 1.3E-42 323.9 22.3 254 33-295 479-876 (1351)
314 cd05065 PTKc_EphR_B Catalytic 100.0 3.9E-37 8.4E-42 292.2 26.4 248 33-289 4-263 (269)
315 KOG4645 MAPKKK (MAP kinase kin 100.0 5.2E-40 1.1E-44 340.7 7.0 264 24-295 1226-1499(1509)
316 KOG0614 cGMP-dependent protein 100.0 8.1E-40 1.8E-44 308.9 7.6 257 33-295 420-682 (732)
317 cd05034 PTKc_Src_like Catalyti 100.0 5E-37 1.1E-41 290.0 26.7 247 31-289 4-256 (261)
318 cd05075 PTKc_Axl Catalytic dom 100.0 3.2E-37 6.8E-42 293.2 25.4 247 35-289 1-266 (272)
319 cd05060 PTKc_Syk_like Catalyti 100.0 4.8E-37 1E-41 289.5 26.3 241 39-289 1-250 (257)
320 cd05035 PTKc_Axl_like Catalyti 100.0 3.5E-37 7.7E-42 293.0 25.5 247 35-289 1-267 (273)
321 cd05045 PTKc_RET Catalytic dom 100.0 4.3E-37 9.3E-42 295.2 26.1 247 34-289 1-281 (290)
322 cd05111 PTK_HER3 Pseudokinase 100.0 5.6E-37 1.2E-41 292.6 26.5 247 33-289 7-263 (279)
323 cd05069 PTKc_Yes Catalytic dom 100.0 7.4E-37 1.6E-41 288.7 27.0 245 32-289 5-255 (260)
324 cd05050 PTKc_Musk Catalytic do 100.0 4.5E-37 9.8E-42 294.7 25.7 248 33-289 5-284 (288)
325 smart00219 TyrKc Tyrosine kina 100.0 6.3E-37 1.4E-41 288.6 26.3 246 35-289 1-256 (258)
326 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 4.9E-37 1.1E-41 289.9 25.6 246 31-289 4-255 (260)
327 cd05082 PTKc_Csk Catalytic dom 100.0 6.4E-37 1.4E-41 288.4 26.2 241 33-289 6-251 (256)
328 cd05067 PTKc_Lck_Blk Catalytic 100.0 6.9E-37 1.5E-41 288.9 26.2 246 31-289 4-255 (260)
329 cd05039 PTKc_Csk_like Catalyti 100.0 6.9E-37 1.5E-41 288.2 26.0 242 33-289 6-251 (256)
330 cd05100 PTKc_FGFR3 Catalytic d 100.0 5.9E-37 1.3E-41 300.2 26.4 252 31-290 10-289 (334)
331 cd08222 STKc_Nek11 Catalytic d 100.0 2.6E-37 5.6E-42 291.8 23.0 252 34-293 1-260 (260)
332 cd05063 PTKc_EphR_A2 Catalytic 100.0 1E-36 2.2E-41 289.1 27.0 248 33-289 5-262 (268)
333 cd05107 PTKc_PDGFR_beta Cataly 100.0 4.8E-37 1E-41 305.6 25.8 251 32-289 36-394 (401)
334 cd05103 PTKc_VEGFR2 Catalytic 100.0 3.4E-37 7.4E-42 302.7 24.3 251 32-290 6-335 (343)
335 cd05057 PTKc_EGFR_like Catalyt 100.0 1.2E-36 2.7E-41 290.3 27.5 247 33-289 7-263 (279)
336 KOG0696 Serine/threonine prote 100.0 1.8E-38 3.8E-43 293.0 14.0 256 33-295 349-611 (683)
337 KOG0194 Protein tyrosine kinas 100.0 9.9E-38 2.2E-42 304.6 19.8 251 33-289 157-415 (474)
338 cd05046 PTK_CCK4 Pseudokinase 100.0 6.8E-37 1.5E-41 291.5 25.2 250 33-290 5-272 (275)
339 cd05115 PTKc_Zap-70 Catalytic 100.0 1.2E-36 2.5E-41 286.8 26.4 240 40-289 2-250 (257)
340 cd05040 PTKc_Ack_like Catalyti 100.0 9.7E-37 2.1E-41 287.4 25.8 242 39-289 1-253 (257)
341 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 7E-37 1.5E-41 292.6 25.2 247 33-289 3-276 (283)
342 cd05056 PTKc_FAK Catalytic dom 100.0 1.1E-36 2.5E-41 289.1 26.2 248 32-289 5-260 (270)
343 cd05112 PTKc_Itk Catalytic dom 100.0 2.1E-36 4.5E-41 284.9 26.7 245 33-289 4-253 (256)
344 cd08216 PK_STRAD Pseudokinase 100.0 6.1E-37 1.3E-41 297.6 23.6 256 35-297 4-302 (314)
345 cd05095 PTKc_DDR2 Catalytic do 100.0 1.6E-36 3.4E-41 292.1 26.2 252 32-289 4-292 (296)
346 cd05043 PTK_Ryk Pseudokinase d 100.0 2.1E-36 4.6E-41 288.8 26.6 249 32-289 5-271 (280)
347 cd05085 PTKc_Fer Catalytic dom 100.0 3.2E-36 6.9E-41 282.6 27.2 241 39-289 1-246 (250)
348 cd05083 PTKc_Chk Catalytic dom 100.0 1.8E-36 4E-41 285.0 25.1 240 33-289 6-249 (254)
349 cd05041 PTKc_Fes_like Catalyti 100.0 2.6E-36 5.6E-41 283.4 25.8 241 39-289 1-247 (251)
350 cd05073 PTKc_Hck Catalytic dom 100.0 3.9E-36 8.5E-41 283.8 26.7 246 31-289 4-255 (260)
351 KOG1026 Nerve growth factor re 100.0 2.4E-37 5.2E-42 311.5 18.8 247 33-288 486-756 (774)
352 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1.8E-36 3.9E-41 290.0 24.1 248 33-289 4-278 (284)
353 cd08528 STKc_Nek10 Catalytic d 100.0 4E-36 8.6E-41 285.2 25.5 251 34-289 1-265 (269)
354 KOG0665 Jun-N-terminal kinase 100.0 1.1E-37 2.5E-42 279.6 13.9 296 27-332 11-355 (369)
355 cd05042 PTKc_Aatyk Catalytic d 100.0 5E-36 1.1E-40 284.5 25.9 244 39-289 1-265 (269)
356 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 6.4E-36 1.4E-40 283.8 26.2 244 39-289 1-265 (269)
357 KOG1187 Serine/threonine prote 100.0 1.4E-36 3.1E-41 295.2 21.8 249 33-289 75-347 (361)
358 cd05110 PTKc_HER4 Catalytic do 100.0 5.3E-36 1.1E-40 289.4 25.6 247 33-289 7-263 (303)
359 KOG1095 Protein tyrosine kinas 100.0 1.6E-36 3.5E-41 316.3 23.0 249 32-289 691-956 (1025)
360 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 1E-35 2.3E-40 284.7 26.7 247 33-289 4-278 (284)
361 KOG0695 Serine/threonine prote 100.0 3.7E-37 8.1E-42 277.3 15.2 256 33-295 250-521 (593)
362 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 5.3E-36 1.1E-40 282.6 23.3 237 39-289 1-256 (259)
363 cd05576 STKc_RPK118_like Catal 100.0 2.7E-36 5.8E-41 280.7 20.8 228 44-293 4-237 (237)
364 KOG1290 Serine/threonine prote 100.0 1.8E-36 3.9E-41 285.5 19.5 272 19-299 66-559 (590)
365 cd05044 PTKc_c-ros Catalytic d 100.0 5.9E-36 1.3E-40 284.0 23.0 245 39-289 1-265 (269)
366 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 2.6E-36 5.7E-41 284.6 20.3 240 39-290 1-256 (258)
367 PLN03225 Serine/threonine-prot 100.0 7.1E-36 1.5E-40 307.9 25.1 343 32-402 131-547 (566)
368 cd05058 PTKc_Met_Ron Catalytic 100.0 1.6E-35 3.6E-40 279.8 25.4 242 39-289 1-254 (262)
369 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.5E-35 3.1E-40 280.1 24.3 240 39-290 1-260 (262)
370 PHA02882 putative serine/threo 100.0 1.6E-35 3.5E-40 284.5 25.0 250 30-289 9-291 (294)
371 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1E-35 2.3E-40 284.6 23.4 248 33-289 4-278 (284)
372 KOG4250 TANK binding protein k 100.0 7.1E-37 1.5E-41 301.1 15.3 205 31-238 11-227 (732)
373 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1.2E-35 2.7E-40 282.4 23.1 239 40-290 2-272 (274)
374 KOG0668 Casein kinase II, alph 100.0 3.5E-37 7.5E-42 263.7 10.9 258 29-297 34-329 (338)
375 cd05074 PTKc_Tyro3 Catalytic d 100.0 2.5E-35 5.5E-40 280.3 24.8 247 35-289 1-267 (273)
376 KOG1006 Mitogen-activated prot 100.0 1.2E-37 2.6E-42 272.2 7.1 259 34-298 65-335 (361)
377 KOG0670 U4/U6-associated splic 100.0 2.6E-37 5.7E-42 292.7 9.5 262 26-295 425-751 (752)
378 cd05086 PTKc_Aatyk2 Catalytic 100.0 6.1E-35 1.3E-39 276.9 25.4 243 40-289 2-264 (268)
379 KOG1151 Tousled-like protein k 100.0 1.2E-36 2.6E-41 283.1 12.1 266 27-295 457-746 (775)
380 KOG0608 Warts/lats-like serine 100.0 5.4E-36 1.2E-40 289.6 16.5 258 33-295 629-933 (1034)
381 smart00220 S_TKc Serine/Threon 100.0 1.7E-34 3.6E-39 269.1 24.7 242 45-293 1-244 (244)
382 KOG0587 Traf2- and Nck-interac 100.0 6.8E-35 1.5E-39 292.5 21.7 258 30-295 16-287 (953)
383 KOG0199 ACK and related non-re 100.0 3.2E-35 6.9E-40 287.3 16.2 253 33-295 110-373 (1039)
384 KOG0196 Tyrosine kinase, EPH ( 100.0 2.9E-35 6.3E-40 291.2 13.3 248 33-289 629-886 (996)
385 KOG4257 Focal adhesion tyrosin 100.0 3.3E-34 7.2E-39 276.9 17.3 248 31-288 387-643 (974)
386 KOG0664 Nemo-like MAPK-related 100.0 1.5E-35 3.3E-40 260.0 6.5 258 32-295 52-348 (449)
387 PLN03224 probable serine/threo 100.0 6.1E-33 1.3E-37 279.0 25.1 260 32-295 144-505 (507)
388 KOG4278 Protein tyrosine kinas 100.0 1.1E-33 2.4E-38 273.1 18.1 246 33-289 267-518 (1157)
389 KOG1094 Discoidin domain recep 100.0 1.2E-33 2.6E-38 271.4 17.6 251 32-289 537-799 (807)
390 KOG1167 Serine/threonine prote 100.0 3.8E-34 8.2E-39 266.4 11.0 262 24-295 27-386 (418)
391 KOG1027 Serine/threonine prote 100.0 5E-34 1.1E-38 285.0 12.5 250 35-296 511-773 (903)
392 KOG0984 Mitogen-activated prot 100.0 3E-32 6.5E-37 230.0 13.9 219 26-250 39-268 (282)
393 KOG2052 Activin A type IB rece 100.0 2.3E-31 5E-36 248.7 18.4 248 30-289 208-498 (513)
394 PLN00113 leucine-rich repeat r 100.0 1.2E-31 2.5E-36 298.4 19.3 240 32-289 689-946 (968)
395 KOG1025 Epidermal growth facto 100.0 1.1E-31 2.4E-36 266.8 15.7 246 34-289 697-952 (1177)
396 KOG0576 Mitogen-activated prot 100.0 1E-32 2.2E-37 268.9 7.6 260 30-296 12-277 (829)
397 KOG0200 Fibroblast/platelet-de 100.0 1.5E-30 3.3E-35 271.0 24.3 249 33-289 296-574 (609)
398 KOG1152 Signal transduction se 100.0 8.5E-32 1.8E-36 258.5 11.1 200 33-236 561-770 (772)
399 KOG3653 Transforming growth fa 100.0 7E-31 1.5E-35 247.3 16.4 241 33-285 210-494 (534)
400 cd00180 PKc Catalytic domain o 100.0 6.9E-29 1.5E-33 225.7 23.4 210 41-291 1-215 (215)
401 smart00221 STYKc Protein kinas 100.0 2.4E-28 5.3E-33 224.9 22.6 211 35-251 1-218 (225)
402 KOG1345 Serine/threonine kinas 100.0 2.5E-30 5.5E-35 227.1 8.5 243 30-281 21-275 (378)
403 PLN00181 protein SPA1-RELATED; 100.0 1.4E-28 3.1E-33 266.5 11.9 197 94-296 33-271 (793)
404 KOG1024 Receptor-like protein 99.9 3.6E-27 7.7E-32 217.1 15.7 248 33-289 284-550 (563)
405 COG5126 FRQ1 Ca2+-binding prot 99.9 7.3E-26 1.6E-30 187.9 15.0 151 327-480 8-159 (160)
406 KOG1164 Casein kinase (serine/ 99.9 9.3E-25 2E-29 211.8 24.0 252 34-289 19-292 (322)
407 smart00750 KIND kinase non-cat 99.9 1E-25 2.2E-30 199.5 12.4 162 119-295 1-170 (176)
408 KOG1163 Casein kinase (serine/ 99.9 4.8E-25 1E-29 190.8 15.9 250 30-285 12-275 (341)
409 COG0515 SPS1 Serine/threonine 99.9 4.6E-23 1E-27 201.2 27.7 254 35-295 2-280 (384)
410 KOG1165 Casein kinase (serine/ 99.9 3.3E-24 7.1E-29 194.0 17.1 249 30-284 25-289 (449)
411 PRK09188 serine/threonine prot 99.9 2E-24 4.3E-29 208.7 16.5 168 27-209 12-193 (365)
412 KOG0590 Checkpoint kinase and 99.9 5.1E-26 1.1E-30 234.0 4.5 261 33-298 317-593 (601)
413 KOG0027 Calmodulin and related 99.9 2.9E-23 6.4E-28 177.5 14.2 142 334-477 3-149 (151)
414 PRK10359 lipopolysaccharide co 99.9 2.6E-23 5.7E-28 186.7 13.4 174 31-229 29-216 (232)
415 PF14531 Kinase-like: Kinase-l 99.9 7.2E-23 1.6E-27 189.3 15.1 235 33-281 12-288 (288)
416 KOG0603 Ribosomal protein S6 k 99.9 1.4E-24 3.1E-29 212.8 3.8 239 41-295 2-248 (612)
417 cd05147 RIO1_euk RIO kinase fa 99.9 2.1E-22 4.6E-27 179.1 13.2 142 38-187 2-167 (190)
418 KOG1240 Protein kinase contain 99.9 2.2E-23 4.8E-28 214.4 6.7 244 34-290 24-291 (1431)
419 KOG0606 Microtubule-associated 99.9 8.7E-23 1.9E-27 209.9 10.4 223 29-296 79-321 (1205)
420 KOG0195 Integrin-linked kinase 99.9 5.4E-23 1.2E-27 181.1 7.4 241 33-288 190-440 (448)
421 PRK12274 serine/threonine prot 99.9 3.1E-21 6.7E-26 169.4 16.1 189 36-240 5-212 (218)
422 cd05145 RIO1_like RIO kinase f 99.9 3E-21 6.5E-26 172.5 15.6 144 37-188 1-168 (190)
423 KOG4158 BRPK/PTEN-induced prot 99.9 8.5E-22 1.8E-26 182.4 7.7 189 92-285 274-505 (598)
424 KOG0028 Ca2+-binding protein ( 99.8 4.6E-20 9.9E-25 148.8 14.0 145 332-478 26-171 (172)
425 PTZ00183 centrin; Provisional 99.8 1.1E-19 2.5E-24 157.6 15.1 148 331-480 9-157 (158)
426 KOG1166 Mitotic checkpoint ser 99.8 1.2E-19 2.6E-24 190.6 17.1 195 32-233 697-901 (974)
427 KOG0031 Myosin regulatory ligh 99.8 2.2E-19 4.7E-24 143.6 13.6 152 323-480 16-168 (171)
428 PRK10345 hypothetical protein; 99.8 3.4E-19 7.4E-24 159.8 15.9 141 36-185 5-158 (210)
429 smart00090 RIO RIO-like kinase 99.8 2E-19 4.3E-24 165.5 12.7 146 33-187 28-198 (237)
430 PTZ00184 calmodulin; Provision 99.8 5.7E-19 1.2E-23 151.6 14.8 145 331-477 3-148 (149)
431 KOG0030 Myosin essential light 99.8 1.8E-18 3.9E-23 136.0 11.1 142 333-477 5-151 (152)
432 KOG1023 Natriuretic peptide re 99.8 1.7E-18 3.7E-23 170.5 13.5 198 88-289 2-219 (484)
433 KOG0044 Ca2+ sensor (EF-Hand s 99.8 5.6E-18 1.2E-22 146.2 14.4 158 330-489 20-187 (193)
434 KOG0034 Ca2+/calmodulin-depend 99.8 2.8E-18 6E-23 148.3 11.8 147 332-483 26-181 (187)
435 PRK14879 serine/threonine prot 99.8 1.4E-17 3E-22 151.9 15.4 137 39-186 2-143 (211)
436 KOG1033 eIF-2alpha kinase PEK/ 99.7 8.5E-19 1.8E-23 169.2 5.1 175 107-293 329-515 (516)
437 TIGR03724 arch_bud32 Kae1-asso 99.7 3.6E-17 7.8E-22 147.6 14.0 133 40-186 1-138 (199)
438 cd05144 RIO2_C RIO kinase fami 99.7 3.8E-17 8.3E-22 147.2 12.8 140 34-188 16-176 (198)
439 KOG0590 Checkpoint kinase and 99.7 6.2E-19 1.3E-23 181.8 0.2 260 32-295 19-291 (601)
440 PRK09605 bifunctional UGMP fam 99.7 1.6E-16 3.4E-21 164.7 15.4 140 33-187 333-477 (535)
441 cd05119 RIO RIO kinase family, 99.7 4.3E-16 9.4E-21 139.1 12.8 140 37-187 1-164 (187)
442 KOG0037 Ca2+-binding protein, 99.7 7.3E-16 1.6E-20 132.0 13.3 132 339-478 57-189 (221)
443 PRK01723 3-deoxy-D-manno-octul 99.6 6E-15 1.3E-19 136.1 15.5 138 39-187 37-192 (239)
444 cd05120 APH_ChoK_like Aminogly 99.6 6.4E-15 1.4E-19 126.5 13.4 133 37-186 2-138 (155)
445 KOG0601 Cyclin-dependent kinas 99.6 1.7E-15 3.7E-20 149.4 6.4 256 30-295 111-384 (524)
446 KOG0036 Predicted mitochondria 99.6 3.7E-14 8E-19 132.0 13.7 139 334-479 9-148 (463)
447 cd05146 RIO3_euk RIO kinase fa 99.5 4.3E-13 9.3E-18 118.1 14.5 143 38-188 2-175 (197)
448 KOG4223 Reticulocalbin, calume 99.5 1.4E-13 3E-18 125.1 8.3 135 337-473 161-301 (325)
449 KOG3087 Serine/threonine prote 99.5 7.8E-13 1.7E-17 111.4 12.1 147 37-186 11-165 (229)
450 TIGR01982 UbiB 2-polyprenylphe 99.5 7.6E-13 1.6E-17 132.7 14.0 143 38-187 122-307 (437)
451 KOG0606 Microtubule-associated 99.5 3.1E-14 6.6E-19 147.7 3.7 261 31-296 802-1098(1205)
452 PRK04750 ubiB putative ubiquin 99.4 4.9E-13 1.1E-17 135.6 11.7 158 22-187 109-314 (537)
453 KOG1266 Protein kinase [Signal 99.4 3.1E-14 6.8E-19 129.6 1.4 238 48-296 81-337 (458)
454 COG3642 Mn2+-dependent serine/ 99.4 2.4E-12 5.1E-17 109.2 12.2 134 39-186 2-140 (204)
455 cd05151 ChoK Choline Kinase (C 99.4 1.8E-12 3.8E-17 113.7 11.3 129 38-186 3-136 (170)
456 KOG0038 Ca2+-binding kinase in 99.3 2.6E-11 5.7E-16 96.3 12.4 150 329-483 18-183 (189)
457 KOG1243 Protein kinase [Genera 99.3 4.2E-11 9.1E-16 119.8 16.0 215 51-295 30-251 (690)
458 PLN02964 phosphatidylserine de 99.3 1.5E-11 3.3E-16 125.6 11.3 105 331-439 135-243 (644)
459 KOG3741 Poly(A) ribonuclease s 99.3 2.7E-09 5.9E-14 103.7 23.7 228 29-290 269-521 (655)
460 KOG0601 Cyclin-dependent kinas 99.2 1.3E-11 2.8E-16 122.2 7.2 255 28-294 260-518 (524)
461 KOG4223 Reticulocalbin, calume 99.2 5E-11 1.1E-15 108.5 9.4 144 335-479 73-230 (325)
462 PF13499 EF-hand_7: EF-hand do 99.2 7E-11 1.5E-15 85.6 6.9 62 412-475 1-66 (66)
463 cd05154 ACAD10_11_like Acyl-Co 99.1 4.1E-10 8.8E-15 103.3 12.2 143 39-186 4-206 (223)
464 COG4248 Uncharacterized protei 99.1 2.2E-09 4.8E-14 101.8 16.7 239 35-285 13-291 (637)
465 cd05022 S-100A13 S-100A13: S-1 99.1 1.5E-10 3.3E-15 87.9 6.1 68 410-478 7-76 (89)
466 KOG0027 Calmodulin and related 99.1 6.6E-10 1.4E-14 95.0 9.2 104 375-478 8-114 (151)
467 cd05022 S-100A13 S-100A13: S-1 99.0 4.6E-10 9.9E-15 85.3 6.4 69 336-404 5-76 (89)
468 COG0478 RIO-like serine/threon 99.0 1.8E-09 4E-14 97.4 10.8 140 35-187 93-252 (304)
469 PF13499 EF-hand_7: EF-hand do 99.0 5.6E-10 1.2E-14 80.8 6.0 62 340-401 1-66 (66)
470 PRK15123 lipopolysaccharide co 99.0 1.3E-08 2.8E-13 95.0 16.3 137 47-186 36-194 (268)
471 PF01163 RIO1: RIO1 family; I 99.0 3.5E-09 7.5E-14 93.1 11.6 130 48-188 1-157 (188)
472 KOG0037 Ca2+-binding protein, 99.0 5E-09 1.1E-13 90.4 11.8 96 335-436 120-217 (221)
473 cd05027 S-100B S-100B: S-100B 99.0 1.1E-09 2.5E-14 83.3 7.1 68 410-478 7-80 (88)
474 KOG2137 Protein kinase [Signal 99.0 2.2E-10 4.9E-15 115.1 4.0 150 143-296 108-271 (700)
475 PTZ00183 centrin; Provisional 99.0 3.5E-09 7.6E-14 91.5 10.3 102 375-477 17-118 (158)
476 KOG0044 Ca2+ sensor (EF-Hand s 99.0 1.4E-09 3.1E-14 94.3 7.6 105 335-439 60-175 (193)
477 cd05029 S-100A6 S-100A6: S-100 99.0 1.9E-09 4.2E-14 82.1 7.2 69 410-478 9-80 (88)
478 cd05027 S-100B S-100B: S-100B 99.0 2.6E-09 5.7E-14 81.3 7.4 68 337-404 6-80 (88)
479 COG5126 FRQ1 Ca2+-binding prot 98.9 6.5E-09 1.4E-13 87.0 10.0 106 370-477 12-120 (160)
480 cd05026 S-100Z S-100Z: S-100Z 98.9 2.3E-09 4.9E-14 83.0 6.8 68 410-477 9-81 (93)
481 PTZ00184 calmodulin; Provision 98.9 7.1E-09 1.5E-13 88.6 10.5 101 376-477 12-112 (149)
482 cd05025 S-100A1 S-100A1: S-100 98.9 3.7E-09 7.9E-14 82.0 6.8 69 409-477 7-80 (92)
483 KOG0028 Ca2+-binding protein ( 98.9 1.2E-08 2.6E-13 83.2 8.8 102 375-477 33-134 (172)
484 cd05031 S-100A10_like S-100A10 98.9 3.5E-09 7.6E-14 82.4 5.6 70 410-479 7-81 (94)
485 PF06293 Kdo: Lipopolysacchari 98.9 5.2E-08 1.1E-12 88.0 13.7 111 76-187 54-171 (206)
486 smart00027 EH Eps15 homology d 98.8 1.2E-08 2.6E-13 79.7 8.1 70 333-404 4-73 (96)
487 PF13833 EF-hand_8: EF-hand do 98.8 1.5E-08 3.3E-13 69.9 7.0 52 424-477 1-53 (54)
488 KOG0377 Protein serine/threoni 98.8 4.6E-08 9.9E-13 92.3 11.9 136 339-476 464-614 (631)
489 PLN02964 phosphatidylserine de 98.8 1.5E-08 3.2E-13 104.0 9.5 127 344-478 112-244 (644)
490 PRK09902 hypothetical protein; 98.8 2.3E-07 5E-12 82.1 15.3 140 42-186 27-179 (216)
491 cd05031 S-100A10_like S-100A10 98.8 2.1E-08 4.6E-13 78.0 7.9 68 338-405 7-81 (94)
492 PF06176 WaaY: Lipopolysacchar 98.8 9.7E-08 2.1E-12 84.7 12.7 141 31-185 29-182 (229)
493 cd05026 S-100Z S-100Z: S-100Z 98.8 1.9E-08 4E-13 77.9 7.2 69 337-405 8-83 (93)
494 cd05029 S-100A6 S-100A6: S-100 98.8 2.2E-08 4.9E-13 76.2 7.4 69 336-404 7-80 (88)
495 cd05023 S-100A11 S-100A11: S-1 98.8 2.2E-08 4.8E-13 76.4 6.9 69 409-477 7-80 (89)
496 cd00052 EH Eps15 homology doma 98.8 1.9E-08 4.1E-13 73.0 6.2 60 414-477 2-61 (67)
497 cd05025 S-100A1 S-100A1: S-100 98.7 3.8E-08 8.2E-13 76.3 7.8 69 337-405 7-82 (92)
498 smart00027 EH Eps15 homology d 98.7 3.6E-08 7.8E-13 77.1 7.5 65 409-477 8-72 (96)
499 cd00213 S-100 S-100: S-100 dom 98.7 2.7E-08 5.9E-13 76.4 6.6 70 335-404 4-80 (88)
500 KOG2562 Protein phosphatase 2 98.7 7.1E-08 1.5E-12 92.1 10.6 145 329-476 268-423 (493)
No 1
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.2e-58 Score=425.28 Aligned_cols=268 Identities=38% Similarity=0.679 Sum_probs=245.8
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh----hHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV----EKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
+...|-+.+.||+|+||.|-+|..+.+|+.||+|++.++...... ......+|+++|++|. ||+|++++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeecC
Confidence 668899999999999999999999999999999999887654422 3445789999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
...|+||||++||.|.+++..++.+.+...+.+++|++.|+.|||++||+||||||+|||+.++..+..+||+|||+|..
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999999999999999999999999999999999999999999999998766789999999999999
Q ss_pred cccCcccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCC
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 261 (494)
......+.+.||||.|.|||++.+. +..++|+||+||++|-+++|.+||....... ..+++.++...+.+..|..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 8888888999999999999999642 4458999999999999999999998776554 8899999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
++++..+||.+||..||++|||++|+|+||||+..+..
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 99999999999999999999999999999999976543
No 2
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=8.6e-54 Score=414.38 Aligned_cols=262 Identities=37% Similarity=0.611 Sum_probs=244.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|..++.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.++|+ ||||++++++|++.+.+|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 57999999999999999999999999999999999988888888999999999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-c
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-K 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~ 191 (494)
.|+|+.++|..++++++.+++.++..+++||+.||.|||+++|+|||||..|+|+ +++.++||+|||+|...... .
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999999999999999999999999999999999999999999999 78889999999999987644 5
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
...+.||||.|.|||++.. .++..+||||+||++|-|+.|++||...+-.+.+..|.......|. .++.++.+||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 6678999999999999975 5899999999999999999999999999999999999988777664 6889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~ 302 (494)
.++|++||.+|||++++|.|+||+....+...
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 99999999999999999999999765555443
No 3
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-51 Score=399.57 Aligned_cols=323 Identities=56% Similarity=0.981 Sum_probs=295.4
Q ss_pred cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
....+...|.+.+.||.|.||.||+|.++.+|+.+|+|++.+...........+.+|+.+|+++.+||||+.++++|.+.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 45677889999999999999999999999999999999999888766666789999999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCcc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSA 185 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~ 185 (494)
..+++|||+|+||.|.+.+... .+++..+..+++|++.++.|||+.|++||||||+|+|+...+. .+.++++|||++.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999999876 4999999999999999999999999999999999999976443 4689999999999
Q ss_pred ccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 186 FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
....+......+||+.|+|||++. ..|+..+|+||+|+++|.|+.|..||++.+..+....+..+...+...+|+.++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 887766778899999999999998 5899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhh
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEK 344 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 344 (494)
.++++|.+||..||.+|+|+.++|+|||+.........+.......+..++..++++++.+........+ +..++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 344 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEM 344 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHH
Confidence 9999999999999999999999999999998777777777777777778888888888877767766655 7888888
Q ss_pred hhccCCCCC
Q 040917 345 FTEMDTDNS 353 (494)
Q Consensus 345 F~~~D~~~~ 353 (494)
|..+|.+++
T Consensus 345 ~~~~~~~~~ 353 (382)
T KOG0032|consen 345 FKLMDTDNN 353 (382)
T ss_pred HHhhccccc
Confidence 999999887
No 4
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-52 Score=383.82 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=228.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVHI 111 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~i 111 (494)
.+.+.++.||+|..|+||+|+|+.|++.+|+|++.. ...+....++.+|+++++.. +||||+.+|+.|..+. .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 467788999999999999999999999999999943 33566789999999999999 5999999999999988 5999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||||+||||.+.++..+++++.....++.+++.||.|||+ ++||||||||+|||+ +..|.|||||||.+....++
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence 99999999999999988999999999999999999999995 899999999999999 78999999999999887666
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE-----TDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
...+..||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... ..-+.+..|..+..+..+. ..+++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence 5578899999999999987 5999999999999999999999999774 4455666666654333322 24899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+++.||..||++||.+||++.++++|||++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999999754
No 5
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-53 Score=368.20 Aligned_cols=298 Identities=39% Similarity=0.740 Sum_probs=270.0
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++....+... ..+.+.+|+++-+.|+ ||||+++.+.+......|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeE
Confidence 55789999999999999999999999999999999987665444 7888999999999996 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+|+|+++|+.|..-+..+..+++..+...++||+++|.|+|.+||||||+||.|+++-+.+...-+||+|||+|.....+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999999877777677899999999999999999999999999999999999988888889999999999988877
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
.......|||.|+|||++.. +|+..+|||+.|+|+|-|+.|.+||++.+...+++.|..+...++.+.|+.++++.++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 77778999999999999975 69999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhh
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 330 (494)
|.+||..||.+|.|+.|+|+|||+.+...-....-....+..+++|...++++-..+.-+.
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~ 307 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVI 307 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 9999999999999999999999999754332233336677899999999999866555543
No 6
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-51 Score=376.38 Aligned_cols=257 Identities=34% Similarity=0.641 Sum_probs=237.1
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||.|+||+||.++.+.+++.+|+|++.+.........+....|..+|.+++ ||.|++++-.|++.+..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence 378999999999999999999999999999999999888777777889999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccC
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~ 190 (494)
|++|+.||.|.-++.+.+.+++..+..++.+|+.||.|||+.|||||||||+|||+ +.+|+++|+|||++... ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence 99999999999999999999999999999999999999999999999999999999 79999999999999853 344
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
....+.+||+.|||||++.+ .|+..+|+||||+++|+|++|..||.+.+...+.+.+.++....++ ..++...+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence 55667899999999999865 6999999999999999999999999999999999999988744433 2478999999
Q ss_pred HHHhcccCCCCCC----CHHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRI----TVAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rp----s~~eil~~~~~~~ 295 (494)
++++|..||++|. ++.+|-+||||..
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 9999999999996 7889999999986
No 7
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1e-50 Score=375.02 Aligned_cols=265 Identities=37% Similarity=0.662 Sum_probs=239.2
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
...++|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.|+ ||||+.++++...++.+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence 345789999999999999999999999999999999987765 4457888999999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCC--CeEEEeecCCccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DEN--AVVKATDFGLSAF 186 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~--~~~kL~Dfg~a~~ 186 (494)
|+|||||.||+|.+++.+.+.+++.+++.++.||+.|+++||+++||||||||+|||+... ..+ ..+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999754 222 7899999999999
Q ss_pred cccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
..++.-..+.||+|.|||||++. .+|+.|+|+||+|+|+|++++|+.||...+..+....+.++....+..+ ..+++.
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCc
Confidence 98887778899999999999984 6899999999999999999999999999999999887776655443322 346677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+.+++...+..+|..|.+..+-+.|+++...+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 78999999999999999999999999998755
No 8
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=9.9e-51 Score=386.73 Aligned_cols=256 Identities=33% Similarity=0.627 Sum_probs=238.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|.+++.||.|+|++|++|.++.+++.||||++.++....+...+.+.+|-.+|.+|.+||.|++++-.|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 58999999999999999999999999999999999888877777888889999999998899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
+||+++|.|.++|++.+.+++..+..++.+|+.||.|||++|||||||||+|||+ +.+++++|.|||.|..+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence 9999999999999999999999999999999999999999999999999999999 7999999999999987643221
Q ss_pred c--------------ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917 193 Y--------------REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257 (494)
Q Consensus 193 ~--------------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (494)
. .+.+||..|.+||++.. ..++.+|||+||||+|+|+.|.+||.+.++--+.+.|..-...++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp-- 307 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP-- 307 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence 1 34789999999999975 578999999999999999999999999999999999998877777
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+.+|+.+++||.++|..||.+|+++++|.+||||..
T Consensus 308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 --EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred --CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 467899999999999999999999999999999986
No 9
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=9.7e-51 Score=360.40 Aligned_cols=257 Identities=28% Similarity=0.557 Sum_probs=224.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|+....+|+|+||+||+|+++.||+.||||.+..+. .++....-..+|+++|++|+ |||++.++++|......++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 57888999999999999999999999999999997554 34456777889999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cC
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~ 190 (494)
+|||+- ++.+.+.+. ..++.+.+..+++|++.|+.|+|+++++||||||+|||+ ..++.+||||||+|+... ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 999965 777777654 358999999999999999999999999999999999999 789999999999999877 77
Q ss_pred cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC--------------Cc--
Q 040917 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------------EI-- 252 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~--------------~~-- 252 (494)
..+..++.|.+|+|||.+.| +|+..+||||+||++.||++|.+.|.+.++-+.+..|.+. ..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 77888999999999999976 6999999999999999999999999999987766554321 11
Q ss_pred ---cCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 253 ---NFQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 253 ---~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.++ +..++.++..+.+|+++||..||++|++-+++|.||||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111 1124567888999999999999999999999999999964
No 10
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-50 Score=364.52 Aligned_cols=301 Identities=29% Similarity=0.490 Sum_probs=250.8
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.....+..+|..++.||.|+||.|+.|.++.+|+.||+|.+.. .+.+........+|+.+|+.++ |+||+.+.+++..
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p 92 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRP 92 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccc
Confidence 3456677889989999999999999999999999999999852 4556667888999999999996 9999999999865
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 106 -----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 106 -----~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
-+.+|+|+|+| +.+|...++.+..++...+..+++||+.||+|+|+.+++||||||+|+++ +.+..+|++|
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~D 168 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICD 168 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEecc
Confidence 45799999999 45888888887779999999999999999999999999999999999999 6788899999
Q ss_pred cCCcccccc---CcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc------
Q 040917 181 FGLSAFIEE---GKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------ 249 (494)
Q Consensus 181 fg~a~~~~~---~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~------ 249 (494)
||+|+...+ ...+..++.|.+|+|||++. ..|+.+.||||+|||+.||++|+..|.|...-..+..+..
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998754 44456788999999999875 3699999999999999999999999988876655544422
Q ss_pred -----------------CCccCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHH
Q 040917 250 -----------------GEINFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308 (494)
Q Consensus 250 -----------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~ 308 (494)
.....++. .++..++.+.+|+.+||..||.+|+|++|+|.|||+.....+.+.|.....
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence 11112221 256789999999999999999999999999999999998888887765544
Q ss_pred HHHHHHHhhhhHHHHHHHHhhhcc
Q 040917 309 IFRMKQFTAMNKLKKLALKVIVEN 332 (494)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~~~~~~~ 332 (494)
........+...|+++...++...
T Consensus 329 ~~~~~~~~~~~~~r~~i~~e~~~~ 352 (359)
T KOG0660|consen 329 FDSFEHELTEEELRELIYKEILDF 352 (359)
T ss_pred CccccccccHHHHHHHHHHHHHhh
Confidence 332222256777888887776553
No 11
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-49 Score=350.34 Aligned_cols=253 Identities=32% Similarity=0.614 Sum_probs=237.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.+++.||.|+||.|-+++++.+|..+|+|++.+.....-...++..+|.++|+.+. ||.++++++.+.+...+|+|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence 67999999999999999999999999999999999887766667788999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||++||.|..++++.+++++..++.++.||+.|+.|||+++|++|||||+|||+ +.+|++||+|||+|......
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--
Confidence 9999999999999999999999999999999999999999999999999999999 79999999999999876433
Q ss_pred cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
..+.||||.|+|||++. .+|+.++|+|||||++|||+.|..||...++..+.+.|..+...++. .+++++++||.
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLK 273 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHH
Confidence 56889999999999886 57999999999999999999999999999999999999999998885 57899999999
Q ss_pred HhcccCCCCC-----CCHHHHhcCCccCc
Q 040917 272 RMLTQDPKRR-----ITVAQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~R-----ps~~eil~~~~~~~ 295 (494)
++|+.|-.+| ....+|.+||||+.
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999 46789999999985
No 12
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-48 Score=379.31 Aligned_cols=259 Identities=43% Similarity=0.753 Sum_probs=234.2
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
...++|.+++.||+|+||.|+.|.+..+|..||+|++.+..... ......+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34579999999999999999999999999999999887653221 1346677799999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC-CeEEEeecCCccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN-AVVKATDFGLSAF 186 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~-~~~kL~Dfg~a~~ 186 (494)
.+++|||||.||.|.+++.+.+++.+..+..+++|++.|+.|||++||+||||||+||++ +.. +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccccccc
Confidence 999999999999999999998999999999999999999999999999999999999999 455 9999999999998
Q ss_pred c-ccCcccccccCCcCccChhhhccc--C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 187 I-EEGKAYREIVGSPYYIAPEVLSQS--Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 187 ~-~~~~~~~~~~~~~~y~aPE~~~~~--~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
. .........+|++.|+|||++.+. | +.++||||+||++|.|++|..||...........+.++...++.. +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----L 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----c
Confidence 7 466677889999999999999863 5 578999999999999999999999988888888888887776643 3
Q ss_pred -CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 263 -SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 263 -~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+++++.++.+||..||.+|+++.++++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 899999999999999999999999999999997
No 13
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.1e-49 Score=384.14 Aligned_cols=257 Identities=39% Similarity=0.679 Sum_probs=240.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
+-|++++.||.|+.|.|-+|++..||+.+|||++.+....++.....+++|+-+|+.+. ||||+.++++|.++.++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence 67999999999999999999999999999999998875556666788999999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
.||++||.|.+++...+++++.++..+++||++|+.|+|..+|+||||||+|+|+ +..+.+||+|||+|..-.++..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999 5666699999999998888888
Q ss_pred cccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
+.+.||.|+|.|||++.|. | +.++||||+|||||.|+||++||++.+...++.++.++.+..+ ..+|.++.+||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence 8999999999999999875 4 6799999999999999999999999999999999999988766 46899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+||..||++|.|.++|++|||+..+.
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998754
No 14
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.3e-50 Score=376.07 Aligned_cols=261 Identities=32% Similarity=0.507 Sum_probs=228.0
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FV 109 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~ 109 (494)
+..+|.+++.||.|.||.||+|..+.+|..||||..++.-.. ...-.-.+|+..|++|..||||+++.+++.++. .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 457999999999999999999999999999999999765432 233345679999999966999999999998877 99
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|+|||||+ .+|+++++.+ ..+++..+..|++||+.||+|+|++|+.|||+||+|||+ .....+||+|||+|+.+.
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccc
Confidence 99999995 5999999865 459999999999999999999999999999999999999 558899999999999999
Q ss_pred cCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC----------
Q 040917 189 EGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR---------- 256 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 256 (494)
+.+++..++.|.+|+|||++. +-|+.+.|+||+|||++|+.+-+..|.|.++-+.+..|..---.+..
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 999999999999999999985 45999999999999999999999999999988777666431111111
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 257 ----------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 257 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..++.++.++.++|.+|+.+||.+||||.++|+||||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11345789999999999999999999999999999998643
No 15
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2.4e-48 Score=339.52 Aligned_cols=261 Identities=31% Similarity=0.498 Sum_probs=226.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|...+.||+|.||.||+|++..+|+.||+|.++...... ...-...+|++.|+.++ ||||+.++++|...+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 47889999999999999999999999999999998776433 34667889999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||++. +|...++.. ..++...++.++.++++|++|||++.|+||||||+|+|+ +++|.+||+|||+|+.+.+..
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence 999975 999988764 468999999999999999999999999999999999999 789999999999999876544
Q ss_pred cc-ccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-----------
Q 040917 192 AY-REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD----------- 257 (494)
Q Consensus 192 ~~-~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 257 (494)
.. ...+.|.+|+|||.+-| .|+..+|+||.|||+.||+.+.+.|.|.++-+++..+.+.--.+.+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33 23477999999999865 59999999999999999999999999999888777665432222222
Q ss_pred -------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 258 -------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 258 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
.++..++++.+|+.+||..||.+|+++.|+|+|+||+..+.+
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 234567888999999999999999999999999999975544
No 16
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=2.6e-48 Score=370.56 Aligned_cols=260 Identities=31% Similarity=0.562 Sum_probs=236.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
-.++|.+++.||+|+||.||+|+.+.||..+|+|+++++.........++..|..+|... ++|.|++++-.|++..++|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence 347899999999999999999999999999999999999888888889999999999996 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE- 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~- 189 (494)
+||||++||++..++.+.+.+++..+..++.+++.|+..+|+.|+|||||||+|+|| +..||+||+|||++.-...
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999 7999999999999842210
Q ss_pred -----------------------Cc-----c-------------------cccccCCcCccChhhhcc-cCCCcchhHHH
Q 040917 190 -----------------------GK-----A-------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSA 221 (494)
Q Consensus 190 -----------------------~~-----~-------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~sl 221 (494)
.. . ..+.+|||.|+|||++.+ .|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 0 012469999999999976 59999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917 222 GVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE 295 (494)
Q Consensus 222 G~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~ 295 (494)
|||+|||+.|.+||.+.++.+....|.+-...+..+.-..+++++++||.+||. ||++|. +++||..||||+.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999999999999998877666666657788999999999999 999997 5899999999986
No 17
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=7.7e-49 Score=343.35 Aligned_cols=262 Identities=36% Similarity=0.700 Sum_probs=241.1
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--C---ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--V---KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~---~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
+-..|.-.+.||.|..++|-++.++.+|+.+|+|++....- . .....+...+|+++|+++.+||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34578888999999999999999999999999999853221 1 222345566899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
+...++|+|.|+.|.|.+++...-.++++...+|++|+++|+.|||.++|+||||||+|||+ +++..++|+|||++.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence 99999999999999999999888789999999999999999999999999999999999999 678899999999999
Q ss_pred ccccCcccccccCCcCccChhhhc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917 186 FIEEGKAYREIVGSPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258 (494)
Q Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (494)
...++...+..||||+|.|||.+. ..|+..+|+||+|+|+|-|+.|..||+.....-++..|..+...+..+.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 999999999999999999999873 2488899999999999999999999999999889999999999999999
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
|.+++...+++|.+||+.||++|.|++|+|.||||..
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999999999999999999964
No 18
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.4e-47 Score=360.79 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=224.9
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--Ce
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QF 108 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~ 108 (494)
..+.|+.++.||+|.||.||+|++..+|+.||+|.+..... .+.......+|+.+|++| +||||+++.++.... ..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCce
Confidence 34678899999999999999999999999999999976543 234567788999999999 599999999998776 68
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
+|+|+|||+. +|.-++... -.+++.+++.+++||+.||.|||.+||.|||||.+|||| +++|.+||+|||+|++.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence 9999999965 888887663 369999999999999999999999999999999999999 78999999999999976
Q ss_pred ccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC-----
Q 040917 188 EEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP----- 258 (494)
Q Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 258 (494)
.... .+...+.|.+|+|||.+.| .|+.++|+||+|||+.||++|++.|.+.++.+++..|.+.--.+....
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 5433 5677888999999999987 599999999999999999999999999999988888754221111111
Q ss_pred --------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 259 --------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 259 --------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+..++....+|+..||..||.+|.||.++|+++||...+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 234678889999999999999999999999999995433
No 19
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-46 Score=351.40 Aligned_cols=264 Identities=30% Similarity=0.473 Sum_probs=229.8
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
+..-...|++...||.|..++||+|+...+++.||||++....... ..+.+.+|+..++.+ +||||++++..|..+.
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDS 97 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecc
Confidence 3444578999999999999999999999999999999998666433 378899999999999 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 108 FVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
.+++||.||.+||+.++++.. ..+++..|..+++++++||.|||++|.||||||+.|||+ +.+|.|+|+|||.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeee
Confidence 999999999999999999864 348999999999999999999999999999999999999 789999999999876
Q ss_pred ccccCc-cc----ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-
Q 040917 186 FIEEGK-AY----REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR- 256 (494)
Q Consensus 186 ~~~~~~-~~----~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 256 (494)
.+-... .. ....||++|+|||++.. .|+.|+||||||++..||.+|+.||....+..++..-+++..+...
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 543322 11 34579999999999654 4999999999999999999999999999998887776676654222
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 257 -----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 257 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+.....+..++.+|..||..||++|||++++|+|+||+...
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 22234678899999999999999999999999999999754
No 20
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-48 Score=343.14 Aligned_cols=246 Identities=33% Similarity=0.581 Sum_probs=215.6
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE-EEE-eCCeE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA-AYE-DDQFV 109 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~-~~~-~~~~~ 109 (494)
..+|+|.+.||.|+||+||+|.+..+|..||+|.+.-.. -+....+....|+.+|++|+ ||||+++++ .+. +...+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence 357999999999999999999999999999999997433 45557888999999999995 999999998 444 44458
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEEeeCCCCCeEEEeec
Q 040917 110 HIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHS--KG--VMHRDLKPENFLFTTGDENAVVKATDF 181 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~--~~--i~H~dikp~NIli~~~~~~~~~kL~Df 181 (494)
+||||+|.+|+|...++. .+.+++.+++.++.|++.||..+|+ .. |+||||||.||++ +..|.+||+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf 172 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF 172 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence 999999999999988863 3469999999999999999999999 44 8999999999999 68899999999
Q ss_pred CCccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917 182 GLSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259 (494)
Q Consensus 182 g~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (494)
|+++...+... ..+.+|||+||+||.+.+ +|+.+|||||+||++|||+.-+.||.+.+..+....|.++..++.+.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-- 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-- 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence 99998766543 356889999999999875 69999999999999999999999999999888889999885543332
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITV 284 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~ 284 (494)
..+|..+..+|..|+..||+.||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 4688999999999999999999987
No 21
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-47 Score=356.04 Aligned_cols=257 Identities=34% Similarity=0.561 Sum_probs=215.1
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--eE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--FV 109 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--~~ 109 (494)
..+|..++.||+|+||.||++.+..+|...|+|.+.... ....+.+.+|+.+|.+|+ ||||+++++...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeee
Confidence 356999999999999999999999999999999986542 112677999999999997 999999999854444 69
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCcccc
Q 040917 110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFI 187 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~~~ 187 (494)
+|+|||++||+|.+++.+.+ ++++..+..+.+||++||.|||++||+|+||||+|||+ +. ++.+||+|||.+...
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKL 168 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccc
Confidence 99999999999999999877 79999999999999999999999999999999999999 56 689999999998866
Q ss_pred cc----CcccccccCCcCccChhhhcccC--CCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCC
Q 040917 188 EE----GKAYREIVGSPYYIAPEVLSQSY--GKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDPFP 260 (494)
Q Consensus 188 ~~----~~~~~~~~~~~~y~aPE~~~~~~--~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (494)
.. ........||+.|||||++.... .+++|||||||++.||+||+.||... ...+..-.+.... ..+....
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~ 246 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPD 246 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCc
Confidence 53 12233578999999999998432 34999999999999999999999763 2222222333332 1223335
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+|+++++||.+|+..+|.+||||+++|+|||.....
T Consensus 247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 6899999999999999999999999999999998644
No 22
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=5.4e-47 Score=340.89 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=224.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~ 110 (494)
+.|..+..|++|.||.||+|+++.|++.||+|.++...-. ....-...+|+.+|.+.+ ||||+.+-++... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence 5789999999999999999999999999999999865522 223445678999999995 9999999998764 34799
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
||||||+. +|..++.+.+ +++..+++.+..|++.|++|||.++|+||||||+|+|+ .+.|.+|++|||+|+...+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcC
Confidence 99999975 9999887765 79999999999999999999999999999999999999 7899999999999998765
Q ss_pred C-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC-------
Q 040917 190 G-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF------- 259 (494)
Q Consensus 190 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 259 (494)
. ..+...+.|.+|+|||.+.+ .|+.+.|+||+|||+.||+++++.|.+.++.+.++.|.+.--.+....|
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 44566778999999999976 4999999999999999999999999999998888777532211111111
Q ss_pred -------------------C--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917 260 -------------------P--SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302 (494)
Q Consensus 260 -------------------~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~ 302 (494)
+ .+++...+|+..+|..||.+|.||+++|+|+||.+.+.+.+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 1 145778899999999999999999999999999997765543
No 23
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.8e-47 Score=364.88 Aligned_cols=255 Identities=31% Similarity=0.579 Sum_probs=231.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..- +.....++.+|+++++.|+ ||||+.++++|+...+.++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 579999999999999999999999999999999987653 3446788999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
+|||.| +|..++...+.++++.+..++.+++.||.|||+++|.|||+||.||++ +..+++|+||||+|+-+..+.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999987 999999999999999999999999999999999999999999999999 789999999999998765433
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......|||.|||||+..+ +|+..+|+||||||+||+++|++||...+.......|.+....++ ...+..+..|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHH
Confidence 3456789999999999875 699999999999999999999999988887777777777655444 47899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..+|.+||.+|.++.+++.|||.+...
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhh
Confidence 999999999999999999999998644
No 24
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-46 Score=365.65 Aligned_cols=255 Identities=29% Similarity=0.545 Sum_probs=236.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||+|++|..+.+++.+|||++++.....+...+....|-+++....+||.++.++.+|+..+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 78999999999999999999999999999999999998888888999999999999988899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~ 191 (494)
|||+.||++..+ ...+.+++..+..++..|+.||.|||++||||||||.+|||+ +..|++||+|||++...- .+.
T Consensus 448 mey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 448 MEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCCC
Confidence 999999995443 344689999999999999999999999999999999999999 789999999999998643 566
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
...+.||||.|+|||++.+ .|+..+|+|||||++|+|+.|..||.+.+++++.+.|.+....++. .++.+...++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il 599 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIM 599 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHH
Confidence 6778999999999999986 5999999999999999999999999999999999999998887774 5789999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 271 RRMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
.++|.+||++|.. +++|..||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999985 578999999986
No 25
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=7.3e-46 Score=355.96 Aligned_cols=253 Identities=29% Similarity=0.564 Sum_probs=224.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence 37999999999999999999999999999999997544333334567889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence 9999999999999888889999999999999999999999999999999999999 67889999999998765432
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+..+...++ ..++..+.++|.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence 234568999999999865 488999999999999999999999999888888888877655443 346889999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 272 RMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
+||..||.+||+ ++++++||||..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999995 999999999975
No 26
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=1.8e-45 Score=359.27 Aligned_cols=253 Identities=32% Similarity=0.614 Sum_probs=224.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++..++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence 6799999999999999999999999999999999765443334466788999999999 499999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC--
Confidence 9999999999999888889999999999999999999999999999999999999 67889999999998765332
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+..+...++ ..++..+.++|.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 247 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVK 247 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHH
Confidence 234578999999999865 578999999999999999999999998888777777777654433 247889999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 272 RMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
+||..||.+||+ +.++++||||..
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999997 799999999986
No 27
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-46 Score=360.24 Aligned_cols=258 Identities=33% Similarity=0.565 Sum_probs=225.8
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
..+...+|+....||+|+.|.||.|....+++.||+|.+.... ....+.+.+|+.+|+.++ |+||+.+++.|...+
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGD 343 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccc
Confidence 3456689999999999999999999999999999999997654 335678999999999996 999999999999889
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+++||||++||+|.+.+... .+++.++..++++++.||+|||.+||+|||||.+|||+ ..++.+||+|||++..+
T Consensus 344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQI 419 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecc
Confidence 999999999999999988665 59999999999999999999999999999999999999 67888999999999887
Q ss_pred ccCcc-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HcCCccCCCCCCCCCCH
Q 040917 188 EEGKA-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFPSISS 264 (494)
Q Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 264 (494)
..... -.+.+|||+|||||+.. ..|++++||||||+++.||+-|..||...++...+..+ .++...... ...+++
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~--~~klS~ 497 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN--PEKLSP 497 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC--ccccCH
Confidence 65543 34678999999999986 47999999999999999999999999866654444433 344333333 367999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.+++|+.+||..|+.+|+++.++|+||||+-
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999999999964
No 28
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-46 Score=333.24 Aligned_cols=278 Identities=37% Similarity=0.680 Sum_probs=244.6
Q ss_pred hhhcccccccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917 22 AILGKAYEDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100 (494)
Q Consensus 22 ~~~~~~~~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~ 100 (494)
+.+....-.+.++|++- +.||-|-.|.|-.|.++.||+.+|+|++.. .....+|+++--...+||||+.++
T Consensus 50 ~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~Ii 121 (400)
T KOG0604|consen 50 SDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSII 121 (400)
T ss_pred hhcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEee
Confidence 33333445577888875 569999999999999999999999999852 334567777766666899999999
Q ss_pred EEEEe----CCeEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 101 AAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 101 ~~~~~----~~~~~iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
++|.+ ...+.+|||.++||.|.+++..++. +++..+.+|++||+.|+.|||+.+|+||||||+|+|+.++..+.
T Consensus 122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence 99854 4578899999999999999988765 99999999999999999999999999999999999999888899
Q ss_pred eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHc
Q 040917 175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILK 249 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~ 249 (494)
.+||+|||+|........+.+.+.||+|.|||++.. .|+...|+||+||++|-|+.|.+||.+... .++...|..
T Consensus 202 ~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 999999999998777777788899999999999964 599999999999999999999999987653 467778889
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHH
Q 040917 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307 (494)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~ 307 (494)
+...|+.+.|..+|+..+++|+.+|..+|++|.|++++++|||+.......+.|+.+.
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~ 339 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTS 339 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhh
Confidence 9999999999999999999999999999999999999999999998777777776554
No 29
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-46 Score=348.59 Aligned_cols=260 Identities=32% Similarity=0.608 Sum_probs=226.0
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----------hhhHHHHHHHHHHHHHccCCCCccEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----------DVEKDDVRREIEIMRHLSGQPNIVQF 99 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~hp~i~~~ 99 (494)
...+|++++.||+|.||.|-+|++..+++.||+|++.+..... ....+...+|+.+|+++. ||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence 3468999999999999999999999999999999997654321 122467899999999995 9999999
Q ss_pred eEEEEeC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917 100 KAAYEDD--QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK 177 (494)
Q Consensus 100 ~~~~~~~--~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k 177 (494)
+++..+. +.+|+|+|||..|.+.+.-.....++..+++.+++.++.||.|||.+||+||||||+|+|+ ++++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcEE
Confidence 9999764 5899999999998886543333338999999999999999999999999999999999999 6789999
Q ss_pred EeecCCcccccc------CcccccccCCcCccChhhhccc-----CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 040917 178 ATDFGLSAFIEE------GKAYREIVGSPYYIAPEVLSQS-----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA 246 (494)
Q Consensus 178 L~Dfg~a~~~~~------~~~~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~ 246 (494)
|+|||.+..... ........|||.|+|||...+. .+.+.||||+||+||+|+.|+.||.+....+..+.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 999999987632 2234457899999999998652 46789999999999999999999999999999999
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
|.+....++.. +.+.+.++++|.+||.+||++|.+..+|..|||....
T Consensus 331 Ivn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 IVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 99988887765 4688999999999999999999999999999999864
No 30
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1e-46 Score=324.60 Aligned_cols=254 Identities=32% Similarity=0.639 Sum_probs=236.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.++++||.|.||.||.|+.+.++..||+|++.++.........++.+|+++-..|+ ||||++++++|.+...+|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence 68999999999999999999999999999999999888777778889999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIV--ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||..+|+|...+. ...++++.....+++|++.|+.|+|.++++||||||+|+|+ +..+.+|++|||.+...+ .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-C
Confidence 99999999999998 56679999999999999999999999999999999999999 788999999999998765 3
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
..-.+.|||..|.+||...+ .++..+|+|++|++.|+++.|..||...+..+.++.+.+....++ ..++..+.++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence 34457899999999999876 589999999999999999999999999999899999988877776 5789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
|.+|+..+|.+|.+..+++.|||+..
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999975
No 31
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=3.4e-45 Score=358.29 Aligned_cols=257 Identities=33% Similarity=0.542 Sum_probs=224.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+. ||||+++++++......|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999997654333334567889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence 9999999999999888889999999999999999999999999999999999999 6788999999999875533 2
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC----CCCCHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF----PSISSSAI 267 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 267 (494)
.....|++.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+.. ..++..+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345678999999999865 5899999999999999999999999988887777666553332222222 25789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
++|.+||..+|.+||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999986
No 32
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.3e-46 Score=344.20 Aligned_cols=258 Identities=39% Similarity=0.682 Sum_probs=241.3
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
..+..-+|.+.+.||.|.||.|.+|.+..+|+.||||.+++....+.+..-.+.+|++++..| +||||+.++++|.+.+
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKD 126 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCc
Confidence 445667999999999999999999999999999999999999998988999999999999999 6999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+.|||||..||.|++++..++.+++.++..+++||+.|+.|+|+++++|||||.+|||+ +.++.+||+|||++...
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLY 203 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999 78899999999999999
Q ss_pred ccCcccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 188 EEGKAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.....+.+.||+|.|.+||+.+|. | ++.+|.||||+++|-|+.|.+||++........+|.++...-+ .-|..
T Consensus 204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PSd 278 (668)
T KOG0611|consen 204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPSD 278 (668)
T ss_pred ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCch
Confidence 888889999999999999999875 4 6899999999999999999999999999999999988755433 34678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
..-||.+||..||++|.|+++|-+|=|+.
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999999999996664
No 33
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=2.8e-45 Score=357.11 Aligned_cols=249 Identities=31% Similarity=0.573 Sum_probs=219.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++. ||||+++++++..++..|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654333444567788999999995 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~ 197 (494)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... ........+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 678899999999987532 222334567
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++||||+||++|+|++|+.||...........+......++ ..+++.+.++|.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 8999999999865 589999999999999999999999998888777777766654443 45789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccCc
Q 040917 277 DPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rp-----s~~eil~~~~~~~ 295 (494)
||++|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999 8999999999986
No 34
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=3.6e-45 Score=350.19 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=216.4
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++ +||+|+++++++..++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78899999999999999999999999999998765443333445678899999999 59999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998877543 358999999999999999999999999999999999999 6788999999999987654444
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++||||+||++|+|++|+.||.+.........+..............+++.+.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 455678999999999864 6899999999999999999999999876543222222221112222233468899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917 272 RMLTQDPKRRIT-----VAQVLEHPWLKES 296 (494)
Q Consensus 272 ~~l~~dp~~Rps-----~~eil~~~~~~~~ 296 (494)
+||+.||.+||+ ++++++||||...
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 8999999999864
No 35
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=9.3e-45 Score=359.15 Aligned_cols=259 Identities=28% Similarity=0.483 Sum_probs=220.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++.+.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 4799999999999999999999999999999999764433334456788899999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 678899999999986432110
Q ss_pred -----------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC
Q 040917 192 -----------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF 235 (494)
Q Consensus 192 -----------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf 235 (494)
.....+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0123578999999999865 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCccCcc
Q 040917 236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPK---RRITVAQVLEHPWLKES 296 (494)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~eil~~~~~~~~ 296 (494)
.+....+....+.........+....+++.+.++|.+|+. +|. .||+++++++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9988888887777643333322234578999999999775 444 46899999999999863
No 36
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=7e-45 Score=355.88 Aligned_cols=254 Identities=30% Similarity=0.574 Sum_probs=223.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCC-cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTG-LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.+++.+. ||||+++++++......+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence 367999999999999999999876654 689999987554434445667889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence 999999999999999888889999999999999999999999999999999999999 67889999999999765432
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
.....||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+.....+.+..+...++ +.+++.+.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 235678999999999865 488999999999999999999999999888777788777655443 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
|.+||..||.+|+ +++++++||||.+
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999995 8999999999986
No 37
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=9.8e-45 Score=359.60 Aligned_cols=259 Identities=29% Similarity=0.567 Sum_probs=222.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+. ||||+++++++..+..+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence 37999999999999999999999999999999997654333344566888999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence 9999999999999888889999999999999999999999999999999999999 6788999999999865322110
Q ss_pred ---------------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCC
Q 040917 193 ---------------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGV 232 (494)
Q Consensus 193 ---------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~ 232 (494)
....+||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 012468999999999864 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCcc
Q 040917 233 PPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKES 296 (494)
Q Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~ 296 (494)
.||.+....+....+.........+....+++.+.++|.+|+. +|.+|++ +.++++||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999888877777776544433333334678999999999996 9999998 9999999999863
No 38
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-44 Score=348.80 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=214.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcE-EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLE-FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~-valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~ 110 (494)
....+.+.||+|+||+||++.++ |+. ||+|++......... ...+.+|+.+|.+|+ ||||+++++++.... ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceE
Confidence 44556677999999999999988 556 999999876654443 788999999999995 999999999998877 799
Q ss_pred EEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEEeeCCCCC-eEEEeecCCccc
Q 040917 111 IVMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKG-VMHRDLKPENFLFTTGDENA-VVKATDFGLSAF 186 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~ 186 (494)
|||||+++|+|.+++.. ...++...+..++.+|+.|+.|||+++ ||||||||.|||+ +.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence 99999999999999987 578999999999999999999999999 9999999999999 5675 999999999987
Q ss_pred cccC-cccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 187 IEEG-KAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
.... .......||+.|||||++.+ .|+.++||||||+++|||+||+.||.......+...+......+..+ ...
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~ 271 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KEC 271 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccC
Confidence 6544 33344789999999999985 39999999999999999999999999999876766666554443322 238
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
++.+..++.+||..||.+||++.+++.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 899999999999999999999999875
No 39
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=7.2e-45 Score=358.76 Aligned_cols=259 Identities=34% Similarity=0.633 Sum_probs=225.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+. ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence 37999999999999999999999999999999997654434345667889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++|++|.+++...+.++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999999999999999999999 678899999999987654332
Q ss_pred -----------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917 192 -----------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ 241 (494)
Q Consensus 192 -----------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~ 241 (494)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1234568999999999875 5899999999999999999999999988887
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCccCcc
Q 040917 242 GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT-VAQVLEHPWLKES 296 (494)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil~~~~~~~~ 296 (494)
.....+.........+....+++.+.++|.+||. ||.+||+ +.++++||||+..
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777776633333333334589999999999997 9999999 9999999999863
No 40
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.1e-44 Score=332.24 Aligned_cols=263 Identities=29% Similarity=0.456 Sum_probs=221.5
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC-ccEEeEEEEeCC---
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN-IVQFKAAYEDDQ--- 107 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-i~~~~~~~~~~~--- 107 (494)
...|..++.||+|.||+||+|+.+.+|+.||+|.+...... +.......+|+.+++.|+ |+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence 45688889999999999999999999999999999755422 234556789999999995 999 999999998877
Q ss_pred ---eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 108 ---FVHIVMELCAGGELFDRIVARG----HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 108 ---~~~iv~e~~~g~sL~~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
..++|+||++ .+|..++.... .++...++.+++||+.||.|||+++|+||||||+||++ ++.|.+||+|
T Consensus 88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence 8999999996 49999998765 47888999999999999999999999999999999999 6799999999
Q ss_pred cCCccccc-cCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917 181 FGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257 (494)
Q Consensus 181 fg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (494)
||+|+... +........+|.+|+|||++.+. |++..||||+|||++||++++..|.+.++.+.+..|.+.--.+...
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99998765 44446677889999999999764 9999999999999999999999999999877766664321111111
Q ss_pred C--------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917 258 P--------------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300 (494)
Q Consensus 258 ~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~ 300 (494)
. .+...+...+++.+||+.+|.+|.|+..+|+||||.......
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 1 122335789999999999999999999999999999865443
No 41
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=3.1e-44 Score=357.68 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=219.2
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
.|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++.+...+++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999997655444445677899999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-- 191 (494)
||++||+|.+++.+...+++..+..++.||+.||.|||++||+||||||+||++ +..++++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 678899999999875321000
Q ss_pred ----------------------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHH
Q 040917 192 ----------------------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVI 224 (494)
Q Consensus 192 ----------------------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~i 224 (494)
......||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123468999999999864 58999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCCccCcc
Q 040917 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT--QDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 225 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dp~~Rps~~eil~~~~~~~~ 296 (494)
+|+|++|..||......+....+.........+....+++.+.++|.+|+. .+|..||++.++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999998887766665555433333333344688999999999654 455569999999999999863
No 42
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=2e-44 Score=349.49 Aligned_cols=248 Identities=29% Similarity=0.540 Sum_probs=217.4
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999999755433444566788899999999 59999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-CcccccccCC
Q 040917 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIVGS 199 (494)
Q Consensus 121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~~~ 199 (494)
|.+++...+.++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ........||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999 6788999999999875322 2223346789
Q ss_pred cCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917 200 PYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278 (494)
Q Consensus 200 ~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 278 (494)
+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+....+......++ ..+++.+.++|.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence 99999999875 589999999999999999999999998888887777776544433 4578999999999999999
Q ss_pred CCCC---CHHHHhcCCccCcc
Q 040917 279 KRRI---TVAQVLEHPWLKES 296 (494)
Q Consensus 279 ~~Rp---s~~eil~~~~~~~~ 296 (494)
.+|| ++.++++||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 57999999999863
No 43
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=2.7e-44 Score=356.15 Aligned_cols=259 Identities=32% Similarity=0.528 Sum_probs=224.1
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
..+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.++...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence 36899999999999999999999999999999999754433334456678899999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 99999999999988654 68899999999999999999999999999999999999 678999999999987654322
Q ss_pred --ccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 192 --AYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 192 --~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
......||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+.........+....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 1234578999999999853 378899999999999999999999999888878787776544444334456899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917 265 SAIELVRRMLTQDPKR--RITVAQVLEHPWLKE 295 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~ 295 (494)
.+.++|.+||..+|.+ |++++++++||||+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999988 999999999999986
No 44
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=2.5e-44 Score=349.79 Aligned_cols=250 Identities=31% Similarity=0.571 Sum_probs=218.4
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997544333334566778888888876799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~ 197 (494)
++|..++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 678899999999987532 222233457
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....++...+......++ ..++..+.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence 8999999999875 588999999999999999999999999988888888877654433 34789999999999999
Q ss_pred CCCCCCCH------HHHhcCCccCc
Q 040917 277 DPKRRITV------AQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rps~------~eil~~~~~~~ 295 (494)
||.+||++ +++++||||..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99999998 99999999985
No 45
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=1.7e-44 Score=359.29 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=220.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+..++.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence 37999999999999999999999999999999997544333334567889999999994 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC--
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-- 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-- 190 (494)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 67889999999987422100
Q ss_pred ------------------------------------------cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHH
Q 040917 191 ------------------------------------------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYI 227 (494)
Q Consensus 191 ------------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~ 227 (494)
.......||+.|+|||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00112468999999999865 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917 228 LLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE 295 (494)
Q Consensus 228 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~ 295 (494)
|++|+.||.+....+....+..............+++.+.++|.+|+ .+|.+|+ ++.++++||||+.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999999988877766666554443333344568899999999976 5999999 9999999999986
No 46
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=3.3e-44 Score=357.81 Aligned_cols=257 Identities=28% Similarity=0.518 Sum_probs=220.7
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.++...|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 699999999999999999999999999999999765443344566788999999999 5999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC---
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG--- 190 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~--- 190 (494)
||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 67889999999987422100
Q ss_pred ---------------------------------------------cccccccCCcCccChhhhcc-cCCCcchhHHHHHH
Q 040917 191 ---------------------------------------------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVI 224 (494)
Q Consensus 191 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~i 224 (494)
......+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00112468999999999864 58999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE 295 (494)
Q Consensus 225 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~ 295 (494)
+|+|++|+.||.+....+....+.........+....+++.+.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999999988877766666654444444444578999999999986 59999997 999999999986
No 47
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=2.4e-44 Score=358.15 Aligned_cols=258 Identities=28% Similarity=0.530 Sum_probs=218.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+....|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 3799999999999999999999999999999998654433334566788999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 678899999999985321100
Q ss_pred -----------c------------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHH
Q 040917 192 -----------A------------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGV 223 (494)
Q Consensus 192 -----------~------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~ 223 (494)
. ....+||+.|+|||++.+ .++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 012468999999999864 5899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCccCc
Q 040917 224 ILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRR---ITVAQVLEHPWLKE 295 (494)
Q Consensus 224 il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~eil~~~~~~~ 295 (494)
++|+|++|..||.+....+....+.........+....++..+.++|.+||. +|.+| +++.++++||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999998888777766666533333322334578999999999997 67665 59999999999985
No 48
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=4.9e-44 Score=348.65 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=222.1
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+..|++|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976543333456678889999999964567889999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~ 192 (494)
||++|++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 678899999999986432 2223
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+....+....+......++ ..+++.+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 345678999999999875 588999999999999999999999999888888888776554433 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCCccCc
Q 040917 272 RMLTQDPKRRITV-----AQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rps~-----~eil~~~~~~~ 295 (494)
+||..||.+|++. .++++||||..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999976 89999999986
No 49
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.2e-44 Score=335.01 Aligned_cols=258 Identities=31% Similarity=0.555 Sum_probs=232.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++++.||.|.-|+||+|..+.++..+|+|++.+..+.......+...|.+||+.+ +||.++.+|..++.+...|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence 6899999999999999999999999999999999988877777788888999999999 699999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917 113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE- 189 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~- 189 (494)
||||+||+|..+..++ +.+++..+..++.+++.||+|||-.|||+|||||+|||| .++|+|-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999999999888765 359999999999999999999999999999999999999 7899999999998743210
Q ss_pred --------------------------------C-c-----------------------ccccccCCcCccChhhhccc-C
Q 040917 190 --------------------------------G-K-----------------------AYREIVGSPYYIAPEVLSQS-Y 212 (494)
Q Consensus 190 --------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~-~ 212 (494)
. . .....+||-.|.|||++.|. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01234588899999999874 8
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHh
Q 040917 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT----VAQVL 288 (494)
Q Consensus 213 ~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~eil 288 (494)
+.++|+|+|||++|||+.|..||.+.+..+.+..|......++..+ .++..+++||.++|.+||.+|.. |.||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999888888763 78899999999999999999998 99999
Q ss_pred cCCccCcc
Q 040917 289 EHPWLKES 296 (494)
Q Consensus 289 ~~~~~~~~ 296 (494)
+||||+..
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999863
No 50
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.8e-45 Score=344.02 Aligned_cols=318 Identities=30% Similarity=0.538 Sum_probs=261.2
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
...|.+=|.+.+.||+|.|++|.+|++..+|..||||++.+..+.. ....++.+|++.++.++ ||||+++|++.....
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT 90 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence 3456778999999999999999999999999999999999887643 46788899999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
.+|+|+|+=.||+|.++|.++ ..+.+..+.+++.||+.|+.|+|+.++|||||||+||.+- ..-|.+||.|||++..
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence 999999999999999999765 4599999999999999999999999999999999998774 6789999999999999
Q ss_pred cccCcccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
+.++..+...||...|.|||++.|. | .+++||||||||+|.|+.|+.||...++.+.+-.|+......+ ..++.
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~ 244 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSK 244 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhH
Confidence 9999999999999999999999875 5 5789999999999999999999999988888888876655444 46889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC--CCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhh
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK--PIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLK 342 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 342 (494)
++++||..||..||.+|.+.++|.+++|++....+... |+.. ... +-.-.+..+.+.+-...+..-.
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvs-------r~~----L~ee~Ha~IIq~Mv~G~IAs~e 313 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVS-------RHH----LPEEAHATIIQQMVAGAIASEE 313 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceee-------hhh----CChHHHHHHHHHHhcccccCHH
Confidence 99999999999999999999999999999975443222 2211 000 1111222222222222222223
Q ss_pred hhhhccCCCCCCcccHHHHHHH
Q 040917 343 EKFTEMDTDNSGTLTYDELKAG 364 (494)
Q Consensus 343 ~~F~~~D~~~~g~i~~~el~~~ 364 (494)
.+.+.++.|.=..|+...|..+
T Consensus 314 ~Il~aLe~n~YNhiTATYfLLA 335 (864)
T KOG4717|consen 314 DILRALENNEYNHITATYFLLA 335 (864)
T ss_pred HHHHHHhccccchhhhHHHHHH
Confidence 4455677887777887776554
No 51
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=3.7e-44 Score=349.71 Aligned_cols=249 Identities=29% Similarity=0.557 Sum_probs=218.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999997654444445667888999999995 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999 6788999999999875322 22233457
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+......++ ..++..+.++|.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence 8999999999864 589999999999999999999999998888777777666554433 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccCc
Q 040917 277 DPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rp-----s~~eil~~~~~~~ 295 (494)
||.+|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999975
No 52
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=5.2e-44 Score=342.69 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=211.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+. ||||+++++++......++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 579999999999999999999999999999999865432 223456778999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
|||++| +|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999975 8998887654 47899999999999999999999999999999999999 67889999999998754322
Q ss_pred cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------------
Q 040917 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------------ 256 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------ 256 (494)
.......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..+....+.........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22234567899999998854 4889999999999999999999999887776655444321110000
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 257 --------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 257 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
...+.++.++.++|.+||..||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123567889999999999999999999999999998
No 53
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=3.7e-44 Score=349.08 Aligned_cols=249 Identities=31% Similarity=0.575 Sum_probs=217.8
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.+. ||||+++++.+......|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654333344566788999999995 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 6788999999999865322 22233467
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+......++ ..+++.+.++|.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 8999999999864 589999999999999999999999998888777777766554433 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccCc
Q 040917 277 DPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rp-----s~~eil~~~~~~~ 295 (494)
||.+|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCC
Confidence 999998 8999999999986
No 54
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=6.2e-44 Score=353.09 Aligned_cols=261 Identities=31% Similarity=0.530 Sum_probs=222.6
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.++...|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence 447899999999999999999999999999999999754433333456678899999999 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence 999999999999988654 68999999999999999999999999999999999999 67889999999999765432
Q ss_pred cc--cccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 191 KA--YREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 191 ~~--~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
.. .....||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+..+....+.........+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 234678999999999864 27889999999999999999999999988877777776654433333334678
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHhcCCccCcc
Q 040917 264 SSAIELVRRMLTQDPKR--RITVAQVLEHPWLKES 296 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~ 296 (494)
..+.+++.+||..++.+ |+++.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999865544 8999999999999863
No 55
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=5.9e-44 Score=347.60 Aligned_cols=250 Identities=27% Similarity=0.520 Sum_probs=218.8
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.+||||+++++++..++..|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654433445566778999998876799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
++|...+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999 6788999999999875322 22233456
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+....+......++ ..++..+.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence 8999999999865 589999999999999999999999999998888888877654433 34789999999999999
Q ss_pred CCCCCC-------CHHHHhcCCccCc
Q 040917 277 DPKRRI-------TVAQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rp-------s~~eil~~~~~~~ 295 (494)
||++|| ++.++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 8999999999975
No 56
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=3.2e-44 Score=351.07 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=222.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 3699999999999999999999999999999999765443444566788899999998 599999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999999999999876 679999999999999999999999999999999999999 678899999999997654332
Q ss_pred cc--ccccCCcCccChhhhc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 192 AY--REIVGSPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
.. ....+|+.|+|||++. ..++.++|||||||++|+|++|..||...........+.........+..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 22 2346899999999985 24788999999999999999999999888877777777665433333333568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+..+.++|.+||. +|.+||++.++++||||..
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 8999999999998 9999999999999999986
No 57
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.9e-46 Score=346.14 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=225.2
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++.+++ +|||.++|+.|..+..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence 3578888999999999999999999999999999976553 335778999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||||.||++.+.++....+.+..+..++++++.|+.|||..+.+|||||+.||++ ...+.+||+|||.+.......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechh
Confidence 99999999999999888777999999999999999999999999999999999999 567999999999998876543
Q ss_pred cc-ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 AY-REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~~-~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
.. .+.+|||.|||||++.+ .|+.++||||||++.+||.+|.+|+....++.++..|-+... +..-..+++.+++|
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P---P~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP---PRLDGDFSPPFKEF 242 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC---CccccccCHHHHHH
Confidence 33 56889999999999986 699999999999999999999999988887655444433322 22223688999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
|..||.+||+.||||.++|+|+|++.
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999999999997
No 58
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=1.1e-43 Score=345.96 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=222.9
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+..||+|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999976543333345567778888888867899999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~ 192 (494)
||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 6788999999999875332 222
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+......++ ..++..+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence 334678999999999874 589999999999999999999999999888888888777655443 357899999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCCccCc
Q 040917 272 RMLTQDPKRRITV-----AQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rps~-----~eil~~~~~~~ 295 (494)
+||..+|.+|++. .++++||||..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999984 89999999985
No 59
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1e-43 Score=340.67 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=211.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+. ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence 379999999999999999999999999999999975432 2334567889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++++.+..+......++...+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence 9999987766555445578999999999999999999999999999999999999 678899999999997654322
Q ss_pred -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN---------------- 253 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------- 253 (494)
......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2234568999999999864 5889999999999999999999999887665443332211000
Q ss_pred ---CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 ---FQR---------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ---~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+. .....++..+.++|.+||..||++|||++++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112367889999999999999999999999999998
No 60
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=1.5e-43 Score=345.69 Aligned_cols=250 Identities=28% Similarity=0.505 Sum_probs=212.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+.+||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999998655444445667888999999997799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~~~~~~~ 197 (494)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 67889999999998642 2223334567
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET---------DQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.... .....+.+.......+ ..++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 8999999999875 58899999999999999999999996321 1123333444433322 35788999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917 268 ELVRRMLTQDPKRRIT------VAQVLEHPWLKE 295 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps------~~eil~~~~~~~ 295 (494)
++|.+||..||.+||+ +.++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999987 789999999975
No 61
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=1.3e-43 Score=344.51 Aligned_cols=250 Identities=29% Similarity=0.536 Sum_probs=218.5
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333444566778999999886799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~ 197 (494)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 678899999999986432 222233456
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+......++ ..++..+.++|.+||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence 8999999999865 589999999999999999999999998888877777766554433 35789999999999999
Q ss_pred CCCCCCCH-----HHHhcCCccCc
Q 040917 277 DPKRRITV-----AQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rps~-----~eil~~~~~~~ 295 (494)
||.+||++ .++++||||..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999 99999999986
No 62
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=9e-44 Score=351.83 Aligned_cols=259 Identities=30% Similarity=0.527 Sum_probs=220.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||+|+++++.+.+...+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999999754433344566788899999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 678899999999986432110
Q ss_pred -----------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC
Q 040917 192 -----------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF 235 (494)
Q Consensus 192 -----------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf 235 (494)
.....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0113468999999999865 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCcc
Q 040917 236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKES 296 (494)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~ 296 (494)
.+.........+.........+....+++.+.++|.+|+ .||.+|+ ++.++++||||...
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 998888777777654333322222347899999999977 5999998 48999999999863
No 63
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=2.2e-43 Score=346.54 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=211.0
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-----Ce
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-----QF 108 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-----~~ 108 (494)
+|++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 69999999999999999999999999999999864322 2223456889999999995 99999999987543 35
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 899999995 6999999888889999999999999999999999999999999999999 678899999999987543
Q ss_pred cCc----ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------------
Q 040917 189 EGK----AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL------------- 248 (494)
Q Consensus 189 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~------------- 248 (494)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 1234578999999999753 58899999999999999999999997765433222111
Q ss_pred --------------cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 249 --------------KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 249 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
..........++.+++.+.+++.+||..||++|||++++|+||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00001111123467888999999999999999999999999999987544
No 64
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=2.9e-43 Score=340.16 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=207.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++......++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence 689999999999999999999999999999999875432 223446778999999994 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
|||+. ++|.+++... +.++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence 99996 5787777654 568999999999999999999999999999999999999 67889999999998654322
Q ss_pred cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCcc--------------
Q 040917 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEIN-------------- 253 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~-------------- 253 (494)
.......+++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.... +....+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22234567899999999854 4788999999999999999999999875432 222222110000
Q ss_pred CCCC--------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 254 FQRD--------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 254 ~~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+.+. .....++.+.+++.+||+.||.+|||+.++|+||||++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000 0012456789999999999999999999999999998743
No 65
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=2.1e-43 Score=342.67 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=214.4
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|+++...............|..++..+.+||||+++++++..+...++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333334555667777777665799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-ccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~ 197 (494)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...... ......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 67889999999998754322 2233457
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+....+......++ ..++..+.+++.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 8999999999875 589999999999999999999999999888877777665433322 35789999999999999
Q ss_pred CCCCCCCH-HHHhcCCccCc
Q 040917 277 DPKRRITV-AQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rps~-~eil~~~~~~~ 295 (494)
||.+||++ .++++||||..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CHHHcCCChHHHHcCcccCC
Confidence 99999986 48889999985
No 66
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=3e-44 Score=328.76 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=217.7
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--- 106 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--- 106 (494)
...-.|.-.+++|+|+||.||+|....+++.||||.+-...- .-.+|+.+|+.+ +||||+++.-+|...
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTES 92 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence 355679999999999999999999999999999998753321 123599999999 599999999888532
Q ss_pred --CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 107 --QFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 107 --~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
-+..+||||++. +|...++. +.+++...++-+..||++|+.|||+.||+||||||+|+|++ ...+.+||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence 145689999976 99988874 56799999999999999999999999999999999999996 5679999999
Q ss_pred cCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--------- 249 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~--------- 249 (494)
||+|.....+....++.++..|+|||.+-| .|+.+.||||.||++.||+-|++.|.|.+..+++..+.+
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999888887788899999999999865 599999999999999999999999999888766655432
Q ss_pred -----C---C---ccCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 250 -----G---E---INFQRD-----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 250 -----~---~---~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
. . ..+... .....++++.+|+.++|..+|.+|.++.+++.||||..-..+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 0 111111 224578999999999999999999999999999999864433
No 67
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=2.4e-43 Score=343.82 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=217.0
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHH---HccCCCCccEEeEEEEeCCeEEE
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR---HLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
|++.+.||+|++|.||+|.+..+++.||+|++.+.........+.+.+|+.++. .+ +||||+++++++......|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 788999999999999999999999999999997654333334566777777665 45 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-C
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-G 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~ 190 (494)
||||++|++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999999999888754 469999999999999999999999999999999999999 6788999999998864322 2
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
.......|++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+....+......++ ..++..+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 22334678999999999865 588999999999999999999999999888888877777655433 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
|.+||..||.+|| ++.++++||||..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999999999 6999999999986
No 68
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=2.4e-43 Score=337.55 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=217.3
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
.|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++.+..+...++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 488999999999999999999999999999999755443333445677899999999 5999999999999989999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999999999887653 358999999999999999999999999999999999999 678899999999987665444
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......|++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.........+..............++..+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 4445578999999999864 588999999999999999999999987765443333322222222222346889999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 271 RRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
.+||..||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 9999999999986
No 69
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=2.7e-43 Score=348.86 Aligned_cols=259 Identities=32% Similarity=0.516 Sum_probs=221.6
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+..+...++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999998754433333456678899999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCC
Confidence 99999999999988664 58999999999999999999999999999999999999 678899999999987654322
Q ss_pred --ccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 192 --AYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 192 --~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.........+..+.++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 1234578999999999853 278899999999999999999999999888878887776554444344457899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917 265 SAIELVRRMLTQDPKR--RITVAQVLEHPWLKE 295 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~ 295 (494)
.+.++|.+||..++.+ |++++++++||||+.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 9999999999854443 789999999999986
No 70
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=2.3e-43 Score=342.46 Aligned_cols=250 Identities=27% Similarity=0.492 Sum_probs=214.5
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.++.+|+.||+|++................|..++..+.+||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997643322234556677888888765799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
++|..++.....++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999 6788999999999864321 22234567
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
|++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.........+......++ ..++..+.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence 8999999999875 589999999999999999999999998888777777665543332 24788999999999999
Q ss_pred CCCCCCCH-HHHhcCCccCc
Q 040917 277 DPKRRITV-AQVLEHPWLKE 295 (494)
Q Consensus 277 dp~~Rps~-~eil~~~~~~~ 295 (494)
||++||++ +++++||||..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CHHHcCCChHHHHcCCCcCC
Confidence 99999998 58999999986
No 71
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=1e-43 Score=346.52 Aligned_cols=249 Identities=32% Similarity=0.579 Sum_probs=217.4
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++..+...|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654434444566788999999994 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREI 196 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~ 196 (494)
++|..++.....+++..+..++.||+.||.|||+ +||+||||||+||++ +.++.++|+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 799999999999999 678899999999986532 22233345
Q ss_pred cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++ ..+++.+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 78999999999864 589999999999999999999999998888777777766555443 3578999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCccCc
Q 040917 276 QDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
.||.+|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 9999999999986
No 72
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.4e-43 Score=346.80 Aligned_cols=255 Identities=30% Similarity=0.540 Sum_probs=213.7
Q ss_pred ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .......+..|+.+++.+++||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 57899999998654321 2233566788999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 6788999999999875432
Q ss_pred Cc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCC
Q 040917 190 GK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+...+...... ....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----FPSF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC----CCCC
Confidence 22 2234578999999999875 37889999999999999999999996432 22333334333222 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 262 ISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
+++.+.+++.+||..||++|| +++++++||||+.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 789999999999999999999 8899999999986
No 73
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1e-42 Score=340.32 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=217.3
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++++. ||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 378999999999999999999999999999999987532 2334677999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999 67889999999998755332
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI----------------- 252 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------------- 252 (494)
......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||......+....+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2234568999999999875 589999999999999999999999977665544332211000
Q ss_pred ---------------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 253 ---------------------------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 253 ---------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..+......+++++.+||.+||..||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 001111124678999999999999999999999999999998643
No 74
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=1.7e-43 Score=346.66 Aligned_cols=263 Identities=29% Similarity=0.438 Sum_probs=219.5
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEe
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFK 100 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~ 100 (494)
-..+++..+|.|.+.||+|.||.|-+|++..|++.||||+++... ....+...|+.+|..|. +.-|+++++
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 345677789999999999999999999999999999999997544 24566778999999996 246899999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 101 AAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
++|...++.|||+|+++ .+|+++++.+. .++...++.++.||+.||..||+.||||+||||+|||+.. .....||+
T Consensus 255 d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~-~~r~~vKV 332 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD-PKRSRIKV 332 (586)
T ss_pred eccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc-CCcCceeE
Confidence 99999999999999995 59999999875 5889999999999999999999999999999999999975 34558999
Q ss_pred eecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc--------
Q 040917 179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK-------- 249 (494)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~-------- 249 (494)
+|||+|....... + .++.+..|+|||++.| +|+.+.||||||||++||++|.+.|.+.++.+++.-|..
T Consensus 333 IDFGSSc~~~q~v-y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 333 IDFGSSCFESQRV-Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred EecccccccCCcc-e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999998754432 2 7788999999999876 799999999999999999999999999888776544421
Q ss_pred -------------C---Cc----------------------------cCCCC--C----CC-CCCHHHHHHHHHhcccCC
Q 040917 250 -------------G---EI----------------------------NFQRD--P----FP-SISSSAIELVRRMLTQDP 278 (494)
Q Consensus 250 -------------~---~~----------------------------~~~~~--~----~~-~~~~~l~~li~~~l~~dp 278 (494)
. .. ..+.. . .+ .-...+.+||.+||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0 00 00000 0 00 123567899999999999
Q ss_pred CCCCCHHHHhcCCccCcc
Q 040917 279 KRRITVAQVLEHPWLKES 296 (494)
Q Consensus 279 ~~Rps~~eil~~~~~~~~ 296 (494)
.+|+|+.++|+|||+...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999953
No 75
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=4.2e-43 Score=340.44 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=214.9
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++................|..++..+.+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654322334456677888888765799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
|+|..++.....++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999887789999999999999999999999999999999999999 6788999999999864322 22233457
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+....+....+......++ ..++..+.++|.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence 8999999999865 589999999999999999999999998888777777665443322 24788999999999999
Q ss_pred CCCCCCCHH-HHhcCCccCcc
Q 040917 277 DPKRRITVA-QVLEHPWLKES 296 (494)
Q Consensus 277 dp~~Rps~~-eil~~~~~~~~ 296 (494)
||.+||++. ++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 89999999863
No 76
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=5.6e-43 Score=340.78 Aligned_cols=256 Identities=27% Similarity=0.501 Sum_probs=221.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++..+.+||+|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999976443333345667789999988876788899999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~ 192 (494)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999 67889999999998754322 22
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.......+.+......++ ..++..+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence 234568999999999864 589999999999999999999999999888888888777655433 357899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917 272 RMLTQDPKRRIT-----VAQVLEHPWLKES 296 (494)
Q Consensus 272 ~~l~~dp~~Rps-----~~eil~~~~~~~~ 296 (494)
+||..+|.+|++ ..++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 5789999999863
No 77
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=4.9e-43 Score=341.98 Aligned_cols=250 Identities=29% Similarity=0.506 Sum_probs=211.2
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998665444445667888999998886799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~ 197 (494)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999998888889999999999999999999999999999999999999 678899999999987532 222334567
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE---------TDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
||+.|+|||++.+ .++.++|+|||||++|+|++|+.||... ......+.+......++ ..++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence 8999999999865 5889999999999999999999999521 11223333444333322 35788999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917 268 ELVRRMLTQDPKRRIT------VAQVLEHPWLKE 295 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps------~~eil~~~~~~~ 295 (494)
++|.+||..||.+||+ +.++++||||..
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999998 579999999976
No 78
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=6.9e-43 Score=335.42 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=208.3
Q ss_pred cceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE-----
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE----- 104 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~----- 104 (494)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 47889999986543222 23445667888877764 5999999999885
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
.....++||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence 2456899999996 5898888653 348999999999999999999999999999999999999 678899999999
Q ss_pred CccccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-----
Q 040917 183 LSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR----- 256 (494)
Q Consensus 183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----- 256 (494)
++.............+++.|+|||++. ..++.++|+|||||++|+|++|+.||.+....+....+........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 997655444444567899999999985 46889999999999999999999999988877766655432111100
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 257 ------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 257 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
...+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0123577889999999999999999999999999997
No 79
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=4.3e-43 Score=341.82 Aligned_cols=249 Identities=29% Similarity=0.552 Sum_probs=212.7
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.+ +||||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999997544333333445555555 45667 59999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI 196 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~ 196 (494)
|++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 6788999999999865322 2223345
Q ss_pred cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
.|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+........ +.++..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 68999999999865 588999999999999999999999999888887777776544332 4578999999999999
Q ss_pred cCCCCCCCH----HHHhcCCccCc
Q 040917 276 QDPKRRITV----AQVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rps~----~eil~~~~~~~ 295 (494)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999987 69999999975
No 80
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=9.7e-43 Score=346.41 Aligned_cols=258 Identities=21% Similarity=0.390 Sum_probs=209.2
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++|. ||||+++++++..+...++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence 368999999999999999999999999999999753 234678999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
|+|++. ++|..++.....++...+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence 999995 6899988887789999999999999999999999999999999999999 67789999999998643221
Q ss_pred -cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHc------------
Q 040917 191 -KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILK------------ 249 (494)
Q Consensus 191 -~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~------------ 249 (494)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22234578999999999865 589999999999999999999988754321 111111110
Q ss_pred --------------CCcc--CCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917 250 --------------GEIN--FQRDP---FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303 (494)
Q Consensus 250 --------------~~~~--~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~ 303 (494)
.... ..... ...++..+.++|.+||+.||.+|||+.++|+||||+..+.+...|
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 389 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP 389 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence 0000 00001 123567899999999999999999999999999999866554444
No 81
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=1.5e-42 Score=338.96 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=217.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++..+...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4799999999999999999999999999999999754433344456688899999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++|++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 999999999999976 4578999999999999999999999999999999999999 678899999999987554322
Q ss_pred cc--ccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCC
Q 040917 192 AY--REIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFPSI 262 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 262 (494)
.. ....||+.|+|||++. +.++.++|+||+||++|+|++|+.||.+....+....+......+. +...+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 21 2246899999999985 2478899999999999999999999988877777666655433222 2223458
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917 263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE 295 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~ 295 (494)
+..++++|.+||..++.+ |+++.++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999998764444 789999999999975
No 82
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=9e-43 Score=339.48 Aligned_cols=250 Identities=32% Similarity=0.587 Sum_probs=215.3
Q ss_pred eeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 38 GREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
++.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.+. ||||+++++.+..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 367999999999999864 57899999999754321 2223456788999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~ 192 (494)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence 999999999999888889999999999999999999999999999999999999 6788999999999864322 222
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..+....+ +.+++.+.++|.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 232 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK 232 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 234578999999999865 578899999999999999999999999888877777777654433 457899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 272 RMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
+||..+|++|| ++.++++||||..
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999 8999999999986
No 83
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.7e-44 Score=340.49 Aligned_cols=256 Identities=33% Similarity=0.556 Sum_probs=231.3
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe-EE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF-VH 110 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~-~~ 110 (494)
.++|.+++.+|+|+||.++.++++..++.+|+|.+........ .+....+|+.++++++ ||||+.+.+.|..++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEE
Confidence 3679999999999999999999999999999999987665444 4558889999999996 9999999999998887 99
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|||+||+||++.+.++..+ .++++.+..|+.|++.|+.|||+++|.|||||++|||+ ..+..|+|+|||+|....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcC
Confidence 9999999999999997654 58999999999999999999999999999999999999 677888999999999887
Q ss_pred cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
+.. ...+..|||.|++||++.+ +|+.++|||||||++|||++-+.+|.+.+-.+....+.++...+.+ ..++.++
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el 234 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSEL 234 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHH
Confidence 766 5567899999999999976 6999999999999999999999999999999998888887733333 4678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+.+|..||..+|..||++.++|.+|.+..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999999988874
No 84
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=3.8e-43 Score=343.36 Aligned_cols=250 Identities=30% Similarity=0.551 Sum_probs=214.2
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
||+|+||+||+|.+..+++.||+|++.+..............|..++..+. +||||+++++++......|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999996544333333444556777776654 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~ 197 (494)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888889999999999999999999999999999999999999 6788999999999865322 22234567
Q ss_pred CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..+...++. ..+++.+.++|.+||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 8999999999864 4789999999999999999999999998888877777766555443 3478999999999999
Q ss_pred cCCCCCC----CHHHHhcCCccCcc
Q 040917 276 QDPKRRI----TVAQVLEHPWLKES 296 (494)
Q Consensus 276 ~dp~~Rp----s~~eil~~~~~~~~ 296 (494)
.||.+|| ++.++++||||...
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 78999999999863
No 85
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=1.6e-42 Score=338.10 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=211.6
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||+|+.+++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998655444445667889999999997799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~ 197 (494)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence 9999998887889999999999999999999999999999999999999 678899999999987532 223334567
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-------DQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
||+.|+|||++.+ .++.++|+|||||++|+|++|..||.... .....+.+.......+ ..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 8999999999864 58899999999999999999999995422 1223333333322222 3578999999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917 270 VRRMLTQDPKRRIT------VAQVLEHPWLKE 295 (494)
Q Consensus 270 i~~~l~~dp~~Rps------~~eil~~~~~~~ 295 (494)
+.+||..||.+|++ ++++++||||..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999999998 579999999986
No 86
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=1.5e-42 Score=331.13 Aligned_cols=252 Identities=26% Similarity=0.461 Sum_probs=206.5
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.+ +||||+++.+++..+...++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999999999999999998755433333446678899999999 59999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-ccc
Q 040917 121 LFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YRE 195 (494)
Q Consensus 121 L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~ 195 (494)
|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence 9887743 3468999999999999999999999999999999999999 6788999999999876543322 234
Q ss_pred ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhc
Q 040917 196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274 (494)
Q Consensus 196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 274 (494)
..|++.|+|||++.+ .++.++|+||+||++|+|++|+.||...........+..............++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 568999999999864 5889999999999999999999999765432211122111111111222458899999999999
Q ss_pred ccCCCCCC-----CHHHHhcCCccCcc
Q 040917 275 TQDPKRRI-----TVAQVLEHPWLKES 296 (494)
Q Consensus 275 ~~dp~~Rp-----s~~eil~~~~~~~~ 296 (494)
..||++|| +++++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999863
No 87
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.2e-42 Score=351.17 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=206.5
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---- 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---- 106 (494)
...+|++++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence 3468999999999999999999999999999999885322 22457999999995 99999999887432
Q ss_pred ----CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 107 ----QFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 107 ----~~~~iv~e~~~g~sL~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
..+++||||+++ +|.+++. ....++...+..++.||+.||.|||++||+||||||+||+++ ...+.+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence 247799999975 7776664 345689999999999999999999999999999999999994 23457999
Q ss_pred eecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-----
Q 040917 179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE----- 251 (494)
Q Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~----- 251 (494)
+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.+..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987655444455678999999998864 58999999999999999999999999887665544443210
Q ss_pred ------------ccCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 252 ------------INFQRD--------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 252 ------------~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
..++.. .....|+++.+||.+||..||.+|||+.++|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 001100 012367889999999999999999999999999999864
No 88
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=4.6e-42 Score=340.27 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=212.5
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.....+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~ 94 (364)
T cd07875 17 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTP 94 (364)
T ss_pred cchhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecc
Confidence 334456789999999999999999999999999999999986543 2233456778899999999 49999999998754
Q ss_pred C------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 106 D------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 106 ~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
. ..+|+||||+++ +|.+.+.. .++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+
T Consensus 95 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 168 (364)
T cd07875 95 QKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 168 (364)
T ss_pred cccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEE
Confidence 3 357999999965 77777643 47889999999999999999999999999999999999 678899999
Q ss_pred ecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-----
Q 040917 180 DFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----- 253 (494)
Q Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----- 253 (494)
|||++.............+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999986654444445678999999999865 5899999999999999999999999887766554444321100
Q ss_pred -----------------CC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 254 -----------------FQ----------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 254 -----------------~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+. .......+..++++|.+||..||.+|||+.++|+||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 0001113467899999999999999999999999999975
No 89
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=3.2e-42 Score=330.44 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=207.4
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEe-----C
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYED-----D 106 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~-----~ 106 (494)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999999999999999987543222 22344567887777764 59999999998854 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917 107 QFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a 184 (494)
...+++||++.+ +|.+++... ..++...+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence 468999999975 888888654 348999999999999999999999999999999999999 67889999999999
Q ss_pred cccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----c-----
Q 040917 185 AFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-----N----- 253 (494)
Q Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----~----- 253 (494)
.............+++.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+....+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 86654444445668899999998864 589999999999999999999999988776655444332100 0
Q ss_pred ------CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 ------FQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ------~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+. ....+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01124578889999999999999999999999999998
No 90
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1e-42 Score=328.58 Aligned_cols=254 Identities=38% Similarity=0.691 Sum_probs=212.5
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++++ .||||+++++++......++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 8999999999999999999999999999999976543222 233345699999999 59999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCccc
Q 040917 115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAY 193 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~~~ 193 (494)
++++++|.+++.....++...+..++.||+.||.+||++|++|+||||+||++ +.++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999877889999999999999999999999999999999999999 68899999999998753 233344
Q ss_pred ccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHcCCccCCCCCCCCCCHHHHH
Q 040917 194 REIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA---ILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 194 ~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
....+++.|+|||++. ..++.++|+||||+++++|++|..||......+.... ................+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 4567899999999987 4689999999999999999999999988743333222 2222222122111223489999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+|.+||+.||++||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999997
No 91
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2e-42 Score=342.21 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=212.6
Q ss_pred hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917 23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA 102 (494)
Q Consensus 23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~ 102 (494)
.++...-.+.++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+. ||||++++++
T Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 88 (359)
T cd07876 11 QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNV 88 (359)
T ss_pred cccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeee
Confidence 344444457789999999999999999999999999999999986543 23334567789999999995 9999999999
Q ss_pred EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
+... ...|+||||+++ +|...+. ..++...+..++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~ 162 (359)
T cd07876 89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTL 162 (359)
T ss_pred eccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCE
Confidence 8643 357999999975 6766653 348899999999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc------
Q 040917 177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------ 249 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~------ 249 (494)
+|+|||++.............+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+..
T Consensus 163 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 163 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred EEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 9999999976544444445678999999999865 589999999999999999999999987765433222111
Q ss_pred ----------------CCccCCCC----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 250 ----------------GEINFQRD----------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 250 ----------------~~~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.....+.. .....++.+.++|.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 11110000 011235778999999999999999999999999999753
No 92
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=3.3e-42 Score=329.62 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=213.3
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++ +|++|+++++.+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence 378889999999999999999999999999998765444443455677899999999 4999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||++|++|.+++...+ .++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 9999999998886433 58999999999999999999999999999999999999 677889999999987654444
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
......|++.|+|||++.+ .++.++|+||+||++|+|++|..||...... +....+... ........+++.+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHH
Confidence 4344578999999999864 5889999999999999999999999765432 122222111 11112245788999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 268 ELVRRMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
+++.+||+.||++||| ++++++||||..
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 999999999975
No 93
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=6.3e-42 Score=327.71 Aligned_cols=259 Identities=27% Similarity=0.487 Sum_probs=218.9
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
.|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+ +|+||+++.+.+..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEE
Confidence 378889999999999999999999999999999765544444456678899999999 5999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||+++++|..++... ..++...+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999999999888653 358999999999999999999999999999999999999 667899999999987654444
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||...........+..............++..+.+++
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 4445678999999999864 588999999999999999999999987766544444433222222233356889999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917 271 RRMLTQDPKRRIT-----VAQVLEHPWLKES 296 (494)
Q Consensus 271 ~~~l~~dp~~Rps-----~~eil~~~~~~~~ 296 (494)
.+||..||.+||+ +.++++|+||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999874
No 94
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=1.6e-42 Score=338.14 Aligned_cols=249 Identities=28% Similarity=0.538 Sum_probs=213.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHH-HHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-MRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ++.+ +||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999976543333344556666654 5667 59999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI 196 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~ 196 (494)
|++|..++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 6788999999999865322 2223456
Q ss_pred cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
.|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+........ +..+..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 78999999999865 588999999999999999999999999888888777776544332 4578999999999999
Q ss_pred cCCCCCCCH----HHHhcCCccCc
Q 040917 276 QDPKRRITV----AQVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rps~----~eil~~~~~~~ 295 (494)
.+|.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999977 58999999986
No 95
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-43 Score=315.62 Aligned_cols=266 Identities=36% Similarity=0.616 Sum_probs=234.6
Q ss_pred cccceEe-eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 31 VQLHYTI-GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 31 ~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+.+-|++ .+.||+|+|+.|-.|....+|..+|||++.+. ..+.+..+.+|++++.+.++|+||+.++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4455664 56799999999999999999999999999765 4557889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
|+|||.+.||+|..+|.++..+++.++.+++++|+.||.+||.+||.||||||+|||...-+.-.-+|||||.+..-+.-
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999997655667799999988754321
Q ss_pred --------CcccccccCCcCccChhhhc---c---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------------
Q 040917 190 --------GKAYREIVGSPYYIAPEVLS---Q---SYGKEADIWSAGVILYILLCGVPPFWAETD--------------- 240 (494)
Q Consensus 190 --------~~~~~~~~~~~~y~aPE~~~---~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~--------------- 240 (494)
.+.+.+.+|+..|||||+.. + .|+.++|.||||+|+|-|+.|.+||.+...
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 22234567888999999863 2 388999999999999999999999976654
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
+.....|..+...|+...|..++.+.+++|..+|..++.+|.++.++++|||++.....
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 34677888999999999999999999999999999999999999999999999975433
No 96
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=4.8e-42 Score=339.05 Aligned_cols=268 Identities=24% Similarity=0.371 Sum_probs=214.6
Q ss_pred hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917 22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA 101 (494)
Q Consensus 22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~ 101 (494)
...++....+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 83 (355)
T cd07874 6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLN 83 (355)
T ss_pred eccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceee
Confidence 3444555567789999999999999999999999999999999986543 23334567788999999995 999999999
Q ss_pred EEEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917 102 AYEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV 175 (494)
Q Consensus 102 ~~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~ 175 (494)
++... ...++||||+++ +|.+.+.. .++...+..++.|++.||.|||++||+||||||+||++ +.++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~ 157 (355)
T cd07874 84 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCT 157 (355)
T ss_pred eeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCC
Confidence 88643 357999999975 67776643 48899999999999999999999999999999999999 67889
Q ss_pred EEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC----
Q 040917 176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG---- 250 (494)
Q Consensus 176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~---- 250 (494)
++|+|||++.............+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+....+...
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999986654444455678999999999865 5899999999999999999999999877654433222110
Q ss_pred ------------------CccCC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 251 ------------------EINFQ----------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 251 ------------------~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
..... .......+..+.++|.+||..||++|||+.++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00000 00111245678999999999999999999999999999854
Q ss_pred C
Q 040917 297 G 297 (494)
Q Consensus 297 ~ 297 (494)
.
T Consensus 318 ~ 318 (355)
T cd07874 318 Y 318 (355)
T ss_pred c
Confidence 3
No 97
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=1.2e-42 Score=338.11 Aligned_cols=248 Identities=29% Similarity=0.533 Sum_probs=214.7
Q ss_pred eeecccCCeEEEEEEE---CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917 39 REVGRGEFGITYLCTE---NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL 115 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~ 115 (494)
+.||+|+||.||++.+ ..+|+.||+|++...... ......+.+|+.+++++. ||||+++++++..+...|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999886 357899999999754422 223456778999999994 99999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cccc
Q 040917 116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYR 194 (494)
Q Consensus 116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~ 194 (494)
++|++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999 67889999999998765433 2233
Q ss_pred cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917 195 EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273 (494)
Q Consensus 195 ~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 273 (494)
...|++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+.+.....+ ..+++.+.++|.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 4678999999999865 578999999999999999999999998888877777766554433 35789999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCccCc
Q 040917 274 LTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 274 l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
|..||++||+ +.++++||||..
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 9999999999 778999999986
No 98
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=6.1e-42 Score=334.93 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=218.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..+ +||+|+++++.+.+....++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 3799999999999999999999999999999998654333333455678899999998 599999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 999999999999976 4578999999999999999999999999999999999999 678899999999986543222
Q ss_pred c--cccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCC
Q 040917 192 A--YREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSI 262 (494)
Q Consensus 192 ~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 262 (494)
. .....||+.|+|||++. +.++.++|+|||||++|+|++|+.||......+....+......... .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 12356899999999875 34788999999999999999999999988887777777665443322 223468
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917 263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE 295 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~ 295 (494)
++.+.+++.+||..++.+ |+++.++++||||..
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999999765554 689999999999986
No 99
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3.4e-42 Score=335.82 Aligned_cols=249 Identities=27% Similarity=0.524 Sum_probs=211.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999997543322223344445544 45667 59999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREI 196 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~ 196 (494)
|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.... ........
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 678899999999987532 22223456
Q ss_pred cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+....... .+.++..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence 78999999999875 58899999999999999999999999988887777776654332 24688999999999999
Q ss_pred cCCCCCCCHH----HHhcCCccCc
Q 040917 276 QDPKRRITVA----QVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rps~~----eil~~~~~~~ 295 (494)
.||.+||++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999975
No 100
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=5.6e-42 Score=334.94 Aligned_cols=259 Identities=27% Similarity=0.483 Sum_probs=219.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+ +||+|+.+++++...+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999998754333333455678899999988 599999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 999999999999977 4578999999999999999999999999999999999999 678899999999987654332
Q ss_pred cc--ccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCC
Q 040917 192 AY--REIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFPSI 262 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 262 (494)
.. ....|++.|+|||++.+ .++.++|+||+||++|+|++|+.||......+....+......+. +..+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 21 23568999999999863 478899999999999999999999998887777777665543332 2233567
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917 263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE 295 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~ 295 (494)
++.+.++|.+||..++.+ |++++++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 899999999999876654 568999999999985
No 101
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=4.6e-42 Score=338.70 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=208.6
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
..+|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+. ||||+++++++...+.+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence 367889999999999999999999999999999986432 2334677889999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 9999999998653 345678888999999999999999999999999999999 67889999999998765432
Q ss_pred cccccccCCcCccChhhhcc-----c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-----S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-----~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.......|+..|+|||++.. . .+.++|||||||++|+|++|+.||......+....+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 12234578999999998743 1 35689999999999999999999974433222222111111112222346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+.++|.+||..||++||++.++|+||||....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999999999754
No 102
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=1.2e-41 Score=332.79 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=214.2
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence 368999999999999999999999999999999986532 2334567899999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||||++|++|.+++...+.++...+..++.+++.|+.|||+. +++|+||||+||++ +.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999 57788999999998754322
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---CC---------------
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---GE--------------- 251 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---~~--------------- 251 (494)
......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+.. +.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234568899999999875 588999999999999999999999976654433222110 00
Q ss_pred ------------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 252 ------------------------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 252 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
...+.......+..+.+||.+||..||++|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000112356789999999999999999999999999999864
No 103
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2e-42 Score=332.12 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=213.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...++.++.||+|.||.||.|.+.. ...||+|.++.... ..+.+.+|+.+|++|+ |++|+++++++..+..+||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEE
Confidence 3556778899999999999999874 44799999975433 4567889999999996 9999999999999888999
Q ss_pred EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
||||++.|+|.+++.. ...+.....+.++.||++|++||+++++|||||-+.|||| +++..+||+|||+|+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCC
Confidence 9999999999999986 4568999999999999999999999999999999999999 7889999999999995543
Q ss_pred Cccccc--ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAYRE--IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~~~--~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
...... ..-...|.|||+++ +.++.+||||||||+|+||+| |+.||.+.+..+++..+.++...+.+ +.+|+.
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~~ 432 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPDE 432 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCHH
Confidence 332211 12245799999987 579999999999999999998 89999999999999999998666555 468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+-+++..||..+|++|||++.+..
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHH
Confidence 999999999999999999997654
No 104
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=6.9e-42 Score=331.44 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=213.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 679999999999999999999999999999999865432 223445778999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||+++ +|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 999975 8888776543 47899999999999999999999999999999999999 678899999999987543222
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--------------- 253 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------------- 253 (494)
......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..+....+.+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2233567899999998854 4789999999999999999999999887766554444321100
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 254 ----FQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 254 ----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
++. ...+.+++++.++|.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 11235788999999999999999999999999999999754
No 105
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=7.9e-42 Score=325.65 Aligned_cols=248 Identities=27% Similarity=0.484 Sum_probs=206.5
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|+||.||+|.++.+|+.||+|++.............+..|+.+++.+ +||||+++++++..+...++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999999754443333345566799999999 59999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917 121 LFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198 (494)
Q Consensus 121 L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 198 (494)
|..++.... .++...+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||++.............+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence 998886543 48889999999999999999999999999999999999 6788999999999876655444445678
Q ss_pred CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQRDPFPSISSSAIELVRRM 273 (494)
Q Consensus 199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 273 (494)
++.|+|||++.+ .++.++|+||+||++|+|++|+.||...... .+........... ....++..+.+++.+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence 999999999864 5899999999999999999999999765432 2222222222221 2246789999999999
Q ss_pred cccCCCCCCCH----HHHhcCCccCc
Q 040917 274 LTQDPKRRITV----AQVLEHPWLKE 295 (494)
Q Consensus 274 l~~dp~~Rps~----~eil~~~~~~~ 295 (494)
|+.||++||++ ++++.||||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999 67889999986
No 106
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=6.2e-42 Score=333.46 Aligned_cols=249 Identities=28% Similarity=0.532 Sum_probs=210.7
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997544333333445555654 56777 59999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI 196 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~ 196 (494)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence 99999988888889999999999999999999999999999999999999 6788999999999875322 2222345
Q ss_pred cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
.|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+.......+ +..+..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 78999999999865 588999999999999999999999998887777777766543332 3567899999999999
Q ss_pred cCCCCCCCH----HHHhcCCccCc
Q 040917 276 QDPKRRITV----AQVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rps~----~eil~~~~~~~ 295 (494)
.||.+||++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999875 59999999975
No 107
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=4.4e-42 Score=337.75 Aligned_cols=269 Identities=24% Similarity=0.416 Sum_probs=216.5
Q ss_pred hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917 23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA 102 (494)
Q Consensus 23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~ 102 (494)
.+.+....+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||++++++
T Consensus 5 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 82 (343)
T cd07878 5 ELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDV 82 (343)
T ss_pred HHhHHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhh
Confidence 4455667788999999999999999999999999999999999865332 2223456778999999995 9999999988
Q ss_pred EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
+... ...|++++++ |++|.+++. ...++...+..++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~ 157 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCEL 157 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCE
Confidence 7532 4578999998 778987765 4569999999999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917 177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-- 252 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-- 252 (494)
||+|||++..... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 158 kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 158 RILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred EEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999876533 2334578999999999865 488999999999999999999999987665444333321100
Q ss_pred ---------------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917 253 ---------------------NFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300 (494)
Q Consensus 253 ---------------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~ 300 (494)
..+. ..+...++.+.++|.+||..||.+|||+.++|+||||.....+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 0000 01224567789999999999999999999999999998755443
No 108
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=2.8e-41 Score=324.15 Aligned_cols=254 Identities=31% Similarity=0.613 Sum_probs=222.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++......++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence 36999999999999999999999999999999997655444445677889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||+++++|.+++.....++...+..++.||+.||.|||++|++|+||+|.||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999999999999999999999 67789999999998765443
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.........+.+..+...++ ..++..+.++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence 234568899999998754 578899999999999999999999988877666666665544333 346899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCccCcc
Q 040917 272 RMLTQDPKRRI-----TVAQVLEHPWLKES 296 (494)
Q Consensus 272 ~~l~~dp~~Rp-----s~~eil~~~~~~~~ 296 (494)
+||..||.+|+ ++.++++||||...
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 99999999999 99999999999763
No 109
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2.9e-41 Score=344.95 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=218.9
Q ss_pred cccceEeeeeecccCCeEEEEEEECCC-CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENST-GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
....|.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+.+|+.+++.+ +||||+++++++..++..
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEE
Confidence 445699999999999999999998877 788999987432 233455678899999999 499999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 110 HIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
|+||||++||+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence 999999999999987753 3468999999999999999999999999999999999999 678899999999998
Q ss_pred ccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 186 FIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 186 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....++...+..+..... ...
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence 6543221 234568999999999865 589999999999999999999999998888888777766544322 135
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
++..+.++|.+||..||++||++.+++.|||++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 7899999999999999999999999999999975
No 110
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=3.7e-41 Score=318.63 Aligned_cols=255 Identities=30% Similarity=0.514 Sum_probs=215.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+.|.+.+.||+|++|.||.|.+..+++.|++|.+....... ......+.+|+.+++++ +||||+++++++..+...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 46999999999999999999999999999999986543222 12245688899999999 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+|+||++|++|.+++...+.++...+..++.+++.|+.|||+.|++||||+|+||++ +.++.++|+|||.+......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence 999999999999999888889999999999999999999999999999999999999 67789999999998754322
Q ss_pred ccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 191 KAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 191 ~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
... ....++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||...........+....... .....++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHH
Confidence 111 23456789999999865 48899999999999999999999997766655544443332221 122467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.++|.+||..+|.+||++.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 111
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=1.3e-41 Score=337.86 Aligned_cols=257 Identities=30% Similarity=0.445 Sum_probs=212.6
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-----e
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-----F 108 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-----~ 108 (494)
+|++++.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++ ||||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 4788999999999999999999999999999986432 22334567889999999995 999999999998766 7
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.|+|+||+. ++|.+.+.....++...+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 899999996 5888888777789999999999999999999999999999999999999 678899999999987543
Q ss_pred cCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------------
Q 040917 189 EGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--------------- 249 (494)
Q Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~--------------- 249 (494)
... ......+++.|+|||++.+ .++.++||||+||++|+|++|+.||.+.........+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 2233467889999999875 378999999999999999999999988776655444322
Q ss_pred --------CCccCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 250 --------GEINFQR-----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 250 --------~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.....+. ......++.+.++|.+||..||.+|||+.++|+||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1111110 1123457889999999999999999999999999999874
No 112
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=3.3e-41 Score=355.13 Aligned_cols=265 Identities=32% Similarity=0.538 Sum_probs=217.6
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-- 105 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-- 105 (494)
.+....+|++++.||+|+||+||+|.+..++..||+|++..... .......+..|+.+++.|. ||||+++++++..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence 44556799999999999999999999999999999999875543 3334677889999999995 9999999998854
Q ss_pred CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEEeeC----
Q 040917 106 DQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSK-------GVMHRDLKPENFLFTTG---- 170 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~-------~i~H~dikp~NIli~~~---- 170 (494)
...+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+. +|+||||||+|||+...
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 45789999999999999988652 5699999999999999999999985 49999999999999531
Q ss_pred ----------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917 171 ----------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWA 237 (494)
Q Consensus 171 ----------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~ 237 (494)
+..+.++|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2245699999999986644433445678999999999853 478999999999999999999999976
Q ss_pred CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 238 ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
............... ..+....+..+.+||..||..+|.+||++.++|.|||++...
T Consensus 246 ~~~~~qli~~lk~~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 246 ANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCcHHHHHHHHhcCC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 655433333222222 222346789999999999999999999999999999998543
No 113
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=3.7e-41 Score=344.30 Aligned_cols=257 Identities=31% Similarity=0.504 Sum_probs=218.8
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--- 107 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--- 107 (494)
...+|++.+.||+|+||+||+|.+..+|+.||+|++..... +......+.+|+.++..+ +|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccC
Confidence 44799999999999999999999999999999999976543 333456788899999999 4999999888764322
Q ss_pred -----eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 108 -----FVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 108 -----~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 478999999999999988643 458999999999999999999999999999999999999 57889999
Q ss_pred eecCCccccccC---cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917 179 TDFGLSAFIEEG---KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 179 ~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....++...+..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999998764322 12234678999999999875 58999999999999999999999999888877777776654432
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
. .+.+++.+.+++.+||..||.+||++.++++|||++.
T Consensus 265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2 2468899999999999999999999999999999875
No 114
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=2.3e-41 Score=345.56 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=204.8
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEeEEEE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFKAAYE 104 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~~~~~ 104 (494)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++ +|++++.+++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999986421 12344566787777774 2456888888887
Q ss_pred eC-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCC-----------
Q 040917 105 DD-QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGD----------- 171 (494)
Q Consensus 105 ~~-~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~----------- 171 (494)
.. .++|+||+++ |++|.+++.+.+.++...+..++.||+.||.|||+ .||+||||||+|||++..+
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 54 5789999998 77999999888889999999999999999999998 5999999999999995322
Q ss_pred --CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 040917 172 --ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248 (494)
Q Consensus 172 --~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~ 248 (494)
....+||+|||.+.... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 12359999999875432 22345678999999999875 58999999999999999999999998877655544332
Q ss_pred cCCccCCC---------------------------C---------CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 249 KGEINFQR---------------------------D---------PF--PSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 249 ~~~~~~~~---------------------------~---------~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.....++. . .+ ...++.+.+||.+||..||.+|||++|+|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 21110000 0 00 0113567899999999999999999999999
Q ss_pred CccCcc
Q 040917 291 PWLKES 296 (494)
Q Consensus 291 ~~~~~~ 296 (494)
|||...
T Consensus 439 p~~~~~ 444 (467)
T PTZ00284 439 PYVLKY 444 (467)
T ss_pred cccccc
Confidence 999874
No 115
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=8.3e-43 Score=330.22 Aligned_cols=253 Identities=33% Similarity=0.637 Sum_probs=232.1
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.+.||+|.||+||-|+++++|+.||||++.+-.+... ..+++.+|+.+|+.+. ||+|+.+.-.++..+.+++|||.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhc
Confidence 4679999999999999999999999999998887665 4588999999999995 9999999999999999999999997
Q ss_pred CCchHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccc
Q 040917 118 GGELFDRI-V-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE 195 (494)
Q Consensus 118 g~sL~~~~-~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 195 (494)
| +..+.| . ..+++++.....++.||+.||.|||-++|+|.||||+|||+.+.+....+||||||+|+.+.....-++
T Consensus 647 G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 647 G-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred c-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 6 555544 3 457899999999999999999999999999999999999998878889999999999999988777788
Q ss_pred ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhc
Q 040917 196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274 (494)
Q Consensus 196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 274 (494)
.+|||.|.|||++.. .|...-|+||+|+|+|.-++|..||. ..+++-++|.+..+.+++.+|..+++.+.+||..+|
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 999999999999964 69999999999999999999999995 345688889999999999999999999999999999
Q ss_pred ccCCCCCCCHHHHhcCCccCc
Q 040917 275 TQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 275 ~~dp~~Rps~~eil~~~~~~~ 295 (494)
+..-.+|.|.++.|.|||+++
T Consensus 804 qVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHhcchHhhccchhhhc
Confidence 999999999999999999997
No 116
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=6.3e-41 Score=323.50 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=212.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+. ||||+++++++......++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 223456778999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||+++ +|.+++... ..++...+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||.+.......
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence 999974 898887654 468899999999999999999999999999999999999 678899999999987543222
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--------------- 253 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------------- 253 (494)
......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||...+..+....+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2233456889999998864 4788999999999999999999999887766554433221100
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 254 ----FQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 254 ----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+. ...+.+++.+.++|.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 01235788999999999999999999999999999998654
No 117
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=9.2e-41 Score=319.94 Aligned_cols=256 Identities=29% Similarity=0.537 Sum_probs=212.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 479999999999999999999999999999999865432 2223456789999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||+++++|..++.....+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 9999998888877666679999999999999999999999999999999999999 677899999999998654433
Q ss_pred ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917 192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI----------------- 252 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------------- 252 (494)
......++..|+|||.+.+ .++.++|+||+|+++++|++|..||.+....+....+.+...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2234457889999999864 478899999999999999999999988776544433321100
Q ss_pred --cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 253 --NFQR--------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 253 --~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..+. ..++.++..+.+++.+||..+|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0124568889999999999999999999999999998
No 118
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-43 Score=337.37 Aligned_cols=260 Identities=31% Similarity=0.489 Sum_probs=228.0
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+..+.|.|+.-||.|+||.||+|.++.++-..|.|++.. .+....+++.-|+++|... +||+|+++++.|..++.+
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkL 104 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKL 104 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCce
Confidence 455789999999999999999999999999999999853 3456788899999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+|..|||.||.+...+..- ..+++..+..+++|+|+||.|||+++|||||||+.|||+ .-+|.++|+|||.+....
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccch
Confidence 9999999999998888764 469999999999999999999999999999999999999 688999999999886543
Q ss_pred cC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 189 EG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
.. ..-.+..|||+|||||+.. .+|++++||||||++|.+|..+.+|-...++..++-.+.+..++....+ ..
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~ 260 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SH 260 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-ch
Confidence 22 2234678999999999863 4699999999999999999999999998898888888877655443322 56
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
|+..+.+|+.+||.+||..||++.++|+|||+++.+
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 889999999999999999999999999999999754
No 119
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=3.3e-41 Score=318.09 Aligned_cols=252 Identities=29% Similarity=0.503 Sum_probs=217.9
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++++ +||||+++++.+..+...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 589999999999999999999999999999999765544444577899999999999 5999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~ 193 (494)
||++|++|.+++.....+++..+..++.+|+.||.|||++|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999 67889999999998766544344
Q ss_pred ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 194 REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 194 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||..... .......... .....+.++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----DVLYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----cccCcccCcHHHHHH
Confidence 45667889999999865 478999999999999999999999987764 3333222221 122224678999999
Q ss_pred HHHhcccCCCCCCCH--HHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITV--AQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~--~eil~~~~~ 293 (494)
|.+||..||.+||++ .++++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
No 120
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=1.5e-40 Score=323.18 Aligned_cols=259 Identities=32% Similarity=0.579 Sum_probs=220.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||+|.+..+++.||+|.+.............+.+|+.+++.+. ||||+++++.+......++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence 37999999999999999999999999999999998765444345667889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9999999999998754 468999999999999999999999999999999999999 56789999999988654221
Q ss_pred cc------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 040917 191 KA------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET 239 (494)
Q Consensus 191 ~~------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~ 239 (494)
.. .....|+..|+|||++.+ .++.++||||||+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 112357888999999865 57889999999999999999999998888
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCccCccC
Q 040917 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT----VAQVLEHPWLKESG 297 (494)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~eil~~~~~~~~~ 297 (494)
.......+......++.. ..++..+.++|.+||..+|++||+ +.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 776666665544333322 337899999999999999999999 99999999998743
No 121
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-42 Score=328.89 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=224.4
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+....|.-.+-||+|+||.||.|++..+.+.||||...-+.-.+...-.++..|+..|++|. |||++.+-++|..+...
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA 101 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence 34456777889999999999999999999999999987655555556678899999999996 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++|||||-| |-.+++.- .+++.+-.|..|....+.||.|||+.+.||||||+.|||+ .+.|.|||+|||.|....
T Consensus 102 WLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcC
Confidence 999999965 77777753 3568899999999999999999999999999999999999 789999999999998764
Q ss_pred cCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
+ .++.+|||+|||||++. |+|+-++||||||++..+|.-.++|+...+....+--|..+..+... .+.|+.
T Consensus 178 P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~ 252 (948)
T KOG0577|consen 178 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSD 252 (948)
T ss_pred c---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHH
Confidence 3 35689999999999984 68999999999999999999999999888888776666655444333 357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.++.|+..||++-|.+|||.+++|.|+|...
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999999999999999986
No 122
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=2.1e-40 Score=320.83 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=214.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..++..+++|.+.... .......+.+|+.+++++ +||||+++++++..++.+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence 36999999999999999999999999999999986432 233456788999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++|++|.+++...+.++...+..++.|++.||.|||+ .+++|+||+|.||++ +.++.++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999997 599999999999999 56788999999998754332
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC----------------
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF---------------- 254 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------- 254 (494)
......+++.|+|||.+.+ .++.++|+|||||++++|++|+.||...........+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2234568899999999865 48889999999999999999999997655443333222111000
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 255 ------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 255 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+..+...++..+.+++.+||..+|++||++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011112367889999999999999999999999999999864
No 123
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.4e-40 Score=316.63 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=218.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||.|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.+. ||||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence 47899999999999999999999999999999986543 2234567889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-c
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-K 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~ 191 (494)
+||+++++|.+++... +++...+..++.|++.|+.|||+.+++|+||+|+||++ ++++.++|+|||.+...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 9999999999998765 78999999999999999999999999999999999999 67889999999998766443 2
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...........+......... ...++..+.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence 2234567888999998864 5899999999999999999999999877665555544443222111 122788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
.+||..+|++||+++++++||||.....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999999999997543
No 124
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-41 Score=324.65 Aligned_cols=254 Identities=26% Similarity=0.474 Sum_probs=203.5
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
+..|++.+.||+||.+.||++..-.. ..+|+|.+.-.. .+....+.+.+|+..|.+|++|.+|+.++++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 36799999999999999999996544 456666554322 3556788999999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+= ..+|..++..... ++.-.+..+..|++.++.++|++||||.||||.|+++ -.|.+||+|||.|..+.+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence 99975 4588888876654 3335888999999999999999999999999999999 4789999999999877543
Q ss_pred cc---cccccCCcCccChhhhcc------------cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccC
Q 040917 191 KA---YREIVGSPYYIAPEVLSQ------------SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINF 254 (494)
Q Consensus 191 ~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~ 254 (494)
.. ....+||+.||+||.+.. ..++++||||||||+|+|+.|+.||..... ..-+..|.......
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 22 245789999999998831 157899999999999999999999955442 22223333332211
Q ss_pred CCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 255 QRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 255 ~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+++.+| .++.++++.||.+||.+||++.++|+|||++-
T Consensus 593 ---efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 ---EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ---cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 222222 23899999999999999999999999999985
No 125
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=2.6e-40 Score=311.48 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=217.5
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+. ||||+++++++......++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence 488999999999999999999999999999998754433 345677889999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||++|++|.+++... ..++...+..++.+++.|+.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence 999999999998764 568999999999999999999999999999999999999 577899999999987654332
Q ss_pred c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....+++.|+|||++.+ .++.++|+|||||++++|++|+.||...........+..+...... ..++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2 223467889999998864 5789999999999999999999999888877766666655432221 2578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.+||..+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999996
No 126
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=9.4e-41 Score=316.63 Aligned_cols=254 Identities=31% Similarity=0.473 Sum_probs=212.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.+ +||||+++++.+......++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999986543 22345678899999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+|||+++++|.+++...+.+++..+..++.|++.|+.|||++|++|+||||+||++ +.++.++|+|||.+.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 99999999999999888889999999999999999999999999999999999999 678899999999986543221
Q ss_pred -ccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCHH
Q 040917 192 -AYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISSS 265 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 265 (494)
......|++.|+|||++. +.++.++|+|||||++|+|++|..||...................+. .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 123456889999999873 35888999999999999999999999765544433333333222211 112357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPW 292 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~ 292 (494)
+.++|.+||..+|++||+++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
No 127
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=2.2e-40 Score=320.30 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=219.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.+ +||||+++++.+..+...++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence 699999999999999999999999999999998765433333456788999999999 4999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-- 191 (494)
||++|++|.+++...+.+++..+..++.+++.|+.|||++|++||||+|.||++ +..+.++|+|||.+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence 999999999999888889999999999999999999999999999999999999 678899999999876311000
Q ss_pred --------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917 192 --------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256 (494)
Q Consensus 192 --------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (494)
......++..|+|||.+.+ .++.++|+|||||++|+|++|..||.+....+............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0012356788999998754 5889999999999999999999999988887777776665544443
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917 257 DPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE 295 (494)
Q Consensus 257 ~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~ 295 (494)
.. ..++..+.++|.+||..+|++||+ +.++|+||||..
T Consensus 238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 32 267899999999999999999998 789999999975
No 128
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-41 Score=341.79 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=216.9
Q ss_pred hhhhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccE
Q 040917 19 LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98 (494)
Q Consensus 19 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~ 98 (494)
......+....--.-+++|.+.|.+|||+.||+|.+...|..||+|.+... +......+.+|+.+|+.|++|+|||.
T Consensus 23 ~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~ 99 (738)
T KOG1989|consen 23 SENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVS 99 (738)
T ss_pred cccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceee
Confidence 334555555555567899999999999999999999988899999998543 56678889999999999999999999
Q ss_pred EeE-EEEe----C--CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEE
Q 040917 99 FKA-AYED----D--QFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLF 167 (494)
Q Consensus 99 ~~~-~~~~----~--~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli 167 (494)
+++ .... + -.+.|.||||.||.|.++|..+ ..|++.++++|++++++||.+||..+ |||||||.+|||+
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 999 3321 1 2577999999999999999743 45999999999999999999999987 9999999999999
Q ss_pred eeCCCCCeEEEeecCCccccccCc-cc---------ccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCC
Q 040917 168 TTGDENAVVKATDFGLSAFIEEGK-AY---------REIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVP 233 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~~~~~-~~---------~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~ 233 (494)
..+++.||||||.|...-... .. -....|+.|+|||++. .+++.|+|||+|||+||-|+....
T Consensus 180 ---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 180 ---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred ---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 678899999999997532222 11 1134689999999984 358999999999999999999999
Q ss_pred CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 234 PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
||...... .|.++...+++. +.++..+.+||..||+.||.+||++.+++.+
T Consensus 257 PFe~sg~l----aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 257 PFEESGKL----AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CcCcCcce----eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 99766443 455666666654 6899999999999999999999999998874
No 129
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=2.1e-40 Score=315.06 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=211.5
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----- 105 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----- 105 (494)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++.+||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4578999999999999999999999999999999986432 2346788899999999679999999999864
Q ss_pred -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 106 -DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 106 -~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
....+++|||+.+++|.+++... ..+++..+..++.|++.|+.|||+++|+|+||+|+||++ +.++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCC
Confidence 24689999999999999998763 358899999999999999999999999999999999999 678899999999
Q ss_pred CccccccC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917 183 LSAFIEEG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
++...... .......+++.|+|||++. ..++.++|+||+||++|+|++|..||...........+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--P 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC--C
Confidence 98754322 1223456788999999874 2478899999999999999999999977665544443333221 2
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
......++..+.+++.+||..+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22224678899999999999999999999999999997
No 130
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=2.9e-40 Score=313.07 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=216.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||.|++|+||+|.+..++..+++|++....... ....+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence 37999999999999999999999899999999986544222 5678899999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 113 MELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|+++|++|.+++... ..+++..+..++.|++.|+.+||++|++||||+|+||++ ++++.++|+|||.+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence 9999999999999764 358999999999999999999999999999999999999 5678899999999876543
Q ss_pred Cccc-----ccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC--CC
Q 040917 190 GKAY-----REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP--FP 260 (494)
Q Consensus 190 ~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 260 (494)
.... ....++..|+|||.+.. .++.++|+|||||++++|++|+.||...+................... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3221 23457889999998864 488999999999999999999999988776665555544432222211 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+++.+.+++.+||..||++||++.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999997
No 131
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=1e-40 Score=327.37 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=200.7
Q ss_pred ccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.++.++.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 36899999999999999999975 2446789999986432 2234567889999999996699999999988654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 040917 107 -QFVHIVMELCAGGELFDRIVAR--------------------------------------------------------- 128 (494)
Q Consensus 107 -~~~~iv~e~~~g~sL~~~~~~~--------------------------------------------------------- 128 (494)
..+++||||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4688999999999999988653
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---ccccCCc
Q 040917 129 -----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP 200 (494)
Q Consensus 129 -----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~ 200 (494)
..++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......... ....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 236778889999999999999999999999999999999 56789999999999764332211 1234567
Q ss_pred CccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917 201 YYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG-VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277 (494)
Q Consensus 201 ~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 277 (494)
.|+|||++.+ .++.++|||||||++|+|++ |..||.+..... ....+..+... . ....+++.+.+++.+||..|
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-R--APENATPEIYRIMLACWQGD 317 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHccCC
Confidence 8999998854 58999999999999999997 999998765433 33333333221 1 12467889999999999999
Q ss_pred CCCCCCHHHHhc
Q 040917 278 PKRRITVAQVLE 289 (494)
Q Consensus 278 p~~Rps~~eil~ 289 (494)
|.+|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
No 132
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=3.5e-40 Score=317.35 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=218.0
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
+.....+|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.+ +||||+++++.+..+.
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGD 90 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCC
Confidence 45566899999999999999999999999999999999865432 2346688999999999 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++||||++|++|.+++.. ..++...+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||.+...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhc
Confidence 99999999999999998865 468999999999999999999999999999999999999 67789999999988754
Q ss_pred ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
..... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+...... .......++..
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI 245 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHH
Confidence 33221 223467889999998865 4789999999999999999999999877665443333332221 11122467889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+.+++.+||..+|++||++.++++||||...
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999864
No 133
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=2.4e-40 Score=316.86 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=207.4
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 58999999999999999999999999999999865432 2223467788999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 114 ELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 114 e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||++ ++|.+++... ..++...+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 9997 5888887543 458999999999999999999999999999999999999 67889999999998654322
Q ss_pred c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc---------------
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI--------------- 252 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--------------- 252 (494)
. ......+++.|+|||++.+ .++.++|+|||||++++|++|+.||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 1223456889999998864 468899999999999999999999987665433322211000
Q ss_pred ----------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 253 ----------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 253 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.........+++++.++|.+||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00011124578899999999999999999999999999997
No 134
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=4.1e-40 Score=310.08 Aligned_cols=253 Identities=31% Similarity=0.526 Sum_probs=217.4
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.+|+|.+....... .....+.+|+.+++.+. ||||+++++.+......++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 5899999999999999999999999999999997654333 34677889999999995 999999999999899999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||++|++|.+++... ..+++..+..++.+++.++.|||++|++|+||+|.||+++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence 999999999999764 3489999999999999999999999999999999999995 345678999999998765444
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......++..|+|||.+.+ .++.++|+||+|+++++|++|+.||...........+........ ...++..+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHHHH
Confidence 4444567889999999864 478899999999999999999999988877666666555433221 135789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcc
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+||..+|.+|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
No 135
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=3.7e-40 Score=312.53 Aligned_cols=253 Identities=31% Similarity=0.525 Sum_probs=213.1
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh------hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD------VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
+|.+...||+|++|.||+|.+..+++.||+|.+........ ...+.+.+|+.+++++. ||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 58889999999999999999999999999998865433221 12356888999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++++||+++++|.+++...+.++...+..++.|++.||.|||++|++||||+|+||++ ++++.++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence 999999999999999999888889999999999999999999999999999999999999 67889999999998765
Q ss_pred ccCcc-------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917 188 EEGKA-------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259 (494)
Q Consensus 188 ~~~~~-------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (494)
..... .....+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...........+..... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence 42111 112357889999998864 578899999999999999999999987766544444433211 1122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..++..+.++|.+||+.+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4578999999999999999999999999999997
No 136
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=2.4e-40 Score=312.92 Aligned_cols=249 Identities=32% Similarity=0.626 Sum_probs=214.7
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||.|++|.||+|.+..+++.|++|++.+...........+.+|+.+++.+ +||||+++++.+.++...++++||++|++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 69999999999999999999999999766554444567899999999999 59999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCc
Q 040917 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200 (494)
Q Consensus 121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 200 (494)
|.+++.+...++...+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.............+++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence 99999887789999999999999999999999999999999999999 678899999999998765443333456788
Q ss_pred CccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917 201 YYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277 (494)
Q Consensus 201 ~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 277 (494)
.|+|||.+.+ .++.++|+||+|+++|+|++|..||.... .......+..+......+ ...+..+.++|.+||..+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 9999998764 58899999999999999999999998777 555555555322222221 234889999999999999
Q ss_pred CCCCCC-----HHHHhcCCccCc
Q 040917 278 PKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 278 p~~Rps-----~~eil~~~~~~~ 295 (494)
|++||+ +.++++||||++
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhC
Confidence 999999 999999999986
No 137
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.8e-40 Score=319.95 Aligned_cols=263 Identities=29% Similarity=0.483 Sum_probs=216.3
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... .......+.+|+.+++.++ ||||+++++++.+....++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 589999999999999999999999999999999765433 1223456778999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||||+ +++|.+++.... .++...+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence 99999 889999997765 79999999999999999999999999999999999999 67889999999998765433
Q ss_pred c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------------
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------------ 255 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------ 255 (494)
. ......+++.|+|||.+.+ .++.++|+|||||++++|++|..||.+....+....+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 2233456788999998854 478899999999999999999888877766554444322110000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917 256 ------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301 (494)
Q Consensus 256 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~ 301 (494)
...+...+..+.++|.+||..+|++|||+.++++||||++...+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0012345788999999999999999999999999999998776543
No 138
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=5e-40 Score=309.78 Aligned_cols=252 Identities=27% Similarity=0.554 Sum_probs=213.0
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCeEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQFVHIV 112 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~~~iv 112 (494)
.|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++ |||++++++.+.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865433 2334567889999999995 9999999998764 4468999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+++++|.+++... ..+++..+..++.+++.|+.+||++|++||||+|+||++ +.++.++|+|||.+......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999999999988763 358999999999999999999999999999999999999 67889999999998765432
Q ss_pred c-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
. ......+++.|+|||++.+ .++.++|+||+||++++|++|+.||...........+..+.... ....+++.+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 2 2233467889999998864 57889999999999999999999998877666655555543322 22457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
++.+||..+|++||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
No 139
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=2.3e-40 Score=312.67 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=212.3
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|++|.||+|.+..+++.||+|++.+...........+..|..++....+|||++++++++..++..++|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999987544322223344555665555544799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198 (494)
Q Consensus 119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 198 (494)
++|.+++...+.++...+..++.|++.||.|||+.+++||||+|+||++ +.++.++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence 9999999888889999999999999999999999999999999999999 6778999999998865432 223457
Q ss_pred CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277 (494)
Q Consensus 199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 277 (494)
++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+......++......++..+.+++.+||..+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 889999999865 4789999999999999999999999888887777776665555544444568999999999999999
Q ss_pred CCCCCC---HHHHhcCCccCc
Q 040917 278 PKRRIT---VAQVLEHPWLKE 295 (494)
Q Consensus 278 p~~Rps---~~eil~~~~~~~ 295 (494)
|++||+ ++++++||||.+
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHccCCCcHHHHHcChHhhc
Confidence 999995 479999999975
No 140
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.9e-40 Score=314.56 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=211.3
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
...+|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++++. ||||+++++++..+...+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW 82 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence 3468999999999999999999999999999999986432 123456888999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||||+++++|.+++.....++...+..++.|++.|+.|||++||+||||+|.||++ +.++.++|+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence 999999999999999887889999999999999999999999999999999999999 67788999999998765322
Q ss_pred c-ccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCH
Q 040917 191 K-AYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISS 264 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 264 (494)
. ......+++.|+|||.+. ..++.++|+||+||++|+|++|..||...........+.......+. .....++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2 123356788999999873 34778999999999999999999999655443332222222222111 11235788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPW 292 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~ 292 (494)
.+.+++.+||..+|++||+++++|+|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999999987
No 141
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=2.2e-40 Score=318.91 Aligned_cols=263 Identities=31% Similarity=0.503 Sum_probs=218.5
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
..+...+|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGD 89 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 35566899999999999999999999999999999999864332 2346688899999999 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++||||++|++|.+++.+ ..++...+..++.+++.||.|||+.|++||||||+||++ +.++.++|+|||.+...
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEc
Confidence 99999999999999998865 468999999999999999999999999999999999999 67889999999998765
Q ss_pred ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
..... .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||...........+...... .......++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSAV 244 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCHH
Confidence 43322 223467889999998865 5789999999999999999999999776654333222222111 11122457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
+.+++.+||..+|++||++.++++||||+.....
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 9999999999999999999999999999975543
No 142
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=2.8e-40 Score=315.69 Aligned_cols=241 Identities=18% Similarity=0.196 Sum_probs=206.7
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CCeEEEEEe
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVME 114 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~~~~iv~e 114 (494)
..||+|+++.||+|.. +|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999997 58999999997654433334577889999999995 9999999999876 347899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917 115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~ 193 (494)
|++||+|.+++.....++......++.+++.|+.|||+. +++||||||+||++ +.++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 999999999998888899999999999999999999985 99999999999999 678899999999987543322
Q ss_pred ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 194 REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 194 ~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+......+..+ ...++.+.+++
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 23467889999999864 68999999999999999999999999888888777776554433322 35789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 040917 271 RRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~ 289 (494)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999986
No 143
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=2.3e-40 Score=316.18 Aligned_cols=257 Identities=33% Similarity=0.494 Sum_probs=217.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|++|.||+|.+..++..|++|++... .......+.+|+.+++++. ||||+++++.+..+...++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence 46799999999999999999999989999999998643 3334567889999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||||+++++|.+++... ..+++..+..++.|++.|+.|||++||+|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence 99999999999988764 468999999999999999999999999999999999999 67889999999987654322
Q ss_pred c-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 191 K-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
. ......+++.|+|||.+. ..++.++|+|||||++|+|++|+.||...........+......... ....++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCC
Confidence 2 223346788999999874 23677999999999999999999999887776665555544322211 124578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
..+.++|.+||..+|.+||++.++++||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999999864
No 144
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-42 Score=296.74 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=206.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----C
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----D 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----~ 106 (494)
+.||+|.+.||+|||+.||++.+..++..+|+|.+.... ....+...+|++..+++. ||||++++++... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence 479999999999999999999999999999999997654 346788899999999995 9999999887643 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEee
Q 040917 107 QFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
...||+++|+..|||.+.+... ..+++..+..|+..|++||++||... ++||||||.||++ .+.+.++|+|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEe
Confidence 3599999999999999988643 25899999999999999999999998 9999999999999 5689999999
Q ss_pred cCCcccccc----Cc------ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH--HHH
Q 040917 181 FGLSAFIEE----GK------AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQ--GVA 244 (494)
Q Consensus 181 fg~a~~~~~----~~------~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~ 244 (494)
||++....- .. .+....+|..|+|||.++- ..+.++|||||||++|.|+.|..||...-.. .+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999876431 11 1123457999999999863 3789999999999999999999999432221 122
Q ss_pred HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
-++.++...++.. ..+|+.+.++|++||+.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2334445555544 3489999999999999999999999999873
No 145
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-43 Score=313.23 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=219.6
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.+-|.+++.||+|+||.||+|.++.+|+.+|+|.+.... ....+..|+.++++.. .|+|+++|+.|-....++|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEe
Confidence 356889999999999999999999999999999986433 6788999999999994 9999999999988889999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||||-.|++.+.+.. ++.+++.++..+++..++||+|||...-+|||||+.|||+ +.+|+.||.|||.|-.....
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhh
Confidence 9999998999998874 4679999999999999999999999999999999999999 67899999999999876544
Q ss_pred cc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 191 KA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 191 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
.. .++..|||.|+|||++.. .|+.++||||||++..+|..|++||....+...+-.+-....+ .......++.++.+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-TF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-TFKKPEEWSSEFND 261 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-CCCChHhhhhHHHH
Confidence 33 246789999999999975 6999999999999999999999999766654332222221111 11112457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
||++||.++|++|-|+.++++|||+++.+.
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 999999999999999999999999998653
No 146
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=5.2e-40 Score=315.73 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=216.3
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..+.|++++.||+|++|.||+|.+..+++.|++|.+... .......+.+|+.+++.+. ||||+++++.+..+...+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence 346799999999999999999999999999999998643 2334677888999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+||||++|++|..++.+ ...++...+..++.|++.++.|||++|++||||+|+||++ +.++.++|+|||.+.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence 99999999999887754 4568999999999999999999999999999999999999 5688999999998865332
Q ss_pred C-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 190 G-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 190 ~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
. .......+++.|+|||.+. ..++.++|+|||||++|+|++|..||...........+........ .....+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCccc
Confidence 2 1223456788999999874 2367899999999999999999999987776555555444322211 112457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+..+.++|.+||..+|++||++.++++||||....
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 88999999999999999999999999999998643
No 147
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=7e-40 Score=315.20 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=219.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
....+|++.+.||.|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++.+. ||||+++++++......
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence 34468999999999999999999999999999999986433 223567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++|+||++|++|..++... .++...+..++.+++.|+.|||++|++||||+|+||++ +.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccc
Confidence 9999999999999988654 68999999999999999999999999999999999999 6788999999999875543
Q ss_pred Ccc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+....... ......++..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFR 246 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHH
Confidence 322 223467889999998864 58899999999999999999999998877655544444332211 112346789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
++|.+||..+|.+||++.+++.||||.....
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999999999999999999999999997553
No 148
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=1.2e-40 Score=318.87 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=205.7
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+|+.|++|.+..... .......+.+|+.+++++. ||||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 58999999999999999999999999999999975432 2223456778999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 114 ELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
||+++ +|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence 99975 88887764 4678999999999999999999999999999999999999 678899999999987543322
Q ss_pred ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHcCCc--------------cC
Q 040917 192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF-WAETDQGVAQAILKGEI--------------NF 254 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~--------------~~ 254 (494)
......+++.|+|||++.+ .++.++|+|||||++|+|++|..|+ .+.+..+....+.+... .+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2233456889999998865 3688999999999999999998885 44443333332211000 00
Q ss_pred ---C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 255 ---Q--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 255 ---~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
. ....+.+++.+.++|.+||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123578899999999999999999999999999997
No 149
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=5.8e-40 Score=313.25 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=208.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++++ +||||+++++.+...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence 36889999999999999999999999999999986542 233456788999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||+++++|..+ ..+++..+..++.|++.|+.|||++||+|+||||+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence 999999998654 357889999999999999999999999999999999999 67889999999998755332 2
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHcCCccCCCCCCCCCCH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||..... ......+..... +.......++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCH
Confidence 234578899999998864 588999999999999999999999965322 122222222211 1122345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.+.+++.+||..+|.+||+++++++||||...
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999999864
No 150
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=7e-40 Score=313.20 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=215.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
+.|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.+ +||||+++++.+......++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence 44889999999999999999999999999999985432 33456788899999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
+||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999999999887765 4568999999999999999999999999999999999999 67789999999998654322
Q ss_pred cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 191 KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.......+++.|+|||++. ..++.++|+||+||++|+|++|+.||......+....+......... ....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence 1223456889999999873 23678999999999999999999999887776665555444322111 1235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+.++|.+||..+|.+||++.++++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999999999643
No 151
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=2.8e-40 Score=315.13 Aligned_cols=251 Identities=30% Similarity=0.517 Sum_probs=208.5
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|+||+||+|.+..+|+.|++|.+.............+.+|+.+++++. ||||+++++.+...+..|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999999999999987644333334556678999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917 121 LFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198 (494)
Q Consensus 121 L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 198 (494)
|.+++.... .+++..+..++.|++.|+.|||++|++||||+|.||++ ++++.++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence 999987765 68999999999999999999999999999999999999 6788999999999876544333334567
Q ss_pred CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277 (494)
Q Consensus 199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 277 (494)
+..|+|||.+.+ .++.++|+||+||++++|++|+.||...........+..............+++.+.++|.+||..+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 889999999864 5888999999999999999999999766542222222222222222233457899999999999999
Q ss_pred CCCCC-----CHHHHhcCCccCc
Q 040917 278 PKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 278 p~~Rp-----s~~eil~~~~~~~ 295 (494)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8899999999975
No 152
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=1.2e-39 Score=312.95 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=212.4
Q ss_pred cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-- 106 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-- 106 (494)
....++|.+.+.||+|++|.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 345688999999999999999999999999999999986432 23456788999999996799999999998643
Q ss_pred ---CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 107 ---QFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 107 ---~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
...++||||++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence 368999999999999998753 3468999999999999999999999999999999999999 677889999
Q ss_pred ecCCccccccCc-ccccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917 180 DFGLSAFIEEGK-AYREIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252 (494)
Q Consensus 180 Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 252 (494)
|||.+....... ......++..|+|||.+.. .++.++|+|||||++|+|++|+.||...........+.+...
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999987654322 1233467889999998743 267899999999999999999999987766555444444322
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
.... ....++..+.++|.+||..+|++||++.++++||||+
T Consensus 251 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2111 1234678899999999999999999999999999985
No 153
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=2.6e-40 Score=321.64 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=192.5
Q ss_pred eeeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEEEEE
Q 040917 38 GREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHIVM 113 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~iv~ 113 (494)
+..||+|+||.||+|.+. .+++.||+|.+.... ....+.+|+.+++++. ||||+++++++.. +...+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999965 467899999986433 2345778999999995 9999999999854 45789999
Q ss_pred eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCC
Q 040917 114 ELCAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGL 183 (494)
Q Consensus 114 e~~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~ 183 (494)
||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++... +..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 4888877532 248899999999999999999999999999999999999542 3567899999999
Q ss_pred ccccccCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 040917 184 SAFIEEGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQAIL 248 (494)
Q Consensus 184 a~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~ 248 (494)
+....... ......+|+.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97654321 2234578999999999864 4789999999999999999999999644321 1111111
Q ss_pred cCCc-----------c---------------C--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 249 KGEI-----------N---------------F--------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 249 ~~~~-----------~---------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+... . . ........+..+.++|.+||+.||.+|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0 0 000011234678899999999999999999999999998
No 154
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.2e-39 Score=306.99 Aligned_cols=252 Identities=32% Similarity=0.539 Sum_probs=219.0
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||.|++|.||.+.+..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++.+....+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence 699999999999999999999999999999998654432 23456788999999999 5999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||++|++|.+++... ..++...+..++.|++.|+.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence 999999999999765 458999999999999999999999999999999999999 567889999999987654333
Q ss_pred -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
......+++.|.|||.+.+ .++.++|+||+|+++++|++|..||......+....+..+...... ..++..+.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2234568899999998865 4788999999999999999999999888877777777665443322 4678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.+||..+|.+||++.++++|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
No 155
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=5e-40 Score=314.82 Aligned_cols=255 Identities=30% Similarity=0.541 Sum_probs=212.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+|+.|++|++...... ......+.+|+.+++++. ||||+++++++..+...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 589999999999999999999999999999998765432 234567889999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 114 ELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
||+ |++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence 999 99999988653 568999999999999999999999999999999999999 568899999999987654332
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--------------- 253 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------------- 253 (494)
......++..|+|||.+.+ .++.++||||+||++++|++|..||.+.........+......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 1334567889999998754 3688999999999999999998888777765544433321100
Q ss_pred ----CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 254 ----FQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 254 ----~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
++ ....+..+..+.++|.+||..+|.+||+++++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 011235678999999999999999999999999999984
No 156
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=9.4e-40 Score=308.77 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=215.2
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||.|++|.||+|.+..+++.+++|++..... .....+.+|+.+++++ +||||+++++.+.....+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999975432 2467788999999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+|||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence 99999999999988776 689999999999999999999999999999999999999 67888999999998765432
Q ss_pred c-ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCH
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISS 264 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 264 (494)
. ......++..|+|||.+.+ .++.++|+||||+++++|++|+.||...........+......... .....++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 2233467889999998753 5788999999999999999999999887765555444443222211 11234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPW 292 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~ 292 (494)
.+.+++.+||..+|.+||++.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
No 157
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.6e-41 Score=329.77 Aligned_cols=257 Identities=22% Similarity=0.439 Sum_probs=221.4
Q ss_pred cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC-CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--e
Q 040917 33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--F 108 (494)
Q Consensus 33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--~ 108 (494)
++| +....||+|+|-+||+|.|..+|..||+--++...+ .++...+.+..|+++|+.|+ ||||++++++|.+.. .
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCce
Confidence 444 456779999999999999999999999876654443 33445688999999999996 999999999997654 5
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
+.+|+|++..|+|..+.++.++++...+..|++||++||.|||++ .|+|||||..||||+ +..|.|||+|+|+|..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 889999999999999999999999999999999999999999988 699999999999997 6789999999999997
Q ss_pred cccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
...+.. ....|||.|||||+....|+..+||||||+.++||+|+..||..... ..+++.+..+..+-.-... -.++
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--~dPe 272 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--KDPE 272 (632)
T ss_pred hhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--CCHH
Confidence 755443 44899999999999999999999999999999999999999976554 4567777776554322221 2578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+++||.+||.. ...|||+.|+|.||||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 8899999999999999975
No 158
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=7.5e-40 Score=310.06 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=211.5
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC---ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++++. ||||+++++++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 589999999999999999986 47889999998644321 1223456889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE- 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~- 189 (494)
+++||++|++|.+++.+...++...+..++.|++.|+.|||+.+++|+||+|.||++ ++++.++|+|||.+.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence 999999999999999887789999999999999999999999999999999999999 6788999999998875421
Q ss_pred ------CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 190 ------GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 190 ------~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
........++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.......+ .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCC
Confidence 111223467889999999865 478999999999999999999999987665544433333211111 222467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+..+.++|.+||..+|.+||++.++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
No 159
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=4.9e-40 Score=309.57 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=212.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..++..+++|.+.... ....+.+|+.+++++ +||||+++++++......+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence 57999999999999999999999999999999986432 267899999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+|++++++|.+++.. ...++...+..++.+++.|+.|||+.+++||||+|+||++ +.++.++|+|||.+.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence 999999999999865 4568999999999999999999999999999999999999 678899999999988654433
Q ss_pred -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
......++..|+|||++.+ .++.++|+||+|+++++|++|+.||...........+....... ......++..+.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence 2233457889999999865 58889999999999999999999998776654443332221111 11123467899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.+||..+|++|||+.++|.||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
No 160
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=8e-40 Score=313.46 Aligned_cols=260 Identities=26% Similarity=0.448 Sum_probs=211.2
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE- 104 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~- 104 (494)
+......++|++.+.||+|++|.||+|.+..+++.+++|++.... .....+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455667789999999999999999999999999999999975422 134567889999999966999999999873
Q ss_pred ----eCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 105 ----DDQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 105 ----~~~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
.+...++||||++|++|.+++.. ...+++..+..++.|++.|+.|||+++++||||||+||++ +..+.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCE
Confidence 34578999999999999987753 3458889999999999999999999999999999999999 567889
Q ss_pred EEeecCCccccccCc-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc
Q 040917 177 KATDFGLSAFIEEGK-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK 249 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~ 249 (494)
+|+|||++....... ......+++.|+|||++. ..++.++|+||+||++|+|++|..||...........+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999987654322 223346889999999874 2378899999999999999999999987665444333322
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.... .......++..+.+++.+||..||++|||+.++++|+||
T Consensus 244 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2111 111112357889999999999999999999999999997
No 161
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.8e-40 Score=326.11 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=198.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++++.||+|+||.||+|.+..++..||+|+..... ...|+.+++++. ||||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence 46999999999999999999999999999999854322 346899999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+|++. ++|.+++.. ...++...+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||.+.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence 99995 588888765 3568999999999999999999999999999999999999 678899999999987544333
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC-CCCChH----------HHHHHHHcC---CccCCC
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF-WAETDQ----------GVAQAILKG---EINFQR 256 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~----------~~~~~~~~~---~~~~~~ 256 (494)
......||+.|+|||++.+ .++.++|||||||++|+|+++..|+ ...... .+...+... ...++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 3345678999999999864 5899999999999999999865554 321110 011111100 000110
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 257 --------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 257 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.....++..+.++|.+||+.||.+|||+.++|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 001245677888999999999999999999999999985
No 162
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=8.1e-40 Score=321.32 Aligned_cols=300 Identities=25% Similarity=0.417 Sum_probs=235.4
Q ss_pred hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917 24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY 103 (494)
Q Consensus 24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~ 103 (494)
+....+.+.++|++.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.+. ||||+++++++
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 83 (343)
T cd07880 6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVF 83 (343)
T ss_pred hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeee
Confidence 34456778899999999999999999999999999999999986432 23334567889999999995 99999999998
Q ss_pred EeCC------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917 104 EDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK 177 (494)
Q Consensus 104 ~~~~------~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k 177 (494)
.... .+++||+++ |++|.+++.. ..++...+..++.||+.||.|||++||+||||+|+||++ +.++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~k 158 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELK 158 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEE
Confidence 6543 468999999 7788887754 578999999999999999999999999999999999999 6788999
Q ss_pred EeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc--
Q 040917 178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-- 253 (494)
Q Consensus 178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-- 253 (494)
|+|||.+...... .....+++.|+|||.+.+ .++.++|+|||||++|++++|+.||.+.........+.+....
T Consensus 159 l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 159 ILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred EeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999998765332 233467889999998864 4788999999999999999999999877655444333221111
Q ss_pred ---------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHH
Q 040917 254 ---------------------FQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308 (494)
Q Consensus 254 ---------------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~ 308 (494)
.. ....+.++..+.++|.+||..||.+|||+.+++.||||+........+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY 316 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence 00 01124577889999999999999999999999999999976544333322233
Q ss_pred HHHHHH-HhhhhHHHHHHHHhhhcc
Q 040917 309 IFRMKQ-FTAMNKLKKLALKVIVEN 332 (494)
Q Consensus 309 ~~~~~~-~~~~~~~~~l~~~~~~~~ 332 (494)
...+.. -.++.+|+.+++..+.+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07880 317 DDSFDEVDQSLEEWKRLTFTEILSF 341 (343)
T ss_pred cccHHhhccchHHHHHHHHHHHHhc
Confidence 333333 457788888888877653
No 163
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=4.8e-40 Score=321.00 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=204.3
Q ss_pred eeeeeccc--CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 37 IGREVGRG--EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 37 i~~~lg~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
+++.||+| ++++||++.++.+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 789999999999999999999965433 233456788899999999 59999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence 99999999998653 458999999999999999999999999999999999999 5678899999986543221100
Q ss_pred --------cccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------
Q 040917 193 --------YREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------ 255 (494)
Q Consensus 193 --------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------ 255 (494)
.....++..|+|||++.+ .++.++||||+||++|+|++|+.||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 112345677999999864 488999999999999999999999976655443333222211100
Q ss_pred ------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 256 ------------------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 256 ------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
......+++.+.+++.+||+.||++|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00012356789999999999999999999999999999863
No 164
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=1.1e-39 Score=307.17 Aligned_cols=252 Identities=27% Similarity=0.574 Sum_probs=216.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|+||.||++.+..+|+.|++|.+...... ......+.+|+.+++++. ||||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 699999999999999999999999999999998654332 234567899999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||+++++|.+.+.... .+++..+..++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 9999999999887643 57899999999999999999999999999999999999 677889999999987654322
Q ss_pred c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....+++.|+|||++.+ .++.++|+|||||++++|++|+.||......+....+..+..... ...++..+.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence 2 123457888999999864 578899999999999999999999988887777777666544322 24578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
|.+||..+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
No 165
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.8e-40 Score=331.56 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=205.8
Q ss_pred ccccceEeeeeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+..+|.+++.||.|+||.||+|... .++..|++|.+... ....+|+.+++++. ||||+++++++....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence 35578999999999999999999754 45788999988532 23457999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..|++||++. ++|.+++.....++...+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence 9999999995 5898888777789999999999999999999999999999999999999 67889999999998755
Q ss_pred ccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHc----CCccCCC
Q 040917 188 EEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILK----GEINFQR 256 (494)
Q Consensus 188 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~----~~~~~~~ 256 (494)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ..+..+.+ ....++.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43221 224568999999999875 5899999999999999999999999765422 11111111 0000000
Q ss_pred ------------------C--C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 257 ------------------D--P------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 257 ------------------~--~------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
. . ...++..+.++|.+||..||++|||+.++|.||||...+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 0 013467788999999999999999999999999998643
No 166
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=6.9e-40 Score=312.40 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=216.4
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.+.|+..+.||.|++|.||+|.+..++..||+|++.... .......+.+|+.+++++ +||||+++++++.++...++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence 357889999999999999999999999999999986543 223467788999999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||||++|++|.+++.. .+++...+..++.+++.|+.|||+++++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence 9999999999998865 568999999999999999999999999999999999999 677889999999987654332
Q ss_pred c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+..... +.....++..+.++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHH
Confidence 2 223457888999998864 578999999999999999999999987776655544433221 22223567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+.+||..+|++||++.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999999999998644
No 167
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=3.3e-40 Score=324.22 Aligned_cols=302 Identities=26% Similarity=0.435 Sum_probs=238.1
Q ss_pred hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917 22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA 101 (494)
Q Consensus 22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~ 101 (494)
+.+.+....+.++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++.+
T Consensus 4 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 81 (343)
T cd07851 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLD 81 (343)
T ss_pred hhhccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHH
Confidence 34556667788999999999999999999999999999999999865322 222445677899999999 5999999998
Q ss_pred EEEeCCe------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917 102 AYEDDQF------VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV 175 (494)
Q Consensus 102 ~~~~~~~------~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~ 175 (494)
++..... .++|+||+ |++|.+++.. ..++...+..++.|++.||.|||+.||+||||+|+||++ +.++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~ 156 (343)
T cd07851 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCE 156 (343)
T ss_pred HhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCC
Confidence 8765543 89999998 6699988865 468999999999999999999999999999999999999 67889
Q ss_pred EEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917 176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253 (494)
Q Consensus 176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 253 (494)
++|+|||.+...... .....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+....+......
T Consensus 157 ~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 157 LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred EEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 999999998765332 234567889999998754 4788999999999999999999999877766555444332110
Q ss_pred CC-----------------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcH
Q 040917 254 FQ-----------------------R----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDT 306 (494)
Q Consensus 254 ~~-----------------------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~ 306 (494)
.. . .....++..+.++|.+||..+|.+|||+.++++||||.....+.+.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~ 314 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP 314 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc
Confidence 00 0 01134588999999999999999999999999999999876655544433
Q ss_pred HHHHHHHH-HhhhhHHHHHHHHhhhcc
Q 040917 307 AVIFRMKQ-FTAMNKLKKLALKVIVEN 332 (494)
Q Consensus 307 ~~~~~~~~-~~~~~~~~~l~~~~~~~~ 332 (494)
.....+.. .-....|+.+...++.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07851 315 PYDQSFESRDLTVDEWKELVYKEIMNF 341 (343)
T ss_pred ccCcchhhhhcCHHHHHHHhHHHHHhc
Confidence 33233333 345677888888777653
No 168
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=1.4e-39 Score=308.30 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=208.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~ 108 (494)
.+|++.+.||+|++|.||+|.+..++..|++|.+....... ......+.+|+.++++++ ||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence 36899999999999999999999999999999986543222 223456888999999995 9999999998865 357
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.++++||+++++|.+++.....++...+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 88999999999999999887789999999999999999999999999999999999999 677889999999987543
Q ss_pred cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
.. .......++..|+|||.+.+ .++.++|+||+||++|+|++|+.||.................. +.....++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHIS 235 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcC
Confidence 21 11123457889999999865 4789999999999999999999999876655444433322111 11123467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
+.+..++ +||..+|++||++.++++||||+
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8888888 67778999999999999999996
No 169
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=9.6e-40 Score=310.86 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=211.7
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--- 107 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--- 107 (494)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++++.+||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3579999999999999999999999999999999986433 235678899999999967999999999986543
Q ss_pred ---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 108 ---FVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 108 ---~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
.+++||||+++++|.+++.. ...++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence 58999999999999998865 3468999999999999999999999999999999999999 6678999999
Q ss_pred cCCccccccCc-ccccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917 181 FGLSAFIEEGK-AYREIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253 (494)
Q Consensus 181 fg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 253 (494)
||.+....... ......+++.|+|||++.. .++.++|+|||||++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987543322 2234567889999998742 3678999999999999999999999876655555554443222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
... ....++..+.++|.+||..||++|||+.++++|||+
T Consensus 237 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111 112377899999999999999999999999999996
No 170
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=5e-40 Score=314.89 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=213.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++++ +||||+++++.+...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999999999999999986432 333456788999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 113 MELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|||++|++|..++... ..+++..+..++.+++.|+.|||+ .+++|+||+|+||++ +.++.++|+|||.+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence 9999999998888663 368999999999999999999997 599999999999999 568899999999986543
Q ss_pred cCcccccccCCcCccChhhhcc-------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 189 EGKAYREIVGSPYYIAPEVLSQ-------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
.. ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...........+.......+....+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2233457889999998753 257899999999999999999999976655444433322111112222345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
++..+.++|.+||..+|++||++.++++||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 889999999999999999999999999999998754
No 171
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=7e-40 Score=321.18 Aligned_cols=267 Identities=31% Similarity=0.456 Sum_probs=215.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--- 106 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--- 106 (494)
++..+|.+.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHRE 79 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheeccccc
Confidence 356789999999999999999999999999999999875432 222355677899999999 599999999987543
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917 107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184 (494)
Q Consensus 107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a 184 (494)
...++++||+. ++|.+++...+.++...+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~ 155 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA 155 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccc
Confidence 35899999995 6899999888889999999999999999999999999999999999999 67789999999998
Q ss_pred cccccC-cccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-----------
Q 040917 185 AFIEEG-KAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG----------- 250 (494)
Q Consensus 185 ~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~----------- 250 (494)
...... .......++..|+|||.+. ..++.++|+|||||++|+|++|+.||.+.........+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 765433 2223456788999999875 35889999999999999999999999776543322222110
Q ss_pred ------------CccCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917 251 ------------EINFQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302 (494)
Q Consensus 251 ------------~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~ 302 (494)
..... ....+.+++.+.++|.+||..+|.+|||+.++++||||.....+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00000 11134678999999999999999999999999999999875544443
No 172
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=1.3e-39 Score=313.56 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=207.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe----
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF---- 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~---- 108 (494)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999999865432 222345688899999999767999999999876555
Q ss_pred -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 109 -VHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 109 -~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++ ..++.++|+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecc
Confidence 8999999986 888887643 3479999999999999999999999999999999999994 237899999999
Q ss_pred CccccccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-----
Q 040917 183 LSAFIEEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF----- 254 (494)
Q Consensus 183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----- 254 (494)
.+...... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98754322 12223456788999998754 47899999999999999999999998876655443332211000
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 255 -------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 255 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
.....+.++..+.++|.+||..||.+||++.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0011245788999999999999999999999999999985
No 173
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=2e-39 Score=306.94 Aligned_cols=254 Identities=27% Similarity=0.484 Sum_probs=213.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++++. ||||++++++.......++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 699999999999999999999999999999999765432 345778999999999994 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~ 193 (494)
||+++++|.+++.....++...+..++.+++.|+.|||++|++|+||+|.||++ ++++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 999999999999887778999999999999999999999999999999999999 66889999999998765432221
Q ss_pred -----ccccCCcCccChhhhcc-c---CCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCC
Q 040917 194 -----REIVGSPYYIAPEVLSQ-S---YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 194 -----~~~~~~~~y~aPE~~~~-~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
....+++.|+|||++.+ . ++.++|+||||++++++++|..||...... .....+.. ......+....++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 12456889999999864 2 688999999999999999999999765333 22222222 2222222334568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..+.++|.+||+.+|.+||++.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999996
No 174
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=7.5e-40 Score=310.57 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=210.6
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+|+..+.||+|++|.||+|.+..+++.||+|++....... ......+.+|+.++++++ ||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 4888999999999999999999999999999986433211 123567889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+|+||++|++|.+++...+++++..+..++.|++.||.|||++|++|+||+|.||+++ ..+..++|+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999994 23347999999998765432
Q ss_pred cc-----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-CccCCCCCCCCCC
Q 040917 191 KA-----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG-EINFQRDPFPSIS 263 (494)
Q Consensus 191 ~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 263 (494)
.. .....++..|+|||.+.+ .++.++|+||+|+++++|++|..||...........+... ...........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 123457889999999864 5789999999999999999999999654432222222111 1111122224578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
+.+.+++.+||..+|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999999999999999999999985
No 175
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=6.9e-40 Score=323.29 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=214.3
Q ss_pred hhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917 21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100 (494)
Q Consensus 21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~ 100 (494)
....++....+..+|++.+.||+|++|.||+|.+..+++.||+|.+.+.. ........+.+|+.+++++. ||||++++
T Consensus 4 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 81 (353)
T cd07850 4 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLL 81 (353)
T ss_pred eecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCccee
Confidence 34455555567789999999999999999999999999999999986433 22334566778999999994 99999999
Q ss_pred EEEEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 101 AAYEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 101 ~~~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
+++... ...|+||||+.+ +|.+.+... ++...+..++.|++.||.|||++|++||||||+||++ +.++
T Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~ 155 (353)
T cd07850 82 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC 155 (353)
T ss_pred eeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCC
Confidence 988643 357999999965 888877654 8999999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--
Q 040917 175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE-- 251 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-- 251 (494)
.++|+|||.+.............+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+....
T Consensus 156 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 156 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999986544433344567889999998865 58999999999999999999999998766544333322100
Q ss_pred --------------------ccCCCC-----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 252 --------------------INFQRD-----------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 252 --------------------~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
...... .....++.+.++|.+||..||.+|||+.++|+||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000000 0113466789999999999999999999999999997
Q ss_pred cc
Q 040917 295 ES 296 (494)
Q Consensus 295 ~~ 296 (494)
..
T Consensus 316 ~~ 317 (353)
T cd07850 316 VW 317 (353)
T ss_pred hc
Confidence 53
No 176
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=7.9e-40 Score=312.86 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=209.7
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE------
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE------ 104 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~------ 104 (494)
..+.|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++.+||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4478999999999999999999999999999999985432 234568889999999977999999999984
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
.....+++|||+++++|.+++... ..+++..+..++.||+.|+.|||++||+|+||+|+||++ +.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence 246789999999999999988753 347888899999999999999999999999999999999 677889999999
Q ss_pred CccccccC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917 183 LSAFIEEG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
.+...... .......+++.|+|||.+. ..++.++|+|||||++|+|++|..||...........+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence 98754322 1223456888999999874 2478899999999999999999999977665444333332211 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
......++..+.++|.+||..||.+||++.++|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11223578999999999999999999999999999997
No 177
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8e-41 Score=324.57 Aligned_cols=260 Identities=36% Similarity=0.628 Sum_probs=236.4
Q ss_pred cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
..-.+.|.+.+.||+|.|++|.+|++..++..||+|.+++...... ....+.+|+++++.| +||||++++.+......
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecce
Confidence 3445789999999999999999999999999999999998776554 445599999999999 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+|+||||+.+|.+.+++.+++.+.+..+..++.|++.|++|||+++|+|||||+.||++ +.+..+||+|||++....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence 99999999999999999999999999999999999999999999999999999999999 677789999999999998
Q ss_pred cCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 189 EGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
.+....+.+|++.|.|||++.+. -++.+|+||+|+++|-|+.|.+||.+.+-.+...-++.+....+. -++.++
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc 282 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC 282 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence 88888999999999999999874 578999999999999999999999998887776666666665553 467899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.++|.++|.++|.+|++.+++..|.|.....
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 9999999999999999999999999998543
No 178
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=4.4e-40 Score=315.24 Aligned_cols=256 Identities=29% Similarity=0.488 Sum_probs=211.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence 36999999999999999999999999999999986544322 3456788899999999 499999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
+||+++++|..+......++...+..++.||+.|+.|||+.|++|+||+|+||++ ++++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 9999998888877666679999999999999999999999999999999999999 678899999999987653322
Q ss_pred ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------------
Q 040917 192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN---------------- 253 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------- 253 (494)
......++..|+|||++.+ .++.++|+||||+++++|++|+.||......+....+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234567889999998864 4678999999999999999999999766654332222210000
Q ss_pred ---CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 ---FQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ---~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+ ....+.++..+.+++.+||..+|++||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 01134678899999999999999999999999999998
No 179
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=9.2e-40 Score=309.63 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=202.3
Q ss_pred cceEeeeee--cccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 33 LHYTIGREV--GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 33 ~~y~i~~~l--g~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
.+|.+.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+.+||||+++++.+..++..+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467777776 99999999999999999999999986543211 13333333446999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC-eEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~~~~ 189 (494)
+||||++|++|.+++.....+++..+..++.|++.|+.|||+.|++||||+|+||+++ ..+ .++|+|||.+.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCC
Confidence 9999999999999998887899999999999999999999999999999999999994 455 899999999875533
Q ss_pred CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
. ....++..|+|||++.+ .++.++|+||+|+++|+|++|..||.....+... ..+.... .......+.+++.+.
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 2 23457889999999864 5889999999999999999999999865544321 2222211 222233346899999
Q ss_pred HHHHHhcccCCCCCCC-HHHHhcCCccCc
Q 040917 268 ELVRRMLTQDPKRRIT-VAQVLEHPWLKE 295 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps-~~eil~~~~~~~ 295 (494)
++|.+||+.+|.+||+ ++++|+||||++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999999996 699999999974
No 180
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=9.7e-40 Score=312.18 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=206.5
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEEE
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHIV 112 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~iv 112 (494)
|++.+.||+|++|.||+|.+..+++.||+|+++..... .......+|+.++.++.+||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 78899999999999999999999999999998654321 12334457899999997799999999999887 889999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||+++ +|.+.+... ..+++..+..++.|++.||.|||++|++||||+|+||++ +. +.++|+|||.+.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCC
Confidence 999975 888877653 468999999999999999999999999999999999999 45 999999999998665444
Q ss_pred ccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917 192 AYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI----------------- 252 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------------- 252 (494)
......+++.|+|||.+. +.++.++|+||+||++|+|++|..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444456788999999764 3478899999999999999999999988776554443321100
Q ss_pred -cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 253 -NFQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 253 -~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.++. ...+.++..+.++|.+||..+|++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 0123568999999999999999999999999999997
No 181
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-41 Score=323.66 Aligned_cols=235 Identities=26% Similarity=0.428 Sum_probs=208.1
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.+.||+|+.|.||+++.. ++.||||.++. .=+.+++-|++|+ ||||+.+.++|.....+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence 466999999999999855 88999998742 2234788899996 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 197 (494)
.|-|.+.++....++......|..+|+.|+.|||.+.|||||||.-|||| ..+..|||+|||.+............+
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999 577899999999998776655566789
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 276 (494)
||..|||||++.+ +.+.|+|||||||+||||+||..||.......++-.+-.+....+-+ ..+|+.++-||+.||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence 9999999999975 68999999999999999999999998777766665555555444433 46899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 040917 277 DPKRRITVAQVLEH 290 (494)
Q Consensus 277 dp~~Rps~~eil~~ 290 (494)
.|..|||+.+||.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999998
No 182
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=1.9e-39 Score=308.47 Aligned_cols=256 Identities=26% Similarity=0.486 Sum_probs=211.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-------hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-------DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
+|.+.+.||+|++|.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.+. |||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 6899999999999999999999999999999885422111 112346788999999995 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
...++||||++|++|.+++...+.++...+..++.||+.||.+||+++++||||+|+||++ +.++.++|+|||.+..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence 9999999999999999999888889999999999999999999999999999999999999 6788999999999875
Q ss_pred cccCc---ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--ccCCCCC
Q 040917 187 IEEGK---AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--INFQRDP 258 (494)
Q Consensus 187 ~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 258 (494)
..... ......++..|+|||.+.. .++.++|+||||++++++++|..||...........+.... ..++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43211 1223457889999998763 37889999999999999999999997655443333322221 2222333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+.++..+.+++.+||..+|++||++.++|+|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 45678999999999999999999999999999996
No 183
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.1e-39 Score=328.22 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=201.9
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++|. ||||+++++++..+...++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999999999999999642 223568999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||+++. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence 999995 5888888654 468999999999999999999999999999999999999 67788999999998764332
Q ss_pred cc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHcCCcc---C-
Q 040917 191 KA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--------DQGVAQAILKGEIN---F- 254 (494)
Q Consensus 191 ~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--------~~~~~~~~~~~~~~---~- 254 (494)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... ...+...+...... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 11 123568999999999865 58999999999999999999876553321 22233333221110 0
Q ss_pred -----------------------CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 255 -----------------------QRDPF---PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 255 -----------------------~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
....| ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01111 134568999999999999999999999999999974
No 184
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=1.1e-39 Score=311.27 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=201.9
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.||+|+||.||+|.+..+++.||+|.+.+.............+|..+++.+. +||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654433323334445554444432 58999999999998889999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 197 (494)
|++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence 99999999888889999999999999999999999999999999999999 678899999999986543322 23346
Q ss_pred CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
+++.|+|||.+.. .++.++|+||+||++|+|++|..||......... .+............+.++..+.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 8999999998853 4789999999999999999999999754322111 111111111222234678999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCccCc
Q 040917 276 QDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 276 ~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
.||.+|| ++.++++||||+.
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999 6999999999987
No 185
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=1.4e-39 Score=315.28 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=213.0
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFV 109 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~ 109 (494)
..+|++.+.||+|++|.||+|.+..+|+.||+|++....... .....+.+|+.++++++ ||||+++++++... +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence 468999999999999999999999999999999986543222 22334667999999995 99999999998754 468
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||||+.+ +|.+++... ..++...+..++.||+.||.|||++|++||||+|+||++ +..+.++|+|||.+....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 999999965 888887653 568999999999999999999999999999999999999 678899999999987654
Q ss_pred cC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc------------
Q 040917 189 EG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN------------ 253 (494)
Q Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------ 253 (494)
.. .......+++.|+|||.+.+ .++.++|+||+||++|+|++|..||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 32 12223345788999998854 4789999999999999999999999988877766655432110
Q ss_pred -------CCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 254 -------FQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 254 -------~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
..... ....++.+.++|.+||..||++|||+.+++.||||+..+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 00000 12357889999999999999999999999999999975544
No 186
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=1.9e-39 Score=314.02 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=216.1
Q ss_pred cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
..+..+|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++.+. ||||+++.+++.....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence 345578999999999999999999999999999999986544334444567889999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.++|+||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++...
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceec
Confidence 9999999975 77776654 4568999999999999999999999999999999999999 67889999999998754
Q ss_pred ccCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 188 EEGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
... ....+++.|+|||++. +.++.++|+||||+++|+|++|..||...........+...... ......++
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhC
Confidence 332 2346788999999873 45888999999999999999999999887766554444333221 11123478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..+.++|.+||..+|++||++.+++.||||....
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 8999999999999999999999999999999743
No 187
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=2.2e-39 Score=305.40 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=214.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++.+ +||||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 58888999999999999999998999999999865332 2233456788999999999 59999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
++||++|++|.+++.+...++...+..++.|++.|+.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence 99999999999999887779999999999999999999999999999999999999 678899999999987654443
Q ss_pred ccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
......+++.|+|||.+.. . ++.++|+|||||++|+|++|+.||...........+..... .....+.+++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence 3345567889999998754 3 78999999999999999999999977665444433332111 112224578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.+||..+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
No 188
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=4e-39 Score=305.10 Aligned_cols=255 Identities=29% Similarity=0.514 Sum_probs=209.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~ 108 (494)
.+|++.+.||+|+||.||.|.+..++..|++|.+..... ........+.+|+.+++++. ||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 579999999999999999999999999999998864321 12233567888999999995 9999999998865 356
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++++|||++|++|.+++.+...++...+..++.+++.||.|||+++++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 88999999999999999887788999999999999999999999999999999999999 678899999999887543
Q ss_pred cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
.. .......++..|+|||++.+ .++.++|+|||||++|+|++|+.||................. .....+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence 21 11223457889999998864 578999999999999999999999987655544443332211 111223567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
..+.++|.+|+. +|.+||+++++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999994 999999999999999973
No 189
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=2.4e-39 Score=306.81 Aligned_cols=248 Identities=18% Similarity=0.281 Sum_probs=208.0
Q ss_pred cceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.+ +||||+++++++..+...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence 57999999999999999999865 456789999987532 233456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||++ +.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 678899999999876533
Q ss_pred cCcccc--cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAYR--EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
...... ...++..|+|||.+. +.++.++|||||||++|++++ |..||......+....+..+... +....+|.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCH
Confidence 222111 123456899999875 468999999999999999775 99999998888877777654322 12356889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|.+||++++|++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999876
No 190
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=3.2e-39 Score=305.47 Aligned_cols=252 Identities=33% Similarity=0.585 Sum_probs=215.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~i 111 (494)
+|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.+++.+. ||||+++++.+.. +...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 58999999999999999999999999999999875443 3345677889999999995 9999999997753 457899
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 112 VMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCH-----SKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH-----~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
+|||+++++|.+++.. ..+++...+..++.+|+.||.||| +.+++|+||+|+||++ +.++.++|+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence 9999999999998865 356899999999999999999999 8999999999999999 578899999999
Q ss_pred CccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917 183 LSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260 (494)
Q Consensus 183 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (494)
.+........ .....+++.|+|||++.+ .++.++|+||||+++++|++|..||.........+.+....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence 9887654433 334568899999999864 57889999999999999999999998888766666666554322 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.++..+.+++.+||..+|.+||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
No 191
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=1.4e-39 Score=319.06 Aligned_cols=266 Identities=32% Similarity=0.495 Sum_probs=210.8
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--- 106 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--- 106 (494)
++.++|++.+.||+|++|.||+|.+..+|+.||+|++.... .......+.+|+.+++.++ ||||+++++++...
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE 78 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence 35679999999999999999999999999999999986322 2234566788999999995 99999999887543
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917 107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184 (494)
Q Consensus 107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a 184 (494)
...++++||+.+ +|.+.+.. ..++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~ 153 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLA 153 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccce
Confidence 358999999965 88877744 568999999999999999999999999999999999999 67889999999998
Q ss_pred cccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------
Q 040917 185 AFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--------- 249 (494)
Q Consensus 185 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~--------- 249 (494)
........ .....+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76432211 123467889999998643 578999999999999999999999977654332222211
Q ss_pred --------------CCccCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917 250 --------------GEINFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303 (494)
Q Consensus 250 --------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~ 303 (494)
....... ...+..++.+.+++.+||..+|++|||+.++++||||.....+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~ 305 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP 305 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence 0000000 01235678899999999999999999999999999998766554433
No 192
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=9e-40 Score=313.79 Aligned_cols=265 Identities=30% Similarity=0.516 Sum_probs=220.2
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
..+..+.|.....||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.+ +||||+++++.+...+
T Consensus 17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGD 92 (292)
T ss_pred cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCC
Confidence 3445567777888999999999999999999999999985432 23456788999999999 5999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++||||+++++|.+++.. +.++...+..++.||+.|+.|||++||+||||+|+||++ +.++.++|+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQV 168 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhc
Confidence 99999999999999988754 468999999999999999999999999999999999999 56789999999998654
Q ss_pred ccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 188 EEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.... ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+...... .......++..
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHH
Confidence 3222 1233567889999999864 5889999999999999999999999887766655544432221 11122357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~ 301 (494)
+.+++.+||..||.+|||+.++++||||.....++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 999999999999999999999999999998766654
No 193
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=9.3e-40 Score=309.38 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=213.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++++. ||||+++++.+......+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence 368889999999999999999999999999999875432 235677889999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+||+++++|.+++... ..++...+..++.|++.|+.|||+ .|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence 9999999999999876 678999999999999999999999 999999999999999 56889999999998765332
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-----DQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.. ....++..|+|||.+.+ .++.++|+||+|+++++|++|..||.... .....+.+...... ..+...++.
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSP 231 (265)
T ss_pred Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCH
Confidence 22 12667889999998865 58899999999999999999999996542 22233333332211 111112788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.+.++|.+||..+|++|||+.+++.||||+..
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99999999999999999999999999999863
No 194
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=3e-39 Score=309.01 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=206.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+..|+..+.+..+||||+++++++..+...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3699999999999999999999999999999998754322 23445666776644444799999999999998999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
|||++ ++|.+++.. ...+++..+..++.||+.|+.|||++ +++||||||+||++ +.++.++|+|||.+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence 99996 588777654 24689999999999999999999997 99999999999999 67889999999998765
Q ss_pred ccCcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCCC
Q 040917 188 EEGKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
..........++..|+|||.+.+ .++.++|+||+||++|+|++|+.||.... ..+.......... +..+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence 43333233567889999998753 36889999999999999999999996432 2223333332211 1112235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+|..+.++|.+||..+|.+||++.++++||||....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 789999999999999999999999999999999744
No 195
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.5e-39 Score=322.83 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=202.0
Q ss_pred cceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||+|+||.||+|.+ ..++..||+|+++.... ....+.+.+|+.++..+.+||||+++++++....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 5799999999999999999974 35677899999864332 2245678899999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------------------------------------------------
Q 040917 108 FVHIVMELCAGGELFDRIVARG---------------------------------------------------------- 129 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~---------------------------------------------------------- 129 (494)
..++||||++||+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 130 -----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 130 -----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
.++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCccc
Confidence 36778889999999999999999999999999999999 5678899999999876543221
Q ss_pred c---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 193 Y---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 193 ~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
. ....++..|+|||++.+ .++.++|+|||||++|+|++ |..||..................... ....+..+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 347 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMY 347 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHHH
Confidence 1 11234567999999864 68999999999999999998 88999776544333333332222211 134678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..||++|||+.++++
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999986
No 196
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=4.3e-39 Score=309.69 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=210.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++++ +||||+++++++......++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 479999999999999999999999999999999865432 222446688899999999 499999999999999999999
Q ss_pred EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||++ ++|.+++..... ++...+..++.||+.||.|||+++++|+||+|+||+++ ..++.+||+|||.+......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCC
Confidence 99996 488887765443 57888899999999999999999999999999999995 24567999999998754322
Q ss_pred -cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-------------
Q 040917 191 -KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF------------- 254 (494)
Q Consensus 191 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------- 254 (494)
.......+++.|+|||.+.+ .++.++|+||+||++|+|++|..||......+....+.......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 12233456889999998864 47889999999999999999999998777655544332210000
Q ss_pred --------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 255 --------QR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 255 --------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.. ...+.+++.+.+++.+||..+|++||++.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 01245788899999999999999999999999999998754
No 197
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1.7e-39 Score=311.49 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=211.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++++. ||||+++++++..++..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence 479999999999999999999999999999999865432 2334577899999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||++++.+..+......++...+..++.+|+.|+.|||+++++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence 9999987776666666679999999999999999999999999999999999999 678999999999987655433
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--------------c--
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--------------I-- 252 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--------------~-- 252 (494)
......++..|+|||++.+ .++.++|+||+|+++|+|++|+.||.+....+....+.... .
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 2334567889999998854 47889999999999999999999998766554333221100 0
Q ss_pred ---cCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 253 ---NFQR---------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 253 ---~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..+. .....++..+.++|.+||..+|++||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0011248889999999999999999999999999997
No 198
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-41 Score=301.09 Aligned_cols=255 Identities=30% Similarity=0.592 Sum_probs=236.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|...+.||+|.||.|-+|+.+.+|+.+|+|++++...-..........|-++|+.-+ ||.+..+--.|+...++|+|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEE
Confidence 67999999999999999999999999999999999887766667788889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc-cccCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF-IEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~-~~~~~ 191 (494)
|||..||.|.-++.+...+++..+..+...|+.||.|||+++||+||||.+|.++ +.+|++||.|||++.. +..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccccc
Confidence 9999999999999888899999999999999999999999999999999999999 7999999999999875 34556
Q ss_pred ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
.....||||.|.|||++. ..|+.++|+|-+||++|+|+.|++||.....+.....|.-....+++ .++++++.++
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktLL 399 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTLL 399 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHHH
Confidence 667899999999999996 57999999999999999999999999999999999999999888885 5789999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 271 RRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
..+|.+||.+|. .+.||..|+||..
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999999999996 5889999999985
No 199
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.9e-39 Score=305.67 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=217.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+..+.+++ ||||+++++++......++|+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence 689999999999999999999999999999998754422 35678999999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++||||+|+||++ +.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 999999999999887889999999999999999999999 999999999999999 6788999999999876544333
Q ss_pred cc-cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCC-CCHHH
Q 040917 193 YR-EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPS-ISSSA 266 (494)
Q Consensus 193 ~~-~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~l 266 (494)
.. ...++..|+|||.+.. .++.++|+||||+++|+|++|..||.... ..+....+........ ... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHHH
Confidence 22 4567889999998864 57889999999999999999999997773 3444444443322211 123 78999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.++|.+||..+|++||++.++++|||++..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999753
No 200
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1.4e-39 Score=312.86 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=209.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~ 110 (494)
++|++.+.||+|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++++. ||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 5799999999999999999999999999999999754432 223445678999999995 99999999998777 8899
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+||||+.+ +|.+++.... .++...+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 99999975 9998887644 48999999999999999999999999999999999999 6788999999999876544
Q ss_pred C-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-------------
Q 040917 190 G-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN------------- 253 (494)
Q Consensus 190 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------- 253 (494)
. .......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 22234557889999998864 3688999999999999999999999877765544433211000
Q ss_pred -------------CCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 -------------FQRDPFPS--ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 -------------~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.....++. +++.+.++|.+||..+|++|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011222 48889999999999999999999999999998
No 201
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=8e-39 Score=306.25 Aligned_cols=258 Identities=31% Similarity=0.567 Sum_probs=216.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|...+.||+|++|.||+|.+..+++.+++|++.... ......+.+|+.+++.+ +||||+++++++...+..+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence 45666789999999999999999999999999985322 22355688999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
+||++|++|.+++.. .+++...+..++.|++.|+.+||++|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 999999999998877 678999999999999999999999999999999999999 678899999999876543321
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||...........+......... ....++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHH
Confidence 2233467889999999865 5889999999999999999999999887766666655544222221 2234789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
.+||..+|++||++.++++||||.....+
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCCc
Confidence 99999999999999999999999986543
No 202
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=1.7e-39 Score=310.06 Aligned_cols=253 Identities=33% Similarity=0.647 Sum_probs=219.6
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|.+.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++++.+||||+++++++......++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 69999999999999999999999999999999976555455556778899999999955999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA- 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~- 192 (494)
|++++++|.+++.+.+.++...+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence 999999999999888889999999999999999999999999999999999999 6788999999999876533221
Q ss_pred --------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917 193 --------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251 (494)
Q Consensus 193 --------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 251 (494)
.....++..|+|||++.. .++.++|+||||++++++++|..||...........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 112346788999998764 57889999999999999999999998887666666655433
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCcc
Q 040917 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITV----AQVLEHPWL 293 (494)
Q Consensus 252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~ 293 (494)
..++ ..+++.+.++|.+||..+|.+||++ +++++||||
T Consensus 239 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3322 4568999999999999999999999 999999997
No 203
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-41 Score=312.81 Aligned_cols=255 Identities=32% Similarity=0.556 Sum_probs=227.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
..|+.-+.||.||||.||-|.-+.||+.+|.|.+.+..........-..+|-.+|.++. .|.|+.+--.|...+.+|+|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence 56888899999999999999999999999999998777666666777889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+..|.||+|.=+|.+.+ .+++..+..++.+|+.||.+||+.+||+|||||+|||+ ++.|+++|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence 99999999988887765 79999999999999999999999999999999999999 78999999999999999999
Q ss_pred cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
......+||.+|||||++.+ .|+...|+|||||++|+|+.|+.||..... +++-+.+......++ ...+++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e 416 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE 416 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence 88888899999999999874 599999999999999999999999965543 344444444444444 468999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917 266 AIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~ 295 (494)
++++...+|.+||.+|. .++++-+||||+.
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999997 5789999999996
No 204
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=4.3e-39 Score=305.20 Aligned_cols=251 Identities=29% Similarity=0.525 Sum_probs=209.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 57999999999999999999999999999999987655445555677889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+||+++++|.+++.. ...++...+..++.+++.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 999999999988753 3447899999999999999999999999999999999999 677889999999987654
Q ss_pred cCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.... .....+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||..... ......+.... +++.....++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 3222 223467889999998864 578899999999999999999999965432 33444443322 22222245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHH
Confidence 9999999999999999999999987
No 205
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.5e-39 Score=308.73 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=215.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|+||+|.+..+|+.||+|++.... .......+.+|+.+++.+. ||||+++++.+.....+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999986432 2334677899999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||+++++|.+++...+.++...+..++.+++.++.|||+ .+++||||+|+||++ ++++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence 9999999999999887789999999999999999999997 599999999999999 67889999999987654222
Q ss_pred ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHcCCccCCCCCC
Q 040917 192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-----------GVAQAILKGEINFQRDPF 259 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~ 259 (494)
......++..|+|||++. +.++.++|+||+||++|+|++|..||...... +....+...... ....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence 223456889999999875 46888999999999999999999999765542 222222222111 1111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~ 300 (494)
..++..+.+++.+||..||++|||+.++++|+||.....+.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 23778999999999999999999999999999998755444
No 206
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=3e-39 Score=308.99 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=210.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCC-----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTG-----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||+|++|.||+|.+...+ ..|++|.+.... .......+.+|+.++..+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 57999999999999999999876554 689999986432 3334667889999999995 999999999999888
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917 108 FVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD 171 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~ 171 (494)
..+++|||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999999999999764 347888999999999999999999999999999999999 6
Q ss_pred CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917 172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA 246 (494)
Q Consensus 172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~ 246 (494)
+++.++|+|||++........ .....+++.|+|||.+. +.++.++|+|||||++|+|++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 778999999999875432221 12344578899999875 568999999999999999998 9999999888888777
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+.+...... ...+|..+.+++.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766543322 24688999999999999999999999999873
No 207
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=2.2e-39 Score=310.11 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=207.3
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++++.||.|++|.||+|.+..+|+.|++|.+..... .......+.+|+.+++++. ||||+++++++.+....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence 48999999999999999999999999999999865432 2223467889999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||+. ++|.+++.. ...++...+..++.|++.|+.|||+++++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence 9996 588888765 3468999999999999999999999999999999999999 678899999999987543322
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC--------------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-------------- 254 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------------- 254 (494)
......+++.|+|||.+.+ .++.++|+|||||++|+|+||+.||.+.........+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1223456788999998764 36889999999999999999999998776544333322110000
Q ss_pred ----C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 255 ----Q-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 255 ----~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+ ....+.+++.+.++|.+||..||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 01123567889999999999999999999999999998
No 208
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=5.9e-39 Score=310.21 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=202.3
Q ss_pred ccceEeeeeecccCCeEEEEEEECC----------------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENS----------------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 95 (494)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 3689999999999999999998643 34579999986532 2334667899999999995 999
Q ss_pred ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 040917 96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-------------------HYSERAAASVFRVIMNVVNVCHSKGVM 156 (494)
Q Consensus 96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~ 156 (494)
|+++++++...+..++||||+++++|.+++.... .++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999899999999999999999886532 356778899999999999999999999
Q ss_pred eccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--
Q 040917 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-- 230 (494)
Q Consensus 157 H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-- 230 (494)
||||||+||++ +.++.+||+|||++........ .....++..|+|||++. +.++.++|+|||||++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 6788999999999875433221 11234467899999875 568999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 231 GVPPFWAETDQGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 231 g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..||...........+.. ..........+.+|..+.+++.+||..+|.+|||+.+|..
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 5678887776665544322 1111111122467899999999999999999999999954
No 209
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=3.2e-39 Score=317.01 Aligned_cols=266 Identities=28% Similarity=0.444 Sum_probs=212.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---- 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---- 106 (494)
+..+|++.+.||.|++|.||+|.+..+|+.|++|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence 56899999999999999999999999999999999865432 3456788899999999 599999999876543
Q ss_pred ----------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 107 ----------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 107 ----------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++ ..++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence 35789999997 488887754 4689999999999999999999999999999999999995 345689
Q ss_pred EEeecCCccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 040917 177 KATDFGLSAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 250 (494)
+|+|||.+........ .....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875432111 122356889999998753 4788999999999999999999999877665544443321
Q ss_pred Ccc----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917 251 EIN----------------------FQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304 (494)
Q Consensus 251 ~~~----------------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~ 304 (494)
... ... ...+.++..+.++|.+||..||.+|||+.++|+||||+....+.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~ 314 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccC
Confidence 100 000 012357788999999999999999999999999999997655544444
No 210
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=1.5e-39 Score=318.60 Aligned_cols=267 Identities=29% Similarity=0.459 Sum_probs=215.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE----eC
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE----DD 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~----~~ 106 (494)
+..+|.+.+.||+|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++++. ||||+++++++. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence 45789999999999999999999999999999999875432 2234567788999999995 999999998875 33
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
...++||||+. ++|.+++.....++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence 57899999995 5899998877789999999999999999999999999999999999999 6788999999999875
Q ss_pred cccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC---------
Q 040917 187 IEEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------- 250 (494)
Q Consensus 187 ~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~--------- 250 (494)
...... .....++..|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 432221 123467889999998754 4889999999999999999999999776554332222110
Q ss_pred --------------CccCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917 251 --------------EINFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303 (494)
Q Consensus 251 --------------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~ 303 (494)
....... ..+..+..+.++|.+||+.+|.+||++.+++.||||.....+...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~ 307 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP 307 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence 0000000 1245789999999999999999999999999999998766555443
No 211
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=2.2e-39 Score=321.25 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=202.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
++|++++.||+|+||.||+|.+..+ +..||+|.+..... ......+.+|+.+++.+.+||||+++++.+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 5799999999999999999986544 35799999975432 2245678899999999956999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-----------------------------------------------------------
Q 040917 108 FVHIVMELCAGGELFDRIVAR----------------------------------------------------------- 128 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~----------------------------------------------------------- 128 (494)
..++||||+++|+|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999988542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---c
Q 040917 129 -----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---R 194 (494)
Q Consensus 129 -----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~ 194 (494)
.+++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......... .
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeecc
Confidence 136778899999999999999999999999999999999 56789999999998764332211 1
Q ss_pred cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
...+++.|+|||++. +.++.++|||||||++|+|++ |+.||.....................+ ..+|+.+.+++.+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~ 350 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKM 350 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHH
Confidence 223456799999875 468999999999999999997 999997766544433333333222221 3468999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 040917 273 MLTQDPKRRITVAQVLE 289 (494)
Q Consensus 273 ~l~~dp~~Rps~~eil~ 289 (494)
||..||.+|||+.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999976
No 212
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-40 Score=289.63 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=217.2
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+.+++..||+|..|+||++..+.+|...|||...+.. +......+++.+.++..-.++|+|++.+++|..+..++|.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456678999999999999999999999999997654 34456778888887776556899999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|.|.. .+..++++ .+++++..+-.+...++.||.||..+ ||+|||+||+|||+ +..|.+||||||.+-....+.
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccc
Confidence 99843 56555554 45688888999999999999999865 89999999999999 789999999999998877776
Q ss_pred ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
......|-+.|||||.+.. .|+.++|+||||+++++|.||..||.+. ++.+++-.+.+...+..+ .-...++.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-GHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-cccCcCHHH
Confidence 6677788999999999853 4889999999999999999999999874 445677777775443332 234589999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.+|+..||++|+.+||.+.++|+|||+....
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999998654
No 213
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=5.4e-39 Score=306.26 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=213.7
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~i 111 (494)
.|++.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.+. .|||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999986432 2224567888999999995 49999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||||++|++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence 9999999999998865 478999999999999999999999999999999999999 568899999999987654332
Q ss_pred c-cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
. .....++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+... ..+......++..+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2 233567889999998864 3688999999999999999999999877665444333222 1111112237889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
++.+||..||++||++.+++.||||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999998644
No 214
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=6e-39 Score=308.23 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=203.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.++.+++.||+|.+...... .....+.+|+.+++.+. ||||+++++++......++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence 6799999999999999999999999999999998654321 12345678999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG- 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~- 190 (494)
|||+.+ +|.+++... ..++...+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||.+......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence 999975 899888664 468999999999999999999999999999999999999 67889999999998653221
Q ss_pred cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCcc--------------
Q 040917 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEIN-------------- 253 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~-------------- 253 (494)
.......++..|+|||++.+ .++.++|+||+|+++|+|++|..||.... ..+....+.+....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11122346788999998864 47889999999999999999999997665 22222221110000
Q ss_pred -----C-------CCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 -----F-------QRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 -----~-------~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
. .....+.++ ..+.+++.+||..+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000112344 788899999999999999999999999998
No 215
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=5.6e-39 Score=337.05 Aligned_cols=252 Identities=29% Similarity=0.384 Sum_probs=205.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++..++..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999997654444445677899999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917 113 MELCAGGELFDRIVAR-----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF 181 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df 181 (494)
|||++|++|.+++... ...+...+..++.||+.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999999999988642 234567788999999999999999999999999999999 67889999999
Q ss_pred CCccccccCc-------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917 182 GLSAFIEEGK-------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ 241 (494)
Q Consensus 182 g~a~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~ 241 (494)
|++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652100 0112468999999999865 5899999999999999999999999876554
Q ss_pred HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 242 GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
......... .+....+...+|+.+.+++.+||..||.+||+..+.+.
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 433221111 11111233568899999999999999999987665543
No 216
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=6.2e-39 Score=310.95 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=204.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-- 107 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-- 107 (494)
..-++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence 344689999999999999999999999999999999864332 2223345668999999995 999999999886543
Q ss_pred ------eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 108 ------FVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 108 ------~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
..++||||+.+ +|.+.+.... .++...+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECc
Confidence 45999999965 8888776543 68999999999999999999999999999999999999 6788999999
Q ss_pred cCCccccccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917 181 FGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253 (494)
Q Consensus 181 fg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 253 (494)
||.+........ .....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+..-...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999876532211 123456788999998764 3688999999999999999999999877665443333221100
Q ss_pred CCCCC----------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 FQRDP----------------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+... ....+..+.++|.+||..||.+|||++++|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 01125678899999999999999999999999998
No 217
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=3.5e-39 Score=305.16 Aligned_cols=249 Identities=35% Similarity=0.632 Sum_probs=215.5
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|++|.||+|.+..+|+.+++|++.............+.+|+.+++++. ||||+++++.+..+...|+++|+++|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999999999999997655444456778899999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc---------
Q 040917 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--------- 191 (494)
Q Consensus 121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--------- 191 (494)
|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999 678899999999987543321
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......++..|+|||.... ..+.++|+||||++++++++|..||......+....+..+...++.. ..++..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 1223457788999998754 47889999999999999999999999888887777776644433322 23589999999
Q ss_pred HHhcccCCCCCCCH---HHHhcCCccCc
Q 040917 271 RRMLTQDPKRRITV---AQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rps~---~eil~~~~~~~ 295 (494)
.+||+.+|.+||++ .++|+||||.+
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999985
No 218
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=1e-38 Score=300.57 Aligned_cols=248 Identities=31% Similarity=0.546 Sum_probs=212.6
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||++.+..+++.+|+|.+..... ....+.+.+|+.+++.+. ||||+++++.+..+...+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999864332 234567888999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 999999999988653 357899999999999999999999999999999999999 678899999999987654322
Q ss_pred c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...........+..+.....+ ..++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2 234567889999999864 5889999999999999999999999988877776666655443222 3578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 040917 270 VRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~ 290 (494)
|.+||..||++||++.++++-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999874
No 219
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=1.4e-39 Score=310.32 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=213.5
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...|++.+.||+|++|.||+|.+..++..||+|.+..... ......+.+|+.+++++ +||||+++++++..+...++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence 3568888999999999999999999999999999864432 23456789999999999 49999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||||+++++|.+++.. ..++...+..++.+++.|+.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence 9999999999988755 568999999999999999999999999999999999999 567899999999987654322
Q ss_pred c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....++..|+|||.+.+ .++.++|+|||||++++|++|+.||...........+...... .....++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHH
Confidence 1 123457889999999865 5788999999999999999999999766655544443332211 1123567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+.+||..+|++||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999863
No 220
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=5.4e-39 Score=310.15 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=203.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcE--EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~--valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
.+|++.+.||+|+||.||+|.++.++.. +++|.+.. .........+.+|+.++.++.+||||+++++++...+.++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4799999999999999999999887765 46666542 2233455678899999999966999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 111 IVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
+||||+++++|.+++...+ .++...+..++.|++.|+.|||++|++||||||+||++ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 9999999999999987542 47889999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc
Q 040917 175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI 252 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 252 (494)
.++|+|||++..............+..|+|||.+.+ .++.++|||||||++|+|+| |..||.+....+....+....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 999999999864321111111223567999998864 47899999999999999998 999998877776665554321
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.......+++.+.+++.+||..+|++||++.+++.+
T Consensus 241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223578899999999999999999999999884
No 221
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.5e-38 Score=299.59 Aligned_cols=252 Identities=33% Similarity=0.608 Sum_probs=218.2
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||.|++|.||+|.+..++..|++|++..... .......+.+|+++++.+. |||++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999975443 2345677889999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 114 ELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 114 e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
|+++|++|.+++... ..++...+..++.+++.|+.+||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999999999998764 678999999999999999999999999999999999999 5678999999999876544
Q ss_pred Cc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||.................... ...++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence 32 2233567889999998754 578899999999999999999999988877777666655433222 236789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+++.+||..+|++||++.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
No 222
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=9.4e-39 Score=304.60 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=209.2
Q ss_pred cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
++|++.+.||+|++|.||+|.+.. ++..|++|.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERL 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence 679999999999999999999977 78899999885432 233456788999999999 4999999999998888
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 108 FVHIVMELCAGGELFDRIVARG-------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
..++||||++|++|.+++.... .++...+..++.||+.|+.|||+++++||||||+||+++..+....++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 8999999999999999987653 478899999999999999999999999999999999996544456799999
Q ss_pred cCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCC
Q 040917 181 FGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 181 fg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
||++......... .....+..|+|||++. ..++.++|||||||++|+|++ |..||...+.++....+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-- 240 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL-- 240 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence 9998765322111 1122346799999985 468999999999999999997 99999988887776666543221
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.....+|..+.+++.+||..+|++||++.++++|
T Consensus 241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1224678999999999999999999999999985
No 223
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=4.9e-39 Score=312.75 Aligned_cols=249 Identities=28% Similarity=0.467 Sum_probs=190.9
Q ss_pred eeeecccCCeEEEEEEECC--CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--eCCeEEEEE
Q 040917 38 GREVGRGEFGITYLCTENS--TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE--DDQFVHIVM 113 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~--~~~~~~iv~ 113 (494)
+..||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++ ||||+++++++. .+...++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 4679999999999999654 66899999986433 2345778999999995 999999999885 356789999
Q ss_pred eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCC
Q 040917 114 ELCAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGL 183 (494)
Q Consensus 114 e~~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~ 183 (494)
||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||++..+ +..+.++|+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 887776421 247889999999999999999999999999999999999542 3567899999999
Q ss_pred ccccccCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 040917 184 SAFIEEGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQAIL 248 (494)
Q Consensus 184 a~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~ 248 (494)
+....... ......+|+.|+|||++.+ .++.++||||+||++|+|+||+.||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 97654321 1234567899999999864 4789999999999999999999999654321 0010000
Q ss_pred cC--------------CccC--------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 249 KG--------------EINF--------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 249 ~~--------------~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.. ...+ ........+..+.+++.+||..||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0000 000011235668899999999999999999999999998
No 224
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-40 Score=322.38 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=214.1
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCC
Q 040917 40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGG 119 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~ 119 (494)
.||.|.||+||-|++..++..+|||-+.... ....+-+..|+.+-++|+ |.||++++|.+..++.+-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 4999999999999999999999999996433 223455778999999997 999999999999999999999999999
Q ss_pred chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-ccc
Q 040917 120 ELFDRIVAR-GHY--SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YRE 195 (494)
Q Consensus 120 sL~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~ 195 (494)
+|.+++... +++ .+.++..+.+||++||+|||++.|||||||-.||||+ .-.|.+||+|||.+.....-.+ ..+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 999999753 667 7899999999999999999999999999999999997 4679999999999876644333 456
Q ss_pred ccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 196 IVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 196 ~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
..||..|||||++.. .|+.++|||||||++.||.||++||...... ....+.-+-.+..++....++.+++.||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 789999999999963 4999999999999999999999999655443 222333344444444445678889999999
Q ss_pred hcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 273 MLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 273 ~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
|+.++|.+|||+.++|.+||++..++.
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCCCC
Confidence 999999999999999999999876433
No 225
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=3.8e-39 Score=309.10 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=207.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++.+||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3567788999999999999999999999999998754422 34667889999999996699999999999888889999
Q ss_pred EeccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 113 MELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 113 ~e~~~g~sL~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
|||+.+ ++.++.. ....+++..+..++.+++.||.|||+. +++||||||+||++ +..+.++|+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence 999864 6554332 235689999999999999999999985 99999999999999 5778999999999876
Q ss_pred cccCcccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCc-cCCCCCCC
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEI-NFQRDPFP 260 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~ 260 (494)
...........+++.|+|||++.+ .++.++|+||+||++|+|++|+.||...... +....+..+.. ........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 544333344567889999999864 4789999999999999999999999765421 11222222221 11222224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.++..+.+|+.+||..+|++|||+.++++||||..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 57899999999999999999999999999999986
No 226
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.1e-38 Score=304.24 Aligned_cols=249 Identities=29% Similarity=0.461 Sum_probs=201.9
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHc--cCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.||+|+||.||+|.+..+++.||+|++................|..+++.+ .+||+|+.+.+.+......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765433222223344444443333 259999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 197 (494)
|++|..++...+.+++..+..++.|++.|+.|||+++++||||+|+||++ +.++.++|+|||++....... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCcC
Confidence 99999999888889999999999999999999999999999999999999 677899999999987543322 23457
Q ss_pred CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
|+..|+|||.+.+ .++.++|+||+||++|+|++|+.||.... ............ ......++..+.+++.+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPDSFSPELRSLLEG 232 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC----CCCCCcCCHHHHHHHHH
Confidence 8999999999863 47899999999999999999999997663 222222222211 11223468999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCccCcc
Q 040917 273 MLTQDPKRRI-----TVAQVLEHPWLKES 296 (494)
Q Consensus 273 ~l~~dp~~Rp-----s~~eil~~~~~~~~ 296 (494)
||..+|.+|| ++.++++||||...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 9999999999 99999999999864
No 227
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=8.7e-39 Score=305.94 Aligned_cols=253 Identities=27% Similarity=0.475 Sum_probs=208.2
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||.|++|.||+|.+..+|..||+|++..... ......+.+|+.+++++. ||||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 58999999999999999999999999999999875432 223466778999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 114 ELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 114 e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||++ ++++.++|+|||.+......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence 99985 888887654 358999999999999999999999999999999999999 67889999999998754322
Q ss_pred c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-------------
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF------------- 254 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------- 254 (494)
. ......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+....+.+.....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1233456889999998854 36889999999999999999999998877665544332211000
Q ss_pred -----CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 255 -----QR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 255 -----~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+. ...+.++..+.+++.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0113457889999999999999999999999999998
No 228
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.8e-38 Score=302.91 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=208.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~ 110 (494)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++++. ||||+++++++.. ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence 368999999999999999999999999999999875432 234677899999999995 9999999998864 34789
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 111 IVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
+||||++|++|.+++.. ...++...+..++.+|+.||.|||+.|++|+||+|.||++ +..+.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence 99999999999887643 3458899999999999999999999999999999999999 5678899999999865
Q ss_pred cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCccCCC-CCC
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-----DQGVAQAILKGEINFQR-DPF 259 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~-~~~ 259 (494)
...... ....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.... ..+....+......... ...
T Consensus 155 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 433221 23456788999998864 58899999999999999999999997652 23334443332211111 111
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 260 --PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 260 --~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..+++.+.+++.+||..+|++|||+.+++.||||+...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 23567899999999999999999999999999997643
No 229
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-40 Score=305.17 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=215.0
Q ss_pred hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CC----cc
Q 040917 23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PN----IV 97 (494)
Q Consensus 23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~----i~ 97 (494)
++.+..+.+..+|.+++++|+|.||.|-.+.++.++..||||+++.-. ...+...-|+++++++..+ |+ ++
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 445556777899999999999999999999999999999999996322 2455667799999999422 22 57
Q ss_pred EEeEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-----
Q 040917 98 QFKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG----- 170 (494)
Q Consensus 98 ~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~----- 170 (494)
.+.++|...++.|||+|.+ |.|+.+++.++. +++...+..+++|++.++++||+.+++|.||||+||++.+.
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 7788899999999999998 779999998765 58899999999999999999999999999999999998532
Q ss_pred ----C--------CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917 171 ----D--------ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA 237 (494)
Q Consensus 171 ----~--------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~ 237 (494)
. ....|+++|||.|....... ...+.|.+|+|||++.+ .++.++||||+||||+|++||...|.+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 1 24579999999998654333 56788999999999987 799999999999999999999999988
Q ss_pred CChHHHHHHHHcCCccCCC----------------CCCC--------------------------CCCHHHHHHHHHhcc
Q 040917 238 ETDQGVAQAILKGEINFQR----------------DPFP--------------------------SISSSAIELVRRMLT 275 (494)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~----------------~~~~--------------------------~~~~~l~~li~~~l~ 275 (494)
....+.+..+.+--.+++. ..|+ .....+.+|+.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 8866644333211111110 0000 012347899999999
Q ss_pred cCCCCCCCHHHHhcCCccCcc
Q 040917 276 QDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 276 ~dp~~Rps~~eil~~~~~~~~ 296 (494)
.||.+|+|+.|+|.||||...
T Consensus 392 fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFARL 412 (415)
T ss_pred cCccccccHHHHhcCHHhhcC
Confidence 999999999999999999864
No 230
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=8e-39 Score=313.62 Aligned_cols=265 Identities=28% Similarity=0.434 Sum_probs=214.1
Q ss_pred cccceEe-eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-----------hHHHHHHHHHHHHHccCCCCccE
Q 040917 31 VQLHYTI-GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-----------EKDDVRREIEIMRHLSGQPNIVQ 98 (494)
Q Consensus 31 ~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hp~i~~ 98 (494)
+.++|.. .+.||+|++|.||+|.+..+++.||+|++......... ....+.+|+.+++++. ||||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 4567764 57799999999999999999999999998654322110 1124678999999995 999999
Q ss_pred EeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 99 FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
+++++..+...++||||+. ++|.+++.....++...+..++.|++.||.|||++|++|+||+|+||++ +..+.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence 9999999999999999997 5999999887789999999999999999999999999999999999999 67889999
Q ss_pred eecCCccccccC---------------cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917 179 TDFGLSAFIEEG---------------KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ 241 (494)
Q Consensus 179 ~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~ 241 (494)
+|||.+...... .......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998754311 11122345788999998864 3688999999999999999999999888776
Q ss_pred HHHHHHHcCCccCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 242 GVAQAILKGEINFQR------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 242 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+....+......... ...+..+..+.++|.+||..+|++||+++++|.||||+...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 555443321110000 01234578899999999999999999999999999999876
Q ss_pred cCC
Q 040917 298 EAS 300 (494)
Q Consensus 298 ~~~ 300 (494)
...
T Consensus 321 ~~~ 323 (335)
T PTZ00024 321 LPC 323 (335)
T ss_pred CCC
Confidence 543
No 231
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=1.7e-38 Score=302.83 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=214.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
+-|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++++ +||||+++++++..+...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence 457889999999999999999999999999999864432 23456788999999999 499999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|||+++++|.+++.. ..++...+..++.+++.++.+||++|++|+||+|.||++ +.++.++|+|||++........
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 999999999988865 468999999999999999999999999999999999999 6778899999999865543221
Q ss_pred -cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 193 -YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 193 -~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
.....++..|+|||.+.+ .++.++|+||+||++++|++|..||...........+...... .....++..+.+++
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence 223457889999998864 5788999999999999999999999877766555554433221 12235789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
.+||..+|.+||++.++++||||...
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999974
No 232
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=2.4e-38 Score=298.17 Aligned_cols=253 Identities=32% Similarity=0.556 Sum_probs=214.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~i 111 (494)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++++. ||||+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 588999999999999999999999999999998755432 345678899999999995 99999999999888 88999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
++|++++++|.+++.....++...+..++.+++.|+.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence 99999999999999887789999999999999999999999999999999999999 568899999999988765544
Q ss_pred c---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 192 A---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 192 ~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
. .....++..|+|||.+.+ .++.++|+||||+++++|++|..||..... ......+... .........++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence 2 344567889999999865 488999999999999999999999977662 2222222211 11112224568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+++.+||..+|++||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
No 233
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=6.5e-39 Score=308.60 Aligned_cols=262 Identities=29% Similarity=0.528 Sum_probs=218.7
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
...-|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+ +||||+++++++..++..+
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEE
Confidence 34456667789999999999999999999999999864332 2356688999999999 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+++||+++++|..++.. ..++...+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccc
Confidence 99999999999887754 568999999999999999999999999999999999999 67889999999998654332
Q ss_pred c-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 191 K-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 191 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
. ......+++.|+|||.+.+ .++.++|+||+||++++|++|+.||......+....+...... .......++..+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHH
Confidence 2 2234568899999999864 5889999999999999999999999877766655554433222 22233467889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~ 301 (494)
+|.+||..+|.+||++.++++||||.....+.+
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 999999999999999999999999998765544
No 234
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=6.8e-39 Score=306.54 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=208.1
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||.|++|.||+|.+..+|..|++|++..... .......+.+|+.+++.+. |||++++++++......+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6788999999999999999999999999999875432 2223456788999999995 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 115 LCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence 995 59999887765 68999999999999999999999999999999999999 568899999999987543221
Q ss_pred ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC------------------
Q 040917 192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE------------------ 251 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~------------------ 251 (494)
......+++.|+|||++.+ .++.++|+||||+++|+|++|..||...........+.+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223356788999998754 46889999999999999999999998776544333322210
Q ss_pred -------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 252 -------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 252 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
........+.++..+.++|.+||+.+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001111234677899999999999999999999999999997
No 235
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-40 Score=341.02 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=228.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|.|++.||+|+||.|.+++++.+++.||.|++.+-.........-|..|..+|..- +.+=|+.++-.|+++.++|+|
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEE
Confidence 7899999999999999999999999999999999875555555677788899888876 588899999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|+|++||+|..++.+..++++.-+..++..|+.||..||+.|+|||||||.|||+ +..|++||+|||.+..+....
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCc
Confidence 9999999999999998889999999999999999999999999999999999999 799999999999998765332
Q ss_pred -ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 192 -AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.+...+|||.|.+||++. +.|++.+|+||+||++|||+.|..||...+--+.+-.|.+....+..+....+|+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 234578999999999984 4589999999999999999999999999998888888887743333333456999
Q ss_pred HHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917 265 SAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE 295 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~ 295 (494)
.+++||.++++ +|+.|.. ++++-.||||.+
T Consensus 311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 99999999986 5778887 999999999975
No 236
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=1.4e-38 Score=299.93 Aligned_cols=253 Identities=30% Similarity=0.563 Sum_probs=212.9
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+|..||+|.+....... ...+.+.+|+.+++.++ ||||+++++.+......++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 5899999999999999999999999999999987543322 24567889999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
||+++++|.+++.... .+++..+..++.+++.|+.|||+++++|+||+|.||+++ +....++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCc
Confidence 9999999999987643 478999999999999999999999999999999999994 233467999999987654332
Q ss_pred c-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 192 A-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 192 ~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
. .....+++.|+|||.+. ..++.++|+||+|+++++|++|..||...........+...... ...+.++..+.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence 2 12345788999999875 45889999999999999999999999877766655555443322 1224678899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCcc
Q 040917 270 VRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
|.+||..+|++|||+.+++.||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
No 237
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=3.9e-38 Score=305.54 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=213.9
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+.+.|...+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.++ |||++++++++.+....+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3355888888999999999999999999999999987654444444567889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+||||+.| +|.+.+.. ...++...+..++.||+.|+.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence 99999965 77777755 4568999999999999999999999999999999999999 6778899999998864322
Q ss_pred CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.....++..|+|||.+. +.++.++|+|||||++|+|++|..||...........+...... ....+.++..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 248 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDS 248 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHH
Confidence 23456788999999873 45888999999999999999999999877765555554443222 2222457788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+.+++.+||+.+|.+||++.+++.||||...
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999973
No 238
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=1e-38 Score=305.83 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=209.6
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEEE
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHIV 112 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~iv 112 (494)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ........+.+|+.+++.+. |||++++++++... ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 788999999999999999999999999999997654 22334566888999999995 99999999999887 789999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||+++ +|.+++... ..++...+..++.||+.|+.+||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence 999975 898888665 578999999999999999999999999999999999999 678899999999987654432
Q ss_pred --ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC----------
Q 040917 192 --AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD---------- 257 (494)
Q Consensus 192 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 257 (494)
......++..|+|||.+.+ .++.++|+||||+++++|++|+.||...........+..........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1233456788999997754 47899999999999999999999998877665554443211111000
Q ss_pred ----------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 258 ----------------PFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 258 ----------------~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.... ++..+.+++.+||..+|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0112 37889999999999999999999999999997
No 239
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=3.9e-38 Score=295.56 Aligned_cols=251 Identities=33% Similarity=0.553 Sum_probs=213.5
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|.+.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.+. ||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence 48899999999999999999999999999999965432 34678889999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 114 ELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
||++|++|.+++... ..++...+..++.+++.|+.+||++|++||||+|+||++ +.++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence 999999999998776 578999999999999999999999999999999999999 5688999999999887654432
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....++..|+|||.+.+ .++.++|+||||+++++|++|..||..................... ....++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence 344567889999998864 4788999999999999999999999877554444444332221111 11234889999999
Q ss_pred HhcccCCCCCCCHHHHhcCCc
Q 040917 272 RMLTQDPKRRITVAQVLEHPW 292 (494)
Q Consensus 272 ~~l~~dp~~Rps~~eil~~~~ 292 (494)
+||..||++|||+.++++|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
No 240
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=4.1e-39 Score=315.12 Aligned_cols=263 Identities=31% Similarity=0.470 Sum_probs=218.7
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-----e
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-----F 108 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-----~ 108 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.+. ||||+++.+++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 6999999999999999999999999999999986532 22334567889999999995 999999999987764 7
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.|++|+|+++ +|.+++.+...++...+..++.+|+.||.+||++||+||||||.||++ +.++.++|+|||.+....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 8999999974 899988887789999999999999999999999999999999999999 567999999999998765
Q ss_pred cCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------
Q 040917 189 EGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------ 256 (494)
Q Consensus 189 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------ 256 (494)
... ......+++.|+|||++.+ .++.++|+||+|+++++|++|+.||.+....+....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 432 2334567889999998864 4788999999999999999999999888776655544332111110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917 257 ---------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302 (494)
Q Consensus 257 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~ 302 (494)
...+.++..+.++|.+||.++|.+||++.+++.||||+....++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 0123468889999999999999999999999999999976655443
No 241
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=1e-38 Score=306.68 Aligned_cols=260 Identities=31% Similarity=0.513 Sum_probs=215.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
....+|.+.+.||+|+||.||++.+..++..|++|.+.... ....+.+.+|+.+++.+. ||||+++++.+...+..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDEL 91 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcE
Confidence 33579999999999999999999998899999999985432 223567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++|+||+++++|.+++.+. .++...+..++.+++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccc
Confidence 9999999999999988654 57899999999999999999999999999999999999 6778999999998765433
Q ss_pred Ccc-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GKA-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
... .....+++.|+|||.+. +.++.++|+||||+++|++++|..||...........+..... ........++..+.
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 246 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR 246 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHH
Confidence 222 22345788899999875 4588999999999999999999999987665443332222211 11112335778899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
+++.+||..+|++||++.+++.||||+....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 9999999999999999999999999997543
No 242
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=1.1e-38 Score=304.59 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=209.7
Q ss_pred cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
++|.+.+.||+|++|.||+|.+.. ++..||+|++.... .......+.+|+.+++.+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence 579999999999999999998753 46889999986433 2334678899999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917 108 FVHIVMELCAGGELFDRIVARG--------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN 173 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~ 173 (494)
..++||||++|++|.+++...+ .++...+..++.|++.|+.|||++|++||||||+||++ +.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence 9999999999999999997542 37888999999999999999999999999999999999 678
Q ss_pred CeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 040917 174 AVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAIL 248 (494)
Q Consensus 174 ~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~ 248 (494)
+.++|+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||......+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 12234567899999886 468999999999999999998 999998888887777777
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+...... ..++..+.+++.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65443322 467899999999999999999999999986
No 243
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=4.2e-38 Score=295.90 Aligned_cols=252 Identities=30% Similarity=0.545 Sum_probs=216.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|++++.++. |||++++++++......+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 589999999999999999999999999999999765432 335678999999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA- 192 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~- 192 (494)
|++++++|.+++.....+++..+..++.+++.|+.+||++|++||||+|.||++ +.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence 999999999999888889999999999999999999999999999999999999 5678999999999986654332
Q ss_pred cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.....++..|+|||...+ .++.++|+||+|+++++|++|..||.................. .....++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence 223467889999998754 4788999999999999999999999877655444444332221 222467899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCcc
Q 040917 272 RMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 272 ~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+||..+|++||++.++++||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 244
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.3e-38 Score=305.69 Aligned_cols=257 Identities=29% Similarity=0.563 Sum_probs=213.2
Q ss_pred ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.|++.+.||+|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++++.+||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 47899999998654321 2223567888999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++||||+++++|.+++.....++...+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 6788999999999876533
Q ss_pred Cc--ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCC
Q 040917 190 GK--AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFP 260 (494)
Q Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 260 (494)
.. ......++..|+|||.+.. .++.++|+||+|+++|+|++|..||..... ..+...+......+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence 22 1223567889999998853 467899999999999999999999964322 33333333333222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCccC
Q 040917 261 SISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKESG 297 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~ 297 (494)
.++..+.+++.+||..+|.+|| ++++++.||||+...
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 5788999999999999999997 899999999998743
No 245
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=4.6e-38 Score=297.64 Aligned_cols=254 Identities=30% Similarity=0.527 Sum_probs=211.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--Ce
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~ 108 (494)
.+|++.+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++++. ||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 579999999999999999999999999999998753221 12334567889999999995 99999999998653 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+++++||++|++|.+++...+.++...+..++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 88999999999999999887788999999999999999999999999999999999999 567889999999987543
Q ss_pred cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
.. .......++..|+|||.+.+ .++.++|+|||||++++|++|+.||...........+..... .+.....++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence 21 11223457889999999865 478899999999999999999999987766555444433221 122235688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.+.+++.+||. +|..||++.++++|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
No 246
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1e-38 Score=302.70 Aligned_cols=251 Identities=28% Similarity=0.546 Sum_probs=208.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||+|.+..++..+++|.+.............+.+|+.+++.+ +||||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 4689999999999999999999999999999988755444444567888999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|||++|++|.+++.. ...+++..+..++.+|+.|+.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 999999999998863 3458999999999999999999999999999999999999 577899999999987654
Q ss_pred cCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ--GVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
.... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+.... .....+... .+++......++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 3222 234567889999998864 5788999999999999999999999755432 222333222 222223345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998875
No 247
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=3.5e-38 Score=298.34 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=209.0
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...|.+.+.||+|++|.||+|.+..+++.|++|++.... .....+.+|+.+++.+. ||||+++++++......++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEE
Confidence 356999999999999999999999999999999986432 23567889999999995 9999999999999899999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||++ ++++.++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccc
Confidence 99999999999998754 358899999999999999999999999999999999999 6788999999999876543
Q ss_pred Ccccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
..... ....++.|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+....+..... ......+|..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPK 233 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHH
Confidence 22111 1223567999998764 58899999999999999998 9999988887777666655322 2223567899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+++.+||..+|++||++.++++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999976
No 248
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1.3e-38 Score=309.56 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=202.9
Q ss_pred ceEeeeeecccCCeEEEEEEECC--CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeE
Q 040917 34 HYTIGREVGRGEFGITYLCTENS--TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFV 109 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~ 109 (494)
+|++.+.||+|++|.||+|.+.. ++..||+|.+.............+.+|+.+++.+. ||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 58999999999999999999988 89999999997643222334566788999999995 99999999999887 789
Q ss_pred EEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecCC
Q 040917 110 HIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGL 183 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg~ 183 (494)
++||||+++ +|.+.+... ..+++..+..++.||+.||.|||+.+|+||||||+||+++. ++..+.++|+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 777766432 25889999999999999999999999999999999999942 12289999999999
Q ss_pred ccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHH
Q 040917 184 SAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQG---------VAQAIL 248 (494)
Q Consensus 184 a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---------~~~~~~ 248 (494)
+........ .....+++.|+|||++.+ .++.++|+|||||++++|++|+.||.+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 876533221 223467889999998764 47889999999999999999999997654322 000000
Q ss_pred cCC---------------------ccCCCCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 249 KGE---------------------INFQRDPFP------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 249 ~~~---------------------~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..- ........+ ..+..+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 000001111 456789999999999999999999999999998
No 249
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-40 Score=317.27 Aligned_cols=250 Identities=21% Similarity=0.386 Sum_probs=212.1
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..+...++..||+|.||+||+|.|.. .||||++...... +...+.|.+|+.+|++-+ |.||+-+.|++..... .
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-A 463 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-e
Confidence 34677889999999999999999975 5999999766644 447889999999999996 9999999999988776 8
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-
Q 040917 111 IVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE- 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~- 188 (494)
||+.+|+|.+|+.+++-. .++...+.+.|++||+.|+.|||.++|||+|||.+|||+ .+++.|||+|||++....
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence 999999999999998743 468999999999999999999999999999999999999 677999999999987542
Q ss_pred --cCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-CCCC
Q 040917 189 --EGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-PFPS 261 (494)
Q Consensus 189 --~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 261 (494)
.........|...|+|||+++ .+|++.+|||||||++|||++|..||.....+.++-++-++-...... ....
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 223334455677899999985 369999999999999999999999999777776666666664433322 2245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.++++|+..||..++++||.+.+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 7789999999999999999999999987
No 250
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=2.6e-38 Score=303.74 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=202.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+|..|++|++..... ......+.+|+.+++.+. |+||+++++++..+...++|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence 689999999999999999999999999999999865432 223345678999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||+. ++|.+.+... ..++...+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence 99996 5777766543 457888899999999999999999999999999999999 678899999999987543221
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc--------------CCcc
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILK--------------GEIN 253 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~--------------~~~~ 253 (494)
......+++.|+|||.+.+ .++.++|+|||||++++|++|..||.+.... +....+.. ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 2233456889999998864 4788999999999999999999999765532 11111110 0000
Q ss_pred CCCC------------CCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 254 FQRD------------PFP--SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 254 ~~~~------------~~~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+... .+. ..+..+.+++.+|+..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 001 125688999999999999999999999999997
No 251
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=4.2e-38 Score=296.53 Aligned_cols=245 Identities=25% Similarity=0.420 Sum_probs=206.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++++. ||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence 46999999999999999999875 456799998764332 3467889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++|++|.+++... +.++...+..++.+++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence 9999999999988753 468999999999999999999999999999999999999 678899999999887543222
Q ss_pred cc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 192 AY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ....++..|+|||.+.+ .++.++|+||+|+++|+|++ |+.||......+....+..+.....+ ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence 21 12234567999999864 58899999999999999999 89999888888787777765433222 34678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..+|++||++.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999986
No 252
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=3e-38 Score=309.03 Aligned_cols=263 Identities=30% Similarity=0.438 Sum_probs=210.8
Q ss_pred ceEeeeeecccCCeEEEEEEECCC--CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CC
Q 040917 34 HYTIGREVGRGEFGITYLCTENST--GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQ 107 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~ 107 (494)
+|++.+.||+|+||.||+|.+..+ +..||+|++.... ........+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 9999999986432 2222356678899999999779999999987532 24
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..+++++++. ++|.+++.....++...+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 5789999985 5999999888889999999999999999999999999999999999999 67889999999998754
Q ss_pred ccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--------
Q 040917 188 EEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-------- 252 (494)
Q Consensus 188 ~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-------- 252 (494)
..... .....+++.|+|||.+.+ .++.++|+||+||++|+|++|..||...........+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 33211 223468899999998754 578999999999999999999999987665443332221100
Q ss_pred -------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917 253 -------------------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301 (494)
Q Consensus 253 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~ 301 (494)
.......+..+..+.+++.+||..||.+|||+.+++.|||+.+...+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~ 303 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence 0001123456789999999999999999999999999999986654433
No 253
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=7.3e-40 Score=292.01 Aligned_cols=265 Identities=29% Similarity=0.458 Sum_probs=207.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~ 106 (494)
...|++++.||+|.||.||+|...+++. .+|+|.++.+..... .....-+|+.+++.|+ ||||+.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3579999999999999999996555433 789999976654333 3456678999999996 9999999999876 7
Q ss_pred CeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEee
Q 040917 107 QFVHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATD 180 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~D 180 (494)
..+++++||.+. +|++.|+-. ..++...+.+|+.||+.|+.|||++.|+||||||+|||+..+ .+.|.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999975 999888532 358999999999999999999999999999999999999753 4569999999
Q ss_pred cCCccccccC----cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 040917 181 FGLSAFIEEG----KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQ 245 (494)
Q Consensus 181 fg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~ 245 (494)
+|+++.+.+. ......+.|.+|+|||.+.| .||++.|+||+|||+.||+|..+.|.+.... +.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999876542 12345677999999999976 5999999999999999999998888544321 1122
Q ss_pred HHHcCCccCCCCCCC---------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917 246 AILKGEINFQRDPFP---------------------------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292 (494)
Q Consensus 246 ~~~~~~~~~~~~~~~---------------------------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~ 292 (494)
.|.+---.+....|+ .-++...+|+.+||+.||.+|.|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 221110011111111 12344778999999999999999999999999
Q ss_pred cCccCcC
Q 040917 293 LKESGEA 299 (494)
Q Consensus 293 ~~~~~~~ 299 (494)
|.+.+-+
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987544
No 254
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=4.3e-38 Score=298.54 Aligned_cols=249 Identities=29% Similarity=0.495 Sum_probs=201.6
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
...||+|+||.||+|.+..++..|++|.+.... ......+.+|+.++++++ ||||+++++++..++..++|+||++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCC
Confidence 457999999999999999999999999986432 224567889999999995 9999999999999999999999999
Q ss_pred CCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-c
Q 040917 118 GGELFDRIVAR-GHY--SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-Y 193 (494)
Q Consensus 118 g~sL~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~ 193 (494)
+++|.+++... ..+ +...+..++.||+.|+.|||++||+||||||+||+++ ...+.++|+|||.+........ .
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCcc
Confidence 99999998764 445 7888999999999999999999999999999999994 2367899999999875433222 2
Q ss_pred ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 194 REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 194 ~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
....+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||............ .............+++.+.+++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHH
Confidence 23457889999998853 3788999999999999999999999754432221111 1101111112235788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCcc
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+||..+|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
No 255
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=3.1e-38 Score=302.47 Aligned_cols=257 Identities=32% Similarity=0.533 Sum_probs=218.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+....|.+...||+|++|.||+|.+..++..|++|++..... ....+.+|+.+++.+. ||||+++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 456789999999999999999999998999999999964332 4567889999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++++||++|++|.+++.... .++...+..++.+++.|+.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence 99999999999999998876 79999999999999999999999999999999999999 678899999999876543
Q ss_pred cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+...... .......++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 322 1123456789999998764 5789999999999999999999999877765554444333222 112223478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.++|.+||+.+|.+||++.++++|+||..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999997
No 256
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.2e-37 Score=302.80 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=215.9
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+...|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.+. |||++++++++..+...+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAW 101 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEE
Confidence 4456889999999999999999999999999999987654444445567889999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+||||+.| +|.+.+.. ..+++...+..++.+++.|+.|||++|++||||+|+||++ +.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence 99999975 77776654 4568999999999999999999999999999999999999 6778999999998865432
Q ss_pred CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
. ....+++.|+|||.+. +.++.++|+||+||++|+|++|..||...........+........ ....+++.
T Consensus 178 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 252 (317)
T cd06635 178 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDY 252 (317)
T ss_pred c---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHH
Confidence 2 2346788999999873 4588899999999999999999999988776666655555433222 22457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+.+++.+||..+|.+||++.++++|+|+...
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 9999999999999999999999999999753
No 257
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=3e-38 Score=304.19 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=204.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++.+||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999877765 4688877532 233345678899999999966999999999999888999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 111 IVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
+++||+++++|.+++.... .++...+..++.|++.|+.|||++|++||||||+||++ +.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence 9999999999999986542 47888999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc
Q 040917 175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI 252 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 252 (494)
.++|+|||++..............+..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+.....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999999864322111111222456999998764 58999999999999999997 9999998888777766655422
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
. .....++..+.+++.+||..+|.+||+++++++
T Consensus 237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 122457899999999999999999999999976
No 258
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=2.3e-38 Score=297.06 Aligned_cols=245 Identities=36% Similarity=0.655 Sum_probs=213.3
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|++|.||+|.+..+++.+++|++.............+.+|+.+++++. ||||+++++.+..+...++|||++++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999999899999999997765544445678899999999995 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cccccccCC
Q 040917 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGS 199 (494)
Q Consensus 121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~ 199 (494)
|.+++.....+++..+..++.|++.|+.|||+.+++|+||+|+||++ +..+.++|+|||.+...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 99999888789999999999999999999999999999999999999 67789999999998765433 223445678
Q ss_pred cCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917 200 PYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278 (494)
Q Consensus 200 ~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 278 (494)
..|+|||...+ ..+.++|+||||+++|++++|..||...........+.......+ ...+..+.+++.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence 89999998865 478899999999999999999999988877666666655333222 3458999999999999999
Q ss_pred CCCCCH---HHHhcCCcc
Q 040917 279 KRRITV---AQVLEHPWL 293 (494)
Q Consensus 279 ~~Rps~---~eil~~~~~ 293 (494)
++||++ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
No 259
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=3.3e-38 Score=300.82 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=206.6
Q ss_pred cccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
..++|++.+.||+|++|.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 4578999999999999999999864 245679999985432 222355688999999999 59999999999998
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917 106 DQFVHIVMELCAGGELFDRIVARG----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV 175 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~ 175 (494)
+...++||||+++++|.+++.... .++...+..++.|++.|+.|||++|++||||||+||++ ++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 899999999999999999986532 24677889999999999999999999999999999999 67889
Q ss_pred EEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 040917 176 VKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG 250 (494)
Q Consensus 176 ~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 250 (494)
++|+|||++......... ....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||.+...+.....+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998754332211 12234678999999864 58999999999999999999 78999888887777766655
Q ss_pred CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 251 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
..... ...++..+.+++.+||..+|++|||+.+++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43222 23578899999999999999999999999863
No 260
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=4.3e-38 Score=301.58 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=207.5
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCe----
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQF---- 108 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~---- 108 (494)
|++.+.||+|++|.||+|.++.+++.||+|.+..... .......+.+|+.++++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999975443 2223455667888887774 49999999999987766
Q ss_pred -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 109 -VHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 109 -~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
.+++||++.+ +|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence 9999999975 8988887643 48999999999999999999999999999999999999 567899999999987
Q ss_pred ccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-----CC----
Q 040917 186 FIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-----FQ---- 255 (494)
Q Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----~~---- 255 (494)
............++..|+|||.+.+ .++.++|+||+||++|+|++|..||.+....+....+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 7654443344557889999998864 5788999999999999999999999888776655544321100 00
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 256 --------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 256 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
....+.++..+.++|.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112456788999999999999999999999999997
No 261
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=4.5e-38 Score=301.60 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=208.0
Q ss_pred cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|.+.+.||+|+||.||++.+. .++..+++|.+... .......+.+|+.+++++. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 57999999999999999999852 34567899988543 2334667899999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 108 FVHIVMELCAGGELFDRIVARG-------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||++ +.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence 9999999999999999987543 38999999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 040917 175 VVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILK 249 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 249 (494)
.++|+|||.+........ .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+.+
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875533221 112334678999998874 58899999999999999998 8999988888777777776
Q ss_pred CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+...... ..++..+.+++.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6433221 357889999999999999999999999966
No 262
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=4.5e-38 Score=304.46 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=214.0
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
....|.+.+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.+. |||++++.+++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence 3456888999999999999999999999999999986543333344567788999999994 999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+||||+. ++|.+.+.. ...++...+..++.+++.|+.|||+++++||||+|+||++ +.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 9999996 478776654 4468999999999999999999999999999999999999 5678999999999875433
Q ss_pred CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
. ....+++.|+|||.+. +.++.++|||||||++|+|++|..||...........+........ ....++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence 2 2346788999999874 3578899999999999999999999977665555544444333221 12357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
+.++|.+||..+|.+||++.++++|||+....
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999999999999999999999999999744
No 263
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=5.7e-38 Score=297.44 Aligned_cols=251 Identities=29% Similarity=0.544 Sum_probs=209.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|++|.||+|.+..+|+.|++|.++............+.+|+.+++++ +|+||+++++.+...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 5799999999999999999999999999999998755444444567889999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|||++|++|.+++.. ...++...+..++.+++.|+.|||+.|++||||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 999999999998864 2358899999999999999999999999999999999999 678899999999987554
Q ss_pred cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
... ......+++.|.|||.+.+ .++.++|+|||||++++|++|+.||..... ......+..+.. ++.+.+.++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence 322 2233567889999998764 588899999999999999999999955432 233333333322 2222236788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.++|.+||..+|++||++.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999886
No 264
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=3.2e-38 Score=314.25 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=204.7
Q ss_pred cccccccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917 27 AYEDVQLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA 101 (494)
Q Consensus 27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~ 101 (494)
+.+-..++|.+++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++++..||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3444467899999999999999999987533 3469999986432 23345678999999999956999999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 040917 102 AYEDDQFVHIVMELCAGGELFDRIVAR----------------------------------------------------- 128 (494)
Q Consensus 102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~----------------------------------------------------- 128 (494)
++......++|||||++|+|.+++..+
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917 129 -------------------------------------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF 165 (494)
Q Consensus 129 -------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI 165 (494)
..++...+..++.||+.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778889999999999999999999999999999
Q ss_pred EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917 166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETD 240 (494)
Q Consensus 166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~ 240 (494)
++ +.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.....
T Consensus 269 ll---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99 5678899999999875433221 122345678999998864 58999999999999999997 8999977654
Q ss_pred HHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 241 QGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.... ..+..+ .... ....++..+.+++.+||..+|++||++.++.+
T Consensus 346 ~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4333 333332 2222 22467899999999999999999999999876
No 265
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=4.6e-38 Score=296.22 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=206.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||.|.+.. +..||+|.+..... ..+.+.+|+.+++++. ||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 579999999999999999998754 55699999864332 3466889999999995 99999999999888889999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence 9999999999998764 368999999999999999999999999999999999999 677899999999987543322
Q ss_pred cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+.++...+.. ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 11 1123456799999986 468899999999999999998 99999888877777777665433222 34678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+++.+||..+|.+||++.+++++
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
No 266
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=3.6e-38 Score=302.60 Aligned_cols=259 Identities=31% Similarity=0.547 Sum_probs=215.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
..|.....||+|++|.||++.+..+++.||+|.+... .......+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEE
Confidence 4455567899999999999999999999999998532 2334667889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK- 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~- 191 (494)
|||+++++|.+++.. ..++...+..++.|++.|+.|||++|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 96 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc
Confidence 999999999987654 468999999999999999999999999999999999999 677889999999886553322
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+...... .......++..+.+++
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 250 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFL 250 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHH
Confidence 1233567889999998754 5788999999999999999999999877766555554332221 1112346789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKESGEAS 300 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~~ 300 (494)
.+||..+|.+||++.++++||||.....++
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 999999999999999999999999876443
No 267
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=4.4e-38 Score=296.21 Aligned_cols=251 Identities=29% Similarity=0.510 Sum_probs=216.3
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+|++.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.+. ||||+++.+++......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 589999999999999999999999999999998754432 334567788999999995 999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 114 ELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 114 e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
||+++++|.+++.. ...++...+..++.+++.||.|||+.|++|+||+|.||++ +.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhcc
Confidence 99999999998866 3468999999999999999999999999999999999999 5678899999999876654
Q ss_pred CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
. ......+++.|+|||.+.+ .++.++|+||+|+++++|++|+.||.....+.....+......... ..++..+.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence 4 3334567889999999865 4788999999999999999999999988877776666554332221 367899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
++.+||..+|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
No 268
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=1.7e-38 Score=299.50 Aligned_cols=245 Identities=29% Similarity=0.480 Sum_probs=201.4
Q ss_pred EeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 36 TIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 36 ~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
++.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 46789999999999999987 55778999999542 2333578899999999999 59999999999998788999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
|+||+++|+|.+++... ..++...+..++.||+.||.|||+++++|++|+++||++ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999886 679999999999999999999999999999999999999 5788999999999976622
Q ss_pred Ccc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 190 GKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 190 ~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
... .........|+|||.+.. .++.++||||||+++|++++ |+.||.......+...+..+..... ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence 211 122345678999999864 58999999999999999999 7899998888888877755544222 246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++..||..+|.+|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
No 269
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=3e-38 Score=310.38 Aligned_cols=272 Identities=26% Similarity=0.452 Sum_probs=216.4
Q ss_pred hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917 23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA 102 (494)
Q Consensus 23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~ 102 (494)
......+.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++ ||||++++++
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~ 84 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDV 84 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeee
Confidence 344456678899999999999999999999999999999999986532 22223566788999999995 9999999998
Q ss_pred EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
+... ...+++++++ |++|.+++.. ..++...+..++.|++.||.|||++||+||||||+||++ +.++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~ 159 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCEL 159 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCE
Confidence 8543 3477888887 7799887754 468999999999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917 177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-- 252 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-- 252 (494)
+|+|||++..... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...........+.....
T Consensus 160 kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 160 KILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred EEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999875432 2234567889999998754 478899999999999999999999977665443333221100
Q ss_pred ---------------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917 253 ---------------------NFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303 (494)
Q Consensus 253 ---------------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~ 303 (494)
..+. ..+...++.+.++|.+||..||.+||++.++++||||+....+...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~ 313 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 313 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence 0000 11124578899999999999999999999999999999766555444
No 270
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=1.9e-38 Score=311.22 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=213.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--C
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--Q 107 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~ 107 (494)
.+.++|++.+.||+|++|.||+|.+..+|+.+|+|++.... ........+.+|+.+++++.+||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 46689999999999999999999999999999999986432 12223456778999999995599999999988643 4
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++||||+.+ +|.+++... .++...+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||.+...
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence 68999999974 999888765 78899999999999999999999999999999999999 67899999999998765
Q ss_pred ccCc------ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--------
Q 040917 188 EEGK------AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE-------- 251 (494)
Q Consensus 188 ~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-------- 251 (494)
.... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 3322 2223467889999998743 47889999999999999999999998766554333221111
Q ss_pred -------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917 252 -------------------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300 (494)
Q Consensus 252 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~ 300 (494)
........+.++..+.++|.+||+.+|++|||+.++++|||++....+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~ 305 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS 305 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence 1111122345789999999999999999999999999999998754443
No 271
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=2.2e-38 Score=309.99 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=200.4
Q ss_pred ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917 32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED- 105 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~- 105 (494)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 368999999999999999999754 345789999986432 222356678899999999669999999998764
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 040917 106 DQFVHIVMELCAGGELFDRIVAR--------------------------------------------------------- 128 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~--------------------------------------------------------- 128 (494)
+..+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45788999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcC
Q 040917 129 ----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPY 201 (494)
Q Consensus 129 ----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~ 201 (494)
..++...+..++.||+.||.|||++||+||||||.||++ +.++.++|+|||++........ .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 257888999999999999999999999999999999999 5678899999999976533221 112345678
Q ss_pred ccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917 202 YIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278 (494)
Q Consensus 202 y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 278 (494)
|+|||++. ..++.++|||||||++|+|++ |..||.+....+.. ..+..... ... ....++.+.+++.+||+.+|
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MRA--PEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CCC--CccCCHHHHHHHHHHccCCh
Confidence 99999875 468999999999999999998 99999775543333 33333222 111 13567899999999999999
Q ss_pred CCCCCHHHHhcC
Q 040917 279 KRRITVAQVLEH 290 (494)
Q Consensus 279 ~~Rps~~eil~~ 290 (494)
++||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999874
No 272
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=7.4e-38 Score=296.59 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=208.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
++|++.+.||+|+||.||+|.+..+ ...|++|.+.... .......+.+|+.+++.+. ||||+++++++......
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 5799999999999999999998654 4579999986433 3334667889999999995 99999999999998999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+++|||+++++|.+++... +.++...+..++.+++.|+.|||+++|+||||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 678899999999998764
Q ss_pred cCc-ccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 189 EGK-AYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 189 ~~~-~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
... ... ...+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||...........+....... ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 211 111 1233567999998864 58899999999999999998 999998888777777666542221 124678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999873
No 273
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=5.7e-38 Score=302.12 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=209.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+..|+.++.++.+||||+++++++......++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3679999999999999999999999999999999975432 22345566788777777679999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|||+.+ +|.+++.. ...++...+..++.+++.|+.|||+ .||+||||+|+||++ ++++.++|+|||.+.....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccC
Confidence 9999854 77776655 3568999999999999999999997 599999999999999 6788999999999876544
Q ss_pred CcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCC
Q 040917 190 GKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
........+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||..... .+....+......... ....++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 246 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGFS 246 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCCCC
Confidence 333334457789999998853 378899999999999999999999976433 2334444333222211 122478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
..+.+++.+||..||.+||++.+++.||||....
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 8999999999999999999999999999998643
No 274
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1e-37 Score=299.19 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=208.2
Q ss_pred ccceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC
Confidence 4789999999999999999997642 35589999886433 222345678899999999 599999999999988
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 107 QFVHIVMELCAGGELFDRIVAR----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
...++||||+++|+|.+++... ..++...+..++.|++.||.|||+++++||||||+||++ +.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence 8999999999999999999653 234567889999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917 177 KATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE 251 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 251 (494)
+|+|||++......... ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.+...++....+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998754332211 1123466799999875 468999999999999999998 788998888777776665543
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCccCc
Q 040917 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE------HPWLKE 295 (494)
Q Consensus 252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~------~~~~~~ 295 (494)
.... ....++.+.+++.+||..+|++|||+.++++ ||||..
T Consensus 239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 3221 1356789999999999999999999999987 888875
No 275
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.4e-38 Score=324.59 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=195.1
Q ss_pred ccccccceEeeeeecccCCeEEEEEEECCCC-cEEEEE--------------EeccCCCCChhhHHHHHHHHHHHHHccC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTENSTG-LEFACK--------------SIPKRKLVKDVEKDDVRREIEIMRHLSG 92 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (494)
.+.+.++|++++.||+|+||+||+|..+... ..++.| .+.+...........+.+|+.+++++.
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~- 221 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN- 221 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-
Confidence 3456689999999999999999998764332 222222 111111112224556889999999994
Q ss_pred CCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917 93 QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF 167 (494)
Q Consensus 93 hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli 167 (494)
||||+++++++......|+|++++. ++|.+++... .......+..++.||+.||.|||++||+||||||+|||+
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 5787776543 123466788899999999999999999999999999999
Q ss_pred eeCCCCCeEEEeecCCccccccCcc--cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC-CC--h-
Q 040917 168 TTGDENAVVKATDFGLSAFIEEGKA--YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA-ET--D- 240 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~-~~--~- 240 (494)
+.++.+||+|||++........ .....|++.|+|||++.+ .++.++|||||||++|+|++|..++.. .. .
T Consensus 301 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 301 ---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred ---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 6788999999999976543322 223578999999999865 589999999999999999998764432 21 1
Q ss_pred HHHHHHHHcCC---ccCCC------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 241 QGVAQAILKGE---INFQR------------------D------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 241 ~~~~~~~~~~~---~~~~~------------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
..+.+.+.... ..++. . ....++..+.++|.+||..||.+|||+.|+|.||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 11111111100 00000 0 001356678888999999999999999999999999
Q ss_pred Ccc
Q 040917 294 KES 296 (494)
Q Consensus 294 ~~~ 296 (494)
...
T Consensus 458 ~~~ 460 (501)
T PHA03210 458 SAE 460 (501)
T ss_pred hcC
Confidence 864
No 276
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=6.5e-38 Score=294.51 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=200.5
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999999999999999886432 333567789999999999 599999999999999999999999999
Q ss_pred CchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccc---
Q 040917 119 GELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--- 194 (494)
Q Consensus 119 ~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~--- 194 (494)
++|.+++...+ .+++..+..++.|++.||.|||++|++||||+|.||++ +.++.++|+|||.+..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999 677889999999987543221110
Q ss_pred cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
....+..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+...... .....++..+.+++.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence 112245699999876 458899999999999999997 88999877776665555543222 1224578999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 040917 273 MLTQDPKRRITVAQVLE 289 (494)
Q Consensus 273 ~l~~dp~~Rps~~eil~ 289 (494)
||..+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
No 277
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=8.2e-38 Score=295.41 Aligned_cols=245 Identities=21% Similarity=0.355 Sum_probs=206.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++++.||+|++|.||+|.+. .+..|++|.+.... ...+.+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence 68999999999999999999864 56779999876432 23567889999999995 99999999999988999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+++++|.+++... ..++...+..++.+++.||.|||+++++||||+|+||++ +.++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCC
Confidence 9999999999998653 457888999999999999999999999999999999999 67889999999999765432
Q ss_pred ccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 191 KAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 191 ~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
... ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+..... .+....++..+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDEL 233 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHH
Confidence 211 1223456799999876 458889999999999999998 9999988887777776655422 22234688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+++.+||..+|++||+++++++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999875
No 278
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=5.6e-38 Score=304.99 Aligned_cols=248 Identities=19% Similarity=0.304 Sum_probs=204.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcE----EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLE----FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 5799999999999999999998766664 8999986432 3334667889999999994 99999999998765 4
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+++++|+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 67999999999999999764 358899999999999999999999999999999999999 67788999999999865
Q ss_pred ccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 188 EEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 188 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
...... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....++...+..+. ..+. .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCC
Confidence 433221 12233567999998864 68999999999999999997 999998877766555444332 2222 2457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+..+.+++.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7899999999999999999999999875
No 279
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=4.4e-38 Score=308.96 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=213.8
Q ss_pred hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917 23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA 102 (494)
Q Consensus 23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~ 102 (494)
...++.+.+..+|.+.+.||+|++|.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+ +||||++++++
T Consensus 5 ~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 82 (342)
T cd07879 5 EVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHM-QHENVIGLLDV 82 (342)
T ss_pred hhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhc-CCCCccchhhe
Confidence 345566777889999999999999999999999999999999987543 2223345678899999999 49999999999
Q ss_pred EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
+... ..+++|++|+.. +|..+. ...++...+..++.|++.||.|||++|++||||+|+||++ +.++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~ 156 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCEL 156 (342)
T ss_pred ecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCE
Confidence 8643 346899999964 676654 3468999999999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917 177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-- 252 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-- 252 (494)
+|+|||++..... ......+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+.........+.....
T Consensus 157 kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 157 KILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred EEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999875432 2234567889999998754 478899999999999999999999988765544443322100
Q ss_pred ---------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 253 ---------------------NFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 253 ---------------------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
..+.. .++..+..+.++|.+||+.||.+||++.+++.||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00111 12456788999999999999999999999999999987543
No 280
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=4.5e-38 Score=303.82 Aligned_cols=257 Identities=31% Similarity=0.497 Sum_probs=208.1
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--- 107 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--- 107 (494)
..++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence 44789999999999999999999999999999999865432 2223456778999999995 999999999886544
Q ss_pred -------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 108 -------FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 108 -------~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
..++|+||+++ ++...+... ..++...+..++.||+.||.|||++||+|+||+|+||++ ++++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 78999999976 777766553 468999999999999999999999999999999999999 678899999
Q ss_pred ecCCccccccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917 180 DFGLSAFIEEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 180 Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
|||.+....... ......++..|+|||.+.+ .++.++|+||+||++++|++|+.||......+....+........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987654322 1222345778999998854 478899999999999999999999987666554443332110000
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 256 --------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 256 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
...+..+|..+.+++.+||..+|.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 01123578999999999999999999999999999997
No 281
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=8.6e-38 Score=295.01 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=209.1
Q ss_pred eeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917 39 REVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL 115 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~ 115 (494)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.+. ||||+++++++......+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 9999999997544322 4678899999999996 99999999999998999999999
Q ss_pred cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 116 CAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 116 ~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999 6779999999999987
Q ss_pred cccCc---ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 187 IEEGK---AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 187 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
..... ......+++.|+|||.+.. .++.++|+||+|+++|+|++ |..||...........+..+.... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 65432 1233456788999998864 68899999999999999999 699999888877777776633221 2245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+|..+.+++.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999874
No 282
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=8.4e-38 Score=301.00 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=207.3
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCC----------------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTG----------------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 95 (494)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 368999999999999999999876544 568999986543 2235677889999999995 999
Q ss_pred ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917 96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN 164 (494)
Q Consensus 96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N 164 (494)
|+++++++..+...++++|++++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999899999999999999999997765 68999999999999999999999999999999999
Q ss_pred eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 040917 165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC--GVPPFWAE 238 (494)
Q Consensus 165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t--g~~pf~~~ 238 (494)
|++ +.++.++|+|||.+........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ +..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 5678999999999875432221 122345678999998764 68999999999999999998 77888877
Q ss_pred ChHHHHHHHHcC----CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 239 TDQGVAQAILKG----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 239 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
........+... .........+.+|..+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766665555432 111111222456789999999999999999999999976
No 283
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=4.3e-38 Score=300.97 Aligned_cols=253 Identities=33% Similarity=0.535 Sum_probs=209.0
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||+|++|+||+|....+++.|++|.+...... .......+|+..++++.+||||+++++++..+...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999998654321 2233456799999999669999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 115 LCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|+ +++|.+.+.... .++...+..++.|++.+|.|||++|++|+||+|.||++ +.++.++|+|||.+........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence 99 779999887764 68999999999999999999999999999999999999 6789999999999987655444
Q ss_pred cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC---------------
Q 040917 193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ--------------- 255 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------------- 255 (494)
.....++..|+|||++.+ .++.++|+||||+++++|++|+.||......+....+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 445667889999998743 478999999999999999999999987766554433321100000
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 256 -----------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 256 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
....+..+..+.++|.+||..+|++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00112346889999999999999999999999999997
No 284
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=7.4e-38 Score=300.96 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=208.0
Q ss_pred ccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
.++|++.+.||+|++|.||++.+... ...+|+|.+.... .......+.+|+.+++++.+||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 36899999999999999999997643 3789999986432 2234566889999999995699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC
Q 040917 107 QFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG 170 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~ 170 (494)
...+++|||+++++|.+++... ..++...+..++.|++.||.|||+++|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 9999999999999999998642 357889999999999999999999999999999999999
Q ss_pred CCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 040917 171 DENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQ 245 (494)
Q Consensus 171 ~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~ 245 (494)
+.++.++|+|||.+......... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 67889999999998765432211 11223567999998754 58899999999999999997 999998888777776
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.+....... .....+..+.+++.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665543221 123568899999999999999999999999873
No 285
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1e-37 Score=301.93 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=207.4
Q ss_pred cccccceEeeeeecccCCeEEEEEEECC-------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENS-------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA 101 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~ 101 (494)
+-..++|.+++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+.+||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3345789999999999999999998643 23569999987532 22345678889999999966999999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917 102 AYEDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF 165 (494)
Q Consensus 102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI 165 (494)
++......++||||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 378889999999999999999999999999999999
Q ss_pred EEeeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917 166 LFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETD 240 (494)
Q Consensus 166 li~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~ 240 (494)
++ +.++.++|+|||.+......... ....+++.|+|||++.+ .++.++|+|||||++|+|++ |..||.+...
T Consensus 172 ll---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99 57789999999998755332211 11223468999998864 58899999999999999998 8899988777
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+....+...... .....++..+.+++.+||..+|.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6666665544321 122467899999999999999999999999987
No 286
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-38 Score=311.39 Aligned_cols=247 Identities=32% Similarity=0.523 Sum_probs=214.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.++.. +..+|+.++....+||||+++.+++.++.+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 466889999999999999999999999999999999976532 2345777777777899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
|+|||.+.|+-|.+.+...+... ..+..|+.+|+.|+.|||.+|++||||||+|||+. ++.++++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999999999887776555 78888999999999999999999999999999995 4788999999999987655
Q ss_pred CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
. +.+.+-|..|.|||++.. .|++++||||||++||+|++|+.||...... ++...+..+.+. ..+|..++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK 540 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK 540 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence 4 445567889999999875 5999999999999999999999999877766 344444333222 57899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 268 ELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
+||..||+.||.+||++.+++.||||.
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcchh
Confidence 999999999999999999999999993
No 287
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.1e-37 Score=298.07 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=206.3
Q ss_pred cceEeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.+|++.+.||+|+||.||+|.+. .++..|++|.+.... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 46899999999999999999853 456789999986432 2334567889999999995 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917 109 VHIVMELCAGGELFDRIVARG-----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD 171 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~ 171 (494)
.+++|||+++++|.+++.... .++...+..++.+++.||.|||++|++||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 999999999999999885332 36788899999999999999999999999999999999 5
Q ss_pred CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917 172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA 246 (494)
Q Consensus 172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~ 246 (494)
.++.++|+|||++........ .....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 778899999999876433221 12234466799999886 468999999999999999998 9999988877767666
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+....... ....+++.+.+++.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 65543322 224678999999999999999999999999763
No 288
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=1.3e-37 Score=303.59 Aligned_cols=266 Identities=31% Similarity=0.493 Sum_probs=213.7
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCe
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQF 108 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~ 108 (494)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++.+++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence 367899999999999999999999999999999999865432 2234567888999999995 9999999999865 557
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.++++||+ +++|..++.. ..++...+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence 89999998 5688887754 457888999999999999999999999999999999999 678899999999987543
Q ss_pred cCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc-----------------
Q 040917 189 EGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK----------------- 249 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~----------------- 249 (494)
. ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.........+.+
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 2234457889999998754 588999999999999999999999977665332211111
Q ss_pred -------C---CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917 250 -------G---EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304 (494)
Q Consensus 250 -------~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~ 304 (494)
. .........+.++..+.++|.+||+.+|++||++.+++.||||.....+...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~ 302 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV 302 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence 0 000001122457889999999999999999999999999999987666554454
No 289
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=1.5e-37 Score=299.85 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=205.6
Q ss_pred cccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
...+|.+.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 346899999999999999999975 3346689999986543 233456789999999999669999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917 106 DQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~ 183 (494)
.+..+++|||+++++|.+++.... .++...+..++.+++.||.|||+++|+|+||||+||++ +.++.++|+|||.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence 999999999999999999987643 38999999999999999999999999999999999999 5778999999999
Q ss_pred ccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917 184 SAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP 258 (494)
Q Consensus 184 a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (494)
+........ .....+++.|+|||.+. +.++.++||||+||++|+|++ |..||......+............. .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 265 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--Q 265 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--C
Confidence 875533221 11234567899999875 458899999999999999998 9999987765544433333222221 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....++.+.+++.+||..+|++||++.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2356889999999999999999999999986
No 290
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=4.4e-38 Score=300.84 Aligned_cols=253 Identities=31% Similarity=0.529 Sum_probs=209.7
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++. ||||+++++++..+...++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 6788999999999999999999999999999875443 2234677888999999995 9999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-c
Q 040917 115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-A 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-~ 192 (494)
|+++ +|.+.+... ..++...+..++.+++.||.|||+++++|+||+|+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence 9976 888877663 578999999999999999999999999999999999999 677899999999987664433 2
Q ss_pred cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC----------------
Q 040917 193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF---------------- 254 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------- 254 (494)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 233557888999998764 47889999999999999999999998777655443332211100
Q ss_pred ---C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 255 ---Q-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 255 ---~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+ ....+.++..+.++|.+||..||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 01123467899999999999999999999999999997
No 291
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=1.4e-37 Score=296.47 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=207.4
Q ss_pred ccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
.++|++.+.||+|+||.||+|.+... +..|++|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence 46899999999999999999998644 4889999986433 223356788899999999 599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 107 QFVHIVMELCAGGELFDRIVARG----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
...++||||+++++|.+++.... .++...+..++.|++.||.|||+++++||||+|+||++ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 99999999999999999986532 36778899999999999999999999999999999999 678899
Q ss_pred EEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917 177 KATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE 251 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 251 (494)
+|+|||.+........ .....++..|+|||.+. +.++.++|+|||||++|++++ |..||...+.......+..+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999875433221 12234567899999875 468899999999999999998 999998888877777766443
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....+ ..++..+.+++.+||..+|++|||+.++++
T Consensus 239 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22211 346899999999999999999999999986
No 292
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=1.5e-37 Score=292.87 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=200.7
Q ss_pred eecccCCeEEEEEEE--CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 40 EVGRGEFGITYLCTE--NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999965 4678899999986443 2333567788999999999 59999999998864 46789999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc----
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---- 193 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---- 193 (494)
+++|.+++.....++...+..++.|++.|+.|||++|++||||||.||++ +.++.++|+|||.+.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence 99999999887789999999999999999999999999999999999999 56789999999998765433221
Q ss_pred ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 194 REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 194 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
....+++.|+|||.+.. .++.++|+|||||++|+|++ |..||......+..+.+.++.... ....+++.+.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHH
Confidence 11223578999998864 57889999999999999998 999998888777777776553321 22468899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 040917 272 RMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 272 ~~l~~dp~~Rps~~eil~ 289 (494)
+||+.||++||++.+|..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999999864
No 293
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=6.2e-38 Score=300.72 Aligned_cols=256 Identities=28% Similarity=0.527 Sum_probs=209.7
Q ss_pred ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+|++.+.||+|++|.||+|.+. .++..||+|++.+.... .......+.+|+.++.++.+||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999998754321 2234566889999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++||||++|++|.+++.....++...+..++.|++.+|.|||+.|++||||+|.||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence 9999999999999999877789999999999999999999999999999999999999 6678999999999876433
Q ss_pred Cccc--ccccCCcCccChhhhccc---CCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCC
Q 040917 190 GKAY--REIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFP 260 (494)
Q Consensus 190 ~~~~--~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 260 (494)
.... ....++..|+|||.+.+. .+.++|+||+|+++++|++|..||.... ..+..+.+..... ....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PFPK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CCCc
Confidence 3221 234578899999988643 6889999999999999999999995432 2233333333322 1224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCcc
Q 040917 261 SISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKES 296 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~ 296 (494)
.++..+.+++.+||+.+|++||| +.++|+||||+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 57889999999999999999998 5678999999863
No 294
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=6.1e-38 Score=304.13 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=204.5
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-----
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD----- 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~----- 106 (494)
.++|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 47899999999999999999999999999999998654322 222345678999999995 99999999887433
Q ss_pred ---CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 107 ---QFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 107 ---~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
..+++|++|+.+ +|...+.. ...++...+..++.|++.||.|||++||+|+||||+||++ ++++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 357999999965 67766654 3479999999999999999999999999999999999999 678899999999
Q ss_pred CccccccCcc------------cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 040917 183 LSAFIEEGKA------------YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248 (494)
Q Consensus 183 ~a~~~~~~~~------------~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~ 248 (494)
++........ .....+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9875432211 112346788999998754 47889999999999999999999998877765544433
Q ss_pred cCCccCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 249 KGEINFQR--------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 249 ~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
........ ..+..+++.+.++|.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 21111000 0112345778999999999999999999999999998
No 295
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=1.9e-37 Score=295.87 Aligned_cols=247 Identities=19% Similarity=0.279 Sum_probs=204.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.+|++.+.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence 579999999999999999999877776 48999986433 3334667889999999994 99999999998754 4
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+++++++++|+|.+++... +.++...+..++.|++.||.|||+++++||||||+||++ .+++.++|+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence 67999999999999998764 468999999999999999999999999999999999999 56778999999998765
Q ss_pred ccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 188 EEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 188 ~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
...... ....+++.|+|||... ..++.++|||||||++|+|++ |..||...........+........ .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccC
Confidence 432221 1123456899999875 458999999999999999998 8999988777666665555432222 2467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+.+++.+||..||++||++.++++
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999985
No 296
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.4e-40 Score=284.76 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=214.9
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE------
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE------ 104 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~------ 104 (494)
-...|.-..+||+|.||.||+|+.+++|+.||+|++-... ..........+|+.+|..|+ |+|++.+++++.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCc
Confidence 3467888899999999999999999999999999764322 12223455778999999996 999999988774
Q ss_pred --eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917 105 --DDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF 181 (494)
Q Consensus 105 --~~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df 181 (494)
+...+|+|+.+|+. +|.-++.+. -+++..++..++..++.||.|+|.+.|+|||+||.|+|| +.++.++|+||
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADF 168 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADF 168 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecc
Confidence 23458999999975 888888765 579999999999999999999999999999999999999 78899999999
Q ss_pred CCcccccc-----CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917 182 GLSAFIEE-----GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 182 g~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
|+++.+.. .+.+...+.|.+|++||.+.| .|+++.|||..|||+.+|.|+.+.+.+.++...+..|..---..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99965432 223445667999999999876 59999999999999999999999999999888777664322222
Q ss_pred CCCCCCC-------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917 255 QRDPFPS-------------------------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 255 ~~~~~~~-------------------------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
.+..||+ -.++..+++.++|..||.+|+.++++|+|.||...+.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 2222221 13467899999999999999999999999999975533
No 297
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-38 Score=262.63 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=216.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|.-.+.||+|.||+||+|+++.+++.||+|.+..... ++.......+|+-+++.|+ |.||++++++...+...-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEe
Confidence 357778899999999999999999999999999976543 3445677899999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+|||.. .|..+... ++.++.+.+.+++.|++.|+.++|++++.|||+||+|.++ +.+|.+||.|||+++-+.-.-
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce
Confidence 999954 88887765 4679999999999999999999999999999999999999 789999999999998664332
Q ss_pred -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC--------
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF-------- 259 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 259 (494)
.....+.|.+|++|.++-+ -|+...|+||.|||+.|+.. |++.|.+..-.+.+..+.+.--.+..+.|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 3345567999999999865 38999999999999999986 67888888877776666432222111111
Q ss_pred -----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 260 -----------------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 260 -----------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
|.++..-+++++++|.-+|.+|.+++.+++||||....
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 23445568999999999999999999999999998753
No 298
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=2.1e-37 Score=292.66 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=206.1
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|++|.||+|.+. +++.||+|.+..... ....+.+|+.+++++. ||||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence 467999999999999999999975 467899999865332 3566889999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|||++|++|.+++.... .++...+..++.+++.|+.+||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence 999999999999997654 68999999999999999999999999999999999999 6788999999999876542
Q ss_pred Cccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.... .....+..|+|||.+.+ .++.++|+||||+++++|++ |+.||.+.........+..... . .....++..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCHH
Confidence 2111 11122357999998764 58899999999999999999 9999988887777666654422 1 122467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+++.+||..+|.+||++.++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999875
No 299
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=6.5e-38 Score=299.52 Aligned_cols=253 Identities=29% Similarity=0.527 Sum_probs=210.2
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||+|++|.||+|.+..+++.|++|++.... ........+.+|+.+++.+. |||++++++++......++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 677899999999999999999999999999997654 22334567788999999995 9999999999999899999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-c
Q 040917 115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-A 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-~ 192 (494)
+++ ++|.+++... ..++...+..++.+++.||.+||++||+||||+|+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence 997 4999999876 579999999999999999999999999999999999999 678899999999987654332 2
Q ss_pred cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc------------------
Q 040917 193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI------------------ 252 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------------------ 252 (494)
.....++..|+|||.+.+ .++.++|+|||||+++++++|..||.+....+....+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 233455778999998753 578899999999999999999999988776554443322100
Q ss_pred cC-------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 253 NF-------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 253 ~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
.+ ....++.++..+.++|.+||..+|++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00 001233457889999999999999999999999999997
No 300
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=2e-37 Score=297.60 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=206.3
Q ss_pred cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++++. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 57999999999999999999854 345678999875332 233467889999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917 108 FVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD 171 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~ 171 (494)
..++||||+++++|.+++.... .++...+..++.||+.|+.|||++||+||||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 9999999999999999997542 37889999999999999999999999999999999999 6
Q ss_pred CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917 172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA 246 (494)
Q Consensus 172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~ 246 (494)
.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 788999999999875433221 122345778999998864 58889999999999999998 9999988887777776
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+..... ...+|..+.+++.+||..+|.+||++.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 655443322 2356889999999999999999999999987
No 301
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=1.7e-37 Score=292.42 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=204.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||+|.+. ++..+|+|++..... ....+.+|+.+++.+. ||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence 46899999999999999999886 467899999864332 3456788999999995 99999999999988999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
|||++|++|.+++... ..++...+..++.|++.|+.|||++|++||||||+||++ ++++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence 9999999999998764 468999999999999999999999999999999999999 678899999999987543221
Q ss_pred cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+....+...... . ....+|..+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-Y--RPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCHHHH
Confidence 11 1112335799999886 468899999999999999998 89999888777776666544221 1 1235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999986
No 302
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=2.4e-37 Score=292.42 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=202.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|++.+.||+|++|.||+|.+..+ ..|++|.+..... ....+.+|+.+++++. ||||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence 37899999999999999999998755 4699999875332 3457889999999995 9999999998754 55789
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
||||+++++|.+++... ..++...+..++.+++.||.|||+++++|+||||.||++ +.++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence 99999999999999763 347899999999999999999999999999999999999 6788999999999876543
Q ss_pred Cccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.... ....++..|+|||... +.++.++|+|||||++|+|++ |..||......+....+....... ....++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC---CccccCHH
Confidence 2211 1233566799999875 468999999999999999999 888998887776666655432211 12467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+++.+|+..+|.+||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999876
No 303
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=2.9e-37 Score=292.72 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=207.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 579999999999999999999865544 79999986433 233466889999999999 499999999999998999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||||++|++|.+++... +.++...+..++.|++.|+.+||++|++||||||+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999999999998765 468999999999999999999999999999999999999 678899999999987654
Q ss_pred cCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 189 EGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 189 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
..... ....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+.... ..+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence 32211 11122457999999864 68999999999999999886 999998887777776666542 222 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
|+.+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999976
No 304
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.7e-37 Score=298.98 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=206.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECC-------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENS-------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY 103 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~ 103 (494)
..++|.+++.||+|++|.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34789999999999999999998632 34579999986432 2234567889999999996699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917 104 EDDQFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF 167 (494)
Q Consensus 104 ~~~~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli 167 (494)
......+++|||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9888999999999999999999653 247888999999999999999999999999999999999
Q ss_pred eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917 168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG 242 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~ 242 (494)
+.++.++|+|||.+......... ....+++.|+|||++.+ .++.++|+|||||++|+|++ |..||.+....+
T Consensus 168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 56789999999999765332111 11223457999998764 58899999999999999998 899998888777
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....+...... .....++..+.+++.+||..+|.+|||+.++++
T Consensus 245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77766554321 122467889999999999999999999999986
No 305
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=2.7e-37 Score=326.41 Aligned_cols=149 Identities=28% Similarity=0.467 Sum_probs=137.5
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++ ||||+++++++.....+|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 67999999999999999999999999999999997665555555678889999999995 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
|||+.|++|.+++...+.++...++.++.||+.||.|||+++|+||||||+|||+ +.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999887889999999999999999999999999999999999999 577899999999874
No 306
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.3e-37 Score=297.63 Aligned_cols=248 Identities=20% Similarity=0.324 Sum_probs=207.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||.|+||.||+|.+..+ ++.||+|++.... .......+.+|+.++..+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 4688999999999999999987543 5789999986433 2234567889999999995 999999999999988
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917 108 FVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD 171 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~ 171 (494)
..++++||+.+++|.+++... ..++...+..++.|++.||.|||++||+||||||+||++ .
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 247888899999999999999999999999999999999 5
Q ss_pred CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917 172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA 246 (494)
Q Consensus 172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~ 246 (494)
+++.+||+|||++........ .....+++.|+|||.+. +.++.++|+|||||++|+|++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 678899999999875432221 12234567899999875 568999999999999999998 8889988888888877
Q ss_pred HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+........+ ..++..+.+++.+||+.+|.+||++.+++.
T Consensus 239 i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7766543322 467899999999999999999999999986
No 307
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=1.1e-37 Score=294.39 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=208.9
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
..+|++.+.||.|++|.||+|.+.. +..+++|++.... ......+.+|+.+++.++ ||||+++++++......++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEE
Confidence 3579999999999999999999987 8999999986543 223566889999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
||||+++++|.+++... ..++...+..++.+|+.|+.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCC
Confidence 99999999999999753 358999999999999999999999999999999999999 6788999999999876533
Q ss_pred Cccc-ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 190 GKAY-REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 190 ~~~~-~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
.... ....++..|+|||.+. +.++.++|+||||+++|+|++ |+.||......+....+..+... .....+++.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---PCPAKCPQEI 233 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---CCCCCCCHHH
Confidence 2211 1223456799999876 458889999999999999998 89999888877777776643221 2225678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999876
No 308
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.9e-37 Score=298.43 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=207.5
Q ss_pred cccceEeeeeecccCCeEEEEEEEC-------CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTEN-------STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY 103 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~ 103 (494)
...+|++.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+.+||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3478999999999999999999753 234579999886432 2334567889999999996699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917 104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF 167 (494)
Q Consensus 104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli 167 (494)
......++||||+++++|.+++.... .++...+..++.||+.||.|||++|++||||||+||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 99999999999999999999987642 36778889999999999999999999999999999999
Q ss_pred eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917 168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG 242 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~ 242 (494)
+.++.++|+|||.+......... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+
T Consensus 171 ---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 171 ---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred ---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 57789999999998765432211 12234567999998864 58999999999999999998 789998888877
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....+........ ...++..+.+++.+||..+|.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 248 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 7777655432211 2467899999999999999999999999987
No 309
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=2.6e-37 Score=295.11 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=205.6
Q ss_pred cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||+|+||.||+|... .++..+++|.+... .......+.+|+.+++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence 57889999999999999999743 35678999987543 233567899999999999 5999999999999989
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917 108 FVHIVMELCAGGELFDRIVARG---------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE 172 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~ 172 (494)
..+++|||+++++|.+++.... .++...+..++.|++.|+.|||++|++||||||+||++ ++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence 9999999999999999987643 37889999999999999999999999999999999999 57
Q ss_pred CCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 040917 173 NAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAI 247 (494)
Q Consensus 173 ~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~ 247 (494)
++.++|+|||++........ .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 88999999999865432221 112234678999998764 58999999999999999998 89999887777777666
Q ss_pred HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+..... ...+|+.+.+++.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55533221 2357899999999999999999999999975
No 310
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=3.2e-37 Score=292.89 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=198.1
Q ss_pred eeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917 39 REVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC 116 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~ 116 (494)
+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++.+||||+++++++......+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 46888875322 23345678899999999967999999999999988999999999
Q ss_pred CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 117 AGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 117 ~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
++++|.+++.... .++...+..++.|++.|+.|||++|++||||||+||++ +.++.++|+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence 9999999987543 37889999999999999999999999999999999999 6788999999
Q ss_pred cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP 258 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (494)
||++..............+..|+|||++.. .++.++|+|||||++++|++ |..||.+.+..+....+...... ..
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---CC
Confidence 999853221111111223567999998854 58899999999999999997 99999888777666665443211 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
...++..+.+++.+||..+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2356789999999999999999999999986
No 311
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=8.8e-38 Score=305.20 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=201.1
Q ss_pred eeeccc--CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917 39 REVGRG--EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC 116 (494)
Q Consensus 39 ~~lg~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~ 116 (494)
..||.| ++|+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+. ||||+++++++..+...++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 9999999999999999999998754332 234578889999999994 999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc-
Q 040917 117 AGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY- 193 (494)
Q Consensus 117 ~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~- 193 (494)
.+++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++++||+.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence 999999988764 348899999999999999999999999999999999999 56789999999765332111000
Q ss_pred -------ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC--------
Q 040917 194 -------REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-------- 255 (494)
Q Consensus 194 -------~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 255 (494)
....++..|+|||++.+ .++.++|+||+||++|+|++|+.||...................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01124567999999864 368899999999999999999999987665443332222111000
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 256 -----------------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 256 -----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
......+++.+.+|+.+||+.||++|||+.++|+||||....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0011235678999999999999999999999999999986443
No 312
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=2.4e-37 Score=297.69 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=202.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCC--------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST--------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~--------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~ 98 (494)
.+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+++++++. ||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 6899999999999999999987543 2358999986432 2334567899999999995 999999
Q ss_pred EeEEEEeCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 040917 99 FKAAYEDDQFVHIVMELCAGGELFDRIVARG------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFL 166 (494)
Q Consensus 99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIl 166 (494)
+++++......++||||+++++|.+++.... .++...+..++.+++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred EeeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--CCCCCCCCCh
Q 040917 167 FTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC--GVPPFWAETD 240 (494)
Q Consensus 167 i~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~ 240 (494)
+ +.++.++|+|||++......... ....++..|+|||++. +.++.++|+|||||++++|++ +..||.....
T Consensus 162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9 56788999999998754322211 1223467899999875 468999999999999999988 6788887776
Q ss_pred HHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 241 QGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 241 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
......+.. ..........+..|+.+.+++.+||..+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 665544322 1111112223457899999999999999999999999976
No 313
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=6e-38 Score=323.88 Aligned_cols=254 Identities=30% Similarity=0.521 Sum_probs=205.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--------
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-------- 104 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-------- 104 (494)
.+|.....||+||||.||+|+++-+|..||||.+.... +......+.+|+..+.+| +||||++++..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccc
Confidence 56888999999999999999999999999999997654 455677899999999999 5999998762110
Q ss_pred ----------------------------------------------------------e---------------------
Q 040917 105 ----------------------------------------------------------D--------------------- 105 (494)
Q Consensus 105 ----------------------------------------------------------~--------------------- 105 (494)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 040917 106 ------------------------D--------QFVHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVVNVCHS 152 (494)
Q Consensus 106 ------------------------~--------~~~~iv~e~~~g~sL~~~~~~~~~l-~~~~~~~i~~~i~~~l~~LH~ 152 (494)
+ ...||-||||+..+|.+++.++... .....+.++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2468999999987777777766544 578899999999999999999
Q ss_pred CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-------------------cCcccccccCCcCccChhhhcc---
Q 040917 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-------------------EGKAYREIVGSPYYIAPEVLSQ--- 210 (494)
Q Consensus 153 ~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~--- 210 (494)
.|||||||||.|||+ ++...|||+|||+|.... +.....+..||.-|.|||++.+
T Consensus 716 ~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred CceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999 688999999999997611 1112345779999999999863
Q ss_pred -cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917 211 -SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288 (494)
Q Consensus 211 -~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil 288 (494)
.|+.|+|+||||++++||+. ||....+. .++..+.++..+.+...+..--+.-..+|.+|++.||.+||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 58999999999999999984 57665554 34556666666555322323335567899999999999999999999
Q ss_pred cCCccCc
Q 040917 289 EHPWLKE 295 (494)
Q Consensus 289 ~~~~~~~ 295 (494)
++.||..
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999984
No 314
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=3.9e-37 Score=292.16 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=206.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.+|++.+.||+|+||.||+|.+..++. .|++|.+.... .......+..|+.+++.+. ||||+++++++..+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 469999999999999999999887665 59999986432 3445677899999999995 99999999999998999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||||+++++|.+++... +.++...+..++.|++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 9999999999999988753 468999999999999999999999999999999999999 678899999999987543
Q ss_pred cCccccc---cc---CCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917 189 EGKAYRE---IV---GSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP 260 (494)
Q Consensus 189 ~~~~~~~---~~---~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (494)
....... .. .+..|+|||.+. +.++.++|+||+||++|++++ |..||......+....+.... . .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R--LPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c--CCCcc
Confidence 3222111 11 134799999986 468899999999999999886 999999888777777664432 1 22234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 261 SISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+|..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999986
No 315
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-40 Score=340.67 Aligned_cols=264 Identities=28% Similarity=0.476 Sum_probs=225.3
Q ss_pred hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917 24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY 103 (494)
Q Consensus 24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~ 103 (494)
+.....++.-+|.-+..||.|.||.||.|.+..+|.-.|+|.+...... ......+.+|..++..+. |||+++++++-
T Consensus 1226 la~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1226 LASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVE 1303 (1509)
T ss_pred HHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCcee
Confidence 3345567778999999999999999999999999999999999765543 445677899999999995 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917 104 EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183 (494)
Q Consensus 104 ~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~ 183 (494)
...+..+|.||||+||+|.+.+...+-.++.....+..|++.|++|||++|||||||||+||++ +.+|.+|++|||.
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGS 1380 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccc
Confidence 9999999999999999999998877777888888899999999999999999999999999999 6788999999999
Q ss_pred ccccccCc-----ccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCcc
Q 040917 184 SAFIEEGK-----AYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEIN 253 (494)
Q Consensus 184 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~ 253 (494)
|..+.+.. ......||+.|||||++.+. ...+.|||||||++.||+||+.||.....+ .+.-.+..+..+
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 98775442 23457899999999999753 567899999999999999999999766544 333334444333
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
..+ ..++.+.++||.+||..||.+|.++.|+|+|.|-+.
T Consensus 1461 q~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 QIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred CCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 222 348999999999999999999999999999988775
No 316
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-40 Score=308.89 Aligned_cols=257 Identities=29% Similarity=0.552 Sum_probs=237.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+.+++..||-||||.|=++.-......+|+|++++.........+++..|-++|...+ .|.|+++|-.|.+..++|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 67888999999999999998876555568999999887777767888999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
||-|-||.|+..+..++.+...++..++..+++|+.|||.+|||+|||||+|.++ +.+|.+||.|||+|..+.++..
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 7899999999999999999999
Q ss_pred cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917 193 YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271 (494)
Q Consensus 193 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 271 (494)
.++.||||.|.|||++. ...+.++|.||||+++|||++|.+||.+.++...+..|+++......+ ..++....++|+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence 99999999999999875 568999999999999999999999999999999999999987766544 468899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 272 RMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 272 ~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
++...+|.+|.. +.+|-+|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999986 789999999975
No 317
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=5e-37 Score=290.01 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=207.7
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..++|++.+.||+|++|.||+|.+. .+..|++|.+..... ....+.+|+.+++++. ||||+++++++......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence 3478999999999999999999976 457899999875432 3567889999999995 999999999999888999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+||||+++++|.+++.... .++...+..++.+++.|+.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence 9999999999999997643 68999999999999999999999999999999999999 678999999999987654
Q ss_pred cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
..... .....+..|+|||.+.+ .++.++|+||+|++++++++ |+.||.+.........+........ ....|.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPE 231 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCH
Confidence 32111 12223567999998864 58889999999999999998 9999988887777777655422211 235688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999875
No 318
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=3.2e-37 Score=293.23 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=201.9
Q ss_pred eEeeeeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe------C
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED------D 106 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~------~ 106 (494)
|.+++.||+|+||.||+|.+..++. .||+|.+.... ........+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 4578899999999999999877765 68999886543 2334567788999999999 59999999997642 1
Q ss_pred CeEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 107 QFVHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
...+++|||+++++|.+++... ..++...+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 2568999999999999887421 247899999999999999999999999999999999999 6788999999
Q ss_pred cCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCC
Q 040917 181 FGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 181 fg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
||++......... ....+++.|+|||...+ .++.++|+|||||++|+|++ |..||.+.........+.++....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9998865433211 12235678999998864 58999999999999999999 889998887777777766654322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+.++..+.+++.+||..||++|||+.++++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 12467889999999999999999999999986
No 319
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=4.8e-37 Score=289.46 Aligned_cols=241 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred eeecccCCeEEEEEEECCCC---cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917 39 REVGRGEFGITYLCTENSTG---LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL 115 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~---~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~ 115 (494)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+ +||||+++++++.. ...++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence 46999999999999876554 78999998755432 3466788999999999 59999999998764 467899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccc-
Q 040917 116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR- 194 (494)
Q Consensus 116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~- 194 (494)
+++++|.+++.....+++..+..++.|++.|+.|||.++++|+||||+||++ +.++.++|+|||.+..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence 9999999999888789999999999999999999999999999999999999 678899999999987654332211
Q ss_pred ---cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917 195 ---EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269 (494)
Q Consensus 195 ---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 269 (494)
...++..|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+...... .....++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence 1112457999998864 58899999999999999998 99999888877776666554322 1224678999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 040917 270 VRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 270 i~~~l~~dp~~Rps~~eil~ 289 (494)
+.+||..+|.+||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999986
No 320
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=3.5e-37 Score=292.97 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=202.9
Q ss_pred eEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe---
Q 040917 35 YTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF--- 108 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~--- 108 (494)
|++++.||+|+||.||+|.... ++..||+|.+..... .......+.+|+..++.+ +||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 6788999999999999998764 347899999875432 233456788999999999 49999999998765443
Q ss_pred ---EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 109 ---VHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 109 ---~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
.++++||+++++|..++... ..++...+..++.|++.||.|||+++++||||||+||++ ++++.++|+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 78999999999999887542 358899999999999999999999999999999999999 678899999
Q ss_pred ecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917 180 DFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 180 Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
|||.+......... ....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+..+.+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99998765433211 11234568999998864 58899999999999999999 889998888777777766553322
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
. ...++..+.+++.+||..||.+||++.++++
T Consensus 236 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 236 Q---PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred C---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 2467899999999999999999999999986
No 321
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=4.3e-37 Score=295.16 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=203.2
Q ss_pred ceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 34 HYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.+. ||||+++++.+.....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 58899999999999999998753 23568888886433 2234567889999999995 9999999999999899
Q ss_pred EEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917 109 VHIVMELCAGGELFDRIVAR------------------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN 164 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N 164 (494)
.++++||+.+++|.+++... ..++...+..++.|++.||.|||+++++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 246788999999999999999999999999999999
Q ss_pred eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 040917 165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAET 239 (494)
Q Consensus 165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~ 239 (494)
|++ ++++.++|+|||++........ .....++..|+|||.+.+ .++.++||||||+++++|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 5678999999999875432221 112334678999998754 58899999999999999998 999998888
Q ss_pred hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+.+.+...... .....++..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77776665543221 122467899999999999999999999999986
No 322
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=5.6e-37 Score=292.60 Aligned_cols=247 Identities=19% Similarity=0.286 Sum_probs=201.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcE----EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLE----FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
++|++.+.||+|+||.||+|.+..++.. |++|.+.... .......+..|+..++++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence 5799999999999999999999877764 6677764221 222345677888888999 59999999998754 45
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.++++||+++|+|.+++... +.+++..+..++.||+.|+.|||++|++||||||+||++ +.++.++|+|||.+...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 77899999999999999764 468999999999999999999999999999999999999 67889999999999754
Q ss_pred ccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 188 EEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 188 ~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
..... .....++..|+|||.+. +.++.++|+|||||++|++++ |..||.+.......+.+.++.....+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence 33221 12334567899999885 568999999999999999998 99999888776666655544333222 245
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+..++.+||..+|.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999999999999999999976
No 323
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=7.4e-37 Score=288.73 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=202.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.++|.+.+.||+|++|.||+|.+..+ ..+++|.+..... ....+.+|+.+++++. |||++++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEE
Confidence 37899999999999999999998654 4699998764332 3466888999999995 9999999998854 56789
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|||+++++|.+++.... .++...+..++.+++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence 999999999999997643 47889999999999999999999999999999999999 6788999999999876533
Q ss_pred Cccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 190 GKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 190 ~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
.... ....++..|+|||... +.++.++|+||||+++|+|++ |..||.+....+....+...... ......+..
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPES 231 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHH
Confidence 2211 1233466799999876 458899999999999999999 89999888877776666554221 122467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+++.+||..||.+||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999876
No 324
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=4.5e-37 Score=294.73 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=206.4
Q ss_pred cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++++ +||||+++++++..+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVGK 81 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCC
Confidence 679999999999999999998743 67899999986432 233456788999999999 5999999999999888
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917 108 FVHIVMELCAGGELFDRIVARG----------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF 165 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI 165 (494)
..++++||+++++|.+++.... .++...+..++.+++.||.|||+++++||||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986432 367788899999999999999999999999999999
Q ss_pred EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917 166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETD 240 (494)
Q Consensus 166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~ 240 (494)
++ +.++.++|+|||.+........ ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.+...
T Consensus 162 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 162 LV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred Ee---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99 6788999999999875432211 11223456799999876 468999999999999999997 8889988888
Q ss_pred HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+....+..+..... ...++..+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 239 EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 877777665543221 1357899999999999999999999999875
No 325
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=6.3e-37 Score=288.59 Aligned_cols=246 Identities=29% Similarity=0.466 Sum_probs=209.0
Q ss_pred eEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 35 YTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
+++.+.||.|+||.||+|.+...+ ..||+|++.... .......+.+|+.+++.+ +||||+++++++...+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 357889999999999999998766 899999996443 222467888999999999 6999999999999989999
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||++++++|.+++..... ++...+..++.|++.|+.+||+.|++|+||+|+||++ ++++.++|+|||.+....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 99999999999999976544 8999999999999999999999999999999999999 677899999999987655
Q ss_pred cCccccc--ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAYRE--IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~~~--~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
....... ..+++.|+|||.+.+ .++.++|+||+|+++++|++ |..||.........+.+.+....... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCH
Confidence 4322221 235688999998854 58899999999999999998 78999888877777777665433222 34789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
No 326
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=4.9e-37 Score=289.92 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=203.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..++|++.+.||+|++|.||+|.+. .+..||+|.+..... ..+.+.+|+.+++++ +|||++++++++.. ...+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEECC-CCcE
Confidence 3468999999999999999999875 566799999875432 345688999999999 49999999998854 5678
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++|||+++++|.+++... ..++...+..++.+++.||.|||++|++|+||+|+||++ ++++.++|+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeecc
Confidence 999999999999998753 358999999999999999999999999999999999999 567899999999987653
Q ss_pred cCccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
..... ....++..|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+....+...... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCH
Confidence 32211 1223456799999875 458899999999999999999 89999888877777766554222 12245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|.+|||+.++++
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999999875
No 327
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=6.4e-37 Score=288.44 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=201.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-eCCeEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHI 111 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-~~~~~~i 111 (494)
.+|++.+.||+|++|.||++... |..|++|.+.... ..+.+.+|+.+++++. |||++++++++. .+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 47999999999999999999865 7889999985322 3567889999999994 999999999754 4567899
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
++||+++++|.+++.... .++...+..++.+++.||.|||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence 999999999999987654 37889999999999999999999999999999999999 6788999999999875432
Q ss_pred CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ....++..|+|||++.+ .++.++|+|||||++|+|++ |+.||......+....+.++.. ....+.+|+.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence 22 22334567999998865 58899999999999999997 9999988777766666655422 222356789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
No 328
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=6.9e-37 Score=288.93 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=204.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
...+|++++.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++++. ||||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ-EPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEcc-CCcE
Confidence 4578999999999999999999865 578899999864432 3467889999999995 9999999998754 5689
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++|||+++++|.+++... ..++...+..++.+++.||.|||++|++||||+|+||++ +.++.++|+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence 999999999999988653 358889999999999999999999999999999999999 678899999999987654
Q ss_pred cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
..... ....++..|+|||++.+ .++.++|+||||+++|++++ |+.||.+....+....+...... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCH
Confidence 22211 12334568999998864 57889999999999999998 99999888877776666544221 12245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|++||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999886
No 329
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=6.9e-37 Score=288.24 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=206.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||.|++|.||+|... |+.||+|.+..... ....+.+|+.+++.+. ||||+++++++......++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence 57999999999999999999864 88999999964431 4667889999999995 99999999999988899999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+++++|.+++.... .++...+..++.|++.|+.|||++|++|+||||+||++ +.++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence 99999999999997765 68999999999999999999999999999999999999 67889999999998765322
Q ss_pred cccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
.. ....+..|+|||.+. +.++.++|+||||++++++++ |..||...+.......+..... ......+|+.+.+
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 230 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK 230 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence 21 233456799999875 468889999999999999997 9999988877766665554322 1122457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 040917 269 LVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~ 289 (494)
+|.+||..+|++||++.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999986
No 330
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.9e-37 Score=300.16 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=206.6
Q ss_pred cccceEeeeeecccCCeEEEEEEECCC-------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENST-------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY 103 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~ 103 (494)
...+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++.+||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346899999999999999999986432 2368999886432 2334677889999999996699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917 104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF 167 (494)
Q Consensus 104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli 167 (494)
......++++||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 98889999999999999999987532 36778889999999999999999999999999999999
Q ss_pred eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917 168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG 242 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~ 242 (494)
+.++.++|+|||.+......... ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus 168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 ---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred ---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 56789999999998755332211 11223467999998864 58899999999999999998 889999888877
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
....+....... .....+..+.+++.+||..+|.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEGHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777765543221 123568899999999999999999999999874
No 331
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=2.6e-37 Score=291.84 Aligned_cols=252 Identities=27% Similarity=0.509 Sum_probs=207.4
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
+|.+.+.||+|++|.||+|.+..++..+++|+++..... .......+..|+.+++.+. ||||+++++.+......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 699999999999999999999888777777776543221 1223445677999999995 9999999999988889999
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 112 VMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
|+||+++++|.+++.. ...+++..+..++.|++.|+.|||++|++|+||+|+||+++ .+.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 9999999999988753 34689999999999999999999999999999999999994 356999999998765
Q ss_pred ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917 188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265 (494)
Q Consensus 188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (494)
..... .....+++.|+|||.+.+ .++.++|+||+|+++++|++|..||...........+..+..... ...++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 33222 234557889999998764 478899999999999999999999987776665555544332221 2357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 266 l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
+.++|.+||..+|++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 332
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1e-36 Score=289.10 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=206.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
.+|+..+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.+++++. ||||+++.+++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence 478899999999999999999876655 69999886432 2334567889999999994 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++||||+++++|.+++... +.++...+..++.+++.|+.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence 9999999999999998764 568999999999999999999999999999999999999 678899999999987553
Q ss_pred cCcccc----cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 189 EGKAYR----EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 189 ~~~~~~----~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
...... ....+..|+|||.+.+ .++.++|+|||||++|+|++ |+.||......+....+..... .+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCCC
Confidence 322111 1122457999998864 58899999999999999997 9999988888777777765422 1222457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999986
No 333
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=4.8e-37 Score=305.61 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=203.2
Q ss_pred ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
..+|.+++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++.++..||||+++++.+...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 367899999999999999999964 345689999997543 2223456889999999995599999999999998
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 040917 107 QFVHIVMELCAGGELFDRIVARG--------------------------------------------------------- 129 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~--------------------------------------------------------- 129 (494)
...++||||+++|+|.+++...+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 89999999999999999886532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917 130 -----------------------------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT 168 (494)
Q Consensus 130 -----------------------------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~ 168 (494)
.++...+..++.||+.||.|||+++++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 24566778899999999999999999999999999999
Q ss_pred eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917 169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGV 243 (494)
Q Consensus 169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~ 243 (494)
+..+.++|+|||++........ .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+.
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 5678999999999875432211 122346778999998864 58899999999999999998 8899977665554
Q ss_pred HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
............ ....++..+.+++.+||..+|.+||++.+|++
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444333332222 22457899999999999999999999999987
No 334
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=3.4e-37 Score=302.71 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=198.9
Q ss_pred ccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917 32 QLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED- 105 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~- 105 (494)
.++|++++.||+|+||.||+|.+ ..+++.||+|.+.... .......+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 36899999999999999999985 3567899999996433 222456788999999999778999999998754
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 040917 106 DQFVHIVMELCAGGELFDRIVARG-------------------------------------------------------- 129 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~-------------------------------------------------------- 129 (494)
+...+++|||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456889999999999999886431
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---cc
Q 040917 130 -----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---RE 195 (494)
Q Consensus 130 -----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~ 195 (494)
.++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 25677788999999999999999999999999999999 67789999999998764322211 12
Q ss_pred ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG-VAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
..++..|+|||.+.+ .++.++|+||||+++|+|++ |..||....... ....+..+.. ...+ ...++.+.+++.+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~ 317 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAP--DYTTPEMYQTMLD 317 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCC--CCCCHHHHHHHHH
Confidence 234567999998754 58999999999999999997 899997654332 3333333322 1111 2367889999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 040917 273 MLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 273 ~l~~dp~~Rps~~eil~~ 290 (494)
||..+|.+|||+.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999975
No 335
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=1.2e-36 Score=290.27 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=207.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.+|++.+.||+|+||.||+|.+..+|. .+++|....... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence 689999999999999999999877665 589998765432 33456788999999999 59999999999887 67
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.++|+||+++++|.+++... ..+++..+..++.||+.|+.|||++|++||||+|+||++ +.++.++|+|||.+...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence 89999999999999998764 468999999999999999999999999999999999999 57789999999999765
Q ss_pred ccCcccc---cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 188 EEGKAYR---EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 188 ~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
....... ...++..|+|||.+. +.++.++|+||||++++++++ |+.||.+....++.+.+..+.....+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---PIC 236 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---CCC
Confidence 4332211 122356799999875 468899999999999999998 99999998888877777654332221 346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+.+++.+||..+|..||++.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 788999999999999999999999876
No 336
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-38 Score=292.95 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=229.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|..+..||.|+||.|.+|..+.+.+.+|||++++...-.....+--..|-++|......|.++.++.+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 68999999999999999999999999999999998876555545555667777887765678889999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~ 191 (494)
|||+.||+|--.+.+-+++.+..+..++.+|+.||-+||++||++||||..|||+ +..|++||.|||++..- ..+.
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 78999999999998753 3444
Q ss_pred ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
...+.+|||.|+|||++. .+|+..+|+||+|++||||+.|+.||.+..+.+..+.|......++. .+|.++..+.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ic 581 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAIC 581 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHH
Confidence 556789999999999886 67999999999999999999999999999999999999988887774 6889999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917 271 RRMLTQDPKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rps-----~~eil~~~~~~~ 295 (494)
+.+|.+.|.+|.. -.+|-.||||..
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999974 357889999985
No 337
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.9e-38 Score=304.64 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=212.3
Q ss_pred cceEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.+-.+.+.||+|+||.||+|..+..+ ..||+|...............+.+|+++++.+ +||||++++|+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence 44456689999999999999876542 23899998764445566788899999999999 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
+++|||+|.||+|.+++.+.+. ++..+...++.+.+.||.|||+++++||||-+.|+|+ ..++.+||+|||++...
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence 9999999999999999998874 9999999999999999999999999999999999999 66778999999998764
Q ss_pred ccCcccc-cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 188 EEGKAYR-EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 188 ~~~~~~~-~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
..-.... ...-...|+|||.+. +-|++++||||+||++||+++ |..||.+....++...+.......+.+ ...|.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~ 390 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPK 390 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHH
Confidence 3111111 112356899999986 569999999999999999999 788999999999988885554443333 36789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+..++.+|+..+|++||++.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 9999999999999999999999877
No 338
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=6.8e-37 Score=291.46 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=208.6
Q ss_pred cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+|++.+.||+|+||.||+|.++. ..+.|++|.+.... .......+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence 689999999999999999999754 35679999885433 222457789999999999 4999999999999888
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 108 FVHIVMELCAGGELFDRIVARG---------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
..++||||+++++|.+++.... .++...+..++.|++.||.|||+++|+||||||.||++ +.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999997665 68999999999999999999999999999999999999 57889999
Q ss_pred eecCCccccccCc--ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917 179 TDFGLSAFIEEGK--AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 179 ~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
+|||.+....... ......+++.|+|||.+. +.++.++|+||||+++|+|++ |..||...........+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986432221 122344567799999875 457889999999999999998 788998777777776666554433
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.. ...+|..+.+++.+||..+|.+||++.+++..
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 24678999999999999999999999999863
No 339
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.2e-36 Score=286.77 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=197.6
Q ss_pred eecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 40 EVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++++ +||||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999775 445679999986442 233456789999999999 49999999998864 46889999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---
Q 040917 118 GGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193 (494)
Q Consensus 118 g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~--- 193 (494)
+++|.+++.. ...++...+..++.|++.|+.|||++|++||||||+||++ +.++.++|+|||.+.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence 9999998875 4468999999999999999999999999999999999999 67889999999998754332221
Q ss_pred -ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917 194 -REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270 (494)
Q Consensus 194 -~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 270 (494)
....+++.|+|||.+.. .++.++|+|||||++|++++ |..||......+....+..+.... ..+..++.+.+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHH
Confidence 11123568999998764 68899999999999999996 999999888877777666654322 1245789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 040917 271 RRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~ 289 (494)
.+||..+|++||++.++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999875
No 340
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=9.7e-37 Score=287.37 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=202.2
Q ss_pred eeecccCCeEEEEEEECC-CCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917 39 REVGRGEFGITYLCTENS-TGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL 115 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~-~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~ 115 (494)
+.||+|++|.||+|.+.. .+. .||+|.+...... .....+.+|+.+++++. ||||+++++.+.. ...++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 333 6999999765432 45778899999999995 9999999999988 889999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917 116 CAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA- 192 (494)
Q Consensus 116 ~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~- 192 (494)
+++++|.+++.... .++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999997764 68999999999999999999999999999999999999 5678999999999876543211
Q ss_pred ---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 193 ---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 193 ---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.....++..|+|||.+.+ .++.++|+|||||++++|++ |+.||...+..+....+........ .....|..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 112345678999998864 68999999999999999998 9999988887777666654322222 1235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..+|.+||++.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999986
No 341
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=7e-37 Score=292.63 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=196.0
Q ss_pred cce-EeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917 33 LHY-TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-- 105 (494)
Q Consensus 33 ~~y-~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-- 105 (494)
++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 455 999999999999998764 34578899999986542 223456788999999999 49999999998765
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
....+++|||+++++|.+++... .++...+..++.|++.|+.|||++|++||||||+||++ ++++.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 34688999999999999998764 59999999999999999999999999999999999999 677899999999987
Q ss_pred ccccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH--H-------------HHH
Q 040917 186 FIEEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ--G-------------VAQ 245 (494)
Q Consensus 186 ~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~-------------~~~ 245 (494)
........ ....++..|+|||.+. +.++.++||||||+++|+|++|..||...... + ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 65432221 1223456799999886 45889999999999999999999998543321 0 000
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+... ... .....++..+.+++.+||..+|++|||++++++
T Consensus 236 ~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERG-MRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcC-CCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111 111 112457899999999999999999999999986
No 342
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=1.1e-36 Score=289.11 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=204.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
..+|.+.+.||+|++|.||+|.+... ...|++|...... .....+.+.+|+.+++++. ||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 46799999999999999999987544 4568999886433 2334667899999999995 9999999998875 45
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.++||||+++++|.+++.+.. .++...+..++.+++.||.|||++|++||||||+||++ +..+.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 679999999999999997644 58999999999999999999999999999999999999 56789999999998765
Q ss_pred ccCcccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 188 EEGKAYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 188 ~~~~~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
....... ...+++.|+|||.+.+ .++.++|+||||++++++++ |..||......+....+.++.... ..+.+|
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCC
Confidence 4332211 1223467999998764 58899999999999999886 999998888777666665543322 225678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+.+++.+|+..+|.+|||+.+++.
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999887
No 343
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=2.1e-36 Score=284.94 Aligned_cols=245 Identities=26% Similarity=0.441 Sum_probs=205.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++.+.||+|++|.||+|.+. .+..+++|.+..... ....+.+|+.+++++ +|||++++++++......+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence 47999999999999999999875 477899999864432 245688899999999 499999999999988899999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
+||+++++|.+++... +.++...+..++.+++.++.+||+++++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence 9999999999988764 458999999999999999999999999999999999999 678899999999987543221
Q ss_pred cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917 192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267 (494)
Q Consensus 192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 267 (494)
.. ....++..|+|||.+. +.++.++|+||||+++|+|++ |..||......+....+..+.....+ ...+..+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence 11 1223456899999886 468889999999999999998 99999888877777777654333222 23678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 040917 268 ELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 268 ~li~~~l~~dp~~Rps~~eil~ 289 (494)
+++.+||..+|++|||+.++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHH
Confidence 9999999999999999999986
No 344
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=6.1e-37 Score=297.59 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=198.4
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|.+++.+|.| |.||.+.+..+++.||+|++..... .......+.+|+.+++.++ ||||+++++++...+..+++||
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEe
Confidence 3444445444 5566666667899999999976432 3345678999999999995 9999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917 115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192 (494)
Q Consensus 115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~ 192 (494)
|+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccc
Confidence 99999999998763 458899999999999999999999999999999999999 5678999999998865432111
Q ss_pred --------cccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------
Q 040917 193 --------YREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------ 255 (494)
Q Consensus 193 --------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------ 255 (494)
.....++..|+|||++.. .++.++|+||+||++++|++|..||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 122345778999999864 478899999999999999999999977654433222111111000
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 256 ------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 256 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
......++..+.+++.+||..||++|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000012346788999999999999999999999999998644
No 345
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.6e-36 Score=292.13 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=200.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECC----------------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENS----------------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 95 (494)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 3679999999999999999986542 34568999986432 2334677899999999995 999
Q ss_pred ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917 96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN 164 (494)
Q Consensus 96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N 164 (494)
|+++++++......+++|||+++++|.+++.... .++...+..++.|++.|+.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999899999999999999999987643 25677899999999999999999999999999999
Q ss_pred eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 040917 165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC--GVPPFWAE 238 (494)
Q Consensus 165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~ 238 (494)
|++ +.++.++|+|||++........ .....+++.|++||... +.++.++|+|||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 5788999999999875433221 11223356899999764 568999999999999999998 77899877
Q ss_pred ChHHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 239 TDQGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 239 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
...+....... .......+....+++.+.+++.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 76655443321 1111111122457799999999999999999999999875
No 346
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=2.1e-36 Score=288.83 Aligned_cols=249 Identities=19% Similarity=0.237 Sum_probs=205.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECC----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENS----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~ 106 (494)
..+|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+++++ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 3689999999999999999999875 3688999988632 2344567788999999999 59999999998765 4
Q ss_pred CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 107 QFVHIVMELCAGGELFDRIVAR--------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
...+++++|+++++|.+++... ..++...+..++.+++.||.|||+++++|+||||+||++ +.++.++|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 6788999999999999998653 348899999999999999999999999999999999999 67789999
Q ss_pred eecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCcc
Q 040917 179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEIN 253 (494)
Q Consensus 179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 253 (494)
+|||++......... ....++..|+|||.+.+ .++.++|||||||++|++++ |+.||......+....+..+. .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999998755332211 12334667999998864 58899999999999999998 999998887776666555432 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.. ....+|+.+.+++.+||..+|++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 22457899999999999999999999999986
No 347
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=3.2e-36 Score=282.61 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=199.3
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
++||+|++|.||+|... ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999864 68899999986433 233455688999999999 599999999999999999999999999
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc--cc
Q 040917 119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--RE 195 (494)
Q Consensus 119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~--~~ 195 (494)
++|.+++... ..++...+..++.+++.++.|||++|++||||+|+||++ +.++.++|+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence 9999988653 457899999999999999999999999999999999999 67889999999998654322111 11
Q ss_pred ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917 196 IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273 (494)
Q Consensus 196 ~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 273 (494)
..++..|+|||++. +.++.++|+||||+++|++++ |..||...........+...... .....++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence 23356799999886 458899999999999999998 99999888776666655543221 22245789999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 040917 274 LTQDPKRRITVAQVLE 289 (494)
Q Consensus 274 l~~dp~~Rps~~eil~ 289 (494)
|..+|++||++.++++
T Consensus 231 l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 231 WDYKPENRPKFSELQK 246 (250)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999976
No 348
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=1.8e-36 Score=284.98 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=202.0
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++++. |||++++++++..+ ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence 579999999999999999987 468899999985432 3467889999999995 99999999998765 47899
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
|||+++++|.+++.... .++...+..++.|++.|+.|||++|++||||||+||++ +.++.++|+|||.+......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence 99999999999997653 47899999999999999999999999999999999999 67789999999998754322
Q ss_pred cccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 191 KAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 191 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
......+..|+|||.+. +.++.++|+|||||++|+|++ |+.||......+....+.++... .....+|..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---EPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---CCCCcCCHHHHH
Confidence 12233456799999876 468899999999999999997 99999888887777766554222 123467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 040917 269 LVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~ 289 (494)
++.+||..+|.+||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
No 349
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=2.6e-36 Score=283.41 Aligned_cols=241 Identities=26% Similarity=0.369 Sum_probs=200.6
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG 118 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g 118 (494)
+.||+|++|.||+|.+.. ++.|++|.+...... .....+.+|+.+++++. ||||+++++++......++||||++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999887 999999998654322 35677899999999995 99999999999999999999999999
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---c
Q 040917 119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---R 194 (494)
Q Consensus 119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~ 194 (494)
++|.+++... ..++...+..++.+++.++.|||+++++||||+|+||++ +.++.++|+|||.+......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence 9999998653 468899999999999999999999999999999999999 67889999999998754321111 1
Q ss_pred cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917 195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272 (494)
Q Consensus 195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (494)
....+..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+..... .. .....+..+.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MP--APQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-CC--CCccCCHHHHHHHHH
Confidence 122355799999876 468899999999999999998 8899988777666665554321 11 124578999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 040917 273 MLTQDPKRRITVAQVLE 289 (494)
Q Consensus 273 ~l~~dp~~Rps~~eil~ 289 (494)
||..+|.+||++.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
No 350
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=3.9e-36 Score=283.79 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=203.6
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
..++|++.+.||+|+||.||+|.+. .+..+++|.+.... ...+.+.+|+.+++.+. |+||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence 4578999999999999999999865 45679999886432 23567889999999995 9999999999887 6789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
++|||+++++|.+++... ..++...+..++.+++.||.|||++|++|+||+|+||++ +..+.++|+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence 999999999999998763 357888899999999999999999999999999999999 678899999999987654
Q ss_pred cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917 189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264 (494)
Q Consensus 189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (494)
..... ....++..|+|||.+.. .++.++|+|||||++|++++ |+.||.+.........+...... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCH
Confidence 32211 12234567999998864 58889999999999999998 99999888777666666544221 12246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 265 SAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 265 ~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998865
No 351
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=2.4e-37 Score=311.52 Aligned_cols=247 Identities=26% Similarity=0.458 Sum_probs=214.2
Q ss_pred cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
.+-...+.||+|+||.||+|+-.. ....||||.++... ....+.+|.+|++++..|+ ||||++++|++..++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence 456678889999999999998543 34579999997433 4447899999999999995 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917 108 FVHIVMELCAGGELFDRIVARG--------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN 173 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~ 173 (494)
..|+|+|||..|+|.+++..+. +++..+.+.|+.||+.|+.||-++.+|||||-..|.|| +++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence 9999999999999999996532 27889999999999999999999999999999999999 789
Q ss_pred CeEEEeecCCccccccCcccc---cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 040917 174 AVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAIL 248 (494)
Q Consensus 174 ~~~kL~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~ 248 (494)
..|||+|||+++.+-+.+.+. ...-..+|||||.+. +.+|.+|||||+||++||+++ |+.||.+.+.+++++.+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 999999999998765444332 122356899999764 789999999999999999998 899999999999999999
Q ss_pred cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288 (494)
Q Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil 288 (494)
++.. ...+ ..+|..+.+|+..||..+|.+||++.||=
T Consensus 720 ~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 AGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9887 4433 47899999999999999999999999973
No 352
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=1.8e-36 Score=289.98 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=197.3
Q ss_pred cceEeeeeecccCCeEEEEEEE----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917 33 LHYTIGREVGRGEFGITYLCTE----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-- 106 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-- 106 (494)
.-|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+. ||||+++.+++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 3578999999999999999974 4678899999986432 2334567899999999995 99999999998764
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
...++||||++|++|.+++.... .++...+..++.+++.||.|||++|++||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence 56889999999999999986643 58999999999999999999999999999999999999 567889999999987
Q ss_pred ccccCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------------HHHHH
Q 040917 186 FIEEGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---------------QGVAQ 245 (494)
Q Consensus 186 ~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---------------~~~~~ 245 (494)
........ ....++..|+|||.+.+ .++.++|+|||||++|+|+++..|...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432221 23345678999998764 588999999999999999998766532111 11111
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+..+. . ......++..+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 238 VLEEGK-R--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHcCc-c--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111111 1 1123467899999999999999999999999987
No 353
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=4e-36 Score=285.21 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=207.7
Q ss_pred ceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCC-------CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 34 HYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKL-------VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.|++.+.||+|++|.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999998854321 1223345677888888764469999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 106 DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
++..+++|||++|++|.+++.. ...++...++.++.|++.|+.+||+ .+++|+||+|.||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 9999999999999999987743 3468999999999999999999996 689999999999999 6788999999
Q ss_pred cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (494)
||.+.............++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+........ ..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence 999986554444445668889999998864 588999999999999999999999987776666655555433322 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+++.+.+++.+||..||++||++.++..
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 357899999999999999999999999875
No 354
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-37 Score=279.56 Aligned_cols=296 Identities=26% Similarity=0.421 Sum_probs=232.9
Q ss_pred cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
..-.+..||.-.+.+|.|.. .|..|.+..++++|++|..... ...........+|..++..+. |+||++++.+|...
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQ 87 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCcc
Confidence 45567789999999999999 8999999999999999998665 455556788899999999995 99999999998643
Q ss_pred ------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 107 ------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 107 ------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
..+|+|||++. .+|.+.+. -.++..++..++.|+++|++|||+.||+||||||+||++ +.+..+|+.|
T Consensus 88 ~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d 161 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD 161 (369)
T ss_pred ccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence 35889999995 49988886 357999999999999999999999999999999999999 7899999999
Q ss_pred cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc----------
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------- 249 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---------- 249 (494)
||+|+.....-....++.|..|+|||++.+ .+...+||||+||++.||++|+..|.|...-+..-++..
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 999987655545567888999999999876 499999999999999999999999987765433322211
Q ss_pred ------------CC---------ccCCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC---ccCc
Q 040917 250 ------------GE---------INFQRDPFP-------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK---ESGE 298 (494)
Q Consensus 250 ------------~~---------~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~---~~~~ 298 (494)
.. ..++...|+ .-...+++++.+||..||++|.|++++|+|||++ ...+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e 321 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE 321 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc
Confidence 00 011111111 1235688999999999999999999999999997 3333
Q ss_pred CCCCCCc-HHHHHHHHHHhhhhHHHHHHHHhhhcc
Q 040917 299 ASDKPID-TAVIFRMKQFTAMNKLKKLALKVIVEN 332 (494)
Q Consensus 299 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~ 332 (494)
....+.. -.........+ ..+|+.++++++...
T Consensus 322 v~ap~pe~~d~~~d~~~~t-~~e~ke~If~ev~~f 355 (369)
T KOG0665|consen 322 VEAPPPEIYDKQLDEREHT-IEEWKELIFKEVQRF 355 (369)
T ss_pred ccCCCCchhhhhcccccCC-HHHHHHHHHHHHHhh
Confidence 3322222 11222333333 788988888887654
No 355
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=5e-36 Score=284.52 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=192.2
Q ss_pred eeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917 39 REVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC 116 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~ 116 (494)
+.||+|+||.||+|... .....+++|.+.... .......+.+|+..++.+ +||||+++++.+......++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence 35899999999999643 245578888875432 233456788899999999 5999999999999888999999999
Q ss_pred CCCchHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 117 AGGELFDRIVARGH-----YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 117 ~g~sL~~~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
++++|.+++..... .+...+..++.||+.|+.|||++||+||||||+||++ +.++.++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 99999999876432 4577888999999999999999999999999999999 678899999999986532221
Q ss_pred c---cccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc-cCCCC-
Q 040917 192 A---YREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI-NFQRD- 257 (494)
Q Consensus 192 ~---~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~-~~~~~- 257 (494)
. .....+++.|+|||++.. .++.++|||||||++|+|++ |..||......+.......... ..+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 122334667999998742 36789999999999999999 7889988777666555444332 22222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....+++.+.+++..|+ .||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 22357888999999998 59999999999986
No 356
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=6.4e-36 Score=283.78 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=192.3
Q ss_pred eeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917 39 REVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC 116 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~ 116 (494)
+.||+|+||.||+|.+. .++..+++|.+.... .......+.+|+.++++++ ||||+++++.+......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 36899999999999864 456789999886543 2234457888999999995 999999999998888899999999
Q ss_pred CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917 117 AGGELFDRIVARG-----HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191 (494)
Q Consensus 117 ~g~sL~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~ 191 (494)
++++|.+++.... .++...+..++.|++.|+.|||+++++|+||||+||++ +..+.++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 9999999986532 35667888999999999999999999999999999999 678899999999986543222
Q ss_pred cc---ccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC-CccCCCCC
Q 040917 192 AY---REIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG-EINFQRDP 258 (494)
Q Consensus 192 ~~---~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 258 (494)
.. ....+++.|+|||++.+ .++.++|+||||+++|+|++ |..||......+........ ......+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11 12346778999998753 25789999999999999996 99999877766554433322 22222221
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 259 -FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 259 -~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
....++.+.+++..|+ .+|++|||+++++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1246788999999998 68999999999975
No 357
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-36 Score=295.17 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=197.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVHI 111 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~i 111 (494)
..|.-...||+||||.||+|.... |..||||.+....... ...|.+|+.++.+++ |||+++++|+|.+.+ ..++
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEE
Confidence 567777899999999999999764 4899999876443221 445999999999996 999999999999888 5999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSK---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
|+||++.|+|.+++.... .+++.....|+..++.||.|||.. .|+||||||+|||+ +.+...||+|||+|..
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCccc
Confidence 999999999999998765 789999999999999999999985 39999999999999 7899999999999976
Q ss_pred ccc-Ccccccc-cCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHH----HHcCCcc-CC
Q 040917 187 IEE-GKAYREI-VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQA----ILKGEIN-FQ 255 (494)
Q Consensus 187 ~~~-~~~~~~~-~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~----~~~~~~~-~~ 255 (494)
... ....... .||..|+|||... +..+.++||||||++++|++||+.+..... ......+ +..+... ..
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 554 3322233 7999999999885 689999999999999999999998886432 1112221 2221111 11
Q ss_pred CCCC--CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 256 RDPF--PSIS-----SSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 256 ~~~~--~~~~-----~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.. ...+ ..+..+..+|++.+|..||++.++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1223 22556788999999999999999754
No 358
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=5.3e-36 Score=289.37 Aligned_cols=247 Identities=20% Similarity=0.291 Sum_probs=201.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
++|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-C
Confidence 578999999999999999999887776 46888875433 222345688899999999 599999999998654 4
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+++++|+++|+|.+++.... .++...+..++.|++.||.|||++||+|+||||+||++ +.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence 679999999999999987654 58899999999999999999999999999999999999 56778999999999765
Q ss_pred ccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 188 EEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 188 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
..... .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........+..+. .++. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCC
Confidence 43222 112334678999998864 58899999999999999997 899998877666555554432 2222 2456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999999999999999877
No 359
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-36 Score=316.33 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=213.5
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCc-----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGL-----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
...-+..+.||+|+||.||.|.-..... .||+|.+. ...+......|.+|..+++.+ +||||++++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCC
Confidence 3567788999999999999998653322 38888876 444667788999999999999 599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 107 QFVHIVMELCAGGELFDRIVAR-------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
...+|++|||+||+|..++++. ..++....+.++.+|++|+.||+++++|||||-+.|+|+ +....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999875 248899999999999999999999999999999999999 677999999
Q ss_pred ecCCccccccCccccc--c-cCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917 180 DFGLSAFIEEGKAYRE--I-VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 180 Dfg~a~~~~~~~~~~~--~-~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
|||+|+.+.....++. . .-...|||||.+. +.++.++|||||||++||++| |..||......++...+.++. ..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 9999995443332221 1 2235799999986 779999999999999999998 789999999999998777776 33
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+ +.+|..+.+++..||+.+|++||++..|++
T Consensus 924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 322 578999999999999999999999999987
No 360
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=1e-35 Score=284.67 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=195.8
Q ss_pred cceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--C
Q 040917 33 LHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--D 106 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~ 106 (494)
.+|++.+.||+|+||.||+|. +..++..|++|.+.... ......+.+|+.+++.++ ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 479999999999999999987 45678899999986432 334567889999999995 9999999998643 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
...++|+||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 4688999999999999998764 458999999999999999999999999999999999999 678899999999998
Q ss_pred ccccCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH---------------
Q 040917 186 FIEEGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ--------------- 245 (494)
Q Consensus 186 ~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~--------------- 245 (494)
........ ....++..|+|||++.+ .++.++|+|||||++++|++|..|+...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHH
Confidence 65433221 11123345999998864 5889999999999999999987765433221 111
Q ss_pred -HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 246 -AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 246 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+....... .....++..+.+++.+||..+|++|||+.++++
T Consensus 236 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111111 122467899999999999999999999999976
No 361
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-37 Score=277.31 Aligned_cols=256 Identities=27% Similarity=0.497 Sum_probs=227.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+|++...||+|+|+.|..++.++|.+.+|+|++++..+..+...+=...|-.+..+-++||.++.++.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 68999999999999999999999999999999999988888878888888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCc
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGK 191 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~ 191 (494)
.||++||+|--.+.+..+++++.+..+...|+.||.|||++||++||||..||++ +..|++||.|+|++... .++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence 9999999998888888899999999999999999999999999999999999999 78999999999998763 4566
Q ss_pred ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC-------ChHH-HHHHHHcCCccCCCCCCCCC
Q 040917 192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE-------TDQG-VAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~-------~~~~-~~~~~~~~~~~~~~~~~~~~ 262 (494)
...+.+|||.|.|||++.+ .|...+|+|+||+++++|+.|+.||... +.++ ..+.++......++ .+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence 6678999999999999987 5999999999999999999999999521 2223 34555666555554 45
Q ss_pred CHHHHHHHHHhcccCCCCCC------CHHHHhcCCccCc
Q 040917 263 SSSAIELVRRMLTQDPKRRI------TVAQVLEHPWLKE 295 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rp------s~~eil~~~~~~~ 295 (494)
+-....+++..|.+||.+|. .+.++..|+||..
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 66778899999999999995 5789999999985
No 362
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=5.3e-36 Score=282.62 Aligned_cols=237 Identities=18% Similarity=0.203 Sum_probs=189.7
Q ss_pred eeecccCCeEEEEEEECCCC----------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 39 REVGRGEFGITYLCTENSTG----------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~----------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.+. ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46899999999999998776 357788765332 12577889999999995 9999999999877 67
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC----CCCeEEEeecCC
Q 040917 109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----ENAVVKATDFGL 183 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~----~~~~~kL~Dfg~ 183 (494)
.++||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.+. ....++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 689999999999999999999999999999999999995321 123799999999
Q ss_pred ccccccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917 184 SAFIEEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF 259 (494)
Q Consensus 184 a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (494)
+..... .....++..|+|||++.+ .++.++|+|||||++++|++ |..||......+.......... .+
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~-~~---- 226 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-LP---- 226 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC-CC----
Confidence 876543 223456778999999864 48899999999999999999 5788876654444333332111 11
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
......+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112378999999999999999999999986
No 363
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=2.7e-36 Score=280.71 Aligned_cols=228 Identities=23% Similarity=0.349 Sum_probs=187.3
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHH
Q 040917 44 GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD 123 (494)
Q Consensus 44 G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~ 123 (494)
|.+|.||+|.+..+++.||+|.+.... ...+|...+... .||||+++++++......++||||++|++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999996532 123344444445 49999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCcc
Q 040917 124 RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203 (494)
Q Consensus 124 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~ 203 (494)
++.....+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999 67888999999987654332 22344577899
Q ss_pred Chhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 040917 204 APEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282 (494)
Q Consensus 204 aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 282 (494)
|||.+.+ .++.++|+||+|+++|+|++|..|+...... . ....... ..+.+++.+.++|.+||+.||.+||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLN--IPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccC--CcccCCHHHHHHHHHHccCCHHHhc
Confidence 9998864 5889999999999999999999887543221 0 0000111 1134788999999999999999999
Q ss_pred CH-----HHHhcCCcc
Q 040917 283 TV-----AQVLEHPWL 293 (494)
Q Consensus 283 s~-----~eil~~~~~ 293 (494)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
No 364
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-36 Score=285.48 Aligned_cols=272 Identities=27% Similarity=0.481 Sum_probs=206.4
Q ss_pred hhhhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-----
Q 040917 19 LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ----- 93 (494)
Q Consensus 19 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----- 93 (494)
+|++.+++.+.+ +||.+.+.||.|.|++||+|++..+.+.||+|+++.. +...+....|+.+|++++.+
T Consensus 66 YHpV~IGD~F~~--gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 66 YHPVRIGDVFNG--GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred CceeeccccccC--ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 556666655432 8999999999999999999999999999999999743 34566778899999998733
Q ss_pred --CCccEEeEEEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 040917 94 --PNIVQFKAAYE----DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPEN 164 (494)
Q Consensus 94 --p~i~~~~~~~~----~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~N 164 (494)
.+|+++++.|. ++.++|+|+|+. |.+|+.+|... +.++...+++|++||+.||.|||.. ||||.||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 46999999985 466999999999 88999999765 4599999999999999999999975 99999999999
Q ss_pred eEEeeC--------------------------------------------------------------------------
Q 040917 165 FLFTTG-------------------------------------------------------------------------- 170 (494)
Q Consensus 165 Ili~~~-------------------------------------------------------------------------- 170 (494)
||+..+
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 998100
Q ss_pred --------------------------------------------------------------------------------
Q 040917 171 -------------------------------------------------------------------------------- 170 (494)
Q Consensus 171 -------------------------------------------------------------------------------- 170 (494)
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence
Q ss_pred ---------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 040917 171 ---------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD 240 (494)
Q Consensus 171 ---------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~ 240 (494)
..+..+||+|||.|+... .....-..|..|+|||++.| .|++.+||||++|+++||.||-..|.....
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG 456 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSG 456 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCC
Confidence 001135666666665431 22233446889999999876 599999999999999999999998843321
Q ss_pred ------HHHHHHHHc-----------------------CCccCCC--CCCC---------CCC----HHHHHHHHHhccc
Q 040917 241 ------QGVAQAILK-----------------------GEINFQR--DPFP---------SIS----SSAIELVRRMLTQ 276 (494)
Q Consensus 241 ------~~~~~~~~~-----------------------~~~~~~~--~~~~---------~~~----~~l~~li~~~l~~ 276 (494)
++.+..+.. +...-.. .+|+ .+| ..+.+|+.-||+.
T Consensus 457 ~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef 536 (590)
T KOG1290|consen 457 ENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF 536 (590)
T ss_pred CCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence 222222211 1110000 0121 122 4577899999999
Q ss_pred CCCCCCCHHHHhcCCccCccCcC
Q 040917 277 DPKRRITVAQVLEHPWLKESGEA 299 (494)
Q Consensus 277 dp~~Rps~~eil~~~~~~~~~~~ 299 (494)
+|++||||.++|+|||+.....+
T Consensus 537 ~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 537 DPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred CccccccHHHHhcCccccCCCCC
Confidence 99999999999999999987654
No 365
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=5.9e-36 Score=284.02 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=197.6
Q ss_pred eeecccCCeEEEEEEECCCC------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 39 REVGRGEFGITYLCTENSTG------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
+.||+|++|.||+|.+.... ..+++|.+.... .......+.+|+.+++.+. ||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999976544 689999886432 1234567889999999994 99999999999988899999
Q ss_pred EeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC--CCCeEEEeecCC
Q 040917 113 MELCAGGELFDRIVAR-------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD--ENAVVKATDFGL 183 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~--~~~~~kL~Dfg~ 183 (494)
|||++|++|.+++... ..++...+..++.+++.|+.|||+++++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2377899999999999999999999999999999999995322 223899999999
Q ss_pred ccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917 184 SAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP 258 (494)
Q Consensus 184 a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (494)
+........ .....++..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence 875432211 11234467899999886 468999999999999999998 99999887776666655443221 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
...+|..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
No 366
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=2.6e-36 Score=284.61 Aligned_cols=240 Identities=17% Similarity=0.228 Sum_probs=191.1
Q ss_pred eeecccCCeEEEEEEECCCCc-------EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 39 REVGRGEFGITYLCTENSTGL-------EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~-------~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
+.||+|+||.||+|.+...+. .|++|.+.... ....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 469999999999999865544 48888875322 234567788999999994 9999999999999888999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-----CCCeEEEeecCCcc
Q 040917 112 VMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-----ENAVVKATDFGLSA 185 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-----~~~~~kL~Dfg~a~ 185 (494)
||||+++|+|..++..++ .++...+..++.||+.|+.|||++||+||||||+||+++.++ ..+.++++|||.+.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 589999999999999999999999999999999999996422 12358999999986
Q ss_pred ccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 186 FIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
..... ....+++.|+|||++.+ .++.++|+|||||++|+|++|. .||........... .......+ ...
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~----~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLP----APK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCC----CCC
Confidence 54322 23457888999999864 4788999999999999999984 66665555443332 22222222 235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
+..+.+++.+||+.+|++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 5789999999999999999999999863
No 367
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=7.1e-36 Score=307.92 Aligned_cols=343 Identities=17% Similarity=0.252 Sum_probs=220.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCC----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-----
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENST----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA----- 102 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~----- 102 (494)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+...++ .+.... +.++..+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRAC-PNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence 36899999999999999999999988 9999999875322 11111111 111111 2222221111
Q ss_pred -EEeCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040917 103 -YEDDQFVHIVMELCAGGELFDRIVARGH--------------------YSERAAASVFRVIMNVVNVCHSKGVMHRDLK 161 (494)
Q Consensus 103 -~~~~~~~~iv~e~~~g~sL~~~~~~~~~--------------------l~~~~~~~i~~~i~~~l~~LH~~~i~H~dik 161 (494)
.......++|+||+.+++|.+++..... .....+..++.||+.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2345678999999999999998865421 1234467899999999999999999999999
Q ss_pred CCceEEeeCCCCCeEEEeecCCccccccCc--ccccccCCcCccChhhhcc-----------------------cCCCcc
Q 040917 162 PENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGSPYYIAPEVLSQ-----------------------SYGKEA 216 (494)
Q Consensus 162 p~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------------------~~~~~~ 216 (494)
|+|||++ +..+.+||+|||++....... ......+++.|+|||.+.. .++.++
T Consensus 283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999995 245789999999997543322 2234678999999997531 123456
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------CCCC-------CCCCCCHHHHHHHHHhcccCCC
Q 040917 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----------FQRD-------PFPSISSSAIELVRRMLTQDPK 279 (494)
Q Consensus 217 Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~l~~li~~~l~~dp~ 279 (494)
||||+||++|+|+++..|+..... .....+...... .... .+...+....+||.+||+.||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999997766532211 111111111100 0000 0011233456899999999999
Q ss_pred CCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHH
Q 040917 280 RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD 359 (494)
Q Consensus 280 ~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~ 359 (494)
+|||+.++|+||||........... ........ .. ......+-.+.+...+..-+++.+|..+.+
T Consensus 440 kR~ta~e~L~Hpff~~~~~~~~~~~-~~~~~~~~--~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 504 (566)
T PLN03225 440 QRISAKAALAHPYFDREGLLGLSVM-QNLRLQLF--RA------------TQQDYGEAAAWVVFLMAKSGTEKEGGFTEA 504 (566)
T ss_pred cCCCHHHHhCCcCcCCCCccccccc-cccccccc--hh------------hHHHHHHHHHHHHHHHHhcCCCCCCCccHH
Confidence 9999999999999987432211110 00000000 00 000011222345555666778888999999
Q ss_pred HHHHHHHhcCCCCCHHHHHH--HHHHhcCCCCCcccchHHHHHHH
Q 040917 360 ELKAGLAKLGSMLTEFDVKQ--YMQAADIDGNGTIDYIEFITATM 402 (494)
Q Consensus 360 el~~~l~~~~~~~~~~~~~~--~~~~~D~~~~g~i~~~ef~~~~~ 402 (494)
++..+...- ...+.+..+ +.+.++.+..|-.++.+++....
T Consensus 505 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (566)
T PLN03225 505 QLQELREKE--PKKKGSAQRNALASALRLQRKGVKTVARTVDEIP 547 (566)
T ss_pred HHHHhhhhc--CcchhhhhhhhHHHHHhhhhhhhhhhhhhhhccc
Confidence 999977654 223333434 77888888888888888776433
No 368
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.6e-35 Score=279.82 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=193.1
Q ss_pred eeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-eCCeEEEEEe
Q 040917 39 REVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVME 114 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-~~~~~~iv~e 114 (494)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++++. .+...++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998643 34579999875322 233456788899999999 5999999999765 4556889999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917 115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191 (494)
Q Consensus 115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-- 191 (494)
|+.+++|.+++... ..++...+..++.+++.||.|||+.+++||||||+||++ ++++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 99999999998764 346778888999999999999999999999999999999 677899999999987543211
Q ss_pred ---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 192 ---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 192 ---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
......+++.|+|||.+. ..++.++|||||||++|+|++ |..||......+....+..+..... ...+|+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 111234567899999875 468899999999999999999 4677777776666666555432221 13468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+++.+||..+|++||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999986
No 369
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.5e-35 Score=280.11 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=189.1
Q ss_pred eeecccCCeEEEEEEECCC------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 39 REVGRGEFGITYLCTENST------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
+.||+|+||.||+|..... ...|++|++.... ......+.+|+.+++.+. ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 4689999999999985422 3358888875432 234556788999999994 99999999999988
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC----CCCeEEEeec
Q 040917 107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----ENAVVKATDF 181 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~----~~~~~kL~Df 181 (494)
...++||||+++++|..++... ..++...+..++.||+.|+.|||+++|+||||||.||+++.+. ....++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 8899999999999998888653 4689999999999999999999999999999999999995321 1224899999
Q ss_pred CCccccccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917 182 GLSAFIEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQRDP 258 (494)
Q Consensus 182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (494)
|.+...... ....++..|+|||.+. ..++.++|||||||++|+|+ +|..||......+... +.......
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~---- 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML---- 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence 998654322 2345778899999885 35889999999999999997 5888887665544322 22222211
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
....+..+.+++.+||..||.+||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12345789999999999999999999999874
No 370
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.6e-35 Score=284.54 Aligned_cols=250 Identities=14% Similarity=0.173 Sum_probs=187.2
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhH--------HHHHHHHHHHHHccCCCCccE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEK--------DDVRREIEIMRHLSGQPNIVQ 98 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~hp~i~~ 98 (494)
....+|++.+.||+|+||.||+|.+..+ +..+++|+............ .....+...+..+ +|+++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence 4457999999999999999999998877 67778876532221100000 0111223334455 5999999
Q ss_pred EeEEEEeCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 99 FKAAYEDDQ----FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 99 ~~~~~~~~~----~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
+++++.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+||++ +..+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence 998765433 4568888874 4777777665557888899999999999999999999999999999999 5678
Q ss_pred eEEEeecCCccccccCc--------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 040917 175 VVKATDFGLSAFIEEGK--------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVA 244 (494)
Q Consensus 175 ~~kL~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~ 244 (494)
.++|+|||++....... ......||+.|+|||++.+ .++.++|||||||++++|++|..||.+... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 89999999987643211 1122468999999999875 589999999999999999999999987733 2221
Q ss_pred --------HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 245 --------QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 245 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+..+.. ..+..++.+.+++..|+..+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22222211 23456899999999999999999999999875
No 371
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=1e-35 Score=284.57 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=200.3
Q ss_pred cceEeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--C
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--D 106 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~ 106 (494)
.+|++.+.||+|+||.||+|.+. .++..||+|++...... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 57889999999999999999864 34889999998754422 34678999999999994 9999999999876 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
...+++|||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||+|.||++ +.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 57899999999999999997654 58999999999999999999999999999999999999 567899999999998
Q ss_pred ccccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---------------HHH
Q 040917 186 FIEEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQG---------------VAQ 245 (494)
Q Consensus 186 ~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---------------~~~ 245 (494)
........ ....++..|+|||.+. ..++.++|+||||+++++|++|..|+....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 66432211 1123455699999875 458889999999999999999999986543221 112
Q ss_pred HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+.. ....+ ....++..+.+++.+||..+|.+||++.++++
T Consensus 238 ~~~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKE-GERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHc-CCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222 22211 12456789999999999999999999999986
No 372
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-37 Score=301.11 Aligned_cols=205 Identities=29% Similarity=0.513 Sum_probs=181.3
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---- 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---- 106 (494)
..+-|...+.||+||||.||+++++.+|..||+|++..... ....+..-+|++++++|. ||||++++++-...
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL 87 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence 34678889999999999999999999999999999976542 335788899999999996 99999999987543
Q ss_pred --CeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEee
Q 040917 107 --QFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATD 180 (494)
Q Consensus 107 --~~~~iv~e~~~g~sL~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~D 180 (494)
....+|||||.||+|+..+.+ ...+++.+++.++..+..|+.|||++||+||||||.||++-. ++.....||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 357799999999999999853 346999999999999999999999999999999999999864 33667899999
Q ss_pred cCCccccccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAE 238 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~ 238 (494)
||.|+..+.+....+..||+.|.+||+.. +.|+..+|.|||||++|+..||..||...
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999998888888999999999999987 56899999999999999999999999543
No 373
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1.2e-35 Score=282.42 Aligned_cols=239 Identities=18% Similarity=0.203 Sum_probs=189.3
Q ss_pred eecccCCeEEEEEEECCC------------------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917 40 EVGRGEFGITYLCTENST------------------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~------------------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 95 (494)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.+. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999875321 2458888885332 223456778899999995 999
Q ss_pred ccEEeEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC----
Q 040917 96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG---- 170 (494)
Q Consensus 96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~---- 170 (494)
|+++++++......++||||+++++|..++.. .+.++...+..++.||+.||.|||++||+||||||+||+++..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988865 4568999999999999999999999999999999999999632
Q ss_pred CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHH-HhCCCCCCCCChHHHHHHH
Q 040917 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYIL-LCGVPPFWAETDQGVAQAI 247 (494)
Q Consensus 171 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l-~tg~~pf~~~~~~~~~~~~ 247 (494)
.....++++|||.+...... ....++..|+|||.+.+ .++.++|+|||||++|++ ++|..||...........+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 12346899999987543221 22356788999998864 478999999999999998 4789999877665543332
Q ss_pred HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
.. ....+ ...++.+.+++.+||..+|++|||+.++|++
T Consensus 235 ~~-~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EK-KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred Hh-ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 11111 2345789999999999999999999999874
No 374
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=3.5e-37 Score=263.73 Aligned_cols=258 Identities=27% Similarity=0.498 Sum_probs=212.0
Q ss_pred cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-- 106 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-- 106 (494)
+.-+++|++++.+|+|.++.||.|.+..+++.+++|+++.. ....+.+|+.+|+.|+++|||++++++..+.
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 44568999999999999999999999999999999999643 4677999999999999999999999998764
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
....+|+|++...+...+ .+.++...+...+.++++||.|+|+.||+|||+||.|++++ .....++|+|+|+|.+
T Consensus 108 ktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEF 182 (338)
T ss_pred cCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhh
Confidence 467799999977555443 35688899999999999999999999999999999999996 4567899999999999
Q ss_pred cccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH-------------cC
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAIL-------------KG 250 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~-------------~~ 250 (494)
.-++...+-.+.+..|..||.+- ..|+..-|+|||||.+..|+..+.||... +..+.+-.+. +-
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 98888888888899999999874 46889999999999999999999998433 3333222221 00
Q ss_pred Cc-----------cCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917 251 EI-----------NFQRDPF---------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297 (494)
Q Consensus 251 ~~-----------~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~ 297 (494)
.. ...+.+| .-.++++.+|+.++|..|-++|||+.|++.||||....
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 00 0011111 12468999999999999999999999999999998543
No 375
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=2.5e-35 Score=280.29 Aligned_cols=247 Identities=22% Similarity=0.360 Sum_probs=199.5
Q ss_pred eEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917 35 YTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---- 107 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---- 107 (494)
|++.+.||+|++|.||+|.+. .+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 678899999999999999864 3578999999865432 3334677889999999995 999999999885432
Q ss_pred --eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917 108 --FVHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 108 --~~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
..+++++|+.+++|..++... ..++...+..++.|++.|+.|||++||+||||||+||++ +.++.++|+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 347889999999998877532 147889999999999999999999999999999999999 678889999
Q ss_pred ecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917 180 DFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 180 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
|||.+........ .....+++.|++||.+.+ .++.++|+|||||++|+|++ |+.||.+....+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999876533221 112234567999998764 57889999999999999999 889998877776666665543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
. .+..+..+.+++.+||..+|++|||+.+++.
T Consensus 236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 1457789999999999999999999999986
No 376
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=272.21 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=212.9
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+.+-...||.|+||+|++..++.+|+..|||.+..... ...+.++..|.+...+-.++|||+++++..-.++..+|.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 34446679999999999999999999999999976543 4467888999998887778999999999998888899999
Q ss_pred eccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 114 ELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 114 e~~~g~sL~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
|+|. .||..+-+ ....+++..+..|....+.||.||... +|+|||+||+|||+ +..|.+||||||.+-..
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhH
Confidence 9994 46654332 345688998889999999999999865 89999999999999 78999999999998766
Q ss_pred ccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCC--CC
Q 040917 188 EEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPF--PS 261 (494)
Q Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~--~~ 261 (494)
..+-....-.|-.+|+|||.+.. .|+-+||+||||++++|+.||+.||.+... .+.+..+..+.++...... -.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 54444444567889999999853 489999999999999999999999977654 2444555666555443322 34
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
++..+..+|.-||.+|-..||.+.+++++||+.-..+
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 7889999999999999999999999999999986543
No 377
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=2.6e-37 Score=292.68 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=218.8
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEe
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFK 100 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~ 100 (494)
.-.+.+..+|.|....|+|=||+|.+|.++.-|+.||||+|.... .....=+.|+++|++|. +.-|++.++
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 334556689999999999999999999999999999999997543 24445567999999996 346899999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917 101 AAYEDDQFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK 177 (494)
Q Consensus 101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k 177 (494)
..|...+++|+|+|.+. .+|.+.++..+ .+....+..++.|++.||..|.++||+|.||||.|||++ .....+|
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLK 577 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILK 577 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceee
Confidence 99999999999999985 59999998765 488899999999999999999999999999999999997 6778999
Q ss_pred EeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917 178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256 (494)
Q Consensus 178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (494)
|||||.|...... ....++.+..|+|||++.| +|+..-|+||+||+||||+||+..|.|.+...++...+...-+++.
T Consensus 578 LCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 578 LCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred eccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9999999876544 3456677888999999877 6999999999999999999999999999998877665432222221
Q ss_pred CC-------------------------------------------------CCCC-------CHHHHHHHHHhcccCCCC
Q 040917 257 DP-------------------------------------------------FPSI-------SSSAIELVRRMLTQDPKR 280 (494)
Q Consensus 257 ~~-------------------------------------------------~~~~-------~~~l~~li~~~l~~dp~~ 280 (494)
.. .+.+ -..+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 10 0011 234788999999999999
Q ss_pred CCCHHHHhcCCccCc
Q 040917 281 RITVAQVLEHPWLKE 295 (494)
Q Consensus 281 Rps~~eil~~~~~~~ 295 (494)
|.|..++|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
No 378
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=6.1e-35 Score=276.90 Aligned_cols=243 Identities=20% Similarity=0.293 Sum_probs=190.4
Q ss_pred eecccCCeEEEEEEECCC--CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 40 EVGRGEFGITYLCTENST--GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.+ +||||+++++.+......++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCC
Confidence 599999999999975432 3456677765432 223467889999999999 59999999999998889999999999
Q ss_pred CCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917 118 GGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191 (494)
Q Consensus 118 g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-- 191 (494)
+++|.+++.+. ...+...+..++.||+.||.|||+++++||||||+||++ +.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence 99999998754 235667788999999999999999999999999999999 678899999999876432211
Q ss_pred -ccccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc-cCCC-CCC
Q 040917 192 -AYREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI-NFQR-DPF 259 (494)
Q Consensus 192 -~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~ 259 (494)
......++..|+|||++.. .++.++|+|||||++|+|++ +..||......+....+.+... .... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1123457889999998732 35789999999999999997 5678887777666665544332 2222 222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..+++.+.+++..|| .+|++||++.++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 357888999999999 68999999999975
No 379
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-36 Score=283.13 Aligned_cols=266 Identities=29% Similarity=0.460 Sum_probs=222.3
Q ss_pred cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhh----HHHHHHHHHHHHHccCCCCccEEeEE
Q 040917 27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE----KDDVRREIEIMRHLSGQPNIVQFKAA 102 (494)
Q Consensus 27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~i~~~~~~ 102 (494)
.-..+.++|-+..+||.|||+.||+|.+...++.||+|+-.......+.. ....-+|.++-+.| +||.|+++|++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDy 535 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDY 535 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeee
Confidence 34456789999999999999999999999999999999976555444433 34456899999999 69999999999
Q ss_pred EE-eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEe
Q 040917 103 YE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKAT 179 (494)
Q Consensus 103 ~~-~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~ 179 (494)
+. +.+.+|-|+|||+|-+|.-+++.+..++++++..|+-||+.||.||... .|||-||||.|||+.+.+..|.+||.
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 96 4567899999999999999999999999999999999999999999876 69999999999999887788999999
Q ss_pred ecCCccccccCcc--------cccccCCcCccChhhhc-c----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 040917 180 DFGLSAFIEEGKA--------YREIVGSPYYIAPEVLS-Q----SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQ 245 (494)
Q Consensus 180 Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~-~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~ 245 (494)
|||++..+..... .....||-+|.+||.+- + ..+.++||||+|||+|..+.|+.||...... ++++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999987753221 12356899999999874 2 2688999999999999999999999765443 3332
Q ss_pred H--HH-cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 246 A--IL-KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 246 ~--~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
. |+ .....|+.. |.++.+...||.+||...-++|....++-.||||..
T Consensus 696 eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2 22 233445544 678999999999999999999999999999999974
No 380
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.4e-36 Score=289.64 Aligned_cols=258 Identities=28% Similarity=0.507 Sum_probs=220.8
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.-|..++.||-|+||.|.+|....|...+|.|.+.+......+......-|..||..- +++-|+++|-.|++.+.+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEE
Confidence 5789999999999999999999999999999999888777777788888999999998 699999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc---
Q 040917 113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE--- 189 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~--- 189 (494)
|+|++||++-.++.+.+.+.+..+..++.++.+|+.+.|+.|+|||||||.|||| +.+|+|||.|||++.-+..
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence 9999999999999999999999999999999999999999999999999999999 7899999999999853210
Q ss_pred ------Cc------------------c----------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHH
Q 040917 190 ------GK------------------A----------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYIL 228 (494)
Q Consensus 190 ------~~------------------~----------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l 228 (494)
+. . ....+||+.|+|||++.. .|+.-+|+||.|||||+|
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00 0 012458999999999865 699999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917 229 LCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE 295 (494)
Q Consensus 229 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~ 295 (494)
+.|+.||...++.+....+.+=.........-.+++++.++|.++.. .++.|. .++++..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 99999998887766555444433333334456789999999988764 567776 4678999999996
No 381
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=1.7e-34 Score=269.06 Aligned_cols=242 Identities=43% Similarity=0.736 Sum_probs=205.6
Q ss_pred CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHH
Q 040917 45 EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR 124 (494)
Q Consensus 45 ~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~ 124 (494)
+||.||+|.+..+++.+++|++....... ....+.+|+..++++ +|+||+++++.+......++++|++++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999999999999999997544322 167899999999999 599999999999998999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccC
Q 040917 125 IVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204 (494)
Q Consensus 125 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~a 204 (494)
+.....++...+..++.+++.++.+||+.+++|+||+|.||++ +.++.++|+|||.+.............++..|+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 9877668999999999999999999999999999999999999 5668999999999987665544455677889999
Q ss_pred hhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 040917 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWA-ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282 (494)
Q Consensus 205 PE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 282 (494)
||.+. ..++.++|+||+|++++++++|..||.. .......+.+....... ......++..+.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCchhcc
Confidence 99886 4688899999999999999999999987 44444444444333322 222222789999999999999999999
Q ss_pred CHHHHhcCCcc
Q 040917 283 TVAQVLEHPWL 293 (494)
Q Consensus 283 s~~eil~~~~~ 293 (494)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
No 382
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-35 Score=292.54 Aligned_cols=258 Identities=27% Similarity=0.470 Sum_probs=219.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-----
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE----- 104 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~----- 104 (494)
...+.|.|.+.||.|.+|.||+++++.+++.+|+|+..... ...+.++.|+++++.++.|||++.++++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34467999999999999999999999999999999986433 346778889999999999999999999984
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917 105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182 (494)
Q Consensus 105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg 182 (494)
.++.+++|||||.|||..+++++- .++.+..+.-|++.++.|+.+||++.++|||||=.|||+ ...+.|||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeee
Confidence 356899999999999999999764 468999999999999999999999999999999999999 678999999999
Q ss_pred CccccccCcc-cccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917 183 LSAFIEEGKA-YREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255 (494)
Q Consensus 183 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 255 (494)
.+....+... ..+..|||.|||||++. ..|+..+|+||||++..||--|.+|+...-+...+-.+.+... +.
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-Pk 247 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PK 247 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-cc
Confidence 9987665433 34578999999999984 2377899999999999999999999987776544333322211 11
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
-..+..++..+.+||..||.+|-++||+..++|.|||+++
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1224568899999999999999999999999999999995
No 383
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-35 Score=287.28 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=213.6
Q ss_pred cceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
++.++.++||+|+||.|++|.|... ...||||++....... ..++|.+|+.+|.+|+ |||++++|++..+ ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 5677889999999999999998753 3469999997554332 6889999999999995 9999999999987 556
Q ss_pred EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 110 HIVMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
.+|+|++++|+|.+.+.+ ...+.......++.||++|+.||..+++|||||-..|+++ -....|||+|||+.+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceecc
Confidence 799999999999999987 3458889999999999999999999999999999999999 56789999999999876
Q ss_pred ccCccccccc----CCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 188 EEGKAYREIV----GSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 188 ~~~~~~~~~~----~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
..+....... -...|+|||.++ ..++.++|+|++||++|||+| |..||.+...-.+++.+..+ ...+++ +.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRP--k~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRP--KY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCC--CC
Confidence 6544432211 234699999986 579999999999999999998 67999999998898888744 333333 46
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
+++.+.++++.||..+|.+||++..|.+.-+...
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 8999999999999999999999999987655544
No 384
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-35 Score=291.16 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=216.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
..-+|.+.||.|.||.||+++.+..|+ .||||.++... .+..+.+|+.|+.||-++ +||||+++.++......+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCcee
Confidence 456789999999999999999887764 69999997544 445678899999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.||+|||+.|+|..+++.+ +.++..++..+++-|+.|++||-+.++|||||-+.|||+ +.+-.+|++|||+++...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence 9999999999999999765 579999999999999999999999999999999999999 789999999999999775
Q ss_pred cCcc-cccccC---CcCccChhhhc-ccCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 189 EGKA-YREIVG---SPYYIAPEVLS-QSYGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 189 ~~~~-~~~~~~---~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
.... ..+..| ..+|.|||.+. ..++.+||+||+|+++||.+ .|..||+..+.+++++.+..+-.-+++ .++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---mDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---MDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---CCC
Confidence 4432 112222 46899999885 67999999999999999965 499999999999999999887444443 578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
|..+-+|+..||++|-.+||.+.+|++
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 999999999999999999999999987
No 385
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-34 Score=276.93 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=209.0
Q ss_pred cccceEeeeeecccCCeEEEEEEECCC----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENST----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
-.+.-.+.+.||.|.||.||+|....- .-.||||+.+... .....+.|..|..+++.+ +||||++++|++...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc
Confidence 334455667899999999999975322 3458889887533 334588999999999999 599999999999764
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917 107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~ 185 (494)
..+||||+++-|.|.+++..+. .++..+..-++.||+.||.|||+..+|||||-..|||+ .+...+||+|||+++
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSR 539 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhh
Confidence 5789999999999999998764 58899999999999999999999999999999999999 678899999999999
Q ss_pred ccccCcccccccC--CcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 186 FIEEGKAYREIVG--SPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 186 ~~~~~~~~~~~~~--~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
.+.....+....| ...|||||-++ ..++.+||+|=|||.+||+++ |..||.+....+++-.+.++...+.+ +.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~n 616 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PN 616 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CC
Confidence 8876555444344 34699999987 469999999999999999876 88999999888887777777655444 57
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVL 288 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil 288 (494)
+|+.+..++.+||..+|.+||.+.++.
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHH
Confidence 899999999999999999999987764
No 386
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-35 Score=259.98 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=209.1
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---- 107 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---- 107 (494)
+.+-+..+.||-|+||.||.+.+..+|+.|++|.+.. .+.+-.....+.+|+.+|..++ |.|++..+++.+..+
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3556667899999999999999999999999999853 3344445677889999999996 999999999886543
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 108 -FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 108 -~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
.+|+++|++. .+|...+..-..++...++.+++||+.||+|||+.+|.||||||.|.++ +++..+||||||+++.
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccc
Confidence 3668889884 4787777777789999999999999999999999999999999999999 7899999999999987
Q ss_pred cccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------------
Q 040917 187 IEEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL-------------- 248 (494)
Q Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~-------------- 248 (494)
..... .+...+.|.+|+|||++.| .|+.+.||||+|||+.||+..+..|...++-+.++.|.
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 64432 3345567899999999987 49999999999999999999999998777765554442
Q ss_pred ---------cCCccCCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 249 ---------KGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 249 ---------~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
++....+.-. ...-..+...++.++|.+||++|.+..+++.|+++.+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111111100 0112345778999999999999999999999999975
No 387
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=6.1e-33 Score=279.03 Aligned_cols=260 Identities=18% Similarity=0.255 Sum_probs=184.5
Q ss_pred ccceEeeeeecccCCeEEEEEEEC----------------CCCcEEEEEEeccCCCCCh-----------hhHHHHHHHH
Q 040917 32 QLHYTIGREVGRGEFGITYLCTEN----------------STGLEFACKSIPKRKLVKD-----------VEKDDVRREI 84 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~----------------~~~~~valK~~~~~~~~~~-----------~~~~~~~~E~ 84 (494)
.++|++.+.||+|+||+||+|... ..++.||||.+........ ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 3456799999864321100 0112233467
Q ss_pred HHHHHccCCCC-----ccEEeEEEEe--------CCeEEEEEeccCCCchHHHHHhcC----------------------
Q 040917 85 EIMRHLSGQPN-----IVQFKAAYED--------DQFVHIVMELCAGGELFDRIVARG---------------------- 129 (494)
Q Consensus 85 ~~l~~l~~hp~-----i~~~~~~~~~--------~~~~~iv~e~~~g~sL~~~~~~~~---------------------- 129 (494)
.++.+++ |.+ ++++++++.. ....++||||+++++|.+++....
T Consensus 224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 7777775 443 3556666532 346789999999999999886421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccc--ccCCcCccCh
Q 040917 130 --HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAP 205 (494)
Q Consensus 130 --~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~~~y~aP 205 (494)
.++...+..++.|++.+|.|||+.+|+||||||+||++ +.++.++|+|||++........... ..+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 13456788899999999999999999999999999999 5678999999999875543322222 2347899999
Q ss_pred hhhccc---------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCChHH-HH-------H-HHHcCCc
Q 040917 206 EVLSQS---------------------Y--GKEADIWSAGVILYILLCGVP-PFWAETDQG-VA-------Q-AILKGEI 252 (494)
Q Consensus 206 E~~~~~---------------------~--~~~~Di~slG~il~~l~tg~~-pf~~~~~~~-~~-------~-~~~~~~~ 252 (494)
|.+... + ..+.|+||+||++++|+++.. ||....... .. . .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 987421 1 124799999999999999875 664322110 00 0 0111111
Q ss_pred cCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCccCc
Q 040917 253 NFQRDPFPSISSSAIELVRRMLTQDP---KRRITVAQVLEHPWLKE 295 (494)
Q Consensus 253 ~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~eil~~~~~~~ 295 (494)
.+....+...++...+++.+||..+| .+|+|++++|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22223456678999999999999866 68999999999999964
No 388
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-33 Score=273.09 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=210.9
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
.+-.....||.|.||.||.+.|++..-.||||.++...+ ..+.|+.|+.+++.++ |||+++++++|..+..+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEE
Confidence 445567789999999999999999999999999975443 5788999999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917 113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~ 190 (494)
+|||..|+|++++.++. .++.-....++.||..|+.||..+++|||||-+.|.|+ .++..+|+.|||+++++...
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCC
Confidence 99999999999998764 37777888999999999999999999999999999999 78899999999999987543
Q ss_pred cccc--cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917 191 KAYR--EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266 (494)
Q Consensus 191 ~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 266 (494)
.... ...-...|.|||-+. +.++.++|+|+|||+|||+.| |-.||.+.....++..+.++-..-.+ ..+|+..
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P---eGCPpkV 495 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP---EGCPPKV 495 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC---CCCCHHH
Confidence 2211 122245799999875 568999999999999999987 77999999888777777665333222 5799999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 040917 267 IELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 267 ~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.+|+..||+++|.+||++.|+-+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999988743
No 389
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-33 Score=271.37 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=207.8
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.....+++.||+|.||.|-+|.-. .+..||+|.++... ..+.+..|..|+++|.+|+ ||||+.++++|..++.+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHH
Confidence 366789999999999999999854 36899999997543 3445788999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
|+||++.|+|.+++.++. ........+++.||+.|++||.+.++|||||.+.|+|+ +.++++||+|||+++..-+
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence 999999999999998763 23456677899999999999999999999999999999 7899999999999986655
Q ss_pred Cccccc---ccCCcCccChhhh-cccCCCcchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHc---CCc-cCCCCCC
Q 040917 190 GKAYRE---IVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLC--GVPPFWAETDQGVAQAILK---GEI-NFQRDPF 259 (494)
Q Consensus 190 ~~~~~~---~~~~~~y~aPE~~-~~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~~~~~~~~~~---~~~-~~~~~~~ 259 (494)
++.++. .+-..+|+|||.+ .+.++++||+|++|+++||+++ ...||...+.+.+.+.... ... .......
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 544322 2335789999965 6899999999999999999876 6799988888877665422 111 1111122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 260 PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+-+|..+.+++.+||..+..+|||++++-.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 467899999999999999999999999854
No 390
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=3.8e-34 Score=266.44 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=207.0
Q ss_pred hcccccccccceEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917 24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100 (494)
Q Consensus 24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~ 100 (494)
+.+....+...|+++.+||+|.|++||+|.+.. .+..||+|.+.... ....+.+|+++|..+.++.||+++.
T Consensus 27 l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 27 LRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred HHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcch
Confidence 344456677889999999999999999999887 78899999997544 3456899999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
+++..++.+.+|+||++.....++.. .++...+..+++.++.||.++|++|||||||||+|++++ ...+.-.|+|
T Consensus 102 ~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvD 176 (418)
T KOG1167|consen 102 GCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVD 176 (418)
T ss_pred hhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEe
Confidence 99999999999999999877777663 467899999999999999999999999999999999997 4567789999
Q ss_pred cCCccccc-----------------c--Cc------------c--------------cccccCCcCccChhhhc--ccCC
Q 040917 181 FGLSAFIE-----------------E--GK------------A--------------YREIVGSPYYIAPEVLS--QSYG 213 (494)
Q Consensus 181 fg~a~~~~-----------------~--~~------------~--------------~~~~~~~~~y~aPE~~~--~~~~ 213 (494)
||+|.... . +. . .-...||++|+|||++. +.-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99996110 0 00 0 00245899999999985 4578
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHH-HcCC---------------------------
Q 040917 214 KEADIWSAGVILYILLCGVPPFWAETDQ--------------GVAQAI-LKGE--------------------------- 251 (494)
Q Consensus 214 ~~~Di~slG~il~~l~tg~~pf~~~~~~--------------~~~~~~-~~~~--------------------------- 251 (494)
+++||||.|+|+..+++++.||...... ++.+.- ..+.
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 8999999999999999999999433221 000000 0000
Q ss_pred ---cc--CCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 252 ---IN--FQRDPF-PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 252 ---~~--~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.. .....+ ...|..+.+++.+||..||.+|.|++++|.||||..
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 000111 224568999999999999999999999999999995
No 391
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=5e-34 Score=285.02 Aligned_cols=250 Identities=31% Similarity=0.475 Sum_probs=198.3
Q ss_pred eEeeeeecccCCeE-EEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 35 YTIGREVGRGEFGI-TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 35 y~i~~~lg~G~~g~-Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
|.-.+.+|.|+.|+ ||+|.- .|+.||||.+-.. ..+...+|+..|+.=..||||+++++.-.++...||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34456789999886 588884 4889999998432 35567899999998889999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCcccc
Q 040917 114 ELCAGGELFDRIVARG-H---YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLSAFI 187 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~-~---l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a~~~ 187 (494)
|+|. .+|.+++...+ . ......+.+..|+++||++||+.+||||||||+||||... +....++|+|||++...
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9996 59999997631 1 1224567899999999999999999999999999999742 24468999999999887
Q ss_pred ccCccc----ccccCCcCccChhhhccc-CCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917 188 EEGKAY----REIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDPFPS 261 (494)
Q Consensus 188 ~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (494)
..+... ....||-+|+|||++.+. -+.++||+|+||++|+.++| .+||...... ...|.++......... .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~-~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP-L 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-C
Confidence 655443 345689999999999764 56789999999999998886 8999655443 2345555444332211 1
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
-..++.+||.+|+.++|..||+|.++|.||+|+..
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11289999999999999999999999999999963
No 392
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.98 E-value=3e-32 Score=230.04 Aligned_cols=219 Identities=25% Similarity=0.363 Sum_probs=180.9
Q ss_pred ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.+.+.-.++...+..||+|++|.|-+.++..+|+..|+|.+..+. +........+|+.+..+-..+|.++.+++.+..
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334445567777888999999999999999999999999997544 344678888999988877789999999999988
Q ss_pred CCeEEEEEeccCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEee
Q 040917 106 DQFVHIVMELCAGGELFDR----IVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
...++|.||.+.- ||..+ ++..+.+++..+-+++..++.||.|||++ .++|||+||+|||+ +..|++|+||
T Consensus 117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCD 192 (282)
T KOG0984|consen 117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICD 192 (282)
T ss_pred cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcc
Confidence 8999999999953 66543 34556799999999999999999999987 89999999999999 7899999999
Q ss_pred cCCccccccCcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcC
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKG 250 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~ 250 (494)
||.+-...++-...--.|-..|+|||.+.. .|+-++||||||+++.||.+++.||... ++.+.+.++...
T Consensus 193 FGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 193 FGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 999877655443333457789999999853 4888999999999999999999999644 444555555554
No 393
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.98 E-value=2.3e-31 Score=248.74 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=193.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHc-cCCCCccEEeEEEEeC--
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL-SGQPNIVQFKAAYEDD-- 106 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~hp~i~~~~~~~~~~-- 106 (494)
.+..+-.+.+.||+|.||.||+|.|+ |+.||||++..+ ....+.+|.++++.+ -+|+||+.+++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 45678899999999999999999998 899999999643 466788899988852 2599999998764322
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEeeCCCCCeE
Q 040917 107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--------GVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dikp~NIli~~~~~~~~~ 176 (494)
...++|++|.+.|||.+++.+ ..++......++..++.||++||-. .|+|||||..|||| .+++.+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence 368999999999999999988 4699999999999999999999952 49999999999999 689999
Q ss_pred EEeecCCccccccCc-----ccccccCCcCccChhhhcccCC-------CcchhHHHHHHHHHHHhC----------CCC
Q 040917 177 KATDFGLSAFIEEGK-----AYREIVGSPYYIAPEVLSQSYG-------KEADIWSAGVILYILLCG----------VPP 234 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-------~~~Di~slG~il~~l~tg----------~~p 234 (494)
-|+|+|+|....+.. ..+..+||.+|||||++..... ..+||||||.++||+... +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998765431 2346789999999999975432 368999999999998642 567
Q ss_pred CCCCC-----hHHHHHHHHcCCcc-CCCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 235 FWAET-----DQGVAQAILKGEIN-FQRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 235 f~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
|.... .+++.+-+.-.... ..+..|...+ ..+.++++.||..||.-|.|+-.|.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 75433 33333333222222 2223333332 34678899999999999999877654
No 394
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.97 E-value=1.2e-31 Score=298.35 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=182.0
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...|+....||+|+||.||+|.+..++..||+|.+..... ....|+..++++ +||||+++++++......++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEE
Confidence 3456777899999999999999999999999999864321 113468889999 49999999999999899999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
||||+++|+|.+++. .+++..+..++.+++.|+.||| +.+|+||||||+||++ +.++..++. ++......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccc
Confidence 999999999999985 3788999999999999999999 6699999999999999 455555554 55443221
Q ss_pred cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHc---CC-c-cCCCC---
Q 040917 189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILK---GE-I-NFQRD--- 257 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~---~~-~-~~~~~--- 257 (494)
. .....+++.|+|||++.+ .++.++||||+||++|||+||+.||..... ..+...... .. . ....+
T Consensus 834 ~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 T---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred c---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 1 122367899999998864 589999999999999999999999853321 111111110 00 0 00000
Q ss_pred -CC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 258 -PF---PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 258 -~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
.. ......+.+++.+||..+|++||++.++++
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 00 011234678899999999999999999987
No 395
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=1.1e-31 Score=266.81 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=207.5
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
..+..+.||+|+||+||++.|-..|+ +||+|++... ........+..|+-.+.+| +|||++++++++.... .
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence 35567889999999999999865554 6888887543 3444678899999999999 5999999999997655 7
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
-||++|+++|+|.++++.+ ..+.....+.|..||++|+.|||.+.++||||-+.|||| ..-.++|+.|||++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccC
Confidence 7999999999999999865 468899999999999999999999999999999999999 678899999999998765
Q ss_pred cCccc-cc--ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 189 EGKAY-RE--IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 189 ~~~~~-~~--~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
..... .. ..-.+.|+|-|.+. ..|++++||||+||++||++| |..|+.+...+++.+.+..+..-..+ +..+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP---piCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP---PICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---CCcc
Confidence 43322 11 12245688888876 469999999999999999988 88999999999999888887663322 4678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
-++.-++.+||..|+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 89999999999999999999999865
No 396
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.97 E-value=1e-32 Score=268.95 Aligned_cols=260 Identities=29% Similarity=0.468 Sum_probs=225.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
+.+++|.+...+|+|.+|.||+|+++.+++..|+|+++... ......+.+|+-+++.-+ ||||+.+++.|......
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence 56789999999999999999999999999999999997543 335667888999999885 99999999999988899
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~ 189 (494)
+|+||||.||+|.+.-.-.+++++.++....+..+.|++|||+.|=+|||||=.||++ .+.+.+||.|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence 9999999999999987777899999999999999999999999999999999999999 7889999999999876643
Q ss_pred Cc-ccccccCCcCccChhhh----cccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCC
Q 040917 190 GK-AYREIVGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSIS 263 (494)
Q Consensus 190 ~~-~~~~~~~~~~y~aPE~~----~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 263 (494)
.- ......|||+|+|||+. .+.|...+|+|++|++..++---+.|....-+........+..++++. .....++
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 22 22457899999999986 357999999999999999998888887666666666666666555543 2334688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
+.+-.|++.+|.++|.+||+++.+|.|||....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999999999853
No 397
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=1.5e-30 Score=270.99 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=207.7
Q ss_pred cceEeeeeecccCCeEEEEEEEC---C----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 33 LHYTIGREVGRGEFGITYLCTEN---S----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~---~----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.+..+.+.||+|+||.|++|.-. . ....||+|..+..... ...+.+..|+.+++.+..||||+.+.+.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34467779999999999998632 1 2567999998755433 4678899999999999889999999999998
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee
Q 040917 106 DQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~ 169 (494)
.+..++|+||++.|+|.+++..++ .++......++.||+.|+.||++.+++||||-+.|||+
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi-- 451 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI-- 451 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--
Confidence 889999999999999999998765 38889999999999999999999999999999999999
Q ss_pred CCCCCeEEEeecCCccccccCcccccc--cC--CcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCC-hHH
Q 040917 170 GDENAVVKATDFGLSAFIEEGKAYREI--VG--SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAET-DQG 242 (494)
Q Consensus 170 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~--~~--~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~-~~~ 242 (494)
..+..+|++|||+|+........... .+ ...|||||.+.. .|+.+||+||+|+++||++| |..||.+.. ..+
T Consensus 452 -~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 -TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred -cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 67789999999999865444433211 22 235999999875 69999999999999999998 779998865 666
Q ss_pred HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
+.+.+..+.....+ ..+++++.+++..||..+|++||++.++.+
T Consensus 531 l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66656555443333 346899999999999999999999999987
No 398
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.97 E-value=8.5e-32 Score=258.51 Aligned_cols=200 Identities=32% Similarity=0.576 Sum_probs=177.4
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhh-----HHHHHHHHHHHHHcc--CCCCccEEeEEEEe
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-----KDDVRREIEIMRHLS--GQPNIVQFKAAYED 105 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~ 105 (494)
.+|...+.+|.|+||.|++|.++.+...|++|.+.++...-+.. ...+-.|+.+|..|. .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45999999999999999999999999999999998766432222 233557999999994 49999999999999
Q ss_pred CCeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917 106 DQFVHIVMELC-AGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184 (494)
Q Consensus 106 ~~~~~iv~e~~-~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a 184 (494)
++.+||+||.- +|.+|.++|...+.+++..+..|++|++.|+++||+.||||||||-+||.+ +.+|.+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 99999999974 467999999999999999999999999999999999999999999999999 78999999999999
Q ss_pred cccccCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCC
Q 040917 185 AFIEEGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFW 236 (494)
Q Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~ 236 (494)
....+++ .....||..|.|||++.|. .+..-|||+||+++|-++....||.
T Consensus 718 a~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8776654 4678999999999999875 4778999999999999999999985
No 399
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=7e-31 Score=247.29 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=189.2
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-CCCCccEEeEEEEeCC----
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-GQPNIVQFKAAYEDDQ---- 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~i~~~~~~~~~~~---- 107 (494)
..-.+.++||+|.||.||+|... ++.||||++. ....+++.+|-++++... .|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 44567889999999999999854 6999999985 335778888888887532 5999999998876544
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceeccCCCCceEEeeCCCCCeEEE
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS---------KGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---------~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
.+.+|++|.+.|+|.++++.+ .++.....+++..++.||+|||+ ..|+|||||..|||| .++.+..|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence 799999999999999999886 58999999999999999999996 359999999999999 68999999
Q ss_pred eecCCccccccCccc---ccccCCcCccChhhhcccCC-------CcchhHHHHHHHHHHHhCCC------------CCC
Q 040917 179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQSYG-------KEADIWSAGVILYILLCGVP------------PFW 236 (494)
Q Consensus 179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-------~~~Di~slG~il~~l~tg~~------------pf~ 236 (494)
+|||+|....++... ...+||.+|||||++.+... .+.||||+|.++|||++.-. ||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999887654432 34789999999999976432 25899999999999998532 232
Q ss_pred -----CCChHHHHHHHHcCCccCC-CCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 040917 237 -----AETDQGVAQAILKGEINFQ-RDPFPS--ISSSAIELVRRMLTQDPKRRITVA 285 (494)
Q Consensus 237 -----~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~ 285 (494)
..+.+++...+.+....+. +..|.. -...+++.+..||..||+.|.|+.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2233444444444333222 222211 235688999999999999999985
No 400
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.97 E-value=6.9e-29 Score=225.72 Aligned_cols=210 Identities=42% Similarity=0.747 Sum_probs=183.8
Q ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917 41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120 (494)
Q Consensus 41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s 120 (494)
||+|++|.||++....+++.+++|++....... ....+.+|+..++.++ |++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999997544221 3577999999999995 9999999999998899999999999899
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCccccccCc-cccccc
Q 040917 121 LFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFIEEGK-AYREIV 197 (494)
Q Consensus 121 L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~~~~~~~-~~~~~~ 197 (494)
|.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||++ +. .+.++|+|||.+....... ......
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99998775 468999999999999999999999999999999999999 45 7899999999987654332 123355
Q ss_pred CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275 (494)
Q Consensus 198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 275 (494)
+...|.+||.+.. .++.++|+|++|++++++ ..+.+++.+|+.
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 6788999999875 678899999999999998 578899999999
Q ss_pred cCCCCCCCHHHHhcCC
Q 040917 276 QDPKRRITVAQVLEHP 291 (494)
Q Consensus 276 ~dp~~Rps~~eil~~~ 291 (494)
.+|++||++.++++++
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 9999999999999874
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.96 E-value=2.4e-28 Score=224.92 Aligned_cols=211 Identities=40% Similarity=0.728 Sum_probs=180.4
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
|++.+.||+|++|.||+|.+..+++.+++|.+...... .....+.+|+..++++ +|+|++++++.+......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence 67889999999999999999988999999999754422 2467888999999999 59999999999998889999999
Q ss_pred ccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917 115 LCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-- 191 (494)
++++++|.+++..... ++...+..++.+++.++.+||+++++|+||+|.||++ +..+.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence 9999999999987766 8999999999999999999999999999999999999 566899999999988765432
Q ss_pred ccccccCCcCccChhhh-c-ccCCCcchhHHHHHHHHHHHhCCCCCCC-CCh-HHHHHHHHcCC
Q 040917 192 AYREIVGSPYYIAPEVL-S-QSYGKEADIWSAGVILYILLCGVPPFWA-ETD-QGVAQAILKGE 251 (494)
Q Consensus 192 ~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~-~~~~~~~~~~~ 251 (494)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ... ..+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 33445678889999987 3 3477799999999999999999999977 333 35556665553
No 402
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.96 E-value=2.5e-30 Score=227.08 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=194.2
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-EEeCCe
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA-YEDDQF 108 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~-~~~~~~ 108 (494)
++.+.|.|.+.||+|.||.+.+|.++.+++.+++|.++... .....|.+|...--.|..|.||+.-|++ |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 45688999999999999999999999999999999997544 3578899999877778789999987775 677778
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+++++||++.|+|.+-+... .+.+.....++.|++.|+.|+|++++||||||.+||||-. .+...+||||||......
T Consensus 97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccC
Confidence 99999999999998877554 4788889999999999999999999999999999999954 345599999999987543
Q ss_pred cCcccccccCCcCccChhhhc----c--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHcCCccCCCC
Q 040917 189 EGKAYREIVGSPYYIAPEVLS----Q--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-----GVAQAILKGEINFQRD 257 (494)
Q Consensus 189 ~~~~~~~~~~~~~y~aPE~~~----~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 257 (494)
..-. ..--+-.|.+||... + ...+.+|+|.||+++|..+||..||...... +..+. ....-.-.+.
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~~~P~ 251 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNPALPK 251 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCccCch
Confidence 2211 122355799999764 2 2578899999999999999999999633221 12222 2222233344
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCC
Q 040917 258 PFPSISSSAIELVRRMLTQDPKRR 281 (494)
Q Consensus 258 ~~~~~~~~l~~li~~~l~~dp~~R 281 (494)
.+..+++.+.+++++-|.++|++|
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhcccCHHHHHHHHHhcCCccccc
Confidence 556788999999999999999988
No 403
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.95 E-value=1.4e-28 Score=266.46 Aligned_cols=197 Identities=19% Similarity=0.291 Sum_probs=142.4
Q ss_pred CCccEEeEEE-------EeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917 94 PNIVQFKAAY-------EDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF 165 (494)
Q Consensus 94 p~i~~~~~~~-------~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI 165 (494)
+||+.+++.+ .....++.++|++ +++|.+++.. ...++...+..+++||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666666655 1223567778887 5699999965 34589999999999999999999999999999999999
Q ss_pred EEee----------------CCCCCeEEEeecCCccccccCc-----------------ccccccCCcCccChhhhcc-c
Q 040917 166 LFTT----------------GDENAVVKATDFGLSAFIEEGK-----------------AYREIVGSPYYIAPEVLSQ-S 211 (494)
Q Consensus 166 li~~----------------~~~~~~~kL~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~-~ 211 (494)
|+.. .+..+.+|++|||++....... ......+|++|+|||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9942 1234567777777775321100 0011357889999999764 6
Q ss_pred CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 040917 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291 (494)
Q Consensus 212 ~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~ 291 (494)
++.++|||||||++|||++|..|+.... .....+..... ++.... ..+....++.+||.++|.+||++.++|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILL-NWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhhhh-cCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 8999999999999999999988874322 12222221111 111111 234567899999999999999999999999
Q ss_pred ccCcc
Q 040917 292 WLKES 296 (494)
Q Consensus 292 ~~~~~ 296 (494)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
No 404
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.95 E-value=3.6e-27 Score=217.10 Aligned_cols=248 Identities=17% Similarity=0.220 Sum_probs=201.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917 33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D 106 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~ 106 (494)
.|++...++.+|.||.||.|.|+.. .+.|.+|+++.. .++.....+..|.-++..+. |||+.++.++... .
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence 5788889999999999999987643 345677777533 24445667888888888885 9999999998754 4
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917 107 QFVHIVMELCAGGELFDRIVARG--------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL 178 (494)
...++++.+..-|+|..++..++ .++..++..++.|+..|+.|||++|++|.||-+.|.+| ++.-.+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEe
Confidence 56788899988899999887332 36777888999999999999999999999999999999 67899999
Q ss_pred eecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCcc
Q 040917 179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEIN 253 (494)
Q Consensus 179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 253 (494)
+|-.+++..-+.... .+......||+||.+. ..|+.++|+||||+++|||+| |+.||...++.++...++.+-.-
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 999888754333211 1223456899999885 569999999999999999998 88999999998888877766443
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
-.+ .++|+++..++..||...|++||+++++..
T Consensus 518 aQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQP---FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222 478999999999999999999999999864
No 405
>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Probab=99.94 E-value=7.3e-26 Score=187.86 Aligned_cols=151 Identities=33% Similarity=0.593 Sum_probs=140.5
Q ss_pred HhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-
Q 040917 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH- 405 (494)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~- 405 (494)
....+.++.+++++|+++|+.+|.|++|.|+..||..+++.+|.++++.++.+++..+|. +.|.|+|.+|+..+....
T Consensus 8 ~~~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~ 86 (160)
T COG5126 8 LLTFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLK 86 (160)
T ss_pred hhhcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhc
Confidence 334567899999999999999999999999999999999999999999999999999999 899999999999998765
Q ss_pred hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917 406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480 (494)
Q Consensus 406 ~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~ 480 (494)
.....+++.+||+.||.|+||+|+..||+++|+. +|+.+++++++.+++.+|.|+||.|+|++|...+...+.
T Consensus 87 ~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~--lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~~~ 159 (160)
T COG5126 87 RGDKEEELREAFKLFDKDHDGYISIGELRRVLKS--LGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDSPT 159 (160)
T ss_pred cCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHh--hcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhccCC
Confidence 4556789999999999999999999999999998 889999999999999999999999999999999887653
No 406
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=9.3e-25 Score=211.78 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=195.1
Q ss_pred ceEeeeeecccCCeEEEEEEECCCC-cEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc---CCCCccEEeEEE-EeCCe
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTG-LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS---GQPNIVQFKAAY-EDDQF 108 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~i~~~~~~~-~~~~~ 108 (494)
+|++.+.||+|+||.||.|.+..++ ..+|+|+........ .. .+..|..++..+. +.+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--Cc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988764 678999876543221 11 5778999999886 347999999999 47778
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC--CCCeEEEeecCCc
Q 040917 109 VHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD--ENAVVKATDFGLS 184 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~--~~~~~kL~Dfg~a 184 (494)
.++||+.+ |.+|.++.... +.++..++..++.|++.+|.+||+.|++||||||+|+++.... ....+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999988654 4799999999999999999999999999999999999996432 2267999999999
Q ss_pred cccc---cCc-------c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917 185 AFIE---EGK-------A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252 (494)
Q Consensus 185 ~~~~---~~~-------~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 252 (494)
+... ... . .....||..|.++.+..+ ..+++.|+||++-++.++..|..||.+.........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8321 111 1 123459999999998876 589999999999999999999999976654333333322222
Q ss_pred cCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 253 NFQRD-PFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 253 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
..... .....+..+.++...+-..+...+|.+..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22211 22345677888888888889999999888766
No 407
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.93 E-value=1e-25 Score=199.46 Aligned_cols=162 Identities=26% Similarity=0.332 Sum_probs=127.1
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917 119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197 (494)
Q Consensus 119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 197 (494)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+||++ +.++.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999764 45999999999999999999999998 9999999 67788888 99987654322 25
Q ss_pred CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCC---CCCCCCCH--HHHHHH
Q 040917 198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQR---DPFPSISS--SAIELV 270 (494)
Q Consensus 198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~l~~li 270 (494)
|++.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+......... .....++. .+.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 7899999999865 5899999999999999999999999765432 223333322221111 11122333 689999
Q ss_pred HHhcccCCCCCCCHHHHhcCCccCc
Q 040917 271 RRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 271 ~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
.+||..+|.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
No 408
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=4.8e-25 Score=190.85 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=200.1
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
-+.++|++++.||+|+||.+|.|....+|..||+|+-.... ...++..|..+++.|++...|..+..+..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 35689999999999999999999999999999999975433 3445788999999999888999999999888899
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
.+||++. |.||.+++.-+ ..++.++++-++-|++.-++|+|.++++||||||+|+|..-+.....+.|+|||+|....
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 88999888644 458999999999999999999999999999999999999655567789999999998654
Q ss_pred cCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---cCCc-cCC
Q 040917 189 EGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL---KGEI-NFQ 255 (494)
Q Consensus 189 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~---~~~~-~~~ 255 (494)
.... .....||.+|.+-....+ .-+.+.|+=|+|-++.++..|..||.+.......+... .... .+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 3221 124568888988776654 45778999999999999999999998887654444332 2211 122
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 040917 256 RDPFPSISSSAIELVRRMLTQDPKRRITVA 285 (494)
Q Consensus 256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 285 (494)
...+...|.++.-.+..|-..--++-|...
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 234567888888888888777666666654
No 409
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.92 E-value=4.6e-23 Score=201.18 Aligned_cols=254 Identities=37% Similarity=0.599 Sum_probs=208.1
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCC-CccEEeEEEEeCCeEEEEE
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP-NIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~i~~~~~~~~~~~~~~iv~ 113 (494)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.++..+. |+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999987 789999997766544345778999999999996 66 7999999998777789999
Q ss_pred eccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC-eEEEeecCCcccccc
Q 040917 114 ELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEE 189 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~~~~ 189 (494)
+++.++++.+.+.... .++......++.|++.++.|+|+.+++|||+||+||++ +... .++++|||.+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCC
Confidence 9999999997777664 68999999999999999999999999999999999999 4555 799999999875443
Q ss_pred Cc-------ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCcc-
Q 040917 190 GK-------AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEIN- 253 (494)
Q Consensus 190 ~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~- 253 (494)
.. ......++..|++||.+.+ .++...|+||+|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 32 2356788999999999865 578899999999999999999999877763 4444444444333
Q ss_pred CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 254 FQRDPFPSI----SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 254 ~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
......... ...+.+++..++..+|..|.+......++|...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 222221222 257899999999999999999999998866664
No 410
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=3.3e-24 Score=193.96 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=195.3
Q ss_pred ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917 30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~ 109 (494)
-++-.|+|++.||+|+||.++.+.+..++++||||.-.... ...++..|.+.++.|.+.++|..++-+...+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 46678999999999999999999999999999999875433 4567888999999999899999999999888888
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee--CCCCCeEEEeecCCccc
Q 040917 110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT--GDENAVVKATDFGLSAF 186 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~--~~~~~~~kL~Dfg~a~~ 186 (494)
.+|+|+. |-||.+++.-++ .++.+++..++.|++.-++|+|++.+|+|||||+|+||.. ......|-++|||+|..
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 889999887664 5999999999999999999999999999999999999963 23456799999999987
Q ss_pred cccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHcCCc-c
Q 040917 187 IEEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQG---VAQAILKGEI-N 253 (494)
Q Consensus 187 ~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---~~~~~~~~~~-~ 253 (494)
...... ..+..||.+||+=.-..| .-+.+.|+=|||-++.+++.|.+||.+..... -.+.|-.... .
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 644322 123568999998765544 46788999999999999999999998765433 2333322211 1
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 040917 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITV 284 (494)
Q Consensus 254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 284 (494)
.....+..+|.++...+...-..+-.+-|.+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 1122344566666666665555555555554
No 411
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.92 E-value=2e-24 Score=208.65 Aligned_cols=168 Identities=19% Similarity=0.228 Sum_probs=129.9
Q ss_pred cccccccceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccE-EeEE
Q 040917 27 AYEDVQLHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQ-FKAA 102 (494)
Q Consensus 27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~-~~~~ 102 (494)
....+..+|.+.+.||+|+||+||+|.++. +++.||+|++..... ........+.+|+.+++++. |+|+++ +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~ 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc
Confidence 344566889999999999999999999876 678889998753211 12334667999999999995 999885 4432
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEeeCCCCCeEEEeec
Q 040917 103 YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL-KPENFLFTTGDENAVVKATDF 181 (494)
Q Consensus 103 ~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-kp~NIli~~~~~~~~~kL~Df 181 (494)
...|+||||++|++|.. +. ... ...++.+++.+|.|||++||+|||| ||+||++ +.++.++|+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 35789999999999963 21 111 1467899999999999999999999 9999999 56678999999
Q ss_pred CCccccccCcc---------cccccCCcCccChhhhc
Q 040917 182 GLSAFIEEGKA---------YREIVGSPYYIAPEVLS 209 (494)
Q Consensus 182 g~a~~~~~~~~---------~~~~~~~~~y~aPE~~~ 209 (494)
|+|........ .....+++.|.|||.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99986543221 13456788899999885
No 412
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.92 E-value=5.1e-26 Score=234.03 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=198.8
Q ss_pred cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccC---CCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR---KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
..| .....+|.|++|.|+.+......+..+.|..... ..........+..|+-+-..|. |||++.....+.....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence 445 4678899999998988887777776677655421 1111112222455666667785 9999877776655544
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
..-+||||++ +|..++...+.++...+-.++.|++.||.|+|..||.|||+||+|+++ ...+.+||+|||.+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence 4455999999 999999888889999999999999999999999999999999999999 678899999999987653
Q ss_pred cC-----cccccccCCcCccChhhhcc-cCC-CcchhHHHHHHHHHHHhCCCCCCCCChHHHH--HHH---HcCCccCCC
Q 040917 189 EG-----KAYREIVGSPYYIAPEVLSQ-SYG-KEADIWSAGVILYILLCGVPPFWAETDQGVA--QAI---LKGEINFQR 256 (494)
Q Consensus 189 ~~-----~~~~~~~~~~~y~aPE~~~~-~~~-~~~Di~slG~il~~l~tg~~pf~~~~~~~~~--~~~---~~~~~~~~~ 256 (494)
.. ......+|+..|.|||++.+ .|. ...||||.|+++..|.+|+.||......+.. ... .......+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 32 22345788999999999875 454 4689999999999999999999766554332 111 011111222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298 (494)
Q Consensus 257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~ 298 (494)
..+..+|...+.+|.+||+.+|.+|.++++|++.+||+....
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 334567888999999999999999999999999999997543
No 413
>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]
Probab=99.90 E-value=2.9e-23 Score=177.50 Aligned_cols=142 Identities=37% Similarity=0.629 Sum_probs=131.9
Q ss_pred chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh-----
Q 040917 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ----- 408 (494)
Q Consensus 334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~----- 408 (494)
+..+...+..+|+.+|++++|+|+..+|..+++.+|..++.+++..+++.+|.+++|.|+++||+.++.......
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~ 82 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA 82 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence 567788999999999999999999999999999999999999999999999999999999999999988754321
Q ss_pred HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
..+++++||+.||.|++|+|+.+||+.+|.. +|++.+.++++.++..+|.|+||.|+|++|+++|..
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~--lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~ 149 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTS--LGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSG 149 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHH--hCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhc
Confidence 3458999999999999999999999999999 788999999999999999999999999999998875
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.90 E-value=2.6e-23 Score=186.66 Aligned_cols=174 Identities=17% Similarity=0.143 Sum_probs=132.3
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHH------HHHHHHHHHHccCCCCccEEeEEEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD------VRREIEIMRHLSGQPNIVQFKAAYE 104 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~hp~i~~~~~~~~ 104 (494)
+.++|++.+.||.|+||.||++.. ++..+|+|++.......+..... +.+|+..+.++. ||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence 468999999999999999999765 46689999997655433333333 678999999995 999999988865
Q ss_pred eC--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917 105 DD--------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV 176 (494)
Q Consensus 105 ~~--------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~ 176 (494)
.. ...+++|||++|.+|.+.. .+++ ....+++.++..+|+.|++|||+||+||++ ++++ +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC-E
Confidence 33 3578999999999997763 2333 346689999999999999999999999999 4556 9
Q ss_pred EEeecCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHH
Q 040917 177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILL 229 (494)
Q Consensus 177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~ 229 (494)
+|+|||............. =++...+..++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 9999998765422211100 112234667999999999887654
No 415
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.90 E-value=7.2e-23 Score=189.35 Aligned_cols=235 Identities=25% Similarity=0.346 Sum_probs=156.7
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccC---------CCCccEEeEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG---------QPNIVQFKAAY 103 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------hp~i~~~~~~~ 103 (494)
..+..++.||.|+++.||.+.+..||+++++|+............+.+.+|......+.+ |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356788999999999999999999999999999876554445566777777755544322 22333333433
Q ss_pred Ee------------CCe-----EEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 040917 104 ED------------DQF-----VHIVMELCAGGELFDRIV---ARGH----YSERAAASVFRVIMNVVNVCHSKGVMHRD 159 (494)
Q Consensus 104 ~~------------~~~-----~~iv~e~~~g~sL~~~~~---~~~~----l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 159 (494)
.. ... .+++|+-+. ++|...+. .... +.......+..|++..+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 21 112 367888875 48876653 2222 22333456668999999999999999999
Q ss_pred CCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc---------cCCCcchhHHHHHHHHHHHh
Q 040917 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---------SYGKEADIWSAGVILYILLC 230 (494)
Q Consensus 160 ikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~il~~l~t 230 (494)
|+|+|+++ +.+|.+.|+||+.......... ....+..|.|||.... .++.+.|.|+||+++|.|..
T Consensus 171 i~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLL---DQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE----TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEE---cCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999 7899999999988765433222 1344678999997632 37889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 040917 231 GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRR 281 (494)
Q Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 281 (494)
+..||........... ....+.++|+.++.+|..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999977655322111 222345789999999999999999988
No 416
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.89 E-value=1.4e-24 Score=212.79 Aligned_cols=239 Identities=28% Similarity=0.486 Sum_probs=205.1
Q ss_pred ecccCCeEEEEEEE---CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 41 VGRGEFGITYLCTE---NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 41 lg~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
+|+|++|.|+++.. ...++-+++|+..+......... ....|..++...++||.++++.-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 78999999998653 45688899999887665554333 667788899999789999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 197 (494)
||.|...+.....+.......+...++-++..+|+.+|+|||+|++||++ +..|++++.|||.++..-.... .|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---AC 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh---cc
Confidence 99999888887788888888999999999999999999999999999999 7899999999999987544332 28
Q ss_pred CCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917 198 GSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277 (494)
Q Consensus 198 ~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 277 (494)
||..|||||+++ .....+|.||+|+++++|+||..||.+ ++...|.+.....+. .++..+++++..++..+
T Consensus 155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRN 225 (612)
T ss_pred cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhC
Confidence 999999999998 667899999999999999999999977 566667666555553 46788999999999999
Q ss_pred CCCCCC-----HHHHhcCCccCc
Q 040917 278 PKRRIT-----VAQVLEHPWLKE 295 (494)
Q Consensus 278 p~~Rps-----~~eil~~~~~~~ 295 (494)
|.+|.- +.++++|+||+.
T Consensus 226 p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 226 PENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHhccCcchhHHHhccchhee
Confidence 999974 478999999974
No 417
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.88 E-value=2.1e-22 Score=179.09 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=111.2
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-----------------------hHHHHHHHHHHHHHccCCC
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-----------------------EKDDVRREIEIMRHLSGQP 94 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~~hp 94 (494)
...||+|++|.||+|.+. +|+.||+|+++........ ......+|+..+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 468999999999999987 8999999999754321111 0123345999999995 77
Q ss_pred CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEEeeCCCC
Q 040917 95 NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-HSKGVMHRDLKPENFLFTTGDEN 173 (494)
Q Consensus 95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dikp~NIli~~~~~~ 173 (494)
++.....+.... .+|||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||+++ +
T Consensus 80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 764444333222 379999999887766544556789999999999999999999 799999999999999994 3
Q ss_pred CeEEEeecCCcccc
Q 040917 174 AVVKATDFGLSAFI 187 (494)
Q Consensus 174 ~~~kL~Dfg~a~~~ 187 (494)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 67999999998754
No 418
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.88 E-value=2.2e-23 Score=214.43 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=181.5
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHH--HHHccCCCCccEEeEEEEeCCeEEE
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI--MRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
.|...+-||++.|=.|.+|+++. |. |++|++-+... ......+.+++.- .... .+||++++.-+...+...|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p--~~sL~~~~qrL~~ik~~l~-~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDP--TISLRPFKQRLEEIKFALM-KAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCC--CCCchHHHHHHHHHHHHhh-cCCcccchHHHHHhhHHHHH
Confidence 68889999999999999999864 55 99999876542 2233334433332 3334 59999999888888888899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc--cc
Q 040917 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI--EE 189 (494)
Q Consensus 112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~--~~ 189 (494)
|-+|.. .+|++++..++.+..-+.+-|+-|++.||..+|..||+|||||.+|||+ .+..-+.|+||...... +.
T Consensus 99 vRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCC
Confidence 999995 5999999999889999999999999999999999999999999999999 67888999999776432 11
Q ss_pred Ccc--c----ccccCCcCccChhhhcc-----------c-CCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 040917 190 GKA--Y----REIVGSPYYIAPEVLSQ-----------S-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG 250 (494)
Q Consensus 190 ~~~--~----~~~~~~~~y~aPE~~~~-----------~-~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 250 (494)
.++ . .+...-..|.|||.+.. . .+++.||||+||+++||++ |++||.- ..+-...++
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc
Confidence 111 1 11223356999998732 1 5789999999999999988 5778731 122222222
Q ss_pred CccCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 251 EINFQRDPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 251 ~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
....+...+.. -+..++.+|..|++.||.+|.|+++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 21111111111 13578999999999999999999999986
No 419
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.88 E-value=8.7e-23 Score=209.94 Aligned_cols=223 Identities=30% Similarity=0.554 Sum_probs=177.0
Q ss_pred cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917 29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF 108 (494)
Q Consensus 29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~ 108 (494)
.-...+|..+++|..|++|.||.++|+.+.+.+|+|+ .+... +.+. ++... ++|.++
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv----------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV----------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--ccccc-CCccee-----------
Confidence 3455789999999999999999999999999999954 32221 1111 22222 455544
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917 109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
|+=..+++.-+.++... +.+++|||+.||+|||+||.|.+| ..-|++|+.|||++....
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhh
Confidence 23344455555555443 678999999999999999999999 689999999999986532
Q ss_pred cCc----------------ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917 189 EGK----------------AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251 (494)
Q Consensus 189 ~~~----------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 251 (494)
... .....+|||.|.|||++. ..|+..+|+|++|+|+|+++-|..||.+.++++.+..+....
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 110 012468999999999875 569999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCcc
Q 040917 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKES 296 (494)
Q Consensus 252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~ 296 (494)
..++... ..+++++++++.++|..+|..|. .+-++.+|+||+..
T Consensus 275 i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 275 IEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 8888774 56889999999999999999995 67788999999863
No 420
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.88 E-value=5.4e-23 Score=181.13 Aligned_cols=241 Identities=19% Similarity=0.240 Sum_probs=193.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV 112 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv 112 (494)
....+...|.+...|..|+++|+ |..+++|++..+....+ ...+|..|...|+.+. ||||+++++.+.......+|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifs-hpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeec-CCchhhhhhhccCCCCceEe
Confidence 34556677899999999999998 56789999876665444 4567888988898885 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-c-eeccCCCCceEEeeCCCCCeEEE--eecCCccc
Q 040917 113 MELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKG-V-MHRDLKPENFLFTTGDENAVVKA--TDFGLSAF 186 (494)
Q Consensus 113 ~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~-i-~H~dikp~NIli~~~~~~~~~kL--~Dfg~a~~ 186 (494)
..|++.|+|++.++.... .+..++.+++.+++.|++|||+.. + ..--|+...|++ +++.+.+| +|-.++..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee
Confidence 999999999999987654 577889999999999999999973 3 344588999999 55555555 34433322
Q ss_pred cccCcccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917 187 IEEGKAYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (494)
.......|.|++||.+... --.++|+|||+++++||.|...||...++.+.-..+.-....... .|.+
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i--ppgi 414 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI--PPGI 414 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC--CCCc
Confidence 1233457899999998643 235789999999999999999999999998887777655554433 3689
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917 263 SSSAIELVRRMLTQDPKRRITVAQVL 288 (494)
Q Consensus 263 ~~~l~~li~~~l~~dp~~Rps~~eil 288 (494)
+....+++.-|+..||.+||.++.++
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999988764
No 421
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.87 E-value=3.1e-21 Score=169.37 Aligned_cols=189 Identities=19% Similarity=0.248 Sum_probs=142.4
Q ss_pred EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-hHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 36 TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 36 ~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
.+...|++|+||+||.+.. .+.+++.+.+......... ....+.+|+++|++|.+++++++++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4578899999999998774 5788887777544432221 122578999999999767889999886 34689999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917 115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL-KPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-kp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~ 193 (494)
|+.|.+|...... . ...++.+++.+|.++|++||+|||| ||+||++ +.++.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence 9999888654311 1 2357889999999999999999999 7999999 56788999999999865433321
Q ss_pred --------------ccccCCcCccChhhhc--ccCC-CcchhHHHHHHHHHHHhCCCCCCCCCh
Q 040917 194 --------------REIVGSPYYIAPEVLS--QSYG-KEADIWSAGVILYILLCGVPPFWAETD 240 (494)
Q Consensus 194 --------------~~~~~~~~y~aPE~~~--~~~~-~~~Di~slG~il~~l~tg~~pf~~~~~ 240 (494)
.-...++.|++|+... ...+ ...+.++.|+-+|.++|+..+.++..+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0122577888887532 2333 578999999999999999999876543
No 422
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.87 E-value=3e-21 Score=172.45 Aligned_cols=144 Identities=15% Similarity=0.172 Sum_probs=113.1
Q ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----------------------hhHHHHHHHHHHHHHccCC
Q 040917 37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----------------------VEKDDVRREIEIMRHLSGQ 93 (494)
Q Consensus 37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~h 93 (494)
+.+.||+|++|.||+|.+. +|+.||+|++........ ........|...+.++. +
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence 3578999999999999987 899999999976531100 01223467899999995 8
Q ss_pred CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCC
Q 040917 94 PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDE 172 (494)
Q Consensus 94 p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~ 172 (494)
+++.....+.... .++||||++|+++.........++...+..++.+++.++.++|+ .||+||||||+||++ +
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~- 152 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H- 152 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E-
Confidence 8875544443332 47999999988665443344568889999999999999999999 999999999999999 3
Q ss_pred CCeEEEeecCCccccc
Q 040917 173 NAVVKATDFGLSAFIE 188 (494)
Q Consensus 173 ~~~~kL~Dfg~a~~~~ 188 (494)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 6789999999997654
No 423
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.85 E-value=8.5e-22 Score=182.38 Aligned_cols=189 Identities=25% Similarity=0.414 Sum_probs=141.4
Q ss_pred CCCCccEEeEEEEe---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 040917 92 GQPNIVQFKAAYED---------------------------DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144 (494)
Q Consensus 92 ~hp~i~~~~~~~~~---------------------------~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~ 144 (494)
.||||+.+...|.+ +...|+||..++ .||..++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999877632 245889999885 49999997754 57778888999999
Q ss_pred HHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecCCcccccc-------CcccccccCCcCccChhhhcccC----
Q 040917 145 NVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEE-------GKAYREIVGSPYYIAPEVLSQSY---- 212 (494)
Q Consensus 145 ~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg~a~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~---- 212 (494)
+|+.|||++||.|||+|.+||++.= ++.-..+.++|||.+--..+ ....-...|....+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999963 34557889999998643221 01112345677899999986422
Q ss_pred ---CCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 040917 213 ---GKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVA 285 (494)
Q Consensus 213 ---~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 285 (494)
-.+.|.|+.|.+.||+++...||.+..+.-.- ......+. + .....+|+.+++++..+|+.||++|+|..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--P-alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--P-ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--C-CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 24899999999999999999999875432110 11111111 1 12246889999999999999999999864
No 424
>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]
Probab=99.84 E-value=4.6e-20 Score=148.79 Aligned_cols=145 Identities=30% Similarity=0.507 Sum_probs=134.7
Q ss_pred cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHH
Q 040917 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRF 410 (494)
Q Consensus 332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~ 410 (494)
.+..++.++++..|..||.+++|+|+..||.-+.+.+|..+.++++..++..+|.++.|.|+|++|...+.... ...+.
T Consensus 26 ~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~ 105 (172)
T KOG0028|consen 26 ELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTK 105 (172)
T ss_pred cccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcH
Confidence 45677789999999999999999999999999999999999999999999999999999999999999876643 23478
Q ss_pred HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
+++..+|+.+|.|++|+|+..+|+.+... +|+.++++++.++|.++|.++||-|+-+||..+|+++
T Consensus 106 eEi~~afrl~D~D~~Gkis~~~lkrvake--LgenltD~El~eMIeEAd~d~dgevneeEF~~imk~t 171 (172)
T KOG0028|consen 106 EEIKKAFRLFDDDKTGKISQRNLKRVAKE--LGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKKT 171 (172)
T ss_pred HHHHHHHHcccccCCCCcCHHHHHHHHHH--hCccccHHHHHHHHHHhcccccccccHHHHHHHHhcC
Confidence 89999999999999999999999999999 8899999999999999999999999999999999864
No 425
>PTZ00183 centrin; Provisional
Probab=99.83 E-value=1.1e-19 Score=157.57 Aligned_cols=148 Identities=33% Similarity=0.561 Sum_probs=133.6
Q ss_pred ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhH
Q 040917 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQR 409 (494)
Q Consensus 331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~ 409 (494)
..+++.+++++..+|..+|.+++|.|+..||..++..+|...+..++..+|..+|.+++|.|+|+||+..+.... ....
T Consensus 9 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 88 (158)
T PTZ00183 9 PGLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDP 88 (158)
T ss_pred CCCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCc
Confidence 346788999999999999999999999999999999999888888999999999999999999999998876532 2334
Q ss_pred HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917 410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480 (494)
Q Consensus 410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~ 480 (494)
...++.+|+.+|.+++|+|+.+||..++.. .+..++++++..++..+|.|++|.|++++|.+++...|.
T Consensus 89 ~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~--~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 157 (158)
T PTZ00183 89 REEILKAFRLFDDDKTGKISLKNLKRVAKE--LGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTNL 157 (158)
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcccC
Confidence 567899999999999999999999999998 566789999999999999999999999999999987664
No 426
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.83 E-value=1.2e-19 Score=190.56 Aligned_cols=195 Identities=21% Similarity=0.337 Sum_probs=158.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFV 109 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~ 109 (494)
+..|.|.+.||.|+||.||+|.+.. |+.||||+-+...... ++--.+++.+|+ --+-|..+...+...+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 4789999999999999999999877 9999999976543222 233344555553 124556666666666677
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee----CCCCCeEEEeecCCcc
Q 040917 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT----GDENAVVKATDFGLSA 185 (494)
Q Consensus 110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~----~~~~~~~kL~Dfg~a~ 185 (494)
++|++|.+.|||.+++...+.+++..+..++.|++..|..||..+||||||||.|+++.. +....-++|+|||-+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 799999999999999998888999999999999999999999999999999999999953 2346679999999986
Q ss_pred ccc---cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCC
Q 040917 186 FIE---EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVP 233 (494)
Q Consensus 186 ~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~ 233 (494)
-+. .+-.....++|-.+-++|+..| ++++..|.|-|+.+++.|+.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 543 3334456778899999999986 59999999999999999998853
No 427
>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]
Probab=99.82 E-value=2.2e-19 Score=143.63 Aligned_cols=152 Identities=28% Similarity=0.455 Sum_probs=137.9
Q ss_pred HHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM 402 (494)
Q Consensus 323 ~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~ 402 (494)
+.+...+...|.+.++++++..|..+|.|+||.|+++||.+.+..+|..++++++..+++.. .|.|+|.-|+.++-
T Consensus 16 ~rasSnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea----~gPINft~FLTmfG 91 (171)
T KOG0031|consen 16 KRASSNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA----PGPINFTVFLTMFG 91 (171)
T ss_pred ccccchHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC----CCCeeHHHHHHHHH
Confidence 34555566778999999999999999999999999999999999999999999999999874 88999999999987
Q ss_pred Hhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917 403 QRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480 (494)
Q Consensus 403 ~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~ 480 (494)
.... ...++.+..||+.||.+++|.|..+.|+++|.. .|++++++++++++..+-.+..|.++|..|..++..+..
T Consensus 92 ekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt--~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ithG~~ 168 (171)
T KOG0031|consen 92 EKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTT--MGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITHGEK 168 (171)
T ss_pred HHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHH--hcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHcccc
Confidence 7554 345778999999999999999999999999999 899999999999999999999999999999999986654
No 428
>PRK10345 hypothetical protein; Provisional
Probab=99.82 E-value=3.4e-19 Score=159.82 Aligned_cols=141 Identities=18% Similarity=0.281 Sum_probs=109.7
Q ss_pred EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc----CCCCccEEeEEEEeCC---e
Q 040917 36 TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS----GQPNIVQFKAAYEDDQ---F 108 (494)
Q Consensus 36 ~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~i~~~~~~~~~~~---~ 108 (494)
.-.+.||+|++|.||. +..++.. +||++..... ...+.+.+|+.+++.+. +||||+++++++..+. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3457899999999995 6666665 6998865332 24567899999999994 3799999999998763 3
Q ss_pred -EEEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEEeeCC-CCCeEEEee-cC
Q 040917 109 -VHIVMEL--CAGGELFDRIVARGHYSERAAASVFRVIMNVV-NVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATD-FG 182 (494)
Q Consensus 109 -~~iv~e~--~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~D-fg 182 (494)
+.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ .|||+++|+||||||+||+++..+ ....++|+| ||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 3378999 5579999999664 46555 35678888777 899999999999999999996432 445899999 55
Q ss_pred Ccc
Q 040917 183 LSA 185 (494)
Q Consensus 183 ~a~ 185 (494)
...
T Consensus 156 ~~~ 158 (210)
T PRK10345 156 EST 158 (210)
T ss_pred Ccc
Confidence 443
No 429
>smart00090 RIO RIO-like kinase.
Probab=99.81 E-value=2e-19 Score=165.51 Aligned_cols=146 Identities=19% Similarity=0.169 Sum_probs=114.7
Q ss_pred cceEeeeeecccCCeEEEEEE-ECCCCcEEEEEEeccCCCCCh---------------------hhHHHHHHHHHHHHHc
Q 040917 33 LHYTIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKD---------------------VEKDDVRREIEIMRHL 90 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~-~~~~~~~valK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l 90 (494)
.-|++.+.||+|++|.||+|. +..+|+.||+|++........ .....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 777899999999875432100 0123467899999999
Q ss_pred cCC--CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEE
Q 040917 91 SGQ--PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG-VMHRDLKPENFLF 167 (494)
Q Consensus 91 ~~h--p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dikp~NIli 167 (494)
. + ..+.++++. . ..++||||++|.+|.........+....+..++.||+.++.+||+.| ++||||||+||++
T Consensus 108 ~-~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 108 Y-EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred H-hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 5 4 234444442 2 34799999999888766544556677778899999999999999999 9999999999999
Q ss_pred eeCCCCCeEEEeecCCcccc
Q 040917 168 TTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 168 ~~~~~~~~~kL~Dfg~a~~~ 187 (494)
+ .+.++|+|||.+...
T Consensus 183 ---~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 ---H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ---E-CCCEEEEEChhhhcc
Confidence 3 678999999998754
No 430
>PTZ00184 calmodulin; Provisional
Probab=99.81 E-value=5.7e-19 Score=151.57 Aligned_cols=145 Identities=37% Similarity=0.641 Sum_probs=129.9
Q ss_pred ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhH
Q 040917 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQR 409 (494)
Q Consensus 331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~ 409 (494)
..++.++.+.++..|..+|.+++|.|+..||..++..++..++.+++..+|..+|.+++|.|+|++|+..+.... ....
T Consensus 3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~ 82 (149)
T PTZ00184 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDS 82 (149)
T ss_pred CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcH
Confidence 446788899999999999999999999999999999999888888999999999999999999999998877542 2234
Q ss_pred HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
...+..+|..+|.|++|+|+.+|+..++.. .+..++.++++.++..+|.+++|.|+|+||..++..
T Consensus 83 ~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~--~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~ 148 (149)
T PTZ00184 83 EEEIKEAFKVFDRDGNGFISAAELRHVMTN--LGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMMS 148 (149)
T ss_pred HHHHHHHHHhhCCCCCCeEeHHHHHHHHHH--HCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHhc
Confidence 567899999999999999999999999998 566788999999999999999999999999988763
No 431
>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]
Probab=99.78 E-value=1.8e-18 Score=136.03 Aligned_cols=142 Identities=23% Similarity=0.418 Sum_probs=127.3
Q ss_pred CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC--CCCcccchHHHHHHHHhhh---h
Q 040917 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNGTIDYIEFITATMQRHK---L 407 (494)
Q Consensus 333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~---~ 407 (494)
+++++..+++.+|..||..+||.|+..+..++++.+|.+|++.++.+.....+.+ +-.+|+|++|+.++....+ .
T Consensus 5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q 84 (152)
T KOG0030|consen 5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQ 84 (152)
T ss_pred cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhcccc
Confidence 5677789999999999999999999999999999999999999999999888776 4578999999998776543 3
Q ss_pred hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
.+-+++-+.++.||++++|.|...||+++|.+ +|++++++|+++++.-.. |.+|.|+|+.|++-+.+
T Consensus 85 ~t~edfvegLrvFDkeg~G~i~~aeLRhvLtt--lGekl~eeEVe~Llag~e-D~nG~i~YE~fVk~i~~ 151 (152)
T KOG0030|consen 85 GTYEDFVEGLRVFDKEGNGTIMGAELRHVLTT--LGEKLTEEEVEELLAGQE-DSNGCINYEAFVKHIMS 151 (152)
T ss_pred CcHHHHHHHHHhhcccCCcceeHHHHHHHHHH--HHhhccHHHHHHHHcccc-ccCCcCcHHHHHHHHhc
Confidence 45688999999999999999999999999999 889999999999998876 88999999999986653
No 432
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.78 E-value=1.7e-18 Score=170.46 Aligned_cols=198 Identities=28% Similarity=0.402 Sum_probs=158.3
Q ss_pred HHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCce
Q 040917 88 RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGV-MHRDLKPENF 165 (494)
Q Consensus 88 ~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i-~H~dikp~NI 165 (494)
+.+ .|.|+.++++.+.++...++|.+||.-|+|.+.+.. ...++......++++|+.|+.|||...| .|+.+++.|.
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 456 499999999999999999999999999999999987 4568899999999999999999999977 9999999999
Q ss_pred EEeeCCCCCeEEEeecCCccccccC---cccccccCCcCccChhhhccc--------CCCcchhHHHHHHHHHHHhCCCC
Q 040917 166 LFTTGDENAVVKATDFGLSAFIEEG---KAYREIVGSPYYIAPEVLSQS--------YGKEADIWSAGVILYILLCGVPP 234 (494)
Q Consensus 166 li~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~--------~~~~~Di~slG~il~~l~tg~~p 234 (494)
++ +....+||.|||+....... .......-...|.|||.+.+. .+.+.|+||+|++++++++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 78999999999998765320 111112234579999998653 46789999999999999999999
Q ss_pred CCCC----ChHHHHHHHHcCCcc-CCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917 235 FWAE----TDQGVAQAILKGEIN-FQRDPF--PSISSSAIELVRRMLTQDPKRRITVAQVLE 289 (494)
Q Consensus 235 f~~~----~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 289 (494)
|... ...++...+.++... +.+..+ ...++.+..++..||..+|.+||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9652 223555666662332 332221 146678999999999999999999998754
No 433
>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]
Probab=99.77 E-value=5.6e-18 Score=146.24 Aligned_cols=158 Identities=26% Similarity=0.374 Sum_probs=135.3
Q ss_pred hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ 408 (494)
Q Consensus 330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~ 408 (494)
.+.++.++++.|++-|.. ...+|.++.++|+.++..++.... +.-...+|..+|.|+||.|+|.||+..+....+++
T Consensus 20 ~t~f~~~ei~~~Yr~Fk~--~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt 97 (193)
T KOG0044|consen 20 QTKFSKKEIQQWYRGFKN--ECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGT 97 (193)
T ss_pred hcCCCHHHHHHHHHHhcc--cCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCc
Confidence 356889999999999955 788999999999999999875333 44578899999999999999999999999988888
Q ss_pred HHHHHHHhccccccCCCCceeHHHHHHHHhhc----CC-----CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDY----GM-----GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479 (494)
Q Consensus 409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~~-----~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~ 479 (494)
..+.++.+|++||.|++|+|+++|+-.++++. +. .....++.++.+|..+|.|.||+||++||.+..+..+
T Consensus 98 ~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~ 177 (193)
T KOG0044|consen 98 LEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADP 177 (193)
T ss_pred HHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCH
Confidence 89999999999999999999999999998752 21 1344566789999999999999999999999999988
Q ss_pred ccchhhhhhh
Q 040917 480 QLRALSSRSL 489 (494)
Q Consensus 480 ~~~~~~~~~~ 489 (494)
.+..+.....
T Consensus 178 ~i~~~l~~~~ 187 (193)
T KOG0044|consen 178 SILRALEQDP 187 (193)
T ss_pred HHHHHhhhcc
Confidence 7777665543
No 434
>KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms]
Probab=99.77 E-value=2.8e-18 Score=148.31 Aligned_cols=147 Identities=27% Similarity=0.465 Sum_probs=123.0
Q ss_pred cCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc-ccchHHHHHHHHhhhhhH
Q 040917 332 NLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT-IDYIEFITATMQRHKLQR 409 (494)
Q Consensus 332 ~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~~~~~~~~~~ 409 (494)
.++.+|+.++..+|.++|.+ ++|+|+.+||..+....-.++ ..+++..+|.+++|. |+|++|+..+........
T Consensus 26 ~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~~~Np~----~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~ 101 (187)
T KOG0034|consen 26 QFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPELALNPL----ADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKAS 101 (187)
T ss_pred ccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHHhcCcH----HHHHHHHHhccCCCCccCHHHHHHHHhhhcCCcc
Confidence 38899999999999999999 999999999999995433333 457888888888888 999999999988765443
Q ss_pred -HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC------CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917 410 -FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD------ATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR 482 (494)
Q Consensus 410 -~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~------~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~ 482 (494)
.++++-||+.||.+++|+|+.+|+.+++..+ ++.. .-++.++.++.++|.++||+|+++||.+++.+.|.+.
T Consensus 102 ~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~-~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~P~~~ 180 (187)
T KOG0034|consen 102 KREKLRFAFRVYDLDGDGFISREELKQILRMM-VGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQPDLL 180 (187)
T ss_pred HHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH-HccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCccHH
Confidence 3589999999999999999999999999985 3322 2234467789999999999999999999999987654
Q ss_pred h
Q 040917 483 A 483 (494)
Q Consensus 483 ~ 483 (494)
+
T Consensus 181 ~ 181 (187)
T KOG0034|consen 181 E 181 (187)
T ss_pred H
Confidence 3
No 435
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.76 E-value=1.4e-17 Score=151.88 Aligned_cols=137 Identities=26% Similarity=0.374 Sum_probs=113.0
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
+.||+|++|.||+|.+ .|..|++|+......... .....+.+|+.++..+. ++++.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 678899998654332221 12345778999999995 888877777776677788999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
||++|++|.+.+..... ....++.+++.++.++|+.|++|||++|.||+++ .+.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999998865432 7889999999999999999999999999999994 67899999999864
No 436
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.74 E-value=8.5e-19 Score=169.25 Aligned_cols=175 Identities=29% Similarity=0.475 Sum_probs=133.9
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917 107 QFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~ 183 (494)
.+.||.|++|+..+|.+++.++. ..+......++.|+..|+.| +|.+|+|+||.||+. ..+..++|.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence 36889999999999999997543 36778889999999999999 999999999999999 5667899999999
Q ss_pred ccccccCc-------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917 184 SAFIEEGK-------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF 254 (494)
Q Consensus 184 a~~~~~~~-------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 254 (494)
........ ......||++|++||.+.+ +|+.++||||||+|++++++ -..++... .....+..+..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~i-- 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGII-- 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCC--
Confidence 87665444 3445789999999999985 69999999999999999987 22333111 11222223322
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293 (494)
Q Consensus 255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~ 293 (494)
++..+.+. +.-..|+.+|+.+.|.+||++.+.--|+|.
T Consensus 478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 21222233 334579999999999999988777777665
No 437
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.74 E-value=3.6e-17 Score=147.64 Aligned_cols=133 Identities=23% Similarity=0.335 Sum_probs=105.7
Q ss_pred eecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917 40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME 114 (494)
Q Consensus 40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e 114 (494)
.||+|++|.||+|.+ ++..|++|+......... .....+.+|+.++..+. ++++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999984 578999998654332221 12356778999999996 7766554445555666789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
|++|++|.+++..... .++.+++.++.+||+.|++|||++|.||+++ .+.++++|||.+..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 9999999988755321 7899999999999999999999999999993 67899999999865
No 438
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.73 E-value=3.8e-17 Score=147.17 Aligned_cols=140 Identities=19% Similarity=0.237 Sum_probs=107.6
Q ss_pred ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-------------------hhhHHHHHHHHHHHHHccCCC
Q 040917 34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-------------------DVEKDDVRREIEIMRHLSGQP 94 (494)
Q Consensus 34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~~hp 94 (494)
.|.+.++||+|++|.||+|.+. +|+.||+|++....... .........|..++..+. ++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 3888999999999999999875 79999999876432100 011223677888999885 65
Q ss_pred --CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917 95 --NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE 172 (494)
Q Consensus 95 --~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~ 172 (494)
.+..+++. ...++||||++|++|..... ......++.+++.++.++|+.|++||||+|+||++ +.
T Consensus 94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 34444432 34589999999998876432 13456788999999999999999999999999999 56
Q ss_pred CCeEEEeecCCccccc
Q 040917 173 NAVVKATDFGLSAFIE 188 (494)
Q Consensus 173 ~~~~kL~Dfg~a~~~~ 188 (494)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 8899999999986443
No 439
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.72 E-value=6.2e-19 Score=181.80 Aligned_cols=260 Identities=27% Similarity=0.465 Sum_probs=208.7
Q ss_pred ccceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 32 QLHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
...|.+.+.||+|+++.|-.+.... +...+|.|.+.... .......++..|..+-+.+.+|+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3578889999999999999988643 34456666654332 233445666678888888866999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEeeCCCCC-eEEEeecCCccc
Q 040917 111 IVMELCAGGELFDRI-VARG-HYSERAAASVFRVIMNVVNVCH-SKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAF 186 (494)
Q Consensus 111 iv~e~~~g~sL~~~~-~~~~-~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~ 186 (494)
+++++..|+++.+.+ .... ..+...+...+.|+..++.|+| ..++.|+||+|+|.++ +..+ .+++.|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhcc
Confidence 999999999999888 5544 6778888999999999999999 9999999999999999 5566 999999999987
Q ss_pred ccc-Cc---ccccccC-CcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCC
Q 040917 187 IEE-GK---AYREIVG-SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDP 258 (494)
Q Consensus 187 ~~~-~~---~~~~~~~-~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 258 (494)
... .. .....+| ++.|.|||...+ ...+..|+||.|+++.-+++|..|+......... .........+...+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 654 22 2234678 999999999876 3577899999999999999999998655443221 12222223334567
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
|..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999999987
No 440
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.70 E-value=1.6e-16 Score=164.67 Aligned_cols=140 Identities=19% Similarity=0.251 Sum_probs=111.1
Q ss_pred cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-----ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917 33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ 107 (494)
Q Consensus 33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~ 107 (494)
..|...+.||+|+||+||++.+. +..+++|+....... .......+.+|+.+++.++ |++++....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCC
Confidence 45567899999999999999865 344555543222111 1123456889999999995 999988777776666
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
..++||||++|++|.+++. ....++.+++.++.+||+.|++||||||+||++ .++.++|+|||++...
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCcccccC
Confidence 7889999999999998875 346789999999999999999999999999999 2567999999998753
No 441
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.68 E-value=4.3e-16 Score=139.11 Aligned_cols=140 Identities=19% Similarity=0.243 Sum_probs=99.3
Q ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHH---------------------HHHHHHHHHHccCC-C
Q 040917 37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---------------------VRREIEIMRHLSGQ-P 94 (494)
Q Consensus 37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~~h-p 94 (494)
+.+.||+|++|.||+|.+. +++.||+|++............. ...|...+.++..+ .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 89999999987543221111111 13566667776422 2
Q ss_pred CccEEeEEEEeCCeEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCC
Q 040917 95 NIVQFKAAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDE 172 (494)
Q Consensus 95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~ 172 (494)
.+.++++. ...++||||++|+++.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~- 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D- 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence 24444443 23589999999854321 111111 1 16778899999999999999 999999999999999 4
Q ss_pred CCeEEEeecCCcccc
Q 040917 173 NAVVKATDFGLSAFI 187 (494)
Q Consensus 173 ~~~~kL~Dfg~a~~~ 187 (494)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 788999999998654
No 442
>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=99.68 E-value=7.3e-16 Score=131.97 Aligned_cols=132 Identities=25% Similarity=0.340 Sum_probs=121.5
Q ss_pred HhhhhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF 417 (494)
Q Consensus 339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F 417 (494)
..+..+|+..|.|+.|.|+.+||+.+|.+. ...++.+.++-|+..+|.+.+|.|+|+||..+|.... .++.+|
T Consensus 57 ~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~------~Wr~vF 130 (221)
T KOG0037|consen 57 PQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYIN------QWRNVF 130 (221)
T ss_pred HHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHH------HHHHHH
Confidence 456788999999999999999999999965 5777889999999999999999999999999998655 799999
Q ss_pred cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
+.||.|++|.|+..||+.+|.. +|..++++-.+-+++.+|.-++|.|.+++|+.++...
T Consensus 131 ~~~D~D~SG~I~~sEL~~Al~~--~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L 189 (221)
T KOG0037|consen 131 RTYDRDRSGTIDSSELRQALTQ--LGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVL 189 (221)
T ss_pred HhcccCCCCcccHHHHHHHHHH--cCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHH
Confidence 9999999999999999999999 7889999999999999998779999999999987753
No 443
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.63 E-value=6e-15 Score=136.08 Aligned_cols=138 Identities=22% Similarity=0.322 Sum_probs=103.2
Q ss_pred eeec-ccCCeEEEEEEECCCCcEEEEEEeccCCC----------CChhhHHHHHHHHHHHHHccCCCCc--cEEeEEEEe
Q 040917 39 REVG-RGEFGITYLCTENSTGLEFACKSIPKRKL----------VKDVEKDDVRREIEIMRHLSGQPNI--VQFKAAYED 105 (494)
Q Consensus 39 ~~lg-~G~~g~Vy~a~~~~~~~~valK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~i--~~~~~~~~~ 105 (494)
..|| .||.|+||.+... +..++||.+..... ........+.+|+.++.+|. +++| +.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence 4576 8899999998864 78899998853221 11123456788999999995 7775 566665432
Q ss_pred C-C---eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 106 D-Q---FVHIVMELCAG-GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 106 ~-~---~~~iv~e~~~g-~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
. . ..++|||+++| .+|.+++.. ..++.. .+.+|+.++.+||++||+||||||.|||+ +.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence 2 2 23599999997 688887754 345554 35789999999999999999999999999 4566899999
Q ss_pred cCCcccc
Q 040917 181 FGLSAFI 187 (494)
Q Consensus 181 fg~a~~~ 187 (494)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9998753
No 444
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.62 E-value=6.4e-15 Score=126.47 Aligned_cols=133 Identities=21% Similarity=0.313 Sum_probs=111.3
Q ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeCCeEEEEEec
Q 040917 37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDDQFVHIVMEL 115 (494)
Q Consensus 37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~~~~~iv~e~ 115 (494)
+++.||+|.++.||++.... ..+++|....... ...+.+|+..++.+..+ +++++++......+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999753 7899999854331 46788999999999733 6889998888877889999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
++|+.+..+ +......++.+++.++.++|.. +++|+|++|.||+++ +.+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 998777543 5567778899999999999985 699999999999994 578899999998864
No 445
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.58 E-value=1.7e-15 Score=149.41 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=198.7
Q ss_pred ccccceEeeeeecc--cCCeEEEEEEE--CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917 30 DVQLHYTIGREVGR--GEFGITYLCTE--NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED 105 (494)
Q Consensus 30 ~~~~~y~i~~~lg~--G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~ 105 (494)
.+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... ........=.+|.....++..|++.++.+..+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCccccc
Confidence 34467888899999 99999999888 8899999999854322 2222333345677777778789999998899999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEEeeCCCC-CeEEEe
Q 040917 106 DQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMN----VVNVCHSKGVMHRDLKPENFLFTTGDEN-AVVKAT 179 (494)
Q Consensus 106 ~~~~~iv~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~----~l~~LH~~~i~H~dikp~NIli~~~~~~-~~~kL~ 179 (494)
.+..++-+|+| |.+|..+...... ++...++..+.+... ||.++|..+++|-|++|.||+. ..+ ...+++
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLT 265 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecC
Confidence 99999999999 5688887765444 888899999999999 9999999999999999999999 455 789999
Q ss_pred ecCCccccccCcccc------cccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHcCC
Q 040917 180 DFGLSAFIEEGKAYR------EIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQGVAQAILKGE 251 (494)
Q Consensus 180 Dfg~a~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~--~~~~~~~~~~~~~ 251 (494)
|||+...+..+.... ...+...|++||...+-++...|+|++|.++.+..++..+.... ...... .+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---r~-- 340 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---RQ-- 340 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---cc--
Confidence 999998776554222 12567889999999999999999999999999888776554333 111110 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295 (494)
Q Consensus 252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~ 295 (494)
...+...+...+..+...+..|+..+|-.|+++..+++++++..
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11222333455677778999999999999999999999999874
No 446
>KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism]
Probab=99.57 E-value=3.7e-14 Score=132.00 Aligned_cols=139 Identities=26% Similarity=0.420 Sum_probs=126.0
Q ss_pred chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHH
Q 040917 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFEN 412 (494)
Q Consensus 334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~ 412 (494)
..+...+++..|+.+|.+++|.++..++...+..+..+ +..+-...+|..+|.|.||.+||+||...+.... .+
T Consensus 9 ~~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~~E-----~~ 83 (463)
T KOG0036|consen 9 DEERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDNKE-----LE 83 (463)
T ss_pred cHHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHHhH-----HH
Confidence 34555689999999999999999999999999999776 6677788999999999999999999998887543 47
Q ss_pred HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479 (494)
Q Consensus 413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~ 479 (494)
+.++|+.+|.+.||.|+..|+.+.|+. +|.++++++++.++.++|+++++.|+++||...+.-.|
T Consensus 84 l~~~F~~iD~~hdG~i~~~Ei~~~l~~--~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p 148 (463)
T KOG0036|consen 84 LYRIFQSIDLEHDGKIDPNEIWRYLKD--LGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLLLYP 148 (463)
T ss_pred HHHHHhhhccccCCccCHHHHHHHHHH--hCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhhcCC
Confidence 899999999999999999999999999 67789999999999999999999999999999887665
No 447
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.51 E-value=4.3e-13 Score=118.12 Aligned_cols=143 Identities=13% Similarity=0.133 Sum_probs=103.3
Q ss_pred eeeecccCCeEEEEEEECC------CCcEEEEEEeccCCC--C-----------------ChhhHHHHH----HHHHHHH
Q 040917 38 GREVGRGEFGITYLCTENS------TGLEFACKSIPKRKL--V-----------------KDVEKDDVR----REIEIMR 88 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~------~~~~valK~~~~~~~--~-----------------~~~~~~~~~----~E~~~l~ 88 (494)
...||.|--+.||.|.... .+..+|+|+.+.+.. . .......+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357999998753211 0 011233333 8999999
Q ss_pred HccCC-CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceE
Q 040917 89 HLSGQ-PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-HSKGVMHRDLKPENFL 166 (494)
Q Consensus 89 ~l~~h-p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dikp~NIl 166 (494)
++... -+++.++++ ...++||||+.+..+..-..+...++......+..+++.++..| |+.|++||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98632 456667665 33569999997654432222233456667788899999999998 8999999999999999
Q ss_pred EeeCCCCCeEEEeecCCccccc
Q 040917 167 FTTGDENAVVKATDFGLSAFIE 188 (494)
Q Consensus 167 i~~~~~~~~~kL~Dfg~a~~~~ 188 (494)
+. ++.+.|+|||.+....
T Consensus 158 ~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE----CCcEEEEECCCceeCC
Confidence 94 4679999999987654
No 448
>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=99.46 E-value=1.4e-13 Score=125.06 Aligned_cols=135 Identities=26% Similarity=0.400 Sum_probs=111.5
Q ss_pred HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH-----H
Q 040917 337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR-----F 410 (494)
Q Consensus 337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~-----~ 410 (494)
.+.+..+.|+..|.|++|.++.+||..+|..--.+ +..--+.+.+..+|+|+||.|+++||+.-+........ .
T Consensus 161 m~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeWv~ 240 (325)
T KOG4223|consen 161 MIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEWVL 240 (325)
T ss_pred HHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCccccc
Confidence 44566788999999999999999999999875433 23445788899999999999999999998887543211 1
Q ss_pred HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHH
Q 040917 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS 473 (494)
Q Consensus 411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~ 473 (494)
.+-...|...|+|+||+++.+|++.|+.. .+....+.+++.++.+.|.|+||++|++|.+.
T Consensus 241 ~Ere~F~~~~DknkDG~L~~dEl~~WI~P--~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~ 301 (325)
T KOG4223|consen 241 TEREQFFEFRDKNKDGKLDGDELLDWILP--SEQDHAKAEARHLLHEADEDKDGKLSKEEILE 301 (325)
T ss_pred ccHHHHHHHhhcCCCCccCHHHHhcccCC--CCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence 22235666789999999999999999988 66677889999999999999999999999876
No 449
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.46 E-value=7.8e-13 Score=111.45 Aligned_cols=147 Identities=18% Similarity=0.216 Sum_probs=112.5
Q ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEe-----ccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917 37 IGREVGRGEFGITYLCTENSTGLEFACKSI-----PKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI 111 (494)
Q Consensus 37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i 111 (494)
...++-+|+-+.|+++.+. |+.++||.= ...............+|++.+.++. --.|.-..-++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 6788999999999999864 888888852 2222333445677888999999886 4466555555555556679
Q ss_pred EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 112 VMELCAG-GELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 112 v~e~~~g-~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
+|||++| .++.+++... ..........+++.|-..+.-||.++|+||||..+||++..++....+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999987 4777777543 2233444478899999999999999999999999999998777778889999999754
No 450
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.46 E-value=7.6e-13 Score=132.74 Aligned_cols=143 Identities=18% Similarity=0.205 Sum_probs=97.5
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---------------------------hh----h------HHHH
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---------------------------DV----E------KDDV 80 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---------------------------~~----~------~~~~ 80 (494)
.++||+|++|.||+|..+ +|+.||||+.+...... .. . .-++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999875 79999999986432100 00 0 0124
Q ss_pred HHHHHHHHHcc----CCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 040917 81 RREIEIMRHLS----GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMN-VVNVCHSKG 154 (494)
Q Consensus 81 ~~E~~~l~~l~----~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~-~l~~LH~~~ 154 (494)
.+|+..+.++. ++|+|.-..-+.......++||||++|++|.+..... .... ...++..++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 45666555553 3455432222222234568999999999998876432 1222 2345555555 467899999
Q ss_pred ceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 155 i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
++|+|+||.||++ ..++.++++|||++...
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeEC
Confidence 9999999999999 67789999999998654
No 451
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.45 E-value=3.1e-14 Score=147.69 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=198.7
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~ 110 (494)
-.+.+.+.+.+.+|+++.++.+.-..+|...+.|+.................+-.++-.. .+|.++...-.+......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcc
Confidence 346788888999999999999998888866666665432221111122222222222212 1455554433444556788
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc--
Q 040917 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-- 188 (494)
Q Consensus 111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-- 188 (494)
++++|..|++|...+++-+..+...+...+..+..+.++||...+.|+|++|.|.+. ...++.++.+|+......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccc
Confidence 999999999999999888878888888888889999999999999999999999999 688999999997432110
Q ss_pred -----c-----------------C--------cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917 189 -----E-----------------G--------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA 237 (494)
Q Consensus 189 -----~-----------------~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~ 237 (494)
. . .......+|+.|.+||...+ ......|+|+.|+++++.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 00112457899999998865 578899999999999999999999999
Q ss_pred CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCccCcc
Q 040917 238 ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVA---QVLEHPWLKES 296 (494)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~---eil~~~~~~~~ 296 (494)
...+.+.+.+.+.....+.-+ ...+....+++.+++..+|.+|..+. ++-.|+||+..
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred cchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999998888877666544 35678899999999999999999887 88999999863
No 452
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.45 E-value=4.9e-13 Score=135.56 Aligned_cols=158 Identities=21% Similarity=0.260 Sum_probs=100.0
Q ss_pred hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC---------------------------Ch
Q 040917 22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---------------------------KD 74 (494)
Q Consensus 22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---------------------------~~ 74 (494)
..+++..+++-..|.. ++||+|++|+||+|..+.+|+.||||+.++.... ..
T Consensus 109 ~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~ 187 (537)
T PRK04750 109 KALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPR 187 (537)
T ss_pred HHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHH
Confidence 4455555556667877 8999999999999999888999999999754200 00
Q ss_pred ----hhHHH------HHHHHHHHHHcc---CCCCccEEeEEEE-eCCeEEEEEeccCCCchHHH--HHhcC----CCCHH
Q 040917 75 ----VEKDD------VRREIEIMRHLS---GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDR--IVARG----HYSER 134 (494)
Q Consensus 75 ----~~~~~------~~~E~~~l~~l~---~hp~i~~~~~~~~-~~~~~~iv~e~~~g~sL~~~--~~~~~----~l~~~ 134 (494)
..... +.+|+..+.++. .+.+.+.+=.++. .....++||||++|+.+.+. +...+ .+...
T Consensus 188 ~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~ 267 (537)
T PRK04750 188 EVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAER 267 (537)
T ss_pred HHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHH
Confidence 01112 334555555543 1222222223332 24456799999999999764 23322 12222
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCCcccc
Q 040917 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGLSAFI 187 (494)
Q Consensus 135 ~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~a~~~ 187 (494)
.+..++.| +...|++|+|+||.||+++.+ ...+.++++|||++...
T Consensus 268 ~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 268 GVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 23333333 446899999999999999532 12349999999998654
No 453
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.43 E-value=3.1e-14 Score=129.61 Aligned_cols=238 Identities=18% Similarity=0.212 Sum_probs=154.0
Q ss_pred EEEEEEECCCCcEEEEEEeccCCCCChhhH-HHHHHHHHHHHHccCCCCccEEeEEEEeC-----CeEEEEEeccCCCch
Q 040917 48 ITYLCTENSTGLEFACKSIPKRKLVKDVEK-DDVRREIEIMRHLSGQPNIVQFKAAYEDD-----QFVHIVMELCAGGEL 121 (494)
Q Consensus 48 ~Vy~a~~~~~~~~valK~~~~~~~~~~~~~-~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-----~~~~iv~e~~~g~sL 121 (494)
.||++.++..|.+|+.-.+.-....+...+ +....-...+-++ .|.||++++.++.+. ....+++||++.|+|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 456666666666666554421111111011 1111112233445 389999999888653 357889999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---
Q 040917 122 FDRIVAR----GHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA--- 192 (494)
Q Consensus 122 ~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~--- 192 (494)
..++++. ..+......+|+.||+.||.|||+. .|+|+++....|++ ..++-+|+..-........-..
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence 9988753 3478899999999999999999987 69999999999999 6778787754322211111000
Q ss_pred --cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917 193 --YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPP-FWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268 (494)
Q Consensus 193 --~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 268 (494)
.....+-++|.+||.=. -..+.++|||++|....+|..+..- -.+.+.-..-..+.+...... ...-+.
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 01123567899998532 2456789999999999999877643 222222112122222111111 122356
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917 269 LVRRMLTQDPKRRITVAQVLEHPWLKES 296 (494)
Q Consensus 269 li~~~l~~dp~~Rps~~eil~~~~~~~~ 296 (494)
++.+|+...|..||++.+++-||.+=+.
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceeeec
Confidence 8999999999999999999999988753
No 454
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.42 E-value=2.4e-12 Score=109.22 Aligned_cols=134 Identities=24% Similarity=0.333 Sum_probs=99.3
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM 113 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~ 113 (494)
..+++|+-+.+|.+.+. |.++++|.=.+..+-. ........+|+.++.+++ .-.|....-+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 46889999999999763 5567887633222222 223455678999999886 445554444444555566999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
||++|-.|.+.+... ...+++.+-..+.-||.+||+||||.++||++. .+.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence 999998888887654 245677777888999999999999999999993 44499999999874
No 455
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.41 E-value=1.8e-12 Score=113.75 Aligned_cols=129 Identities=15% Similarity=0.152 Sum_probs=96.2
Q ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917 38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA 117 (494)
Q Consensus 38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~ 117 (494)
++.|++|.++.||++... +..|++|+...... ....+..|+.+++.+.+...+.+++.... ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 78899999754321 12346789999999863333455555443 23479999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV-----MHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
|.++... .. ....++.+++.++..||+.++ +|||++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9888643 11 123456789999999999985 9999999999994 45799999999763
No 456
>KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only]
Probab=99.33 E-value=2.6e-11 Score=96.33 Aligned_cols=150 Identities=19% Similarity=0.335 Sum_probs=110.2
Q ss_pred hhccCchhHHHhhhhhhhccCCCC-----CC------cccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHH
Q 040917 329 IVENLPTEEIQKLKEKFTEMDTDN-----SG------TLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397 (494)
Q Consensus 329 ~~~~~~~~~~~~~~~~F~~~D~~~-----~g------~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef 397 (494)
--+.|+..++-++...|..+.++- .| .++.+....+-. +..++-+. ++.+.+..||.|.++|++|
T Consensus 18 DCTFFtrKdIlrl~~Rf~~L~P~lVP~~~~~~~~~~v~vp~e~i~kMPE-Lkenpfk~---ri~e~FSeDG~GnlsfddF 93 (189)
T KOG0038|consen 18 DCTFFTRKDILRLHKRFYELAPHLVPTDMTGNRPPIVKVPFELIEKMPE-LKENPFKR---RICEVFSEDGRGNLSFDDF 93 (189)
T ss_pred ccccccHHHHHHHHHHHHHhCcccccccccCCCCCceeecHHHHhhChh-hhcChHHH---HHHHHhccCCCCcccHHHH
Confidence 345678888888888888776651 11 344444443322 23333333 4555566889999999999
Q ss_pred HHHHHHhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHH----HHHHHHhCCCCCCceeHHHHH
Q 040917 398 ITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI----KEIMSEVDRDKDGRISYDEFR 472 (494)
Q Consensus 398 ~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~----~~~~~~~d~~~dg~i~~~ef~ 472 (494)
+.+++.... .++.-.+.-||++||.|+|++|...+|...+..+.. ..++++++ ++++.+.|.||||++++.||.
T Consensus 94 lDmfSV~sE~APrdlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr-~eLs~eEv~~i~ekvieEAD~DgDgkl~~~eFe 172 (189)
T KOG0038|consen 94 LDMFSVFSEMAPRDLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTR-DELSDEEVELICEKVIEEADLDGDGKLSFAEFE 172 (189)
T ss_pred HHHHHHHHhhChHHhhhhheeEEeecCCCCcccHHHHHHHHHHHhh-ccCCHHHHHHHHHHHHHHhcCCCCCcccHHHHH
Confidence 998765432 345556788999999999999999999999998643 34666664 567999999999999999999
Q ss_pred HHHhcccccch
Q 040917 473 SMMKCGTQLRA 483 (494)
Q Consensus 473 ~~~~~~~~~~~ 483 (494)
+.+.+.|.+-.
T Consensus 173 ~~i~raPDFls 183 (189)
T KOG0038|consen 173 HVILRAPDFLS 183 (189)
T ss_pred HHHHhCcchHh
Confidence 99998887543
No 457
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.32 E-value=4.2e-11 Score=119.76 Aligned_cols=215 Identities=16% Similarity=0.195 Sum_probs=148.5
Q ss_pred EEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCC
Q 040917 51 LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130 (494)
Q Consensus 51 ~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~ 130 (494)
.|..+.++.+|.+.+++.+.- ...+...+-++-++.|+ ||+|+++++.+......|||+|.+ ..|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-
Confidence 456667899999999875542 34667788889999996 999999999999999999999998 46776776543
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-cccccCCcCccChhhh
Q 040917 131 YSERAAASVFRVIMNVVNVCH-SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPEVL 208 (494)
Q Consensus 131 l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~ 208 (494)
.....--+.||+.||.+|| ..+++|++|..+.|+| +..|..||++|..+........ .....-.-.|..|+.+
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 6677778999999999998 5689999999999999 7899999999988754322111 0111111235555543
Q ss_pred cccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH--
Q 040917 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQ-- 286 (494)
Q Consensus 209 ~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-- 286 (494)
... +-..|.|-|||++++++.|..+ ...... . ...+|.....+..+.+.-.+..||....
T Consensus 178 ~~s-~~s~D~~~Lg~li~el~ng~~~--~~~~~~------~---------~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~ 239 (690)
T KOG1243|consen 178 DPS-EWSIDSWGLGCLIEELFNGSLL--TKTDLS------N---------TGKIPKALIELYCKKLGATELKRPNKLRFI 239 (690)
T ss_pred Ccc-ccchhhhhHHHHHHHHhCcccC--cchhhh------c---------cCccchhHHHHHHHHhccccccccchhhHH
Confidence 211 1235999999999999998332 111110 0 0134445555555555556666665332
Q ss_pred --H-hcCCccCc
Q 040917 287 --V-LEHPWLKE 295 (494)
Q Consensus 287 --i-l~~~~~~~ 295 (494)
+ +-|+||++
T Consensus 240 ~~~~~~~gff~n 251 (690)
T KOG1243|consen 240 LECRLLGGFFRN 251 (690)
T ss_pred HHHHhccccccc
Confidence 2 33888875
No 458
>PLN02964 phosphatidylserine decarboxylase
Probab=99.29 E-value=1.5e-11 Score=125.57 Aligned_cols=105 Identities=19% Similarity=0.261 Sum_probs=94.0
Q ss_pred ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC-CCCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHhhh
Q 040917 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQRHK 406 (494)
Q Consensus 331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~ 406 (494)
+.+..+|++++.+.|..+|.|++|.+ +..+++.+| ..+++++ +.++|+.+|.|++|.|+|+||+.++.....
T Consensus 135 t~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~ 210 (644)
T PLN02964 135 FDFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGN 210 (644)
T ss_pred hhccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcc
Confidence 44677888999999999999999997 999999999 5888776 799999999999999999999998886544
Q ss_pred hhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917 407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439 (494)
Q Consensus 407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~ 439 (494)
....+++.++|+.||.|++|+|+.+||.+++..
T Consensus 211 ~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~ 243 (644)
T PLN02964 211 LVAANKKEELFKAADLNGDGVVTIDELAALLAL 243 (644)
T ss_pred CCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence 456778999999999999999999999999987
No 459
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.25 E-value=2.7e-09 Score=103.73 Aligned_cols=228 Identities=16% Similarity=0.203 Sum_probs=160.4
Q ss_pred cccccceEeeeeec--c-cCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-
Q 040917 29 EDVQLHYTIGREVG--R-GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE- 104 (494)
Q Consensus 29 ~~~~~~y~i~~~lg--~-G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~- 104 (494)
....+.|.-.-.+. . --..+.|+|....+|..|++|.++......... .-.-+++++++. |+||+++.+++.
T Consensus 269 p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~-h~NvV~frevf~t 344 (655)
T KOG3741|consen 269 PSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLC-HTNVVPFREVFLT 344 (655)
T ss_pred CcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhc-cCceeehhhhhhh
Confidence 33344444444433 2 246789999999999999999995444333211 223467899996 999999999886
Q ss_pred ---eCCeEEEEEeccCC-CchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917 105 ---DDQFVHIVMELCAG-GELFDRIVAR---------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF 165 (494)
Q Consensus 105 ---~~~~~~iv~e~~~g-~sL~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI 165 (494)
.+..+++|++|+++ ++|.++-... .+.++..+|.++.|+..||.++|+.|+.-+-|.|.+|
T Consensus 345 ~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 345 YTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred hccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 34578999999986 5787765322 2367899999999999999999999999999999999
Q ss_pred EEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHH-
Q 040917 166 LFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAET-DQGV- 243 (494)
Q Consensus 166 li~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~- 243 (494)
++ ..+.+++|...|........+ .+| +. --.+-|.=.||.+++.|.||..--+-.. ..+.
T Consensus 425 lv---~G~~RIriS~C~i~Dvl~~d~-----------~~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~ 486 (655)
T KOG3741|consen 425 LV---TGKMRIRISGCGIMDVLQEDP-----------TEP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH 486 (655)
T ss_pred Ee---eCcceEEEecccceeeecCCC-----------Ccc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence 99 455588888877765443332 011 10 0135689999999999999965422111 1111
Q ss_pred HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290 (494)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 290 (494)
...+ ...++.+++++|..+...++.+ -++.+++.+
T Consensus 487 ~~~I-----------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 LTRI-----------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHh-----------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1111 1357788999999999998876 788888764
No 460
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.23 E-value=1.3e-11 Score=122.23 Aligned_cols=255 Identities=20% Similarity=0.218 Sum_probs=184.4
Q ss_pred ccccccceEeeeeecccCCeEEEEEEEC-CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917 28 YEDVQLHYTIGREVGRGEFGITYLCTEN-STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD 106 (494)
Q Consensus 28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~ 106 (494)
.....++|..+..||.|.|+.|+.+..+ .++..+++|-+........ ....-..|+-+...+.-|.+++..+..|...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 4445678999999999999999987755 6788899998765443332 2333445777777777788998888888777
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
...|+=-|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+ ..+..++.|||....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhccccccccc
Confidence 777799999999988776655556888889999999999999999999999999999999953 128889999998753
Q ss_pred cccCcccccccCCcCcc-Chhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917 187 IEEGKAYREIVGSPYYI-APEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263 (494)
Q Consensus 187 ~~~~~~~~~~~~~~~y~-aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (494)
..-. .......-++. .+|++.. .+..+.|++|||..+.+..++...-+..... ..+..+.. ...+...
T Consensus 417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~~----p~~~~~~ 487 (524)
T KOG0601|consen 417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGDT----PNLPGLK 487 (524)
T ss_pred ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecccc----cCCCchH
Confidence 2111 01112233344 3565544 4677999999999999999886543222211 11111111 1123445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294 (494)
Q Consensus 264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~ 294 (494)
..+..+.+.++..++..||++.++..|+-|-
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 7788889999999999999999998876554
No 461
>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=99.22 E-value=5e-11 Score=108.55 Aligned_cols=144 Identities=22% Similarity=0.316 Sum_probs=115.6
Q ss_pred hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh--------h
Q 040917 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH--------K 406 (494)
Q Consensus 335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--------~ 406 (494)
.+...++...+..+|.+++|.|+..|++..+..........+..+-|..+|.|.||.|+|+|+...+.... .
T Consensus 73 ee~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k~~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~~~~~~~~~~~~d~ 152 (325)
T KOG4223|consen 73 EESQERLGKLVPKIDSDSDGFVTESELKAWIMQSQKKYVVEEAARRWDEYDKNKDGFITWEEYLPQTYGRVDLPDEFPDE 152 (325)
T ss_pred chhHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeHHHhhhhhhhcccCccccccc
Confidence 44567888999999999999999999999988776555666778889999999999999999998877421 0
Q ss_pred --hhH----HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917 407 --LQR----FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479 (494)
Q Consensus 407 --~~~----~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~ 479 (494)
... ...-++-|+.-|.|+||.++.+||..+|..= -...+.+-.+.+.+.+.|.|+||+|+++||+.-|.+..
T Consensus 153 e~~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPE-e~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~ 230 (325)
T KOG4223|consen 153 EDNEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPE-EHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHE 230 (325)
T ss_pred hhcHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChh-hcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhcc
Confidence 011 1234668999999999999999999999751 12345555678899999999999999999999776543
No 462
>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E ....
Probab=99.18 E-value=7e-11 Score=85.61 Aligned_cols=62 Identities=48% Similarity=0.824 Sum_probs=53.0
Q ss_pred HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCC----cHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917 412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA----TIATIKEIMSEVDRDKDGRISYDEFRSMM 475 (494)
Q Consensus 412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~----~~~~~~~~~~~~d~~~dg~i~~~ef~~~~ 475 (494)
+++++|+.+|.|++|+|+.+||..++.. .+... .++.++.++..+|.|+||.|+++||.++|
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~--~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKH--LGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHH--TTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHH--hcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 4788999999999999999999999999 44333 34456667999999999999999999875
No 463
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.15 E-value=4.1e-10 Score=103.33 Aligned_cols=143 Identities=29% Similarity=0.433 Sum_probs=104.2
Q ss_pred eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeC---CeEEEEEe
Q 040917 39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDD---QFVHIVME 114 (494)
Q Consensus 39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~---~~~~iv~e 114 (494)
+.|+.|..+.||++.... |..+++|........ .....+.+|+.+++.+..+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998653 689999997644321 1345688999999999632 3456677776553 25689999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 040917 115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS------------------------------------------ 152 (494)
Q Consensus 115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------ 152 (494)
+++|.++...+.. ..++......++.+++.++..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666667777777777777773
Q ss_pred --------------CCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 153 --------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 153 --------------~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
..++|||++|.||+++.. ..+.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999421 156789999998764
No 464
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=99.14 E-value=2.2e-09 Score=101.79 Aligned_cols=239 Identities=18% Similarity=0.192 Sum_probs=159.9
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-----E--EeCC
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA-----Y--EDDQ 107 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~-----~--~~~~ 107 (494)
-..+..||+|+.+.+|..-.- ...+.|+++..... ...+ -+..|...-+||-+..-+.+ + ....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa---~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA---AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCch---HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 346788999999999975432 23567888654421 1111 23334444456554331111 1 1223
Q ss_pred eEEEEEeccCCCc-hHHHH---Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 108 FVHIVMELCAGGE-LFDRI---VAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 108 ~~~iv~e~~~g~s-L~~~~---~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
...+.|..++|.. ...+. .++ .......+...++.++.+...||..|-+-||++++|+|+ .+++.+.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEc
Confidence 4778888887752 22221 111 235678899999999999999999999999999999999 6788999998
Q ss_pred cCCccccccCcccccccCCcCccChhhhc-cc-----CCCcchhHHHHHHHHHHHhC-CCCCCCCChH----HHHH-HHH
Q 040917 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLS-QS-----YGKEADIWSAGVILYILLCG-VPPFWAETDQ----GVAQ-AIL 248 (494)
Q Consensus 181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~-----~~~~~Di~slG~il~~l~tg-~~pf~~~~~~----~~~~-~~~ 248 (494)
-+......++......+|.+.|.+||... +. -+...|.|-||+++++++.| ++||.+.... ...+ .|.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 77665555555566678899999999876 32 46789999999999998886 8999654321 0011 111
Q ss_pred cCC-----------cc-CCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHH
Q 040917 249 KGE-----------IN-FQRDPFPSISSSAIELVRRMLTQ--DPKRRITVA 285 (494)
Q Consensus 249 ~~~-----------~~-~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~ 285 (494)
.+. .+ +...+|.-+++.+..++.+|+.. ++.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111 11 11224566899999999999974 567899874
No 465
>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13. S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu
Probab=99.10 E-value=1.5e-10 Score=87.87 Aligned_cols=68 Identities=18% Similarity=0.286 Sum_probs=60.1
Q ss_pred HHHHHHhcccccc-CCCCceeHHHHHHHHhhcCCCCCCcH-HHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 410 FENLYKAFQYFDK-DNNGYITVDELGKAFKDYGMGDDATI-ATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 410 ~~~~~~~F~~~D~-d~~G~I~~~el~~~l~~~~~~~~~~~-~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
...+..+|+.||. +++|+|+.+||+.+|..- ++..++. +++++++..+|.|+||+|+|+||..+|.+.
T Consensus 7 i~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~e-lg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l 76 (89)
T cd05022 7 IETLVSNFHKASVKGGKESLTASEFQELLTQQ-LPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGEL 76 (89)
T ss_pred HHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH-hhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 4578999999999 999999999999999871 3455677 899999999999999999999999988763
No 466
>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]
Probab=99.07 E-value=6.6e-10 Score=94.98 Aligned_cols=104 Identities=25% Similarity=0.328 Sum_probs=91.0
Q ss_pred HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC---CcHHHH
Q 040917 375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD---ATIATI 451 (494)
Q Consensus 375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~---~~~~~~ 451 (494)
.++.++|+.+|.|++|.|+-.|+-..+.......+..++..++..+|.|++|.|+..||..++........ ...+++
T Consensus 8 ~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el 87 (151)
T KOG0027|consen 8 LELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEEL 87 (151)
T ss_pred HHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHH
Confidence 46888999999999999999999998888777778889999999999999999999999999987432221 235689
Q ss_pred HHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 452 KEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 452 ~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
.++|+.+|.|++|.|+.+|+.++|+..
T Consensus 88 ~eaF~~fD~d~~G~Is~~el~~~l~~l 114 (151)
T KOG0027|consen 88 KEAFRVFDKDGDGFISASELKKVLTSL 114 (151)
T ss_pred HHHHHHHccCCCCcCcHHHHHHHHHHh
Confidence 999999999999999999999999863
No 467
>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13. S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu
Probab=99.05 E-value=4.6e-10 Score=85.28 Aligned_cols=69 Identities=19% Similarity=0.330 Sum_probs=63.0
Q ss_pred hHHHhhhhhhhccCC-CCCCcccHHHHHHHHHh-cCCCCCH-HHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917 336 EEIQKLKEKFTEMDT-DNSGTLTYDELKAGLAK-LGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 336 ~~~~~~~~~F~~~D~-~~~g~i~~~el~~~l~~-~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 404 (494)
..+..+..+|+.||. +++|+|+..||+.++.. +|..++. +++..++..+|.|+||.|+|+||+..+...
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l 76 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGEL 76 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 345678899999999 99999999999999999 8887888 899999999999999999999999887754
No 468
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=99.03 E-value=1.8e-09 Score=97.35 Aligned_cols=140 Identities=22% Similarity=0.275 Sum_probs=104.6
Q ss_pred eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC-------------------CChhhHHHHHHHHHHHHHccCC-C
Q 040917 35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-------------------VKDVEKDDVRREIEIMRHLSGQ-P 94 (494)
Q Consensus 35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~~h-p 94 (494)
+.++..||.|.-|.||.|.+. .|.++|+|.-..... .-..+.....+|..+|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567889999999999999976 699999997532110 0122345677899999999633 2
Q ss_pred CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917 95 NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA 174 (494)
Q Consensus 95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~ 174 (494)
.|++.+++ +...+|||+++|..|... +++.+....++..|++-+..+-..|++|||+++-||++ +++|
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence 45555543 345699999999766542 23466666777788888887779999999999999999 6788
Q ss_pred eEEEeecCCcccc
Q 040917 175 VVKATDFGLSAFI 187 (494)
Q Consensus 175 ~~kL~Dfg~a~~~ 187 (494)
.+.++||-.+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999887643
No 469
>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E ....
Probab=99.03 E-value=5.6e-10 Score=80.84 Aligned_cols=62 Identities=32% Similarity=0.634 Sum_probs=52.7
Q ss_pred hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHH----HHHHHHHhcCCCCCcccchHHHHHH
Q 040917 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD----VKQYMQAADIDGNGTIDYIEFITAT 401 (494)
Q Consensus 340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~----~~~~~~~~D~~~~g~i~~~ef~~~~ 401 (494)
+++++|+.+|+|++|+|+.+||..++..++...+... +..+|+.+|.|+||.|+|+||+..+
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 4788999999999999999999999999987665544 4556999999999999999998754
No 470
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.02 E-value=1.3e-08 Score=95.00 Aligned_cols=137 Identities=18% Similarity=0.129 Sum_probs=95.0
Q ss_pred eEEEEEEECCCCcEEEEEEeccCCCC---C-----hhhHHHHHHHHHHHHHccCCCCc--cEEeEEEEe-----CCeEEE
Q 040917 47 GITYLCTENSTGLEFACKSIPKRKLV---K-----DVEKDDVRREIEIMRHLSGQPNI--VQFKAAYED-----DQFVHI 111 (494)
Q Consensus 47 g~Vy~a~~~~~~~~valK~~~~~~~~---~-----~~~~~~~~~E~~~l~~l~~hp~i--~~~~~~~~~-----~~~~~i 111 (494)
..|.++.. .|+.|.||........ . ......+.+|...+.+|. .-+| +.++.+... ....++
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence 34556653 4778999976432210 0 011224778998888885 3233 233444432 235779
Q ss_pred EEeccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC----CCCCeEEEeecCCc
Q 040917 112 VMELCAGG-ELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG----DENAVVKATDFGLS 184 (494)
Q Consensus 112 v~e~~~g~-sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~----~~~~~~kL~Dfg~a 184 (494)
|||+++|. +|.+++.. ....+......++.++...+..||.+||+|+|++++|||++.+ ++...+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999885 78888754 2345667788999999999999999999999999999999631 34578999999987
Q ss_pred cc
Q 040917 185 AF 186 (494)
Q Consensus 185 ~~ 186 (494)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
No 471
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.01 E-value=3.5e-09 Score=93.12 Aligned_cols=130 Identities=20% Similarity=0.231 Sum_probs=81.8
Q ss_pred EEEEEEECCCCcEEEEEEeccCCC-----------------------CChhhHHHHHHHHHHHHHccCC-CCccEEeEEE
Q 040917 48 ITYLCTENSTGLEFACKSIPKRKL-----------------------VKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAY 103 (494)
Q Consensus 48 ~Vy~a~~~~~~~~valK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~ 103 (494)
.||.|.. ..|..+|+|+...... ..........+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888886 4578999998753211 0112235567899999999633 2466666553
Q ss_pred EeCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917 104 EDDQFVHIVMELCA--GGELFDRIVARGHYSERAAASVFRVIMNVVNV-CHSKGVMHRDLKPENFLFTTGDENAVVKATD 180 (494)
Q Consensus 104 ~~~~~~~iv~e~~~--g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~i~H~dikp~NIli~~~~~~~~~kL~D 180 (494)
.+ +|||||++ |..+.. +... .++......++.+++..+.. +|..||+||||++.||+++ . +.+.++|
T Consensus 80 --~~--~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~-~~~~iID 149 (188)
T PF01163_consen 80 --RN--VIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---D-GKVYIID 149 (188)
T ss_dssp --TT--EEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---T-TCEEE--
T ss_pred --CC--EEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---c-ceEEEEe
Confidence 33 49999998 655544 3332 12245566777888885555 6799999999999999994 3 3899999
Q ss_pred cCCccccc
Q 040917 181 FGLSAFIE 188 (494)
Q Consensus 181 fg~a~~~~ 188 (494)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987543
No 472
>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=99.00 E-value=5e-09 Score=90.38 Aligned_cols=96 Identities=29% Similarity=0.406 Sum_probs=84.4
Q ss_pred hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY 414 (494)
Q Consensus 335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 414 (494)
..-++.|+.+|+.+|+|++|.|+..||..+|..+|..++.+-...++..+|..++|.|+|++|+.++.... .+-
T Consensus 120 w~~i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~------~lt 193 (221)
T KOG0037|consen 120 WKYINQWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQ------RLT 193 (221)
T ss_pred HHHHHHHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHH------HHH
Confidence 45678899999999999999999999999999999999999999999999988899999999999988655 578
Q ss_pred HhccccccCCCCcee--HHHHHHH
Q 040917 415 KAFQYFDKDNNGYIT--VDELGKA 436 (494)
Q Consensus 415 ~~F~~~D~d~~G~I~--~~el~~~ 436 (494)
++|+.+|.+.+|.|+ .++|..+
T Consensus 194 ~~Fr~~D~~q~G~i~~~y~dfl~~ 217 (221)
T KOG0037|consen 194 EAFRRRDTAQQGSITISYDDFLQM 217 (221)
T ss_pred HHHHHhccccceeEEEeHHHHHHH
Confidence 899999999999875 4444443
No 473
>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B. S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i
Probab=99.00 E-value=1.1e-09 Score=83.31 Aligned_cols=68 Identities=16% Similarity=0.412 Sum_probs=59.6
Q ss_pred HHHHHHhccccc-cCCCC-ceeHHHHHHHHhh----cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 410 FENLYKAFQYFD-KDNNG-YITVDELGKAFKD----YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 410 ~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~----~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
...+.++|+.|| .|++| +|+.+||+.+|+. + +|...+++++++++..+|.|+||+|+|+||..++...
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~-lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~ 80 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHF-LEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV 80 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHH-hcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 457899999998 79999 6999999999997 2 3456788999999999999999999999999887653
No 474
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.00 E-value=2.2e-10 Score=115.09 Aligned_cols=150 Identities=19% Similarity=0.297 Sum_probs=109.7
Q ss_pred HHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc-----cc-----ccCCcCccChhhhcc-
Q 040917 143 IMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-----RE-----IVGSPYYIAPEVLSQ- 210 (494)
Q Consensus 143 i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~-----~~-----~~~~~~y~aPE~~~~- 210 (494)
+..|+.++|.. ++||++|.|.+|.+ +..+..||+.|+++....++..+ .. ......|.|||.+.+
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred ccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 33899999976 89999999999999 68899999999988755432111 11 123567999998875
Q ss_pred cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917 211 SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF-QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288 (494)
Q Consensus 211 ~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil 288 (494)
..+.++|++|+||++|.+.. |+..+........... ....... ....-..+|+++++-+.+++..++..||++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 46889999999999999994 5555544433222211 1111111 1111257899999999999999999999999999
Q ss_pred cCCccCcc
Q 040917 289 EHPWLKES 296 (494)
Q Consensus 289 ~~~~~~~~ 296 (494)
..|||.+.
T Consensus 264 ~~~ff~D~ 271 (700)
T KOG2137|consen 264 SIPFFSDP 271 (700)
T ss_pred cccccCCc
Confidence 99999864
No 475
>PTZ00183 centrin; Provisional
Probab=98.98 E-value=3.5e-09 Score=91.54 Aligned_cols=102 Identities=25% Similarity=0.332 Sum_probs=85.5
Q ss_pred HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917 375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454 (494)
Q Consensus 375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 454 (494)
+++..+|..+|.+++|.|+++||...+...........+..+|..+|.+++|.|+..||..++... ......++.++.+
T Consensus 17 ~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~l~~~ 95 (158)
T PTZ00183 17 KEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKK-LGERDPREEILKA 95 (158)
T ss_pred HHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH-hcCCCcHHHHHHH
Confidence 346778999999999999999998887654332345678999999999999999999999988752 2344567789999
Q ss_pred HHHhCCCCCCceeHHHHHHHHhc
Q 040917 455 MSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 455 ~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
|..+|.+++|.|+.+||..++..
T Consensus 96 F~~~D~~~~G~i~~~e~~~~l~~ 118 (158)
T PTZ00183 96 FRLFDDDKTGKISLKNLKRVAKE 118 (158)
T ss_pred HHHhCCCCCCcCcHHHHHHHHHH
Confidence 99999999999999999998874
No 476
>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]
Probab=98.98 E-value=1.4e-09 Score=94.30 Aligned_cols=105 Identities=22% Similarity=0.284 Sum_probs=87.8
Q ss_pred hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh---------
Q 040917 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH--------- 405 (494)
Q Consensus 335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--------- 405 (494)
.....-...+|..+|.|++|+|+..||..+|..+-..-.++.+.+.|+.+|.|++|.|+++|++.++....
T Consensus 60 gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~ 139 (193)
T KOG0044|consen 60 GDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALP 139 (193)
T ss_pred CCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCC
Confidence 34445677889999999999999999999998876656667788999999999999999999988765421
Q ss_pred --hhhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917 406 --KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439 (494)
Q Consensus 406 --~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~ 439 (494)
....++.+..+|+.+|.|+||.||.+||.....+
T Consensus 140 ~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~ 175 (193)
T KOG0044|consen 140 EDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKA 175 (193)
T ss_pred cccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhh
Confidence 1224567888999999999999999999988765
No 477
>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6. S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact
Probab=98.97 E-value=1.9e-09 Score=82.08 Aligned_cols=69 Identities=19% Similarity=0.407 Sum_probs=60.9
Q ss_pred HHHHHHhcccccc-CC-CCceeHHHHHHHHhh-cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 410 FENLYKAFQYFDK-DN-NGYITVDELGKAFKD-YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 410 ~~~~~~~F~~~D~-d~-~G~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
...+-.+|..||. |+ +|+|+.+||+++|+. +.+|.+.++++++++++.+|.|++|+|+|+||+.++.+-
T Consensus 9 ~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l 80 (88)
T cd05029 9 IGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL 80 (88)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence 3568889999998 77 899999999999974 236788999999999999999999999999999988753
No 478
>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B. S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i
Probab=98.95 E-value=2.6e-09 Score=81.34 Aligned_cols=68 Identities=24% Similarity=0.357 Sum_probs=62.0
Q ss_pred HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917 337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 404 (494)
-+..+..+|+.+| .+++| +|+..||+.+++. +|...+.+++.++++.+|.|++|.|+|+||+..+...
T Consensus 6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~ 80 (88)
T cd05027 6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV 80 (88)
T ss_pred HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 4567899999998 79999 6999999999999 8988899999999999999999999999999887654
No 479
>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Probab=98.94 E-value=6.5e-09 Score=87.00 Aligned_cols=106 Identities=25% Similarity=0.267 Sum_probs=90.9
Q ss_pred CCCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCC
Q 040917 370 SMLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446 (494)
Q Consensus 370 ~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~ 446 (494)
..++.++ +.+.|..+|.|++|.|++.++..++.......+...+..+|..+|. +.|.|+..+|..++... .....
T Consensus 12 ~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~-~~~~~ 89 (160)
T COG5126 12 TQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVK-LKRGD 89 (160)
T ss_pred ccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHH-hccCC
Confidence 3445544 5667888899999999999999998866666678889999999999 99999999999999874 33455
Q ss_pred cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
+++++.+.|+.+|.|+||+|+..|++..++.
T Consensus 90 ~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~ 120 (160)
T COG5126 90 KEEELREAFKLFDKDHDGYISIGELRRVLKS 120 (160)
T ss_pred cHHHHHHHHHHhCCCCCceecHHHHHHHHHh
Confidence 7889999999999999999999999999884
No 480
>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z. S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac
Probab=98.94 E-value=2.3e-09 Score=82.97 Aligned_cols=68 Identities=18% Similarity=0.456 Sum_probs=57.7
Q ss_pred HHHHHHhccccc-cCCCC-ceeHHHHHHHHhhc-C--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 410 FENLYKAFQYFD-KDNNG-YITVDELGKAFKDY-G--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 410 ~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~~-~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
...+.++|..|| .|++| +|+.+||+.++... + ++...++.++++++.++|.|+||.|+|+||..+|..
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~ 81 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAA 81 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 457888999998 78998 59999999999762 1 233457789999999999999999999999998875
No 481
>PTZ00184 calmodulin; Provisional
Probab=98.93 E-value=7.1e-09 Score=88.56 Aligned_cols=101 Identities=30% Similarity=0.319 Sum_probs=84.2
Q ss_pred HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917 376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM 455 (494)
Q Consensus 376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~ 455 (494)
.+...|..+|.+++|.|+++||...+.........+.+..+|..+|.+++|.|+.++|..++... ......+..+..+|
T Consensus 12 ~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~-~~~~~~~~~~~~~F 90 (149)
T PTZ00184 12 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARK-MKDTDSEEEIKEAF 90 (149)
T ss_pred HHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHh-ccCCcHHHHHHHHH
Confidence 46778999999999999999998877654333345678999999999999999999999998752 22234556788999
Q ss_pred HHhCCCCCCceeHHHHHHHHhc
Q 040917 456 SEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 456 ~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
..+|.+++|.|+.+||..++..
T Consensus 91 ~~~D~~~~g~i~~~e~~~~l~~ 112 (149)
T PTZ00184 91 KVFDRDGNGFISAAELRHVMTN 112 (149)
T ss_pred HhhCCCCCCeEeHHHHHHHHHH
Confidence 9999999999999999998875
No 482
>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1. S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.
Probab=98.90 E-value=3.7e-09 Score=81.97 Aligned_cols=69 Identities=22% Similarity=0.506 Sum_probs=59.3
Q ss_pred HHHHHHHhccccc-cCCCCc-eeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 409 RFENLYKAFQYFD-KDNNGY-ITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 409 ~~~~~~~~F~~~D-~d~~G~-I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
..+.++++|+.|| .|++|+ |+.+||+.+|+. +| ++...+++++++++..+|.|++|.|+|+||..++..
T Consensus 7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~ 80 (92)
T cd05025 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (92)
T ss_pred HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 3467999999997 999995 999999999975 33 233468889999999999999999999999998875
No 483
>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]
Probab=98.87 E-value=1.2e-08 Score=83.22 Aligned_cols=102 Identities=25% Similarity=0.331 Sum_probs=87.7
Q ss_pred HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917 375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454 (494)
Q Consensus 375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 454 (494)
.++...|..+|.+++|.|+++|+-..+....-..+.+++..+..-+|++++|+|+.++|.+.+... ++..-+.+++..+
T Consensus 33 q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k-~~e~dt~eEi~~a 111 (172)
T KOG0028|consen 33 QEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVK-LGERDTKEEIKKA 111 (172)
T ss_pred hhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHH-HhccCcHHHHHHH
Confidence 458889999999999999999996666554444566788999999999999999999999998753 4444589999999
Q ss_pred HHHhCCCCCCceeHHHHHHHHhc
Q 040917 455 MSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 455 ~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
|+.+|.|++|+|+..+|..++..
T Consensus 112 frl~D~D~~Gkis~~~lkrvake 134 (172)
T KOG0028|consen 112 FRLFDDDKTGKISQRNLKRVAKE 134 (172)
T ss_pred HHcccccCCCCcCHHHHHHHHHH
Confidence 99999999999999999998886
No 484
>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10. S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.
Probab=98.87 E-value=3.5e-09 Score=82.38 Aligned_cols=70 Identities=21% Similarity=0.494 Sum_probs=60.3
Q ss_pred HHHHHHhcccccc-CC-CCceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917 410 FENLYKAFQYFDK-DN-NGYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479 (494)
Q Consensus 410 ~~~~~~~F~~~D~-d~-~G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~ 479 (494)
...++.+|..||. |+ +|+|+.+||+.+|.. +| +|...++++++.++..+|.|++|.|+|+||+.++....
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~ 81 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLS 81 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 4578999999997 97 699999999999985 22 35577889999999999999999999999999887543
No 485
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.86 E-value=5.2e-08 Score=87.97 Aligned_cols=111 Identities=19% Similarity=0.264 Sum_probs=85.6
Q ss_pred hHHHHHHHHHHHHHccCCCC--ccEEeEEEEeC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 040917 76 EKDDVRREIEIMRHLSGQPN--IVQFKAAYEDD----QFVHIVMELCAGG-ELFDRIVARGHYSERAAASVFRVIMNVVN 148 (494)
Q Consensus 76 ~~~~~~~E~~~l~~l~~hp~--i~~~~~~~~~~----~~~~iv~e~~~g~-sL~~~~~~~~~l~~~~~~~i~~~i~~~l~ 148 (494)
......+|...+..|. .-+ +++++.+.... ...++|+|+++|. +|.+++.....++......++.++...+.
T Consensus 54 ~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 3456778888888775 323 34455555432 2457999999884 78888877555778888999999999999
Q ss_pred HHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187 (494)
Q Consensus 149 ~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~ 187 (494)
-||.+||+|+|++|.|||++.++....+.|+||+-+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999975444568999999987643
No 486
>smart00027 EH Eps15 homology domain. Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.
Probab=98.85 E-value=1.2e-08 Score=79.72 Aligned_cols=70 Identities=30% Similarity=0.383 Sum_probs=63.9
Q ss_pred CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 404 (494)
++.+++..+...|..+|.+++|.|+.+|+..+++..+ ++.+++.+++..+|.+++|.|+|+||+.++...
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~ 73 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHLI 73 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHH
Confidence 4678899999999999999999999999999999975 678889999999999999999999999877653
No 487
>PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A ....
Probab=98.82 E-value=1.5e-08 Score=69.86 Aligned_cols=52 Identities=37% Similarity=0.606 Sum_probs=47.7
Q ss_pred CCCceeHHHHHHHHhhcCCCCC-CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 424 NNGYITVDELGKAFKDYGMGDD-ATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 424 ~~G~I~~~el~~~l~~~~~~~~-~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
++|.|+.++|+.+|.. +|.. +++++++.++..+|.|++|.|+|+||..+++.
T Consensus 1 ~~G~i~~~~~~~~l~~--~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~~ 53 (54)
T PF13833_consen 1 KDGKITREEFRRALSK--LGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQR 53 (54)
T ss_dssp SSSEEEHHHHHHHHHH--TTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHHH
T ss_pred CcCEECHHHHHHHHHH--hCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Confidence 4799999999999987 5666 99999999999999999999999999998874
No 488
>KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms]
Probab=98.81 E-value=4.6e-08 Score=92.29 Aligned_cols=136 Identities=24% Similarity=0.368 Sum_probs=104.3
Q ss_pred HhhhhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh----h------
Q 040917 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK----L------ 407 (494)
Q Consensus 339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~----~------ 407 (494)
..+.+.|+.+|.+.+|+|+..+...++..+ |.++.=--+..-. ...+.||.|.|.+.+..+..... .
T Consensus 464 sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LPWr~L~~kl--a~~s~d~~v~Y~~~~~~l~~e~~~~ea~~slvet 541 (631)
T KOG0377|consen 464 SDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLPWRLLRPKL--ANGSDDGKVEYKSTLDNLDTEVILEEAGSSLVET 541 (631)
T ss_pred hHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCcHHHhhhhc--cCCCcCcceehHhHHHHhhhhhHHHHHHhHHHHH
Confidence 457889999999999999999999999885 5555532222212 23456788999887765432111 0
Q ss_pred --hHHHHHHHhccccccCCCCceeHHHHHHHHhhcC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917 408 --QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476 (494)
Q Consensus 408 --~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~ 476 (494)
-....+..+|+++|.|++|.|+.+||+.+..-++ +....+.+++.++-+.+|.|+||.|++.||++.+.
T Consensus 542 LYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~IDlNEfLeAFr 614 (631)
T KOG0377|consen 542 LYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKIDLNEFLEAFR 614 (631)
T ss_pred HHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCcccHHHHHHHHh
Confidence 1234578899999999999999999999887532 33567888999999999999999999999999876
No 489
>PLN02964 phosphatidylserine decarboxylase
Probab=98.81 E-value=1.5e-08 Score=103.98 Aligned_cols=127 Identities=13% Similarity=0.152 Sum_probs=91.9
Q ss_pred hhhccCCCCCCcccHHHHHHHHHhcCCCC---CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH---HHHHHhc
Q 040917 344 KFTEMDTDNSGTLTYDELKAGLAKLGSML---TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF---ENLYKAF 417 (494)
Q Consensus 344 ~F~~~D~~~~g~i~~~el~~~l~~~~~~~---~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~---~~~~~~F 417 (494)
.|+.+|+++ ++.+++......-...+ ..+++.+.|..+|.|++|.+ ....+..+.. ...++ ..+..+|
T Consensus 112 ~~~~~~~~~---~s~n~lv~~~e~~~t~f~~kqi~elkeaF~lfD~dgdG~i-Lg~ilrslG~--~~pte~e~~fi~~mf 185 (644)
T PLN02964 112 RISVFETNR---LSKNTLVGYCELDLFDFVTQEPESACESFDLLDPSSSNKV-VGSIFVSCSI--EDPVETERSFARRIL 185 (644)
T ss_pred EEEEEecCC---CCHHHhhhheeecHhhccHHHHHHHHHHHHHHCCCCCCcC-HHHHHHHhCC--CCCCHHHHHHHHHHH
Confidence 566677554 44555554433311112 22457888999999999997 3333222221 11222 2389999
Q ss_pred cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917 418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478 (494)
Q Consensus 418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~ 478 (494)
+.+|.|++|.|+.+||..++.. ++...+++++.++|..+|.|++|.|+++||..+++..
T Consensus 186 ~~~D~DgdG~IdfdEFl~lL~~--lg~~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~~ 244 (644)
T PLN02964 186 AIVDYDEDGQLSFSEFSDLIKA--FGNLVAANKKEELFKAADLNGDGVVTIDELAALLALQ 244 (644)
T ss_pred HHhCCCCCCeEcHHHHHHHHHH--hccCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhc
Confidence 9999999999999999999998 5566788999999999999999999999999998874
No 490
>PRK09902 hypothetical protein; Provisional
Probab=98.80 E-value=2.3e-07 Score=82.09 Aligned_cols=140 Identities=16% Similarity=0.155 Sum_probs=100.4
Q ss_pred cccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE---e--CCeEEE
Q 040917 42 GRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE---D--DQFVHI 111 (494)
Q Consensus 42 g~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~---~--~~~~~i 111 (494)
|.||-|-|+..... |+.+-+|.-......+ +.....+.+|...+.+|. +-| +.++. ++. . .-..+|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence 46899999987643 4468888764221111 335788999999999886 223 44444 222 1 224679
Q ss_pred EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917 112 VMELCAG-GELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186 (494)
Q Consensus 112 v~e~~~g-~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~ 186 (494)
|+|-+.| .+|.+++... .+++......++.++..++.-||+.|+.|+|+.+.||+++.++ ...+.++||.-+..
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 9997754 5887777553 3457777889999999999999999999999999999995322 34599999987653
No 491
>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10. S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.
Probab=98.80 E-value=2.1e-08 Score=77.99 Aligned_cols=68 Identities=24% Similarity=0.365 Sum_probs=60.1
Q ss_pred HHhhhhhhhccCC-CC-CCcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917 338 IQKLKEKFTEMDT-DN-SGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH 405 (494)
Q Consensus 338 ~~~~~~~F~~~D~-~~-~g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 405 (494)
...+..+|..+|. |+ +|+|+..||..+++. +|..++.+++..+++.+|.+++|.|+|+||+.++....
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~ 81 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLS 81 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 4568899999997 97 799999999999986 46678889999999999999999999999998877543
No 492
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.79 E-value=9.7e-08 Score=84.70 Aligned_cols=141 Identities=19% Similarity=0.180 Sum_probs=92.4
Q ss_pred cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhH------HHHHHHHHHHHHcc--CCCCccEEeEE
Q 040917 31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK------DDVRREIEIMRHLS--GQPNIVQFKAA 102 (494)
Q Consensus 31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~hp~i~~~~~~ 102 (494)
+.++|++.+.+.......|.+.. ..|+.+++|......--..... +...+++..+.+++ +.-....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34789999999998888888877 4588999999864331111111 11234444444443 12222222222
Q ss_pred E-----EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917 103 Y-----EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK 177 (494)
Q Consensus 103 ~-----~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k 177 (494)
. ......+++|||++|..|.+... +++ .+...+..++.-||+.|+.|||.+|.|+++. ++.++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEE
Confidence 1 22345668999999988866431 222 2445677788999999999999999999993 44599
Q ss_pred EeecCCcc
Q 040917 178 ATDFGLSA 185 (494)
Q Consensus 178 L~Dfg~a~ 185 (494)
++|++...
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99997754
No 493
>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z. S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac
Probab=98.79 E-value=1.9e-08 Score=77.85 Aligned_cols=69 Identities=22% Similarity=0.317 Sum_probs=58.4
Q ss_pred HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-c----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917 337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-L----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH 405 (494)
Q Consensus 337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-~----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 405 (494)
-+..+.++|+.|| .|++| +|+.+||+.++.. + ....+..++.++++.+|.|+||.|+|+||+..+....
T Consensus 8 a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~ 83 (93)
T cd05026 8 AMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALT 83 (93)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Confidence 4567888899999 78998 5999999999977 2 3344778899999999999999999999999877543
No 494
>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6. S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact
Probab=98.79 E-value=2.2e-08 Score=76.22 Aligned_cols=69 Identities=23% Similarity=0.368 Sum_probs=61.0
Q ss_pred hHHHhhhhhhhccCC-CC-CCcccHHHHHHHHHh---cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917 336 EEIQKLKEKFTEMDT-DN-SGTLTYDELKAGLAK---LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 336 ~~~~~~~~~F~~~D~-~~-~g~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 404 (494)
+.+..+-..|..+|. ++ +|+|+.+||..++.. +|..++.+++.++++.+|.|++|.|+|+||+..+...
T Consensus 7 ~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l 80 (88)
T cd05029 7 QAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL 80 (88)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence 455677889999998 67 899999999999973 6888999999999999999999999999999877653
No 495
>cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11. S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S
Probab=98.77 E-value=2.2e-08 Score=76.35 Aligned_cols=69 Identities=19% Similarity=0.333 Sum_probs=57.9
Q ss_pred HHHHHHHhccc-cccCCCC-ceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 409 RFENLYKAFQY-FDKDNNG-YITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 409 ~~~~~~~~F~~-~D~d~~G-~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
....+..+|+. +|.|++| +|+.+||+.++.... ++....+.++++++..+|.|+||+|+|+||..+|..
T Consensus 7 ~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~ 80 (89)
T cd05023 7 CIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGG 80 (89)
T ss_pred HHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence 34578899998 7788876 999999999998731 134556789999999999999999999999998775
No 496
>cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction. The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs.
Probab=98.76 E-value=1.9e-08 Score=72.99 Aligned_cols=60 Identities=28% Similarity=0.444 Sum_probs=54.3
Q ss_pred HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
+++|..+|.|++|.|+.+|+..++... | .+++++++++..+|.+++|.|+++||+.++..
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~--g--~~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~ 61 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKS--G--LPRSVLAQIWDLADTDKDGKLDKEEFAIAMHL 61 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHc--C--CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 568999999999999999999999984 3 37888999999999999999999999998864
No 497
>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1. S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.
Probab=98.75 E-value=3.8e-08 Score=76.25 Aligned_cols=69 Identities=23% Similarity=0.361 Sum_probs=59.5
Q ss_pred HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-cC----CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917 337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-LG----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH 405 (494)
Q Consensus 337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~ 405 (494)
-...+.++|+.+| .+++| +|+..||..+++. +| ..++.+++.++++.+|.|++|.|+|+||+..+....
T Consensus 7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~ 82 (92)
T cd05025 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (92)
T ss_pred HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 3467899999997 99999 4999999999986 43 456888999999999999999999999998877544
No 498
>smart00027 EH Eps15 homology domain. Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.
Probab=98.74 E-value=3.6e-08 Score=77.07 Aligned_cols=65 Identities=23% Similarity=0.328 Sum_probs=58.2
Q ss_pred HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477 (494)
Q Consensus 409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~ 477 (494)
....+..+|..+|.|++|.|+.+|++.++...+ .+++++++++..+|.+++|.|+++||+.++..
T Consensus 8 ~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~----~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~ 72 (96)
T smart00027 8 DKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG----LPQTLLAKIWNLADIDNDGELDKDEFALAMHL 72 (96)
T ss_pred HHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC----CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHH
Confidence 345789999999999999999999999999843 57889999999999999999999999987764
No 499
>cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif. Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th
Probab=98.74 E-value=2.7e-08 Score=76.45 Aligned_cols=70 Identities=24% Similarity=0.404 Sum_probs=61.8
Q ss_pred hhHHHhhhhhhhccCC--CCCCcccHHHHHHHHHh-cCCCC----CHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917 335 TEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAK-LGSML----TEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 335 ~~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~-~~~~~----~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 404 (494)
.++++.++..|..+|+ +++|+|+..+|..+++. +|..+ +.+++..++..+|.+++|.|+|++|+..+...
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~ 80 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKL 80 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHH
Confidence 5678889999999999 89999999999999986 55443 58899999999999999999999999987754
No 500
>KOG2562 consensus Protein phosphatase 2 regulatory subunit [RNA processing and modification]
Probab=98.73 E-value=7.1e-08 Score=92.12 Aligned_cols=145 Identities=20% Similarity=0.300 Sum_probs=113.5
Q ss_pred hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh----cCCCCCcccchHHHHHHHHh
Q 040917 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA----DIDGNGTIDYIEFITATMQR 404 (494)
Q Consensus 329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~----D~~~~g~i~~~ef~~~~~~~ 404 (494)
..+.|+-+.-..++-.|-.+|+|+||.|+.++|...-...+ +.--++++|... =.-.+|+++|++|+-.+...
T Consensus 268 ~~~~FS~e~f~viy~kFweLD~Dhd~lidk~~L~ry~d~tl---t~~ivdRIFs~v~r~~~~~~eGrmdykdFv~FilA~ 344 (493)
T KOG2562|consen 268 VTRYFSYEHFYVIYCKFWELDTDHDGLIDKEDLKRYGDHTL---TERIVDRIFSQVPRGFTVKVEGRMDYKDFVDFILAE 344 (493)
T ss_pred hhhheeHHHHHHHHHHHhhhccccccccCHHHHHHHhccch---hhHHHHHHHhhccccceeeecCcccHHHHHHHHHHh
Confidence 34556677777788889999999999999999988766543 455578999933 34579999999999888776
Q ss_pred hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhh-------cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917 405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD-------YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476 (494)
Q Consensus 405 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~-------~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~ 476 (494)
....+..-+.-+|+.+|.+++|.|+..|++-+... ++...-.-++.+.+++..+-+-..++|+.++|.+.=+
T Consensus 345 e~k~t~~SleYwFrclDld~~G~Lt~~el~~fyeeq~~rm~~~~~e~l~fed~l~qi~DMvkP~~~~kItLqDlk~skl 423 (493)
T KOG2562|consen 345 EDKDTPASLEYWFRCLDLDGDGILTLNELRYFYEEQLQRMECMGQEALPFEDALCQIRDMVKPEDENKITLQDLKGSKL 423 (493)
T ss_pred ccCCCccchhhheeeeeccCCCcccHHHHHHHHHHHHHHHHhcCCCcccHHHHHHHHHHHhCccCCCceeHHHHhhccc
Confidence 66556677899999999999999999999887764 3333333355567888888888889999999988433
Done!